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ABSTRACT
Embryonic development is regulated by a number of signalling pathways, \\ hich are
critical for normal growth. Many of these genes then continue to play an important role
in the regulation of cell growth and differentiation in adult. One such pathway is the
sonic hedgehog (SHH) pathway; SHH protein is secreted which binds to its receptor
patched (PTCH), leading to the activation and repression of target genes via zinc-finger
GLI family transcription factors. Deregulation of this pathway, leads to a number of
human birth defects and diseases such as Basal Cell Carcinoma (BCC) of the skin. In
transgenic mouse model systems activation of GLI1 by SHH-signalling is a key step in
initiating BCC formation. However, there is limited understanding of the molecular
mechanisms involved in response to hedgehog signalling and GLI activity in human
BCC formation and how this pathway interacts with other pathways. The aim of this
thesis was to establish in vitro and in vivo model systems to investigate the molecular
events leading to BCC formation. I have shown that Gl.Il , Gi12, Gi13, PTCH, SMO
and KlF4 were induced and a-TUB was repressed in BCC relative to normal skin. Using
an in vitro model I further showed that Gl.ll , Gi12, Gi13, PTCH, SMO and a-TUB
were induced and KlF4 was repressed in GLII expressing keratinocytes. Collaborative
work with Dr Fritz Aberger's laboratory in Salzburg showed that Gl.Il and FOXEI are
direct targets of GLI2 and I showed that Gl.I? and FOXEI were expressed in the
interfollicular epidermis and the outer root sheath of hair follicles in normal skin as well
as in BCC tumour islands suggesting a possible link between hair follicle and BCe. I
further showed that epidermal growth factor (EGF) signalling reduces transcription
activity of GLI 1 by shuttling GLII out of nucleus and altering the expression of PTCH,
SMO, Gil2 and Gl.B SHH genes. In addition, I demonstrated that whilst EGF induced
Vimentin and Snail2 expression and GLII repressed their expression suggesting that
GLI is able to counter epithelial-mesenchymal transition associated with EGF and this
may in part explain why Bee very rarely metastasise. Furthermore, GLI1 appears to
upregulate stem cell like signature and EGF downregulates this signature. Finally, we
were able to generate a KRTI4- Floxed-GFP-Gill transgenic mouse but were unable to
activate the target gene (KRTI4-GFP-GiIl). In conclusion, I have identified possible
targets of GLI activity and shown interactions between EGF signalling and GLI that
will help us to understand the potential molecular actions of SHH signalling with the
goal of developing better therapeutic strategies.
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1.1.0 Structure of skin
The integumentary system consists of skin together with its appendages; hair follicles.
apocrine sebaceous and sweat glands and nails. A diagrammatical representation of the
structure of skin is given in Figure 1.1. The skin covers the entire body and is the
largest organ of the body making up in total about 160/0 of normal bodx weight. Its
. '-'
function is to act as a barrier to physical, biological and chemical agents, as well as to
ultraviolet (UV) radiation. The barrier function also prevents dehydration by controlling
loss and gain of fluid. Other functions include sensory and thermoregulatory roles.
vitam in 0 synthesis, immune surveillance, excretion of wastes through sweat glands.
sociosexual communication and reproduction, by virtue of its appearance and smell (e.g.
hormones and pheromones). The skin consists of two layers epidermis and dermis
during embryogenesis epidermis is derived from the ectoderm and the dermis from the
mesoderm and these two layers are firmly attached to each other. Skin is also classified
according to thickness of the epidermis, thick or thin. Thick skin covers palms and soles
and has sweat glands, erector pili muscles, and sebaceous glands, but lacks hair
follicles. Thin skin covers most of the body contains hair follicles, erector pili muscles.
sweat glands, and sebaceous glands.
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Figure 1.1: Diagrammatic representation of the structure of human skin and it
appendages, image was obtained from
http: //www.healthandage.comlhtml/artpopup/skin l .htm.
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1.1.1 The epidermis.
The epidermis is the major protective layer 80% of which consists of keratinocy tes and
the rest consists of; Melanocytes which produce melanin and contributes to skin colour
to provide UV protection, Dendritic (Langerhans) cells are involved in the epidermal
immune system, Merkel cells have a sensory function. Keratinocytes proliferate and
differentiate from the basal layer and rise to the surface forming different sub layers.
The four main layers of epidermis are stratum basal, stratum spinosum, stratum
granulosum and stratum corneum (Figure 1.2) reviewed in (Watt, 1989). Thick skin has
a fifth layer called the stratum lucidum which is found between the stratum granulosum
and the stratum corneum. These layers reflect the sequential differentiation of
keratinocytes. As keratinocytes migrate from the basal layer to the outermost cornified
layer, they are committed to terminal differentiation and lose the ability to proliferate
and are shed from the surface as dead cells. The process of terminal differentiation
involves a series of biochemical and morphological changes, which result in the
production of anucleated cornified keratinocytes that form the stratum corneum.
The stratum basal layer has a single layer of cells attached to the basement membrane
by adheren junctions these consist of hemidesmosomes that containing integrins and
desmosomes containing cadherins. The majority of cells in this layer are mitotically
active and are involved in continual renewal of the epidermis. These mitotically active
cells derive from a population of putative stem cells that are thought to reside in the
deep ridges of the skin and at the tips of the dermal papillae in interfollicular epidermis
(Jensen et al., 1999) or in the bulge region of the outer root sheath (ORS) of adult
human hair follicles in hairy skin (Cotsarelis et aI., 1990; Lyle et aI., 1998b). Basal cells
contain cytokeratins organised in bundles around the periphery of the nucleus and
attached to desmosomes.
The stratum spinosum layer consists of several layers of irregularly shaped cells that
display spiky projections. As cells from the basal layer loose contact with the basement
membrane and are subsequently pushed up to form the stratum spinosum layer. some
cells remain mitotically active and become progressively flattened. :\s they I1lU\-: up
wards they start to acquire lamellar granules which contain epidermal lipids r-:"11l)l1sibk
for the barrier properties of the stratified corneum and more desmosome- for stronger
cell to cell adhesion.
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The stratum granulosum layer comprises of three to five layers of flattened cells which
have lamellar granules containing lipids and keratohyalin granules within the
cytoplasm. Keratohyalin granules contain pro-filaggrin, a precursor of filaggrin that
bundles the keratin filaments together.
The stratum lucidum layer has several layers of flattened cells without nuclei and
organelles, and these cells have keratin rich cytoplasm.
The stratum corneum layer consists of dead keratinised cells called squames or
corneocytes. Keratin filaments polymerise by forming strong disulphide bonds.
Filaggrin, a protein component of the keratohyalin granule is involved in this process.
The cornified envelope forms due to the catalytic activity of the enzyme
transglutaminase which crosslinks proteins such as involucrin (an insoluble cysteine
rich protein) in the plasma membrane. Other proteins found as components of the
cornified cell envelope include keratolinin, loricrin, small proline-rich proteins, the
serine proteinase inhibitor elafin, filaggrin linker-segment peptide, and envoplakin.
Lipids discharged by lamellar granules fill the intercellular spaces which contribute to
the barrier properties of the epidermis. The lack of desmosomes in the cells that are
closest to the outermost layer results in shedding of corneocytes from the skin
(Latkowski, 1999).
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Figure 1.2: Haematoxylin Eosin (H & E) staining of thin skin indicating different
compartments of skin and hair follicle. (A) Showing the epidermis, dennis, hypodenni ,
erector pili muscle and hair follicles . (B) Different layers of the epidermis; stratuem ba ale,
stratum spinosum, stratum granulosum and stratum corneum. (C) Different regions of hair
follicle ; dennal papilla, bulb , inner & outer root sheath, dennal sheath and hair ( lornianka,
2002 http: //www.lab.anhb.uwa.edu.au/mb140/CorePages/Integumentary/Integum.htm).
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1.1.2 Keratins.
The cytoskeleton of all epithelial cells is formed from three groups of filaments. actin
(microfilaments), tubulin (microtubules) and intermediate filaments. Keratins belong to
the intermediate filament group of proteins. Recent genomic analysis has determined
that there are total of 54 functional keratin genes of which 28 are type I keratins (acidic)
and 26 type II keratins. Example of type I keratins are keratin K9 (K9) to K20. and t) pe
II keratins are K1 to K8 (Hesse et aI., 2001; Hesse et a\., 2004; Moll et al., 1982; Rogers
et a\., 2005; Rogers et aI., 2004; Smack et a\., 1994). In most cases type I and type II
keratin subunits pair up and form heterodimers which are expressed according to
epithelial type and in a differentiation-specific manner. For example, in simple epithelia.
K8 and K18 are expressed and in basal layer of stratified epithelia K5 and K1.+ are
expressed. The differentiating suprabasal layers are characterised by expression of
keratin K1 and keratin K10 pair, whereas, keratin K6 and keratin K16 are not expressed
in normal epidermis except in the outer root sheath (ORS) of hair follicle and junctional
region of sublayers (Wilson et aI., 1994). K6 and K16 pair is also constitutively
expressed in certain stratified squamous mucosal epithelia and in the skin of palm and
sole (Morgan et aI., 1987). Expression of K6 and K16 is induced in wound healing
epidermis, hyperproliferative epidermis such as psoriasis, squamous cell carcinomas
and hypertrophic scarring (Machesney et al., 1998). Therefore, keratin expression has
been used as specific epithelial cell marker to assess epithelial proliferation and
differentiation (see figure Figure 1.3 for expression profile of different keratins in
normal skin).
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1.1.3 The dermis.
Derm is consists mostly of fibroelastic connective tissue composed of extracellular
matrix (ECM, see section 1.1.5) and is much thicker than the epidermis and is irregular
in shape. It is mostly composed of interwoven type I collagen with some type I \I
collagen which provides the skin with its mechanical, tensile strength. Dermis is
subdivided into superficial papillary dermis, which is in contact with the epiderm is. and
deep reticular dermis. Superficial papillary dermis is loosely woven and interdigitates
with the epidermal ridges along the dermo-epidermal junction and contains thinner and
more loosely arranged collagen and elastin fibres. The reticular dermis contains more
tightly bound collagen fibres. At the arbitrary plane of this division there are sub-
papillary plexus of blood vessels which supplies the avascular epidermis \\ ith nutrients.
Other ECM material making up the dermis consists of an amorphous substance that is
made up of glycosaminoglycans (GAGs) namely, hyaluronic acid, derrnatan sulphate,
chondroitin-6-sulphate, chondroitin-4-sulphate, and heparin sulphate. Dermis also
contains; Sweat Gland, Sebaceous Gland (see section 1.1.11), Hair Follicle. Meissner's
corpuscles, Pacinian corpuscles and free nerve endings that pass through the dermis and
often extend into the underlying subcutaneous fat. Sweat Glands consist of a single
tube, a coiled body and a superficial duct. They are involved in thermoregulation, as
they cool the skin by producing sweat. Hair follicles generate from the epidermal tissue
growing downward into the dermis and produce hair. Different structural areas of hair
follicle can be seen in Figure 1.1 and Figure 1.5). Erector pili muscle is attached to the
base of the hair follicle (Figure 1.1 and Figure 1.2). Cold or fright stimulates the
muscle to contract and pulls the hair follicle up, causing it to stand up right. vlcissner's
corpuscles are receptors that detect light touch and soft, fleeting movements. Pacinian
corpuscles function as receptors for deep pressure and vibration. Free nerve endings are
sensitive to pain, temperature changes and itchiness.
The subcutaneous layer is below the dermis, it consists of IUllSC connectiv c tissue and
fat (Figure 1.1 and 1.2). It acts as a protective cushion and helps to insulate the body by
monitoring heat gain and heat loss. Not all authors consider this layer a part or the skin.
but it definitely has a strong impact on the \\ay the skin looks.
The cell types found in the dennis include fibroblasts. macrophage- and ma-: cells
( . . d i 'H ke 1999) The predominant cell type of the dermis is the fibroblast.rcvicwc In \ aa.· .
.'~
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These cells synthesise and degrade connective tissue matrix proteins and a number of
proteins that provide structural ECM and basement membrane framework inv olved in
dermal modelling (Sorrell and Caplan, 2004; Wang et aI., 2004). Fibroblasts migrate on
and between the surfaces of collagen fibre bundles and promote the interaction between
epidermis and dermis by synthesising growth factors/cytokines include the keratinocy k
growth factor (KGF) 1 and 2, transforming growth factor-B I (TGF-~ I), platelet derived
growth factor-A (PDGF-A), vascular endothelial growth factor (VEGF) and
granulocyte/macrophage colony-stimulating factor (GM-CSF) (Maas-Szabowski and
Fusenig, 1996; Smola et aI., 1993) that are important in the regulation of normal skin
physiology as well as in wound healing. This suggests that fibroblasts engage in
paracrine and autocrine interactions in skin. Fibroblasts also exist as a highly diverse
population (Sempowski et aI., 1995). For example, the papillary dermis and reticular
dermis have distinct fibroblast subpopulations with different characteristics (Sorrell et
aI., 2004).
1.1.4 The basement membrane zone dermal epidermal junction.
The basement membrane zone is at the interface between the epidermis and the dermis
and its function is to strongly attach these two layers together and supports the avascular
epidermis. Four layers have been identified within the basement membrane zone, these
layers are; 1) The plasma membrane of the basal keratinocyte, which is penetrated b)
hemidesmosomes, 2) The lamina lucida that contains laminin, bullous pemphigoid
glycoprotein, anchoring filaments and sub-basal dense plates, 3) The lamina densa that
contains collagen type IV and proteoglycans. 4) The collagen type VII rich-lamina
fibroreticularis that contains anchoring fibrils (Figure 1""). Fibroblasts and or
keratinocytes are capable of synthesising many of the components of the basement
membrane zone (McKay et aI., 1994). However, the combination of both cell types
leads to the correct assembly of the basement membrane zone (Bohnert et al.. 1986).
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Figure 1.4: The different layers of the basement membrane zone at the dermal-epidermal
junction (IBC Ltd, USA "Bioengineering of Skin Substitutes" handbook September 1997).
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1.1.5 Extracellular matrix.
The extracellular matrix (ECM) is also known as the connective tissue or mesenchyme.
ECM is composed of a mixture of proteins and polysaccharides in which cells arc
embedded. The two main classes of extracellular macromolecules are structural and
adhesive proteins and proteoglycans. Within the structural proteins it is collagen that is
the most abundant ECM component that provides tensile strength and helps to organise
the matrix. In the dermis matrix macromolecules are secreted and oriented largely by
fibroblasts. ECM degradation and remodeling appears to be tightly controlled (Alberts,
2002). Elastin, another structural protein, functions to give resil ience to the matrix. The
adhesive proteins link components of the ECM both to one another and to the surfaces
of cells. For example, laminin, an adhesive protein, promotes the attachment of
epithelial cells to the basement membrane and; fibronectin promotes the attachment of
fibroblasts and other cells to the ECM in the dermis (Alberts, 2002).
The major cell surface receptors responsible for the attachment of cells to the ECM are
the transmembrane glycoproteins, integrins. The extracellular portion of integrins binds
to collagens, laminins and fibronectin whereas; the intracellular portion binds to the
actin filaments of the cytoskeleton. This cytoskeleton-ECM Iinkage is responsible for
providing the stability of cell-matrix junctions (Alberts, 2002).
The proteoglycans are polymorphic macromolecules consisting predominantly of
molecules with a core protein and glycosaminoglycan (GAG) side chain extensions
consisting of repeating disaccharide units. They are divided into intracellular,
membrane-bound and extracellular groups. The extracellular molecules are relatively
inflexible, take up a spiral shape and have following properties; negative charge.
hygroscopic and hydrostatic. Proteoglycans regulate the function of several cellular
processes cell proliferation, differentiation and exert control over the behavior of the
tissue as a whole under normal physiological conditions, during morphogenesis and
tissue repair processes. Proteoglycans, GAGs and the basal lamina associate to form
large complexes of ECM, the can also bind potentially active ligand pol) peptide, and
modulate their bioactivity to influence cell adhesion and or transmembrane signaling
(Alberts, 2002). The ECl\l function is to provide structural support. substrates fur cell
adhesion, cell migration and to regulate cell behax ior. This enables the cell t~) influence
development, migration. proliferation, shape and function.
CI J':\P'n~R I: Introduction
1.1.6 Epithelial mesenchymal interactions.
Mesenchyme (Dermis) plays a crucial role in epidermal homeostasis. Epidermis
(Epithelia) influence the dermis with regards to structural remodelling. re-innervations
and vascularisation (Kangesu et aI., 1998; McKay and Leigh, 1991). Epithelial-
mesenchymal interactions are orchestrated by a complex body of networks involving
communications between cell to cell and cell matrix, cytokines and growth factors
(Harris et al., 2001), (Fusenig, 1994).
The size and position of the developing hair follicles is determined by direct
mesenchymal signals (Oliver and Jahoda, 1988). During hair follicle morphogenesis
epithelial-mesenchymal interactions take place, this is initiated first by the dermal signal
which results in the formation of a fully developed hair follicle (Hardy, 19(2).
Signalling between dermal papilla (DP) and hair follicle epithelium is crucial for hair
follicle development and function (reviewed in (Jahoda and Reynolds, 1996). The
importance of DP has been demonstrated in a variety of studies some of which are
summarised in section 1.1.9.
The mesenchyme determines the fate of the epithelium. For example, the formation of
epidermis and hair follicles is induced when cultured rabbit corneal epithelium is
combined with embryonic hair-forming mouse dermis (Ferraris et al., 1994; Ferraris et
al., 2000).
An understanding of the epithelial-mesenchymal interactions that takes place in skin has
been brought about by wound healing studies. Initially, Rheinwald and Green (1975)
showed that keratinocytes grown on an irradiated mouse fibroblast feeder layer have
improved growth rates (Rheinwald and Green, 1975b). Since then, the importance of a
dermal component for the improved clinical uptake of cultured epithelium has been \\ ell
documented (Cuono et aI., 1986; Navsaria et al., 1994).
In vitro skin models have been used to study the importance of epithet ial mesenchy mal
interactions. These organotypic cultures are composed of kcratinocytcs and
mesenchymal cells grown ill vitro via an ECI\I at an air-liquid interlace that induces
differentiation. They also share similarities with wound healing, h) perproliferativc and
psoriatic skin (:\sselineau et al., 1986: Leigh ct al.. 1995). lhesc models hav c been
useful for elucidating the importance of epithelial-mesenchx mal interactions on a
number of processes including epidermal homeostasis, production and deposition of
basement membrane and ECM components and secretion of diffusible factors (Ghosh et
al., 1997; Krejci et aI., 1991; Maas-Szabowski et al.. 200 1: Ralston et al., 1999:
Saintigny et aI., 1993; Smola et aI., 1998).
1.1.7 Structure and function of the hair follicle.
Adult humans have an estimated 5 million hair follicles in the skin of which Ix 105 hair
follicles are found on the scalp. The growth of human scalp hairs is approximately 0.35
mm per day (Myers and Hamilton, 1951). In humans, hair functions in social and sexual
interactions, it also acts as a sensory organ for skin, provides protection from the
environment (e.g. eyelashes, eyebrows, nostril hairs and external ear hairs) and has
insulating properties (Lavker, 1999).
The hair follicle is a dynamic and complex skin appendage that comprises both
epithelial portions; outer root sheath, inner root sheath and matrix and dermal portions:
dermal sheath and dermal papilla. The basic adult human late anagen hair follicle
structure is shown in Figure 1.1 and Figure 1.5. The hair follicle is arranged into
several concentric cellular compartments. The innermost hair fibre or shaft consists of
three layers; the cuticle, the cortex that forms the bulk of the hair fibre, and the medulla.
Surrounding the hair fibre is the inner root sheath (I RS) composed of three layers:
Henle's layer, Huxles layer and the IRS cuticle. On the periphery of the IRS is the
outer root sheath (ORS) compartment which is continuous with the epidermis. Cells in
the distal ORS are similar in structure with the epidermis. The sebaceous gland arises
from an outgrowth of ORS. The epithelial compartments of the hair follicle are bounded
by a basement membrane and connective tissue sheath (dermal sheath).
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1.1.8 Hair follicle bulb.
At the base of the hair follicle is located the follicle bulb consisting of the germinatix c
and hair matrix epithelium, dermal sheath cells, melanocytes and endothelial cells and
dermal papilla (OP) which is richly vascularised and contains abundant nerve endings.
(Spearman, 1977). The germinative epithelium are highly proliferative cells (Weinstein
and Mooney, 1980) which give rise to hair matrix cells that undergo lineage restricted
differentiation to form the IRS and hair fibre. This differentiation process results in the
expression of hair-specific keratins (reviewed in (Yu et al., 1993).
1.1.9 The dermal papilla.
The dermal papilla (DP) is an almond-shaped structure surrounded by the follicle bulb
epithelium. The DP contains mesoderm-derived fibroblasts and receives a rich
neurovascular supply. DP size is closely related with hair follicle size (Elliott et al.,
1999). DP plays a pivotal role in the induction of hair follicle formation and growth
(Jahoda et al., 1984; Sengel, 1976). DP implanted into vibrissal follicles in which the
lower bulbs were excised has been shown to induce new bulb formation and hair growth
(Oliver, 1967). Follicle formation is also induced when cultured sole epithelium is
combined with DP and sole dermis in a recombinant study (Xing and Kobayashi, 200I).
Whisker growth stops following amputation of DP (Oliver, 1966b) but commences
when DP is re introduced (Jahoda et al., 1984). DP or cultured DP cells implanted into
skin adjacent to the epidermis induce hair follicle formation (Jahoda, 1992; Reynolds
and Jahoda, 1992).
1.1.10 Connective tissue sheath.
The connective tissue sheath (CTS), also known as the dermal sheath, is specialised
mesenchyme that surrounds the epithelial components of the hair foil ide (Figure 1.1
and Figure 1.5). It provides the follicle with structural support. The CTS is composed
of a collagen rich ECM embedded with fibroblasts and endothelial cells, the latter of
which forms perifollicular blood vessels. Epithelial-mesenchymal interactions occur
between the CTS and ORS, which are important in hair follicle function. The CIS is
adjacent to DP in the follicle bulb and migration ma) take place betw ecn both
·w
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compartments. CTS cells can form new DP and follicle bulb thus restoring hair function
when the base of the follicle is amputated (Jahoda et al., 1992: Oliver. 1966a: Oliver,
1966b). In addition, the transplantation of male derived CTS onto female skin wounds
leads to the production of new follicles and fibres in a human model without an)
apparent sign of rejection (Reynolds et aI., 1999). In the context of wound healing, it
has been hypothesised that CTS may provide a progenitor population for wound healing
fibroblasts (Jahoda and Reynolds, 2001). Indeed, they express a-smooth muscle actin,
similar to wound healing fibroblasts (Jahoda et a\., 1991) and behave in a manner
similar to dermal fibroblasts in an in vivo wound healing model in rats (Gharzi et al.,
2003). In addition, both CTS and DP cells have been shown to display haematopoietic
activity both in vivo and in vitro (Lako et a\., 2002) as well as adipogenic and
osteogenic differentiation in vitro (Jahoda et a\., 2003).
1.1.11 Sebaceous gland.
The hair follicle is often associated with the sebaceous gland and together, is termed the
pilosebaceous unit. The sebaceous gland develops from an outgrowth of the hair follicle
ORS and is attached at the base of the infundibulum by a duct. The sebaceous gland is a
holocrine gland that secretes sebum, a lipid rich substance required for processing the
hair fibre and protecting the surface of the epidermis. Sebaceous glands are found all
over the body, but they are more numerous in the scalp area and around the forehead,
chin, cheeks and nose (Deplewski and Rosenfield, 2000).
~I
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Figure 1.5: Diagrammatic representation of hair follicle. Longitudinally, the hair follicle is
arranged into three distinct anatomical regions. 1) The infundibulum, distal upper end of
hair follicle which extends from the interfollicular epidermis down to the opening of the
sebaceous duct. 2) The isthmus, distal upper end of hair follicle which comprises the area
of the sebaceous gland down to the bulge region, near the site of insertion of the arrector
pili muscle. The bulge region is thought to be the reservoir for follicle epithelial stem cells.
3) The proximal, lower portion of the hair follicle which comprises the area just belo the
bulge arrector pili muscle complex right down to the base of the follicle including the bulb
region. Diagram reproduced by kind permission of Centre for Cutaneous Re earch, Queen
Mary University of London.
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1.1.12 Hair follicle morphogenesis and hair growth cycle.
Hair follicle development commences around 8 to 9 weeks during human
embryogenesis on eyebrows, eyelids, upper lip, chin and scalp. Hair follicle
development generally expands in a symmetrical fashion to other regions of the embryo
except on palm and sole regions. Not all hair follicles reach the same developmental
stages simultaneously, for example, hair starts to appear on the eyebrow at around 17
weeks and on the scalp at around 18-21 weeks. Lanugo hairs is a term given to the first
generation of hairs formed, which are fine and unpigmented. Most of these are shed
before birth and are replaced by coarser hairs during the prenatal period. After birth hair
growth is synchronised for the first few months, but soon changes to an asynchronous
mosaic pattern (reviewed in (Philpott, 1998).
During embryogenesis, hair follicles are formed as a result of coordinated signalling
between the embryonic epithelial and mesenchymal cells. This epithelial-mesenchymal
communication governs the induction, morphogenesis and differentiation processes
required for follicle formation (Hardy, 1992). The first signal from dermis to epidermis
'dermal signal', induces the formation of the epidermal placode (Hardy, 1992). Next the
signal from epidermis to dermis 'epithelial signal', causes the mesoderm to aggregate
just below the epidermal placode to form a dermal condensate. This is destined to
become the hair follicle and DP. As a result of a 'sec dermal signal', from dermal
condensate to epidermal placode, the cells of the epidermal placode undergo
proliferation and invade the dermis causing a downward growth into the dermis,
eventually enclosing the DP. Further proliferation and differentiation of the follicular
epithelial cells take place, resulting in the formation of a fully developed hair follicle
(Hardy, 1992). A summary diagrammatic representation of different stages of human
hair follicle morphogenesis is shown in Figure 1.6. (Philpott, 1998). Stage 0, Uniform
ectoderm appears. Stage L Epidermal placode formation and mesenchymal aggregate.
Stage 2, Hair germ elongates as cords of epithelial cells (called 'hair peg') with a
convex proximal end into the dermis at a slight angle. dermal condensate remains
adjacent to the convex proximal end of the hair peg. Stage 3, Hair peg grows into the
dermis with a concave proximal end, still in contact with the dermal fibroblast
condensate. Stage .... Bulb region starts to develop at the proximal end of the hair peg
and encloses the DP cells. Hair peg cells start to differentiate into the hair matrix and
give rise to IRS. Stage 5. Hair peg and IRS elongates and Dr cells are further enclosed
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by the follicle epithelium. Buds develop towards the distal end of the gro« ing hair peg
which become the bulge region, sebaceous gland and in some hair follicle, the apocrine
sweat gland. Stage 6, Hair follicle continues to elongate, the hair fibre shaft is formed
by hair matrix cell differentiation and grows up into the developing hair canal. Further
development of the bulge region, sebaceous gland and apocrine gland takes place. The
apocrine gland only develops in axillary and pubic body regions. In other body regions,
it atrophies. Stage 7, Hair follicle continues to elongate and the hair fibre elongates
further up towards the developing distal hair canal. The sebaceous gland also continues
further development. Stage 8, Maximum length of the hair follicle is reached and the
hair fibre emerges from the surface of the epidermis. Morphogenesis is completed
resulting in the appearance of a mature late anagen hair follicle.
Hair growth and cycle (Figure 1.7) in adult mammals has three distinct phases: Anagen
phase, which is an active hair growth phase during which the hair fibre is produced;
Catagen Phase, in which regression, shortening and partial degeneration of the follicle
takes place and Telogen phase, is a resting phase where no cell proliferation takes place
and the hair follicle awaits signals to re-enter anagen (Dry, 1926). During hair follicle
cycling, only the upper part of the hair follicle is permanent but undergoes remodelling
(Lindner et al., 2000).
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Figure 1.6: Different stages of hair follicle morphogenesis. Induction phase (stage 0-1)
coordinated signalling between ectoderm and underlying mesenchymal cells induce
placode formation. Morphogenesis phase (stages 2-4) appendage elongates into hair peg.
Elongation phase (stages 5-8) further prol iferation and differentiation into di tinct
compartments to form developed hair follicle. Abbreviations: DP, dermal papilla; IR .
inner root sheath; SO, sebaceous gland. (Centre for Cutaneou Re earc h. Queen ar
College Universi ty of London) .
1oh,1I1l1nl:d...1krarn
CHAPTER 1: Introduction
Catagen VII
Telogen
Sebaceous gland
nagen VI
j/-- Arrector pili muscle
Melani
.----
Outer root sheath
In er root sheath
I lIffl'---- Hair shaft
Normal ollicular
cycle
An gen
/
Shedding
hair
Exogen
New \
hair \
Anage III
Hair follicle cycle
Figure 1.7: Hair follicle cycle. The normal hair cycle can be divided into four relatively
distinct, successive periods: active growth phase (Anagen), a short tran sition pha se with
regression (Catagen), a resting phase (Telogen) and a shedding stage (Exogen). In the
anagen phase, the follicle regenerates from the active epithel ial stem cells, which reside in,
or close to , the permanent 'bulge' region of the follicl e. Although the size and length of the
hair shaft are related to the size of the hair follicle and the duration of anagen, the e
attributes are remarkably diverse with body site and can change as a result of di ea e ( tenn
and Paus, 2001 )
tohamm d.' lkram 6
CHAP'rER I; Introduction
1.1.13 Signalling pathways in hair follicle development and cycling.
Many of the processes that occur during hair follicle morphogenesis, development and
cycling require epithelial-mesenchymal interactions. Several key regulators hax e been
identified and implicated in these processes, although the first dermal signal during hair
follicle development has yet to be determined. Wnt signalling pathway through ~_
catenin, Lymphoid enhancer binding factor 1 (LefI) and T cell factor (TCF) are
involved in the early stages of hair follicle morphogenesis and development (DasGupta
and Fuchs, 1999; Millar, 2002). A simplified version of the Wnt pathway is shown in
Figure 1.8. Wnts proteins are a family of secreted glycoproteins that control cell fate
during development and differentiation. A number of Wnt family members are
expressed at different stages of the developing hair follicle some of these include Wnt 3,
Wnt 3A, Wnt 4, Wnt 5A, Wnt 7A, Wnt lOA and Wnt lOB (Reddy et al., 2001).
Wnts bind to frizzled (Fz) receptors as well as co-receptors lipoprotein receptor-related
proteins 5 and 6 (LRP5/6), this activates Dishevelled (Dsd) proteins which then interact
with a multi-protein complex consisting of glycogen synthase kinase-Sf (GSK-3~),
adenomatous polyposis coli (APC) and Axin that controls ~-catenin levels in the
cytoplasm. Phosphorylation of ~-catenin by GSK-3~ is inhibited (reviewed in (Nelson
and Nusse, 2004). This causes the stabilisation and accumulation of ~-catenin which
then translocates to the nucleus where it forms a transcription complex with the Lef-
I/TCF family of DNA-binding proteins and switches on specific target genes including
c-myc and cyclin D I, which then influence various developmental processes (Barker et
aI., 2000). Hair follicle placodes fail to develop in mice with a mutation in the ~-catenin
gene (Huelsken et aI., 2001). A new hair follicle in neo-natal mice was induced \\ hen a
truncated and stabilised form of ~-catenin was ectopically expressed in murine
epidermis (Gat et al., 1998). In the absence of Wnt signalling, excess cytoplasmic ~­
catenin are phosphorylated and targeted for ubiquitination and degradation in the
proteosome except for the pools of ~-catenin that form the structural component of the
adherens junctions that link cadherins through o.-catcnin to the actin C) ioskeleton
(reviewed in (Nelson and Nusse, 2004).
~7
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During embryonic development transcripts of sonic hedgehog (SHH) (see section 1.3.0)
and secreted protein are expressed in epithelial cells of the proliferating hair follicles.
SHH also influences proliferating hair follicle cells and adjacent aggregating dermal
cells as indicated by their expression of SHH target genes Ptchl and Glil (see section
1.3.1 and section 1.3.2) (Bitgood and McMahon, 1995; Oro et aI., 1997). SHH null
mice form dermal condensate but fail to develop a mature hair follicle (Chiang et al.,
1999a; Karlsson et aI., 1999b). 13-catenin null mice lack SHH expression which
indicates that SHH is down stream of Wnt signalling in hair follicle development
(Huelsken et aI., 2001).
Bone morphogenic proteins (BMP) are a large family of secreted signalling molecules
of the transforming growth factor-B (TGF-13) superfamily. BM? signalling has been
shown to promote hair follicle cell differentiation. Inhibition of this pathway leads to
impaired hair shaft differentiation (Kulessa et aI., 2000). Noggin inhibits BM?
signalling and is required for new hair growth (Botchkarev et al., 1999). Noggin also
acts in conjunction with the Wnt pathway to activate Lef-l for placode formation in first
stage of hair follicle morphogenesis (Jamora et aI., 2003). Lef-l induces placode
formation by simultaneously downregulating and upregulating E-Cadherin and p,
Cadherin of the adherens junction, respectively. The cellular interactions that govern
placode formation are thus represented by integrating different signalling pathways.
Other key mediators of hair follicle development include fibroblast growth factors,
transforming growth factor-a and transforming growth factor-B. Delta I, epidermal
growth factor and hepatocyte growth factor (reviewed in (Millar, 2002) and recently,
GATA-3 (Kaufman et aI., 2003). Many of these growth factors and receptors are also
important in hair cycling. For a detailed review of key mediators involved in hair
cycling see (Stenn and Paus, 2001).The hair follicle plays a key role in epidermal
homeostasis, wound repair and has been implicated in skin tumourigenesis (Miller et al.,
1993; Morris et al.. 2000).
-+8
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Figure 1.8: Schematic representation of the Wnt signalling pathway III follicle
development. Wnts bind to frizzled (Fz) receptors as well as co-receptors lipoprotein
receptor related proteins 5 and 6 (LRP5/6), this activates Dishevelled (Dsd) proteins which
then interact with a multi-protein complex consisting of glycogen synthase kinase-Sf
(GSK-3r3), adenomatous polyposis coli (APC), Axin and r3-catenin (,B-Catenin also exists in
a cadherin bound form that regulates adhesion) and phosphorylation of ~-catenin by GSK-
3r3 is inhibited. This causes the stabilisation and accumulation of ~-catenin which then
translocates to the nucleus where it forms a transcription complex with Lef-l/TCF family
of DNA-binding proteins and switches on specific target genes including c-myc and cyclin
D, which then influence various developmental processes. The Wnt pathway is also subject
to regulation and feedback control by extracellular factors that bind Wnt [Wnt inhibitory
factor (WIF) and Frizz led-related protein (FRP)] or the coreceptor LRP (Dickkopf). The
box displays possible levels of interactions between Wnt signalling and cadherin-mediat d
adhesion indicated by dotted lines (Nelson and usse, 2004).
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1.1.14 Epidermal stem cell characteristics and their niche.
The epidermis and its appendage undergo constant renewal throughout life and this
suggests that there must be an existing source of epithelial stem cells to replace the lost
cells. Epidermal stem cells are relatively quiescent and undifferentiated cells that have
the capacity to self renew tissues (Watt, 1998). Stem cells are believed to give rise to
daughter stem cells and transit amplifying (TA) daughter cells. TA cells undergoing a
finite number of cell divisions (estimated at 3-5 divisions) before withdrawing from the
cell cycle and undergo terminal differentiation (these cells are called post-mitotic or
committed cells) (Watt, 1998). The endpoint of terminal differentiation pathway is the
formation of stratum corneum in interfollicular epidermis, hair fibre production in the
hair follicle and sebocytes in the sebaceous gland. Under normal physiological
conditions, distinct stem cell populations maintain each epidermal lineage (Ghazizadeh
and Taichrnan, 2001).
Stem cells are found in protected microenvironments (called 'niches'), they are
innervated and vascularised. Here stem cells are protected from environmental insults
such as UV and other carcinogens. The human hair follicle is known to harbour a
population of stem cells, mostly located at fraction lower down from the bulge region
(Rochat et aI., 1994). Other studies contradictory to this study demonstrated that the hair
follicle stem cell population is situated in the bulge region (Cotsarelis et al., 1990; Lyle
et al., 1998b), and these cells are more proliferative than those of the interfollicular
epidermis (Yang et al., 1993). The bulge region of the hair follicle is maintained
throughout the hair cycle whereas the area below this undergoes remodelling. It also
remains after hair plucking and its position below the epidermis allows the region to be
spared if the overlying epidermis is damaged. As a result, it can contribute to the
regeneration of the overlying epithelium. This has been shown in partial-thickness
wounds where epidermal regeneration from the skin appendages is a well recognised
event in humans (Irvin, 1981) and in mice (Argyris, 1976). In a wound repair mouse
model and chimeric vibrissal follicle-transplantation study cells from the ORS of the
upper follicle gave rise to the regenerated epidermis (Oshima et aI., 2001; Taylor ct aI.,
2000b). Thus, bulge cells act as a reserve of stem cells for both interfollicular and
follicular epithelium in hairy skin. Its advantageous, protected and \\ ell vasculariscd
position makes the bulge a very suitable niche for the presence of stem cells.
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Ultrastructural studies propose that stem cells and their progeny are organised in an
epidermal proliferative unit (EPU) in mouse epidermis (Christophers. 1971: \ lackenzie
et aI., 1981; Potten, 1981). The slow cycling stem cells appear to make up 10% of the
total basal cells and are found at the centre of the EPU. The more proliferative, transit
amplifying cells are found at the periphery of the EPU (Christophers, 1971: Mackenzie
et aI., 1981; Potten, 1981).
In several studies using a cell surface ~1 integrin as primary keratinocytes stem cell
marker (Gandarillas and Watt, 1997; Jones et aI., 1995; Jones and Watt, 1993~ Zhu and
Watt, 1999) have shown that in human interfollicular epidermis, clusters of stem cells
reside in the tips of the dermal papilla, they are also found in the bottom of the deep
ridges of the interfollicular epidermis (Jensen et al., 1999; Jones et al., 1995). Activel ,
dividing TA cells displayed a more scattered distribution away from the stem cell
clusters in the basal layers and moved upwards to the suprabasal layers (Watt, 1998).
TA cells are also found to be more motile in vitro compared to stem cells (Jensen et aI.,
1999). Stem cells are normally slow cycling in vivo (Tomakidi et al.. 1997), this is
biologically significant as this conserves their proliferative potential and minimises
DNA errors that could occur during replication thereby protecting the tissue from neo-
plastic transformation. Slow cycling cells are detected by administrating mice with
tritiated thymidine CH-TdR), a radioactively labelled DNA precursor (Bickenbach,
1981) or 5-bromodeoxy-uridine (BrdU), a thymidine analogue (Tomakidi et aI., 1997).
These labels get incorporated into the DNA of cells during S-phase of the cell cycle.
During the chase period when no label is administered, the normal cycling cells
continue to divide and the label gets diluted. However, cells that divide less frequently
retain the label for longer periods and are known as 'label retaining cells' (LRCs). Based
on this technique, label retaining studies have confirmed the model of the EPU in mouse
epidermis (Morris et aI., 1985). This technique has located LRCs to the bulge region of
the hair follicle ORS in mice (Cotsarelis et aI., 1990; Lavker et al., 1993~ Morris and
Potten, 1999). Human scalp skin grafted onto athymic mice shows label retaining cells
in the bulge region (Lyle et al., 1998b). Where the chase period of more than I year
shows the bulge region contains the slowest cycling cells of the entire cutaneous
epithelium (reviewed in (Cotsarelis et aI., 1999) thus, the bulge cells of the hair fall icle
may be the main repository of stem cells for the entire epidermis.
~ I
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Keratinocytes in culture have a heterogeneous population with regards to their
clonogenicity, based on the morphology criteria. Three types of colonies are produced
from keratinocytes isolated from skin, these are holoclones. paraclones and meroclones
(Barrandon and Green, 1987). Holoclones are large and circular colonies containing
small regular shaped cells that have the greatest proliferative potential. These colonies
have the ability to self renew and generate terminally differentiated cells that give rise to
both meroclones and paraclones. Paraclones form small irregular shaped colonies and
are believed to be post mitotic committed cells. These cells only possess a short
replicative life span. Meroclones form an intermediary population group containing a
mixture of cells of varying growth potential, giving rise to both paraclones and
meroclones and are believed to be TA cells and keratinocyte size is inversely
proportional to clonogenic potential in first passage (Barrandon and Green, 1985).
Further confirmation of the presence of stem cells in in-vitro culture comes from the use
of sheets of cultured epithelial auto grafts, derived from non-hairy skin, used in the
treatment of burn patients. These produce a normal epidermis that persists for several
years (Compton et aI., 1998). These observations confirm the survival of stem cells in
vitro and that stem cells from the hair follicles are not mandatory for the long term
upkeep of interfollicular epidermis. The identification of some stem cell markers is now
leading to the elucidation of molecules and signalling pathways involved in the process
of epidermal cell fate and regulation.
1.1.15 Epidermal stem sell markers.
Lack of molecular markers for epidermal stem cells causes a major problem in terms of
precise stem cell identification and hence, their exact location in vivo. As yet in vivo
label retaining cell experiments and in vitro colony forming assays are still the best
methods of choice for the selection of stem cells. However, other molecules have been
put forward as putative epidermal stem cell markers. These include ~ I integrin (Jones
and Watt, 1993), a6-integrin positive and transferrin receptor dull (a6briCD71 dlnl) (Tani
et al., 2000a), p63 (Pellegrini et al., 2001), keratin 15 (Lyle et aI., 1998b) and keratin 19
(Commo et al., 2000; Michel et al., 1996a). Adhesion molecules present on the
keratinocyte may be used as additional markers. These include the Notch ligand. Delta I
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(Lowell et aI., 2000), ~-catenin (Zhu and Watt, 1999), E-Cadherin and plakoglobin l';'-
catenin) (reviewed in (O'Shaughnessy and Christiano, 2001).
1.1.16 Epidermal, homeostasis and regulation.
Epidermal homeostasis is achieved by controlled regulation of cell proliferation.
differentiation and apoptosis. Any imbalance in these processes may give rise to varying
epidermal thickness, example a very thick epidermis may be caused by
hyperproliferative disorders of the skin such as psoriasis and carcinomas, whereas a
very thin epidermis may be due to aging or Discoid Lupus Erythematosus. In response
to tissue damage homeostasis is still maintained because the proliferation rates of stem
cells and TA cells increases leading to the regeneration of the epidermis. However,
many questions remain unanswered such as what are the exact processes that are
required for keratinocyte stem cells to renew proliferate or differentiate and when does a
keratinocyte stem cell transit to a TA cell? What are the specific cues that direct lineage
commitment? The mechanisms underlying all these processes are not properly
understood but it appears that the fate of stem cells is dependant upon cellular
interaction with its microenvironment rather than being pre-programmed. This is
indicated by a study that shows some differentiated keratinocytes in the suprabasal
layers of regenerating epidermis in leg ulcers reverted back to an undifferentiated stem
cell phenotype (de-differentiation) in the presence of growth factors, as assessed by ~ 1
integrin and K19 expression (Fu et al., 2001). The control of epidermal homeostasis
regulation is influenced by microenvironment factors these includes cell-to-cell
interaction, basement membrane, ECM, growth factors, cytokines, signalling pathways
(Watt, 1998).
The epidermis is almost unique in that it continues to proliferate and differentiate. from
formation of cornified squames and the continual cycling of hair follicle- throughout
life. There are human diseases that affect any or all of this processes, from the earliest
point of differentiation of the ectoderm, through to terminal differentiation of the
epidermis and hair follicle cycling. The discovery of the genetic basis of these diseases
is the primary source of insight into the molecular mechanisms of epidermal
development and differentiation.
- ...
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Skin is the most environmentally exposed organ of the human body. Thus, somatic
mutations accumulate in the epidermis far more than any other region of the body. It has
been known for many years that mutations of genes involved in DNA repair can lead to
skin cancer predisposition, the classical example being xeroderma pigmentosum
(Cleaver et aI., 1999) and Gorlin syndrome [Naevoid Basal Cell Carcinoma Syndrome
(NBCCS)] a disorder that predisposes to the formation of basal cell carcinomas (sec
section 1.2.0) (Gorlin, 1987; Gorlin, 1995). Basal cell carcinoma arises from the basal
layer of the epidermis which is the subject of this study.
1.2.0 Basal cell carcinoma (BCC).
Nonmelanoma skin cancers (NMSCs) constitute more than one-third of all cancers in
the United States with an estimated incidence of over 600,000 cases per year. NMSCs
are the most common malignancies occurring in the Caucasian population each year. Of
these 600,000 cases approximately 500,000 are Basal cell carcinoma (BCe) (Miller and
Weinstock, 1994), BCC was first described by Jacob in 1827 (Jacob, 1827). In 1994 it
was estimated that lifetime risks to a child born in 1994 getting Bee was 22-33%. BCC
represents 75% of NMSC (Miller and Weinstock, 1994) and is, therefore, the most
common malignant disease throughout the western world. Worldwide incidence of BeC
is increasing by about 100/0 per annum, so the prevalence of BCC will soon equal that of
all other cancers combined (Karagas MR, 1995). There is a geographical variation in
incidence of BCC, in the UK the age-standardised annual incidence was estimated as
114.2 per 100,000 population, while in Australia the figure is much higher at 726 per
100,000 (Holme et aI., 2000; Marks et aI., 1993).
There are several clinical and histological subtypes of BCC (see section 1.2.1). \\ hich
exhibit different patterns of behaviour. Clinically BCC are divided into five major
types; nodular, superficial, morpheaform, pigmented, solid cystic (Crowson, 2006;
Ramsey, 2004). Nodular BCC (Figure 1.9 and 1.10) is the most common variety of
BCe it often occurs on the head, neck, and upper back and has some of the Iollowing
features: Waxy papule(s) with central depression and crusted. erosion. Superfic ial BeC
presents as scaly patches or papules that are pink to red brown in colour, often with
central clearing (Figure 1.11 and 1.12). A threadlike border is common. Superficial
BCC is common on the trunk and has little tendency to become invasive. Morphcaform
(Figure 1.13) an infiltrating Bee are aggressive subtypes with sclerotic (scar like)
5.+
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plaques or papules. The border usually is not well defined and often extends well
beyond clinical margins. Clinically, ulceration, bleeding, and crusting are uncommon in
this subtype of tumour and they are often mistaken for scar tissue (Ramsey, 2004)
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Figure .1.9 Nodular basal cell carcinoma. This translucent pink papule has dilated
superficial blood vessels and crusted erosion, characteristic of nodular basal cell carcinoma(Ramsey ML, 2002 ).
Figure 1.10 Nodular basal cell carcinoma presenting as a waxy translucent papule with
central depression and a few small erosions (Ramsey ML, 2002).
Figure 1.11 Superficial basal cell. Scale, erythema (an abnormal re~ne of the kin). and a
threadlike raised border are present in this superficial basal cell carcmorna on th trunk
(Ramsey ML, 2002).
Mohammed.. Ikrarn
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Figure 1.12 Larger superficial basal cell carcinoma (Ramsey ML, 2002).
Figure 1.13 Morpheaform infiltrating basal cell cancer has ill defined borders and
telangiectases (Ramsey ML, 2002).
lohammcd. '.I1-..ram
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1.2.1 Histology of Basal Cell carcinoma
Tumour cells of nodular BCC, sometimes called basalioma cells , typicall y have large,
hyperchromatic, oval nuclei and little cytoplasm. Cells appear rather uniform, and if
present, mitotic figures are usually few in numbers. Nodular tumour aggregates may be of
varying sizes, but tumour cells tend to align more dens ely has islands (Figure 1.14).
Superficial BCC appears as buds of basaloid cells attached to the under surface of the
epidermis. Nests of various sizes often are seen in the upper dermis (Figure 1.15).
Morpheaform BCC has thin strands of tumour cells extending deeper into the dermis and
the tumour as a whole is poorly defined histologically, as it is clinically (Figure 1.16)
(Ramsey, 2004).
BCC is believed to arise from the epidermis and occasionally from the outer root sheath of
a hair follicle, specifically from hair follicle stem cells residing just below the sebaceou
gland duct in an area called the bulge (Figur e 1.5) (Kruger et al., 1999).
Figure 1.14 Histology of nodular basal cell carcinoma, nodular aggregate (indicat d b
black arrows) of basalioma cells are present in the dermis (Ram ey L, 2002 ,
Moh.nnm 1. ',Ikwm
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Figure 1.15 Histology of superficial basal cell carcinoma. Nests of basaloid cells (indicated
by black arrows) are seen budding from the undersurface of the epidermis (Ramsey ML,
2002).
Figure 1.16 Histology of morpheaform basal cell carcinoma, thin strand of tumour
(indicated by black arrows) extending deeper into the dermis (ww .drmelton.com ).
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1.2.2 Factors that lead to basal cell carcinoma formation.
There is an increased risk of non melanoma skin cancers (NMSe) in the white
population, especially those who have blue eyes, a fair complexion, sunburn easily,
suntan poorly, freckle with sun exposure, have red blonde or light brown hair (\\'om~ et
al., 2003), Bee is uncommon in Black, Asian, and Hispanic populations, There is a
higher incidence of Bee in the Albino black population than in normall. pigmented
black population. Compared with the white population, the black population have a
decreased risk of Bee on sun-exposed areas, but have same incidence of Bee on non
sun-exposed skin, Bee develops on hair-bearing skin, most frequently on sun exposed
areas, approximately 850/0 of Bee are found on the head, neck and most commonly on
the nose (Ramsey, 2004; Wong et al., 2003).
The reported increases in the incidence of Bee have partially been attributed to a larger
amount of UV-B exposure, such as outdoor workers, or those with more frequent
outdoor activities are at greater risk of developing Bee (Brooke, 2005; Ramsey, 200-L
Wong et al., 2003). The risk of developing a Bee also increasing with age. the
incidence of Bee in individuals over 75 years old is approximately 5 times higher
compared to individuals between 50 and 55 years old (Holme et al., 2000). Exposure to
short wavelength UV-B radiation (280-320nm) is believed to playa greater role in Bee
formation than is longer wavelength UV-A radiation (320-400 nm) used in tanning
saloons. A long latency period of 20-50 years is typical between the time of UV damage
and clinical onset of Bee (Brooke, 2005; Ramsey, 2004).
Individuals who never tan and always get sun burnt have red or blond hair and blue or
green eyes have been shown to have increased risk of Bee development. Family
history of Bee, exposure to ionising radiation, low vitamin intake, high intake of fats,
various chemical and particularly arsenic from 'tonics' and dust exposures predispose to
Bee development (Wong et al., 2003). Renal transplant patients \\ ho ha. c
immunosuppressive therapy have a tenfold greater risk of developing skin cancers
(Hartevelt et al., 1990). There is a modest increased risk of Bee formation in patient
treated with Psoralen and UVA (PUVA) for psoriasis (Brooke, 2005), Several grour1s or
di I . I e due to eeneticullx determined disorders are associ.ucd \\ ith theiseases w llC 1 ar b '-l. -
i I t f Bee these includinu albinism is a defect of melanin production,l eve opmen o. c-
d ' t is an inherited inabilitx of the skin to repair D"-:,\ darn.rue from",ero erma pigrnen osa J c ". ~
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ultraviolet light, predisposes to rapid ageing of sun exposed skin, starting \\ ith
pigmentary changes and progressing to skin tumours (Ramsey. 2004). \'ae\ oid basal
cell carcinoma syndrome (NBCC) also called Gorlins syndrome is an autosomal
dominant disorder in which multiple BCCs develop with associated palmer and plantar
pits, jaw cysts, spine and rib abnormalities, calcification of the falx cerebri and cataracts
(Bale et aI., 1994; Gorlin, 1995; Howell and Caro, 1959; Howell and Mehregan. 1l)~0:
Ramsey, 2004). NBCC patients also present developmental abnormalities, these include
bossing of the forehead, coarse facial features, bifid ribs and wedge shaped vertebrae.
cardiac and ovarian fibromas also occur in some individuals (Goldstein et al., 1993:
Gorlin, 1995; Howell and Mehregan, 1970; Kimonis et al.. 1997: Smith et al., 2002).
Some children with NBCCS develop medulloblastoma with a peak incidence of two
years of age (Amlashi et aI., 2003).
Genetic studies of Gorlin syndrome identified a germline mutation which inactivates
Hedgehog (HH) (See section 1.3.0) developmental pathway receptor protein Patched
(PTCH) (see section 1.3.1) to be the primary event in the formation of Bce which was
mapped to chromosome 9q22-31 and the same region is deleted in high percentages of
BCCs and other tumours related to this disorder (Gailani et al., 1996; Hahn et aI.,
1996b; Johnson et aI., 1996). Further evidence supporting the role of activated HH-
signalling in BCC comes from studies of genetic mouse models and skin grafting
experiments: upon UV irradiation heterozygous Ptc+/- mice develop Bee like tumours,
although sporadic BCC formation does not normally occur in these mice (Aszterbaum
et aI., 1999) and human keratinocytes expressing Sonic hedgehog (SHH) (see section
1.3.0) grafted onto the back of nude mice form BCC like structures (Fan et al., 1997).
1.2.3 Treatment for basal cell carcinoma.
A variety of treatment options are available for BCe and these dependent on
histological confirmation, type, number, site and size of lesion(s). There may also be
implications for the patient. such as age and previous clinical history, which influences
treatment strategies employed. The main treatments currently available for Bees are as
follows, excision surgery and Mohs surgery: destructive surgical technique". c.g
, tt d cauterv topical chcmotherapv: non-invasive techniques. c.g.cryosurgery, cure e an . ' .
I d . I (PDT) and radiotherapy (Telfer et al., 1999). Earlv detection andphoto ynamlc therapy l • ,.
treatment has a high success rate in treating Bee. Howe. er. the high occurrence
(1\
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increases the cost of treatment. Understanding the molecular events leading to BCC \\ ill
allow us to develop better strategies for treatment and preventati\ e measures that are
cost effective.
1.3.0 Sonic Hedgehog pathway.
Hedgehog (HH) proteins are a highly conserved family of extracellular signalling
molecules with fundamental roles in embryonic development both in vertebrates and in
invertebrates (Hammerschmidt et al., 1997; Ingham, 1998; Weed et al.. 1997). The most
extensively characterised mammalian homolog is Sonic Hedgehog (SHH). an overview
of this pathway is given in Figure 1.17. SHH belongs to a vertebrate evolutionarily
conserved family of genes including Desert hedgehog (DHH) and Indian hedgehog
(lHH), which are related to the Drosophila segment polarity Hh gene (Echelard et al.,
1993; Goodrich et al., 1996; Marigo et al., 1995). During the development of the human
embryo, SHH is expressed in the brain, developing limbs and the gut (Odent et al.,
1999). The tissue specific expression of SHH-pathway genes has not yet been
determined in human embryogenesis. However, in mouse and chick development SHH
has been shown to playa key role in the central nervous system (CNS), limb, lung. gut,
teeth development and in controlling growth and morphogenesis of the hair follicle
(Bellusci et al., 1997; Goodrich et al., 1996; Hardcastle et al., 1998; Litingtung et al.,
1998; Marigo and Tabin, 1996; Riddle et al., 1993; St-Jacques et al., 1998). SHH is
expressed in numerous tissues known to have polarizing activities during development,
its expression is initially detected in the node. and later in the notochord, floor plate of
the neural tube, and in the zone of polarizing activity in the limb buds (Echelard et al.,
1993; Krauss et al., 1993: Riddle et al., 1993; Roelink et al., 1994). DHH is involved in
gennline spermatogenesis and IHH in skeletal development (Bitgood et al .. 1996:
Vortkamp et al., 1996). In vitro studies suggest that SHH, DHH and IHI-1 can act
through the same signal transduction pathway (Echelard et al., 1993: [\ larigo ct al.,
1996b; Stone et al., 1996).
In humans. sporadic and inherited mutations in the SHH gene have been shown to cause
Holoprosencephaly (HPE) which is the most common developmental defect \,1' the
forebrain and the face (Belloni et al., 1996; Nanni et al., 1999: Roessler et al., ll)l)h:
Roessler et al., 1997). SHH protein is cleaved to an actix e :\-terminal form. \\ hich i"
then modified by the addition of a cholesterol moiety (Pepinsky ct al., 199~L Williams ct
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aI., 1999) a defects in addition of a cholesterol moiety can lead to the autosomal
recessive Smith-Lemli-Opitz syndrome (SLOS). This is a genetic disorder that affects
the development of children before and after birth with poor growth. developmental
delay and a common pattern of congenital heart defects including cleft palate. genital
malformations, and extra fingers and toes (Donnai et aI., 1987; Kelley et al., 1996: Tint
et aI., 1994).
1.3.1 Patched and smoothened.
An overview of the SHH pathway is shown in Figure 1.17. SHH functions by binding a
12-span transmembrane receptor protein Patched1 (PTCH I) and Patched2 (PTCH2) in
target cells (Smyth et aI., 1999; Stone et aI., 1996). PTCH1 normally inhibits
downstream signalling through a physical interaction with a 7-span transmembrane
protein Smoothened (SMO). PTCH2 can also interact with Hedgehog proteins, but its
functional role in HH-pathway is currently unclear (Motoyama et al.. 1998b; Smyth et
aI., 1999). SHH binding to PTCH1 releases the inhibition of SMO by PTCH I which
leads to increased expression of down stream HH target genes GUI (See section 1.3.2)
and PTCH 1 itself (Goodrich and Scott, 1998; Hahn et aI., 1999; Ingham, 1998; Murone
et aI., 1999; Toftgard, 2000; Villavicencio et aI., 2000).
Mutations in human PTCH1, PTCH2 and SMO have all been detected in BCC and in a
childhood brain tumour (medulloblastomas), which result in deregulated SHh-PTCH
signalling (Johnson et aI., 1996; Stone et aI., 1996; Xie et aI., 1998). Sporadic
inactivating PTCH-1 mutations have also been reported in trichoepitheliomas, which arc
multiple small benign nodules that occur mostly on the face, derived from basal cells of
hair follicles enclosing small keratin cysts (Vorechovsky et aI., 1997) and in
oesophageal squamous cell carcinomas (SCC) (Maesawa et aI., 1998).
The molecular mechanism of HH signalling pathway has been worked out in ~rl'atest
detail in Drosophila development (Hammerschmidt et al., 1997), down stream uf the
pathway is the zinc-finger containing transcription factor Cubitus interruptus Cei).
which appears to be required for all aspects of Hh signalling in Drosophila (\ktlwt and
Basler, 1999).
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Figure 1.17 Overview of the SHH-PTCH-GLI signal transduction pathway. (a) In the
absence of sonic hedgehog (SHH), Patched 1 (Pte 1) inhibits Smoothened (Smo),
thereby inhibits the downstream cascade. The Gli proteins are phosphorylated by
protein kinase A (PKA) and this leads to their cleavage by the proteasome and the
formation of carboxyl-terminus truncated repressor Glis. Which move to the nucleus
and repress the Gli dependent transcription of target genes Ptc l , etc (Rowitch et al.). On
SHH binding to Ptcl (Smo receptor), a macromolecular complex that is associated \ ith
the cytoskeleton, and this includes Su (fu) (Suppressor of fused), Fu (Fused), PKA, Gli
proteins and other possible components (represented as X, Y, Z), acts to produce labil
Gli acti vators. These are imported into the nucleus and transacti ate target gene . Th
regulation of Gli activity takes place at many levels, including nuclear e port and th
presence of positive or negative cofactors. The inhibitory Hedgehog-interacting prot in
(Hip) also regulates Gli activity through inhibition of SHH. In addition, HH activat
transcription of Ptcl , which, when overexpressed attenuat the HH re p n by
preventing SHH from bind ing Pte 1 molecules within the rec ptor compl x Ruiz t I..
2002).
C11\ 1"1 ER 1: 1111 roduction
1.3.2 GLII.
Three homologues of Cubitus interruptus (Ci), GLII, GLI2 (see section 1.3.3) and
GLB (see section 1.3.4) have been identified in human and mouse (Hui et al.. 1994:
Ruppert et al., 1990). All three GLI proteins share high homology to Ci in their the
zinc-finger domains, but limited homology outside of this region (Matise and Joyner,
1999). GLII, GLI2, and GLB encode transcription factors that share five highly
conserved tandem C2-H2 zinc fingers and a consensus histidine-cysteine linker
sequence between zinc fingers (Ruppert et al., 1988). The GLII and GLI3 proteins
recognize a conserved GACCACCCA nucleotide sequence in the promoters of target
genes (Kinzler and Vogelstein, 1990a; Pavletich and Pabo, 1993; Ruppert et al., 1990;
Vortkamp et al., 1995). GLI2 recognizes a GAACCACCCA motif (Tanimura et al.,
1998).
The first human GLI gene to be discovered was GLII (also known as GLI), which was
amplified in a glioblastoma (Kinzler et al., 1987). GLII has also been detected as an
amplified gene in some malignant bone tumour (osteosarcomas), and B cell lymphomas
(Roberts et al., 1989; Werner et al., 1997). GLI1 is also overexpressed in Bee
compared with normal human skin (Dahmane et aI., 1997; Ghali et aI., 1999), and the
degree of GLII overexpression correlates with tumour grade in adult bone and soft-
tissue sarcomas (Stein et al., 1999). GLII is classified as an oncogene because it can
transform cells when co-transfected with adenovirus E1A (Ruppert et aI., 1991).
Overexpression of human GLII in transgenic mice results in a range of developmental
defects, including failure to thrive, early death and Hirschsprung-like dilatation of the
gastrointestinal tract (Yang et al., 1997). Overexpression of human GLII in basal
keratinocytes of transgenic mice results in the development of several types of skin
tumours some of which show BCC like features (Nilsson et al., 2000). Further evidence
for a critical role of GLI1 in tumorigenesis comes from overexpression studies in frogs,
where Gli1 can also induce structures resembling epidermal tumours (Dahmane et al.,
1997; Hynes et al., 1997).
Mouse Twist protein can activate human GLII at the transcriptional level by interacting
with E-boxes in first intron of GLI1. TWIST is a developmental regulatory gene and
potential oncogene (Bourgeois et al., 1998; Gitelrnan, 1997; Maestro et al., 1999).
N . se deletion and insertion mutations in several regions of the humanonsense, mIss-sen , '
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TWIST gene have been shown to cause Saethre-Chotzen syndrome (SCS), an
autosomal dominant disease characterised by the following traits: fusion of the cranial
structures which sometimes produces an asymmetric head and face. Low set hairline
droopy eyelids (ptosis) and/or widely spaced eyes, beaked nose and possible deviated
septum. Abnormalities of the fingers and/or toes, which are often short (brachydactyly)
and intelligence is usually not impaired (EI Ghouzzi et aI., 2000; Howard et aI., 1997).
Some patients with SCS have a mutation in the TWIST gene that appears to disrupt
either the stability of protein or its ability to correctly localise to the nucleus (EI
Ghouzzi et aI., 2000). The clinical phenotype of SCS partially overlaps with those of
other SHh pathway related human diseases, indicating that deregulation of GLI family
transcription factors by either SHh signalling defects or TWIST mutations may lead to
similar downstream effects. It is not yet known if SHh signalling regulates TWIST.
However, it does appear to be linked to SHh signal transduction.
1.3.3 GLI2.
There are four isoforms of human GLI2, alpha, beta, gamma, and delta and these
isoforms encode 133, 131, 88, and 86-kDa proteins, respectively (Tanimura et aI.,
1998). Gli2-null mice display a lack of hair follicle development with a reduction in cell
proliferation and a loss of SHH/GLI mediated signalling but epidermal differentiation
remains unchanged. However, restoration of a constitutively active form of GLI2
increases cell proliferation and restores SHH/GLI function (Mill et aI., 2003a). This
indicates that GLI2 plays a key role in mediating SHH responses in skin and a major
role in epithelial homeostasis, in particular to hair follicle development, by stimulating
proliferation. Most studies of GLI2 have focused on embryonic development, where it
plays a crucial role in neural, lung, and skeletal development (Ding et aI., 1998;
Hardcastle et aI., 1998; Matise et aI., 1998; Motoyama et aI., 1998a; Park et al., 2000;
Ruiz i Altaba, 1998). Overexpression of mouse GLI2 in the basal epidermal layer of
transgenic mice induces the formation of BCC like tumours and skeletal defects
(Grachtchouk et aI., 2000; Park et aI., 2000; Sasaki et aI., 1999). GLI2 mutants with a
deletion of the exons encoding zinc finger domains 3-5 have numerous skeletal defects
and abnormal lungs (Mo et aI., 1997b; Motoyama et aI., 1998a). Overexpression of
SHH, GLII and GLI2 and an oncogenic form of Smoothened (SMO) in epidermal cells
of transgenic mice leads to induction of BCe like tumours (Fan et al., 1997;
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Grachtchouk et al., 2000; Nilsson et al., 2000; Oro et al.. 1997; Xie et al., 1998), We
have shown GLI2 expression to be up regulated in BCC compared to normal skin. and
there is a positive feedback mechanism between GLll and GL12 in human keratinocx tes
(Regl et al., 2002). Expression of the key antiapoptotic factor BCL2 is predominantly
activated by GLI2 compared with GLI I, and GLI2 and BCL2 are co-expressed in the
outer root sheath of hair follicles and BCC and in plasma cel1s that infiltrated BCC
tumour islands (Regl et al., 2004). This suggests that GLI2 activates prosurvival factor
BCL2 and this may represent an important mechanism in development or maintenance
of cancers associated with HH signalling.
1.3.4 GLI3.
The only reported association of mutation in the GLI gene with tumour formation and
development defects is with GLI3. A translocations, deletions, and point mutations
throughout the GLI3 gene causes Greig cephalo polysyndactyly syndrome (GCPS).
GCPS is characterised by joined fingers (syndactyly), predominantly thumb duplication
(preaxial polydactyly), and facial anomalies in which eyes are too far apart grossly
deforming the appearance (hypertelorism) (Jones, 1997; Kalff-Suske et al., 1999;
Vortkamp et aI., 1991; Wild et aI., 1997). Frame shift and nonsense mutations in GLI3
lead to Pallister-Hall syndrome (PHS) which is an autosomal dominant disease.
involving hypothalamic hamartoma (benign brain tumour located near the
hypothalamus), central or postaxial polydactyly, syndactyly, imperforate anus and other
facial abnormalities (Jones, 1997; Kang et al., 1997).
Human GLI3 protein has been shown to bind and be co-activated by mouse Creb-
binding protein (CBP), which is a common transcriptional co-activator (Akimaru et al.,
1997; Dai et aI., 1999). Human mutation in CBP lead to insufficiency of CBP and this
causes Rubinstein-Taybi syndrome RTS (Blough et al., 2000; Petrij et al.. 1995). RTS is
a developmental disorder with symptoms that include broad thumbs and first toc-; short
stature, delayed osseous maturation, vertebrate anomalies, mental retardation. and an
increased risk of neural and developmental tumours (Jones. 1997; \Iiller and
Rubinstein, 1995; Rubinstein. 1990). The similarity between the RTS and diseases
caused by GLI3 mutations suggests that the biochemical interaction between C13P and
GL 13 av siunificantlv influence SHH signalling. CBP interacts \\ ith C;L12 and (i I L', mll) 0 •
but not GLII (Dai et al., 1999; Hammerschmidt et al., 1997).
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1.3.5 GLI protein processing and their overlapping roles.
The three GLI proteins that participate in the mediation, interpretation of or response to
the SHH signal, act in a combinatorial fashion, GLII and GLI2 have activating effects,
whereas GLI3 (and at times GLI2) antagonises the function of SHH-GLI I (Lee et al..
1997; Litingtung and Chiang, 2000; Ruiz, 1999).
A GLI homologue in Drosophila, Ci- I55 a full-length form is detected primarily in the
cytoplasm which is cleaved via protein kinase-A (PKA) mediated phosporylation to C-
terminal truncated nuclear form Ci-75 (Chen et aI., 1999; Jiang and Struhl, 1995: Li et
al., 1995; Price and Kalderon, 1999). Ci-75 appears to represses Hh and full-length Ci-
I55 activates pte (Aza-Blanc et aI., 1997; Methot and Basler, 1999). An important
feature of post-translational regulation of Ci by Hh is that Ci can either activate or
repress Hh targets depending on the concentration of Hh.
In vertebrate C-terminally truncated forms of both GLI2 and GLI3 proteins have been
shown to repress reporter genes expressed in cell lines or SHH target genes in vivo (Dai
et aI., 1999; Ruiz i Altaba, I999b; Shin et aI., 1999). Full-length GLI2 and to a lesser
extent GLI3 can also activate reporter gene expression in cell lines (Sasaki et aI., I999;
Shin et aI., 1999), a full-length GLI2 can also induce motoneuron differentiation in frog
embryos (Ruiz i Altaba, 1998). GLII does not appear to possess an N-terminal repressor
domain instead it functions only as an activator of transcription in its full length form
(Sasaki et aI., 1999; Shin et aI., 1999). This demonstrates that GLI2 and GLI3 to have
activator and repressor activities, while GLII may only function as an activator.
Deletion ofN-terminal sequences proximal to the zinc-finger domains in both GLI2 and
GLI3 produces proteins with a constitutive strong activation function both in vitro and
in vivo (Sasaki et al., 1999). This indicates that both GLI2 and GLI3 may have
additional regulatory domains in the N-terminai.
There is no evidence as yet whether any of the human GLI proteins are cleaved in l'i,'().
However, human GLI3 transfected into IOTI/2 mouse embryonic fibroblast cell line
produces a single full-length GLI3 band. whereas the same construct transfccted into
monkey COS cell line has shown a full-length band 170-kD, as well as a 100-kD band
(Ruiz i Altaba, 1999b). In mouse cells, human GLI3 is detected as a full-length form at
all times, but additional processed forms are observed in absence of SHH (Dai et al..
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1999). Phosphorylation of full-length GLI3 and PKA dependent cleavage of human
GLI3 to an 83-kD is observed in COS cells, PKA-dependent cleavage of human GLI3 is
also observed in mouse and chick limb buds (Pan et aI., 2006; Wang et al., 2000a).
No cleavage or phosphorylation of human GLI2 has been reported. A recent study has
shown that in mouse embryos GLI2 is proteolytically processed and this processing is
extremely inefficient, as a result the vast majority of mouse GLI2 protein is present in
the full-length form and only a small fraction exists in the processed form. Interestingly,
in addition to being processed, GLI2 is readily degraded and this degradation is
dependent on the phosphorylation of a cluster of four PKA sites as well as the PKA-
primed phosphorylation of multiple adjacent CK1 and GSK3 sites within the GLI2 C-
terminal region (Pan et aI., 2006). This study has also shown that hyperphosphorylation
of GLI2 protein creates binding sites for TrCP, which in turn conjugates the multiple
ubiquitin molecules onto the GLI2 protein and triggers the proteasorne-mediated protein
degradation. Both GLI2 processing and degradation are inhibited by SHH signalling in
vivo (Pan et aI., 2006), thus GLI2 transcriptional activity in SHH signalling may be
regulated by altering processing and degradation mechanism of GLI2. In the same study
it has been shown that at least half of GLI3 protein is processed and is present as a
transcriptional repressor.
The ratio of full-length (GLI2-185 kD) and processed form (Gli2-78 kD) is slightly
reduced in Shh mutant embryos and this ratio change is not nearly as great as that of
GLI3-190 kD to GLI3-83 kD in the presence and absence of SHH (Pan et aI., 2006).
These observations provide a molecular explanation of why GLI3 mainly exhibits a
repressor function and why its weak activator function can be detected only when GLI2
is mutated whereas GLI2 mostly acts as a transcriptional activator in mice and its weak
repressing activity can only be revealed when the GLI3 repressor function is removed
(Buttitta et aI., 2003; McDermott et aI., 2005).
Human GLI3 has been shown to both activate and repress GLI1 transcription or protein
activity (Dai et aI., 1999; Wang et aI., 2000a). GLI3 function as either an activator or
repressor of down stream genes such as Hepatocyte nuclear factor 3-beta (HNF-3fJ),
GIll, and PTCHI (Sasaki et al., 1999). Details of the mechanism of S\\ itching between
activation and repression has not yet been clearly determined, although one possible
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mechanism suggested may be the cleavage of full-length GLI3 protein to release C-
terminal activation domain and N-terminal repressor domain (Sasaki et a!., 1999).
Human GLll has been shown to contain a VP16-like, C-terminal activation domain and
activates transcription of endogenous genes such as HNF-3f3 and of reporter constructs
containing the GLll binding domains. GLII repressor functions have not been reported
(Dai et al., 1999; Lee et a!., 1997; Yoon et aI., 1998). GLII is widely expressed during
embryonic development but not in adult tissue. In contrast GLI2 and GLI3 continue to
be expressed in many adult tissues such as testes, kidney, colon and lung (Ruppert et al.,
1988). In normal epidermal skin GLI3 but not GLI 1 is expressed in keratinocytes and in
dermal fibroblast. However, GLII is only expressed in BCC and not in SCC and normal
skin (Green et a!., 1998). Human GLI2 has been shown to function as an activator only.
whereas mouse GLI2 can function as either an activator or a repressor (Ruiz i Altaba,
1999b; Sasaki et al., 1997; Sasaki et aI., 1999; Tanimura et aI., 1998).
Immunocytochemistry of several human tumour cell lines has demonstrated GLll
protein to be in both the nucleus and the cytoplasm, in varying proportions in different
cell lines (Stein et a!., 1999). Other studies have shown GLll to be in the nucleus only
in Tera-l and D259MG cell lines (Kinzler and Vogelstein, 1990a) or mainly in the
cytoplasm in basal cell carcinomas (Ghali et a!., 1999). Human GLII transfected in to
COS cells accumulates primarily in the nucleus and to a limited extent in the cytoplasm
(Dahmane et aI., 1997; Lee et a!., 1997). However, in 10Tl/2 mouse cells GLll is
localised primarily in the cytoplasm, particularly in the presence of SUFU (Stone et al.,
1999). This suggests that human GLII is shuffled between the nucleus and cytoplasm
and this may be one of mechanisms in controlling its transcriptional activity.
GL13 localisation also differed between cell lines, with mainly cytoplasmic in COS cells
(Lee et a!., 1997) and nuclear in 1OTl/2 cells (Ruiz i Altaba, 1999b). In transfected Hela
cells full-length human GL13 is in the cytoplasm and GL13 with a Pallister-Hall
syndrome (PHS) type frameshift mutation is in the nucleus, and GLl3 with Greig
syndrome (characterised by development defects of the skull, face, and limbs)
frameshift type mutation is localised in both the cytoplasm and nucleus (Shin et al..
1999). Experiments with mouse fibroblasts and frog tissues suggest that N-terminal GLI
protein motifs are targeted to the nucleus, whereas the C-terminal GLI protein motifs
are targeted to the cytoplasm (Ruiz i Altaba, 1999b)
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The discrepancies between localisation of GLI proteins in the nucleolus or cytoplasm
may be due to differences in cell type and cell cycle states. It is also unclear whether the
sub-cellular localisation of GLI proteins observed in non-human transfected cells
accurately reflects the sub-cellular localisation of human GLI in wild-type and tumour
cells.
In vertebrates GLIl and PTCHI expression are restricted to proliferating cells adjacent
to SHH expressing tissues, while GLI2 and GL13 are more broadly expressed in
proliferating cells in regions more distant to SHH, GL13 being the most distant (Hui et
aI., 1994; Marigo and Tabin, 1996; Platt et aI., 1997; Stone et al., 1996).
SHH pathway mutational studies in mice have shown that Shh and Ptchl mice mutants
have a severe embryonic phenotype that includes the absence of anterior/posterior limb
polarity, lung mesoderm, and virtually all ventral cell types for example, motoneurons
in the CNS (Chiang et aI., 1996; Goodrich et aI., 1997; Litingtung et aI., 1998). GLI 1
and SHH can induce the expression of some ventral cell types when expressed in the
dorsal CNS, whereas GLI2 and GL13 cannot (Hynes et aI., 1997; Lee et aI., 1997). GLI 1
can induce SHH targets genes and in homozygous mice that have most of the zinc-
finger domains removed (Glil zfd mutant) develop normally, indicating that the DNA
binding activity of GLIl is not required for SHH signalling during development (Matise
et aI., 1998; Park et aI., 2000). However, Gli2zfd/zfd mutants exhibit a number of defects
in the ventral CNS (Ding et aI., 1998; Matise et aI., 1998), as well as defects in
development of the vertebrate, lungs and bones (Mo et al., 1997b; Motoyama et aI.,
1998a). Most Glilzfdlzfd and cur": mutants die at birth and have CNS and lung defects
that are similar to, but less than Gli2 mutants (Park et aI., 2000). However, in Glilltlli?
double homozygotes mutants, motoneurons are induced and anterior posterior limb
patterning is largely normal (Matise et aI., 1998; Park et aI., 2000). This suggesting that
not all events that require SHH also require GLll and GLI2, these double mutant
studies also indicate that GLI2 is primarily required for induction of certain SHH
responsive cell types, while GLll is only required in certain tissues in combination with
GLI2.
A Gli3xtJ (XtJ) mutation 111 which most of G/i3 is deleted leads to extra tOI:S. this
mutation has a similar phenotype to Greig's cephalopolysyn dactyly syndrome (GCPS)
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in humans (Biesecker, 1997; Hui and Joyner, 1993; Kalff-Suske et aI., 1999; Vortkamp
et aI., 1992). Certain aspects of the phenotype of Gli3-xtJ mutants indicate a role for
GLI3 in the repression of SHH expression in the developing CNS and limbs (Biesecker,
1997; Marigo et aI., 1996b; Ruiz i Altaba, 1998). However, in vitro GLI3 can activate
transcription through a Glil promoter region (Dai et aI., 1999). Gli2+/-; Gli3-/- double
mutants have more severe skeletal abnormalities than either mutant alone (Mo et al.,
1997b), and in Glil/Gli2 double homozygotes, the lungs are more severely affected than
in either single mutant (Park et aI., 2000). If GLI proteins represent both positive and
negative functions like the Ci in Drosophila, then in the CNS GLII may function only
as an activator which is sufficient, and this function could be made redundant with
activation functions of GLI2 and GLI3. Also repressor function of GLI2 in the dorsal
CNS could be made redundant by GLI3.
Analysis of HH-dependent regulatory regions for the wingless (wg) gene in flies and the
Coup-TFII (see section 1.3.7) gene in mice has revealed that they do not contain
consensus Ci binding sites (Krishnan et al., 1997; Lessing and Nusse, 1998) and SHH-
dependent activation of the motoneuron specific CoupTFII promoter appears to involve
a PP-2A-like phosphatase (Krishnan et aI., 1997). Double mutants of Glil /Gli2,
Gli2/Gli3 and Glil/Gli3 are less severely affected than SHh mutants and in most tissues
except lungs, GLI2 and GLI3 are expressed widely in many regions of the embryo that
are far from SHH sources (Hui et aI., 1994; Matise et aI., 1998; Mo et aI., 1997b; Park
et aI., 2000). In addition, defects in GLI2 and GLI3 mutant mice are found in some
regions of the embryo that are not likely to result from loss of SHH signalling (Grindley
et aI., 1997). Thus, these studies suggest that there is a possibility that GLl genes
possess activities independent of SHH signalling and there may be GLI independent
SHH pathway.
1.3.6 Suppressor-Fused.
Little is known about the signalling pathway between the PTCH and SMO response to
the SHH and expression of GLI1. In Drosophila the serine-threonine kinase Fused (Fu),
the kinesin-related protein Costal-2 (Cos-2) interacts physical with microtubules.
However, Cos-2 and Fu have not yet been demonstrated in vertebrates. The only
cytoplasmic element that has been shown to function upstream of the GLI genes in
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human cells is Suppressor of Fused (SUFU), which cooperates with the F box-
containing protein Slimb to inhibit transactivation by GLII (Stone et al.. 1999). SUFU
inhibits SHH induced osteogenic differentiation and retain GLII in the cytoplasm
(Kogerman et al., 1999). It is not clear if SUFU acts immediately down-stream of PTCH
in the SHH-pathway or is independent regulator of GLI mediated signalling. Children
with medulloblastoma carry germline and somatic mutations in SUFU accompanied by
loss of hetrozygosity of the wild-type allele (Taylor et al., 2002). This indicates that
SUFU is a human tumour-suppressor gene most likely because of its normal role as a
negative regulator of hedgehog signalling.
1.3.7 Chicken Ovalbumin Upstream Promoter Transcription Factor II
(COUP-TFII).
All effects of SHH may not be mediated vial GLI1, this is suggested by the observation
that SHH can directly induce transcription of the orphan receptors COUP-TFII via a
regulatory sequence lacking GLI binding sites (Krishnan et al., 1997). COUP-TFIl
transcription factors belonging to the nuclear receptor super-family which plays a major
role in development and differentiation in regulating angiogenesis and vein identity
(Pereira et al., 1999; Tsai and Tsai, 1997; You et al., 2005a), in addition, it plays an
important role in organ development such as stomach, limb, heart and diaphragm (Lee
et al., 2004; Pereira et al., 1999; Takamoto et al., 2005; You et al., 2005b). These
receptors are initially expressed in all three germ layers and subsequently their
expression is restricted to organs that require mesenchymal-epithelial interaction for
organogenesis (Pereira et al., 1999; Tsai and Tsai, 1997; You et al., 2005a). COUP-TFs
are induced during differentiation of embryonic carcinoma cells by retinoic acid (Ben-
Shushan et al., 1995), suggesting their requirement in differentiated cells. Expression of
COUP-TFII is substantially lower in 30% of breast cancer cell lines (Nakshatri et al..
2000) and there are no reports on its expression levels in BCC.
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1.3.8 TFIID.
Initiation of transcription is a key regulatory step affecting gene expression in response
to a variety of extra and intracellular signals, during developmental processes and for
tissue specificity. The rate of transcription initiation is determined by enhancer elements
that are bound by gene-specific transcription factors. They typically consist of a DNA
binding domain and one or more activation (or repression) domains. The transcription
initiation site is determined by core promoter elements that direct the assembly of
general transcription factors (GTFs) and RNA polymerase II to form the pre-initiation
complex (PIC). The general transcription factor TFIID plays an essential role in
transcription initiation as it recognises and binds the core promoter and keeps PIC
assembly in the nucleus. In addition, TFIID plays an important role in mediating
transcription activation signals by gene specific activators (Rashevsky-Finkel et al.,
2001). Studies of transcriptional regulatory properties of GLI have identified
contributions of specific domains to transcriptional regulation. GLI transcription
activation domain is identified at the carboxyl terminus of the protein. This includes an
18 amino acid acidic-helix, highly similar to the herpes simplex viral protein 16 (VP16)
transcription activation domain, which targets TAFII 31 in human Hela cells and in
Drosophila targets TAFII 40 (Goodrich et al., 1993; Uesugi et aI., 1997; Yoon et al.,
1998).
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1.4.0 Retroviral gene expression.
Much of our understanding of how biological pathways function and what are the key
components and how they interact with other pathways has come from trying to isolate
and identify the component and then deleting or inducing its function or expression.
Using standard plasmid based transfection, transfection efficiency of pnrnary
keratinocytes is very low and they are difficult to transfect. In order to overcome the
limitation of plasmid based transfection retroviral expression vector are used. The
advantage of using a retrovirus as a gene delivery system is that the transduction
efficiency is much higher, almost 1000/0. Also expression systems based on retroviral
gene del ivery are generally more reliable and have broader usefulness than standard
plasmid-based transfection systems. Retroviral gene delivery systems are also used for
cells that are difficult to transfect. Retroviral DNA integrates into actively transcribing
regions of the host genome efficiently, with no internal rearrangement of the gene of
interest, resulting in reliable and heritable expression, without variability or loss of
expression due to loss of construct. The infection yields a cell line that stably expresses
gene of interest.
1.4.1 Retroviral Structure and Genomic Organisation.
Retrovirus particles range in size from 80-120 nm in diameter and consist of an outer
envelope lipid bilayer and virus encoded proteins. The protein core of the virus consists
of viral replication enzymes and the viral RNA genome. The RNA genome consists of
two copies of linear single-stranded (sense) RNA linked by 7-11 bp regions near the 5'
termini (Beemon et a\., 1974; Billeter et al., 1994; Kung et al., 1975). Retroviruses are
divided into two categories based on the complexity of their genomes, simple or
complex. RNA of simple retroviruses consists of three major coding domains gag. pol.
env and a smaller domain pro. Figure 1.18 shows the genomic structure of the
retrovirus and the changes that occur from RNA retrovirus sequence to host integrated
DNA form.
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Changes in the retrovirus sequence
RNA sequence
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-2100 -1100 171.1260' 10·801Reverse transcribed
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gag
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Figure 1.18: Showing the genomic structure of the retrovirus and the changes that take
place during integration in to the host genome. The RNA virus sequence is reverse
transcribed to a linear DNA form. The retroviral genome is flanked by a Long Terminal
Repeat sequence (LTR). This region contains enhancer, promoter, transcription initiation,
transcription terminator and polyadenylation signal. The integrated provirus has two LTRs;
the 5' LTR normally acts as an RNA polymerase II promoter whereas the 3' LTR functions
as the terminator sequence. An LTR is composed of U3, Rand U5 regions. U3 includes
most of the transcriptional control elements and carries the promoter/enhancer sequence; it
is the first part of the genome to be reverse-transcribed, forming the 3' end of the provirus
genome. R region provides the sequence homology for strand transfer during reverse
transcription of the RNA genome.U5 region carries the poly A-site and, together with the
R region, determines the poly-A addition. Both U3 and U5 regions contain the ATT sites
required for integration. In addition, the retroviral genome has a non-translated region
downstream of the transcription start site at 5' end of the virus RNA, which is responsible
for initiating (+) strand synthesis during reverse transcription to form a linear DNA form
this is then integrated in to the host genome (Figure adopted from Clontech web site)..
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1.4.2 Retroviral replication.
Retroviral replication is a multi-step process. In brief, retroviruses enter the host cell
through attachment of their surface glycoproteins to specific plasma membrane
receptors leading to fusion of virus with the cell membranes. The RNA is then reverse
transcribed into double stranded DNA. Reverse transcription of the RNA involves two
jumps of the reverse transcriptase from the 5' end to the 3' end of the template RNA,
The process results in the duplication of the LTRs at the 5' and 3' ends of the viral DNA
that regulates viral gene expression. The DNA is translocated into the nucleus where it
is inserted into the host genome by the viral integrase. The integrated viral DNA is
known as the provirus. The provirus can be transcribed and expressed like any cellular
gene by host cell RNA polymerase II. Transcription is regulated by the viral LTR
through interactions with cellular trans-activating factors. Viral RNA is translated by
cellular ribosomes, and translation products together with progeny RNA are packaged
into viral particles and released from the cell via budding of the plasma membrane (see
Figure 1.19).
1.4.3 Retroviral vector as gene delivery tool.
Retroviruses have been widely used as gene delivery tools. Because the retroviral
genome inserts into the host cell genome following infection, it can be utilized as a
permanent gene delivery vehicle. It allows the viral genome to be maintained for the life
of the cell. The advantages of retroviral vector gene delivery are. 1) The ability to
transduce a variety of cell types. 2) The ability to integrate efficiently into the genomic
DNA of the dividing or mitotically active recipient cell. 3) The ability to express the
transduced gene at high levels. 4) Capacity for long-term persistence and stable
transmission of the gene to all future progeny of the transduced cell. 5) Up to 6.5 kb of
foreign gene sequence can be packaged in a retroviral vector, which is adequate for
most applications. 6) Ability to be manufactured in large quantities to meet verx
stringent safety specifications.
One of the key factor in using a retrovirus as a gene delivery vehicle is biological safer, ,
This is overcome by designing vectors that produce replication incompetent virus, This
is possible by separating the packaging function from the genetic material t\) be
transferred. A basic retroviral vector is designed that contains the Cis-acting elements
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required for replication as a virus, but lacks some or all of the viral genes. which are
replaced by gene of interest. For a retroviral vector to replicate as a virus, it is necessary
to provide the missing viral gene(s), these are provided in Trans, by a specially
engineered cell lines that express the essential viral genes gag, pol and env, from
heterologous promoters. The genetically-engineered cell lines are called packaging cell
Iines (see Figure 1.20). This minimises the chance of generating a replication
competent virus (RCR). Gene transfer and expression by a retroviral vector is called
transduction to distinguish the process from infection.
1.4.4 Self Inactivating retroviral vectors.
Self Inactivating (SIN) retroviral vectors are engineered so that transcription of the
target gene can only be driven by an internal promoter (Miyoshi et al., 1998), once the
expression cassette is integrated into the host genome. These vectors are constructed by
deleting the enhancer and/or the promoter in the U3 region of the 3' LTR. During
reverse transcription, a circular intermediate is formed that transfers the deletion to the
5' LTR of the proviral DNA. The deletion abolishes any transcriptional activity driven
by the LTR so that no full-length vector RNA is produced in the transduced cells.
Following a single round of replication, the changes are copied into both 5' and 3' LTRs
resulting in inactive provirus. In this way, expression of a gene of interest is driven by
the internal promoter.
There are several major advantages in using self inactivating retroviral vector. It
minimizes the risk of producing replication competent retrovirus. It also reduces the
likelihood that cellular coding sequences located adjacent to the vector integration site
will be aberrantly expressed, either due to the promoter activity of the 3' LTR or
through an enhancer effect. Finally, a potential transcriptional interference bet» ecn the
LTR and the internal promoter driving the transgene is prevented by using the SIN-
retroviral vector.
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Figure 1.19: An over view of retroviraI replication. Retroviruses particle enter the host cell
through attachment of their surface glycoproteins to specific plasma membrane receptor
leading to fusion of virus with the cell membrane. The RNA is then reverse transcribed into
double stranded DNA. The DNA is translocated into the nucleus where it is inserted into
the host genome. The integrated viral DNA is transcribed and expressed like any cellular
gene by host cell RNA polymerase II. Viral RNA is translated by cellular ribosome , and
translation products together with progeny RNA are assembled into viral particle and
released from the cell via budding of the plasma membrane (Figure adopted from lontech
web site).
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Figure 1.20 Basic principles of retroviral transduction. Self Inactivating retroviral vector
which has a deletion in 3 'LTR and lacks the essential viral genes but containing the internal
promoter (Miyoshi et al., 1998) and the gene x is transfected into the packaging cell line
that express the essential viral genes x. The IP-gene x integrate into host genome and i
transcribed into retroviral RNA, this is then assembled into retroviral particle u ing the
viral structural proteins expressed in packaging cell. The viral particles containing the gene
x are used to transduce target cells to express gene x. (Figure adopted from lontech web
site).
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Aim of this study.
Although the sonic hedgehog pathway is well characterised in Drosophila and murine
not much is known about this pathway in humans particularl', with regards to Bee
formation, the aims of this study were;
1. To investigate SOniC hedgehog signalling pathway gene expression In BCC.
Normal Skin and in GLll trnsduced human primary keratinocytes and quantify
levels of their expression.
2. Determine the localisation of GLI2 in normal human skin and BeC and its
expression in GLII trnsduced human primary keratinocytes.
3. Determine the localisation of FOXE1 a down stream target of GLI2 in normal
skin and BCC.
4. Determine the Effects of EGF on pattern of gene expression in GLll expressing
keratinocytes.
5. Generation of a Zp3-Cre-GLI 1 transgenic mouse model system to understand
GLII molecular mechanism in vivo.
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2.1.0 Cell Culture.
To avoid cross contamination of cell cultures and contamination of cell cultures from
micro-organisms. Standard sterile tissue culture techniques (practiced in all tissue
culture laboratories) were used when handling all cell types described below.
2.1.1 Mouse 3T3 fibroblast cell line (feeder layer).
The mouse Swiss 3T3 fibroblast cell line was obtained from the Imperial Cancer
Research Fund (lCRF) now Cancer Research UK (CRUK). This cell line was
established by G. Todaro and H Green in 1962 from disaggregated embryos of Swiss
mouse (Todaro and Green, 1963). The cells were cultured in T175 ern" polystyrene
tissue culture flasks (Corning, VWR International Ltd., Leicester, UK.) with Dulbeccos
Eagle's Medium (DMEM) (obtained form CRUK) supplemented with 10% (v/v) foetal
calf serum (FCS) (PAA laboratories GmbH, Austria) and 2 mM L-glutamine (obtained
from CRUK). The Flasks were incubated at 37°C in a humidified 10% CO2 90% air
atmosphere, the medium was changed twice weekly. When cells reached confluence,
they were passaged to prevent contact growth inhibition.
Confluent T175 flask of 3T3 fibroblasts were passaged by aspirating the old culture
medium from the flasks and 5 ml 0.02% ethylenediaminotetra-acetic acid (EDTA) (w/v)
(obtained from CRUK.) was added to the flasks to wash the cells. The addition of
0.020/0 EDTA to the flasks primarily chelates divalent cations (calcium and magnesium
ions). This results in the weakening of the adhesiveness of cells to each other and to the
flask. This also prevents cationic inhibition of trypsin activity. The 0.02% EDTA
solution was aspirated and 5 ml of 0.05% (v/v) trypsin solution (obtained from CRUK.)
in 0.020/0 EDTA (prepared by dilution of 1 part of 250/0 wlv trypsin and -+ parts of 0.02%
EDTA) was added to the flasks. The flask was incubated at 37°C in 10% CO2 for 3 to 5
min. Incubation with trypsin cleaves extracellular cell adhesion proteins required for
cell to cell attachment and cell to flask attachment. Detachment of cells was also aided
by tapping the sides of the flasks gently with hand. Once the cells had detached from the
flask, 5 ml of (DMEM) culture medium containing 100/0 (v/v) FCS \\ as added to the
flask to inhibit the protease activity of trypsin. Leaving the cells too long in trypsin is
harmful to the cells. 8 ml cell suspension was transferred to a 50 ml centrifuge tube
(Falcon, BD Biosciences Oxford, UK.) and centrifuged at 1.000 rpm for 5 min at room
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temperature using the IEC 215A rotor centrifuge. After removing the supernatant. the
cell pellet was resuspended in 20 ml of the culture medium. The concentration of cell
suspension was determined by pipetting 20 III of cell suspension under the coxer slip of
a Neubauer haemocytometer (Weber Scientific International, West Sussex, UK.). Cell
concentration was calculated by taking an average of cell count in each of four ~ x ~
square grids under the microscope. The average number was then multipl ied by IO~ to
give number of cells per ml. To the remaining 2 ml of cell suspension left in the flask 38
ml of (OMEM) culture medium containing 100/0 FCS was added and incubated at 37''('
in a humidified 100/0 CO2, 90% air atmosphere, to maintain culture stocks of 3T3
fibroblasts.
3T3 fibroblast cell suspension in a 50 ml centrifuge tube was Gamma irradiated with
6,000 rads (cobalt'") for 32 min. Gamma radiation suppress 3T3 fibroblast cell division
but allows active cell metabolism. Irradiated 3T3 fibroblasts secret extra cellular matrix
(ECM) proteins and growth factors, The ECM proteins encourage keratinocyte
attachment and growth factors stimulate their proliferation (Rheinwald, 1980), thus
Gamma irradiated 3T3 mouse fibroblasts act as feeder layer for keratinocytes. Gamma
irradiated 3T3 mouse fibroblasts were seeded at a density of 2 x 106/15 ml in T75 cm2
flask (Corning, VWR International Ltd., Leicester, UK.) in keratinocyte culture medium
(OMEM and Ham's F12 medium in ratio of 3:1, 10% v/v FCS, OAllg/ml
hydrocortisone, 10-10 M cholera toxin, 5 ug/rnl insulin, 5 ug/rnl transferrin and 2x Io-
Il M Iyothyronine). The cells were allowed to attach for 2 hours to the surface of the
flask in a humidified 100/0 CO2, 900/0 air atmosphere. Keratinocytes can be added at the
same time as feeders or after the feeders have attached to the flask. Irradiated feeders
unused were stored at 4°C for up to two days, after which they discarded.
The 3T3 mouse fibroblast were routinely split at a 1:5 ratio twice a week and \\ere
maintained in culture for 8 to 12 weeks after which they tended to transform or senesce
and were no longer efficient as feeder layers for keratinocyte cultures. Fresh stocks of
early passage of 3T3 mouse Fibroblast feeder cell were routinely supplied from CRUK.
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2.1.2 Isolation of primary keratinocytes from human skin.
Human epidermal keratinocytes were isolated from discarded breast and abdominal skin
obtained from plastic surgery, foreskins from circumcisions and facial skin from facelift
operations. Ethical committee approval was obtained (ethics number: T/01/034) as well
as informed consent from the patient for the use of the redundant skin for scientific
research.
The skin specimen collected was transported from the theatre to the laboratory in
transport medium (DMEM supplemented with 5% (v/v) FCS and antibiotic mix
consisting of a cocktail of 600 units/ml Penicillin-G, 600 ug/rnl Streptomycin sulphate,
250 ug/rnl Gentamycin sulphate (Sigma, Poole, UK.) and 2.5 ug/rnl Fungizone
(Invitrogen Life technologies, UK.). The skin was processed on the same day or stored
overnight at 4°C. However, the latter resulted in reduced cell viability.
The isolation of primary keratinocytes was carried out as described by (Rheinwald and
Green, 1975a) with some modifications. All excess dermis and connective tissue were
removed from the skin specimen. For small skin biopsies a scissors was used to remove
excess dermis and connective tissue, for large skin samples a dermatome or a skin graft
knife was used. Following removal of connective tissue the skin pieces were washed in
0.020/0 (w/v) EDTA, and then cut or minced into tiny pieces less than 0.5 mm' in size.
The tissue was then transferred into 0.25% (w/v) trypsin solution and incubated at 37°C
for I-2 hours, agitating every 30 min. Following incubation with trypsin solution, all
contents were transferred to a 50 ml centrifuge tube and equal volumes of Ready Mix
minus (RM-) medium (DMEM and Ham's FI2 in ratio of3:1, with 10% (v/v) FCS and
2 mM glutamine and the following supplements: 0.4 ug/ml hydrocortisone, 10- l oM
cholera toxin, 5 ug/rnl transferrin, 2 x 10-11M Iyothyronine and 5 ug/rnl insulin (all
supplied by Sigma, UK.) were added. The centrifuge tube was shaken vigorously for a
few min and then the contents were transferred to a clean tube by filtering through a
sterile sieve or cell strainer. The filtrate predominantly contained primary keratinocyics
and the solid skin debris left beHind in the strainer contained fibroblasts and the dermis.
The 50 ml centrifuge tube containing the filtrate was centrifuged at 1.000 rpm for ~ min
and the supernatant was aspirated. Fresh 30 mI RM- medium containing 10% (\ /v) FCS
was added to the pellet and a single cell suspension was prepared by gentle pipetting the
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medium up and down. 300 III of this suspension was mixed with 300 III trypan blue
stain (Invitrogen Life technologies, UK.). 20 III of cell suspension and the blue d) e mix
was placed under the cover slip of the haemocytometer. Using the 111 icroscope viable
cells were identified by their ability to exclude the blue dye, cells that stained blue were
identified as dead cells. Only viable cells were counted in each of four -+ x -+ square
grids and cell concentration was calculated by taking an average of cell count in each of
four 4 x 4 square grids. The average number of cells was then multiplied by 104 and by
the dilution factor (2) to give number of cells per ml. Primary keratinocytes were seeded
at a density of approximately 2 x 106 cells in a T75 ern" flasks on Gamma irradiated
3T3 feeder cells (see section 2.1.1) in a RM- (Reday Mix minus epidermal growth
factor [EGF], see Appendix II, Dulbecco-Vogt Egles Medium [OMEM] and Ham's
F12 in ratio of 3:1 supplemented with 10% FCS and 2 mM glutamine and the following
supplements: 0.4 ug/ml hydrocortisone, 10- loM cholera toxin, 5 ug/ml transferrin, :2 x
10-11M lyothyronine, 5 ug/ml insulin [Sigma Poole, UK]) culture medium and incubated
at 37°C in a humidified 10% CO2, 90% air atmosphere for 48 hours. After which
medium was aspirated and replaced with RM+ (Reday Mix plus EGF, see Appendix II,
oMEM and Ham's F12 in ratio of 3:1 supplemented with 10% FCS and 2 mM
glutamine and the following supplements: 0.4 ug/ml hydrocortisone, 10- loM cholera
toxin, 5 ug/ml transferrin, 2 x 10-11M lyothyronine, 5 ug/rnl insulin [Sigma Poole, UK],
10ng/ml EGF [Serote, Oxford, UK]) culture medium. RM+ culture medium was
changed two to three times weekly and the 3T3 feeder density was maintained by
adding more irradiated 3T3 feeders when existing feeder cells become sparse. Primary
keratinocytes grew as tightly packed rounded colonies and once they grow to more than
750/0 confluent they start to differentiate and stratify. Growth rate of primary
keratinocytes also slows down after 8 to 11 days even if they do not reach 75%
confluent. Therefore, to maintain maximum growth rate and prevent them
differentiating, keratinocytes were subcultured before they reached 75% confluent or if
they were cultured for 8 to 11 days.
2.1.3 Passaging keratinocyte cultures.
Keratinocvics were passaged by aspirating the culture medium and washing the (ells
with 5 III I phosphate-buffered saline (PBS) (calcium/magnesium-free) and then with 5
III I of 0.020/0 (w/v) EOTA. 3T3 feeder cells were removed by incubating with ~ ml
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0.050/0 (v/v) trypsin in 0.02% (w/v) EDTA (1 part 0.25% trypsin with -+ parts 0.02%
EDTA) at 37°C in 100/0 CO2, 90% air atmosphere for 30-60 sec. Alternatively, 5 ml of
0.02% (w/v) EDTA only was added and flasks incubated at 37°C in 10% CO2• 90% air
atmosphere for about 10-15 min. Once feeders were removed, 5 ml of 0.05% (v/v)
trypsin in 0.020/0 (w/v) EDTA was added to the flasks before incubating at 37°C in 10° a
CO2, 900/0 air atmosphere for 5 to 15 min. Once keratinocytes appear rounded up. side
of the flask was taped with hand to detach them from the flask. Then equal volume (5
ml) of RM+ culture medium containing 10% (v/v) FCS was added to the flask to
neutralise trypsin activity. Cell suspension was then transferred to 50 ml centrifuge tube
and centrifuged at 1,000 rpm for 5 min. Following this, the supernatant was aspirated
and fresh RM+ culture medium containing 10% (v/v) FCS was added to the cell pellet.
Using a haemocytometer cell concentration was determined as described above. The
primary keratinocytes were routinely split at a ratio of 1:5 T75 cm2 flasks and plated
with fresh Gamma irradiated 3T3 feeders as described above. Passages number one to
three were used for experiments.
2.1.4 Removal of fibroblast contamination in keratinocyte cultures.
The addition of 3T3 feeder cells discourages the growth of dermal fibroblast in
keratinocyte cultures. However, if density of 3T3 feeders is low, fibroblast
contamination can occur. To remove the dermis fibroblasts, the flask was washed once
in 0.020/0 (w/v) EDTA and then trypsinised with 0.05% (v/v) trypsin in 0.02% (w/v)
EDTA at 37°C in 10% CO2, 90% air atmosphere for 30-60 sec or until the 3T3 feeders
and the human fibroblasts had detached from the flask. Tapping the side of flask gentl)
aided the detachment of the fibroblasts and 3T3 feeders. Contaminating fibroblasts and
the 3T3 feeders detached from the flask very easily whereas the keratinocytes remain
attached. Once the fibroblasts had detached, trypsin reaction was neutralised by adding
equal volume of RM+ culture medium containing 10% (v/v) FCS and the media
containing the fibroblast and 3T3 feeder cells was aspirated. The keratinocytes were
cultured, by adding fresh Gamma irradiated 3T3 feeders and RM+ culture medium
containing 10% (v/v) FCS to the flask as described above. This was repeated unti I no
fibroblast contamination was observed.
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2.1.5 HaCat, A375 and N-TERT-keratinocyte cells.
Spontaneously immortalised primary keratinocytes HaCat cell line were obtained from
CRUK and N-TERT immortalised keratinocytes were (gift from Dr J. Rheinwald). The)
were cultured in DMEM/F 12 medium (CRUK) supplemented with 10% (v/v) FCS and
2 mM glutamine medium with out the 3T3 feeders. A375 melanoma cell line was also
obtained from CRUK, A375 cell line was cultured in DMEM medium (CRUK)
supplemented with 100/0 (v/v) FCS and 2 mM glutamine. All cell lines were incubated at
37°C in 10% CO2, 900/0 air atmosphere, and cultures and stocks were maintained as
described in section 2.1.1 to 2.1.3.
2.1.6 Freezing and recovery of cells.
To maintain cell stocks for experiments, the majority of the cells were cryo-preserved at
each passage. Cells were detached from the flasks using trypsin as described above and
centrifuged to obtain cell pellet. The cell pellet was resuspended in 10% (v/v)
dimethylsulphoxide (OMSO) (SOH Laboratories Supplies, Poole, Dorset, UK), 90%
(v/v) FCS to give a concentration of 2x106 cells /m!. One ml of DMSO/FCS cell
suspension was placed in 1.8 ml freezing cryogenic vial (Sigma UK). To ensure a
constant cooling rate of 1°C/min, the cryovials containing cells were transferred to
isopropyl freezing container (NALGENE Cryo 1°C Freezing Container, SOH
Laboratories Supplies, UK) and stored at -70°C for 24 hours. The cryovials were then
transferred to liquid nitrogen for long term storage. This two step procedure is essential
for cells to survive cryopreservation.
Frozen cells were recovered by thawing the DMSO/FCS cell suspension rapidly, by
incubating at 37°C. The vial was swabbed with 70% (v/v) ethanol before opening. The
DMSO/FCS cell suspension was immediately transferred into 5 ml culture medium in a
15 ml Falcon tube and mixed to avoid toxicity from the DMSO. The cells were
centrifuged at 1,000 rpm for 5 min, the supernatant was discarded and the cell pellet
resuspended in a fresh culture medium. Cells were plated at appropriate density and
cultured as described in sections 2.1.1 to 2.1.5.
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2.2.0 Retroviral transduction.
Most of the work done in this section was part of collaboration work carried out with
other group members headed by Professor Anthony Quinn and later by Professor \ Iike
Philpott. All of the cloning and transduction work described in this section was carried
out by Dr Graham Neill.
Dr J Green in this lab showed that GLII is induced in human BCC (Green et al., 1998),
in order to understand what role GLII transcription factor plays in BCC formation a
full-length GLIl mRNA in bluescript vector cloned form Glioma (Gift form K \\"
Kinzler) was cloned into a pcDNA3.1-His vector by Dr J Green to generate pcDNA3.I-
His-GLI plasmid, this was then transfected into the human primary keratinocytes using
standard liposome-mediated transfection reagents to induce GLII expression. The
transfection efficiency was low and primary keratinocytes were also difficult to
transfect. In order to overcome the limitation of plasmid based transfection. Full-length
GLIl /GLI2, were cloned into a SIN-IP-GFP (Self Inactivating Internal Promoter Green
Fluorescence Protein vector gift from P Khavari USA) retroviral expression vector by
Dr G Neill.
2.2.1 Generating SIN-EGFP/GLIl fusion protein retroviral construct.
Full-length GLII was cloned in to a Self Inactivating Internal Promoter Green
Fluorescence Protein (SIN-IP-GFP) retroviral vector (gift from P Khavari) by Dr
Graham Neill. A brief out line of the protocols is as follows, Enhanced Green
Fluorescent (pEGFP-C3) plasmid (Cat No 6082, Clontech) was modified by cloning an
adaptor containing a Sail site into the vector AseI site. Full-length GLI I cDNA was
amplified by PCR with sense primer 5'-GACAGAGTGTCGACACACCCT-3' and anti-
sense primer 5'-GATTCCCTACTCTTTTAGGCA-3' and after digesting with Sacl and
HindIII was cloned into the modified pEGFP-C3 vector at Sacl, Hindlll site to create
pEGFP-GLII-C3 construct. A retroviral fusion EGFP/GLI 1 expression construct \\ as
generated by digesting pEGFP-GLII-C3 vector with SaIl and Hindlll to cut out the
CMV-EGFP-GLll sequence. The retroviral vector SIN-IP-GFP was digested \\ ith
XhoI/NotI to excise the CMV-GFP sequence to create (SIN-IP). C\l\'-EGFP-GLI I \\as
then cloned into SIN-IP at XhoI and NotI site to create SI1'\-EGFP-GLI 1 retroviral
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vector (see Figure 2.1). A control construct SIN-EGFP was also generated. Both SI~­
EGFP-GLII and SIN-EGFP constructs were verified by DNA sequencing.
2.2.2 Generating SIN-GLI-EGFP bicistronic retroviral constructs.
GLI I-Internal-Ribosomal-Entry-Sequence-Enhanced-Green-Fluorescence-Protein
(GLII-IRES-EGFP) bicistronic construct was cloned into a SIN-IP-GFP retroviral
vector by Dr Graham Neill. A brief description on how this was carried out is as
follows, GLI I-IRES-EGFP was generate by modifying pIRES2-EGFP plasmid (Cat No
6029.1, Clontech) by cloning an adapter containing a Sail site into the vector AseI site
to create pI2E-A. GLII coding cDNA was amplified by PCR with the sense primer 5'-
GACAGAGTGTCGACACACCCT-3' and antisense pruner 5'-
GATTCCCTACTCTTTTAGGCA-3' and after digestion with Sail was cloned into
pI2E-A at the XhoI/SmaI sites creating pI2E-A-GLI I. To generate the retroviral
bicistronic GLI2-EGFP expression construct, N-terminally HIS-tagged GLI2 (Gift form
Dr Fritz Aberger) was cloned into XhoI/SmaI site of pI2E-A to generate pI2E-A-GLI2
construct. Both pI2E-A-GLll and pI2E-A-GLI2 were digested with Sall/Notl to isolate
the CMV -GLI l-IRES-EGFP and CMV-GLI2-IRES-EGFP sequence. Retroviral vector
SIN-IP-GFP was digested with Xhol/Notl to excise the CMV-GFP sequence to generate
SIN-IP. CMV-GLII-IRES-EGFP, CMV-GLI2-IRES-EGFP and CMV-IRES-EGFP
were cloned into Xhol/Notl digested SIN-IP creating SIN-GLII-IRES-EGFP, SIN-
GLI2-IRES-EGFP and SIN-IRES-EGFP (control) constructs (see Figure 2.2). All
constructs were verified by DNA sequencing. Figure 2.3 showes GIll constructs used
to transform baby rat kidney cell line and GIll construct used to transduce human
primary keratinocytes and also expected mRNA transcripts from these cell lines.
2.2.3 Generating a SIN-GLIl-mutated Nuclear Localization Signal (mNLS)
construct.
GLll coding cDNA was cloned into pEGFP-C3 (Clontech) to create pEGFP-GLI I b)
Dr Judith Green. A brief description of the protocol is as follows. Quick Change Site-
Directed Mutagenesis Kit (Stratagene) was used to mutate GLI l-Nuclear-Localisation-
Signal (NLSI. NLS2 and NLS3) to generate pEGFP-GLII-mutated-:\uclear-
Local isation-Signal (pEGFP-G L11-mNLS). GLII-Nuclear-Export-Sequence \\ as also
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muted to generate pEGFP-GLII-mutated-Nuclear-Export-Signal (pEGFP-GLII-
mNES).
The mutated residues and their positions are shown in Table: 2.1. Retroviral plasmids
SIN-EGFP-GLIl-mNLS and SIN-EGFP-GLII-mNES (see Figure 204) \\ ere created by
sub-cloning of the CMV-EGFP-GLII-mNLS and SIN-EGFP-GLII-mNES regions from
pEGFP-GLIl-mNLS and pEGFP-GLIl-mNES in to SIN-IP-GFP retroviral vector as
described in section 2.2.2 above.
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Table 2.1 : Showing the amino acid residues of GLIl nuclear localisation signals
(NLS1, 2 and 3) and nuclear export signal (NES) and the positions of the residues
mutated
Wild type residue Mutated residue Positions of residues mutated
sequence sequence
NLS1 RKHVKT LIHVMT 380,381,384
- -
NLS2 KRHRGD KLHLGD 396,398
- -
NLS3 PKREREG PKSELEG 415,418
NES LENLRL VENVRV 498,501,503
- - -
SIN-EGFP-GLll-mNLS
Transcription
start point
.....-----" T, + ...-- 1-
LTR '.I." CMV-590bp
ATG
IDNA binding domain
~
GLIl-3.6Kb
!NLS1 NLS2 LS3
!JHVMT , KbH~GD PK§E~EG
Figure 2.4: SIN-EGFP-GLIl-mNLS (mutated-Nuclear-Localisation-Signal) construct.
The positions of the cloning sites and the amino acid residue sequence of m L
regions,
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2.2.4 Generating retroviral particles in packaging cell line.
Retrovirus encoding SIN-EGFP-GLI 1, SIN-EGFP-GLIl-mNLS. SIN-EGFP-GLll-
mNES, SIN-GLI2-EGFP, and SIN-EGFP (from sections 2.2.1, 2.2.2 and 2.2.3) were
produced by Dr Graham Neill using the packaging line Phoenix-HEK-293 'I-based cells
(Amphotropic form) derived from highly transfectable mammalian foetal kidney
epithelial cells (Clonetech) as previously described by (Oeng et al., 1997). Arnphotropic
form of virus replicates in cells of BOTH the natural host and foreign origin. Phoenix-A
packaging cells were seeded at density of 1.5 x 106 cells/60-mm plate in a 15 ml
Oulbecco's Modified Eagle's Medium (OMEM, Sigma Cat. No. 05796) supplemented
with (l00 units/ml penicillin G sodium, 1Ouug/ml streptomycin, 4mM L-glutamine.
ImM sodium pyruvate and 10% (v/v) foetal bovine serum) and incubate at 3T'C in 5%
CO2 950/0 air atmosphere for 18-24 hours.
The media was removed and replaced with fresh 15 ml supplemented OMEM medium
before adding the transfecting reagent, 200 ul OMEM with no supplements, 25 ~I
FuGENE® 6 Transfection Reagent (Cat No 1181509100I, Roche Diagnostics)
containing 10 ug of retroviral vector (from sections 2.2.1, 2.2.2 and 2.2.3) and
incubated at 37°C in 5% CO2 95% air atmosphere for 24 hours. The transfection media
was removed and fresh OMEM media supplemented with (100 units/ml penicillin G
sodium, 100 ug/rnl streptomycin, 4mM L-glutamine, ImM sodium pyruvate, 10% (v/v)
foetal bovine serum and l-Zug/rnl puromycin) was added and incubated at 37°C in 5%
CO2 95% air atmosphere, to select for transfected Phoenix-HEK-293 cells. Upon
confluence the cells were incubated in 4ml fresh medium with out puromycin at 32°C in
50/0 CO2 95% air atmosphere for 24 hours, after which the medium containing the viral
particles was removed and filtered through a 0.45-~m filter to remove any debris.
Filtered medium containing the virus was snap frozen in liquid nitrogen in 15 ml Falcon
tubes and stored at -80°C. Viruses were harvested from same cell cultures 2 or 3 times.
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2.2.5 Transducing primary and N/TERT keratinocytes.
Primary keratinocytes (from section 2.1.2) were given to Dr Graham Neill to transduce
with retroviral particles generated from the packaging cell line (from section 2.2A) as
described by (Deng et aI., 1997). In brief for gene expression and morphological
analysis, 1xl 05 keratinocytes were seeded in 6-well plates in 2ml defined keratinocyte
culture medium (Cat No 10744-019 Invotrogen) supplemented with growth
supplements (l0% v/v FCS) and incubated at 37°C in 100/0 CO2 90% air atmosphere for
16-18 hours. The cells were then primed with hexadimethrine bromide (polybrene) 1-10
mg/ml for 10 min prior to transduction. Polybrene was also added at 1-10 mg/ml to 2 ml
retroviral suspension from section 2.2.4 and the cells were transduced with recombinant
retrovirus (encoding SIN-EGFP-GLI 1, SIN-GLII-EGFP, SIN-GLI2-EGFP and SIN-
EGFP) in triplicate wells by centrifuging the plates at 300-350 x g for 1 hour at 32°C
then washed with sterile phosphate buffer saline (PBS). Post-transduction. cells were
incubated for 24 hours at 37°C in 10% CO2, 900/0 air atmosphere in defined keratinocyte
culture medium containing the growth supplements (10% v/v FCS) to allow the
expression of the tranduced gene. Then cells were cultured in defined keratinocyte
culture medium containing no growth supplement for 24 hours, to remove the effect of
growth supplement stimulation. After which the media was removed and cells were
cultured under following conditions; 1) Defined keratinocyte culture medium containing
10 ng/ml EGF (Cat No E 9644 Sigma) and at 37°C in 10% CO2, 90% air atmosphere for
24 hours. 2) Defined keratinocyte culture medium containing no growth supplement
(controls), and incubated at 37°C in 10% CO2, 90% air atmosphere for 24 hours.
EGFP fluorescence and change in cell morphology was visualised using a light
microscope (Leica DM IRS) fitted with a krypton/argon mixed-gas laser for emitting
excitation wavelength at 488 nm. Cell Images were captured with a digital imaging
system attached to the microscope (Leica DC200 imager with DC Viewer SOn\\ arc
V3.2). After capturing the images of transduced cells, the cells were either processed for
total RNA extraction (see section 2.5.0) or protein extract (see section 2.t·tO). The
N/TERT cells (gift from Dr J. Rheinwald) were also transduced \\ ith SIN-GLlI-EGFP.
SIN-EGFP and SIN-EGFP-GLI ImNLS in triplicate wells as described for primary
keratinocytes in section 2.2.5.
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2.3.0 GLII polyclonal baby rat kidney cells.
GLII transformed polyclonal baby rat kidney cell lines were obtained from Dr Judith
Green and GLI I transformed 10Tl/2 mouse fibroblast cell line were obtained from Dr
Muy-Teck Teh, these cells were cultured in DMEM medium supplemented with 10%
(v/v) FCS, 4 mM L-Glutamine.
2.3.0 Normal human skin and basal cell carcinoma (BCC).
Normal human skin was obtained from plastic surgery from facelift and breast reduction
surgery carried out at the Holey House Hospital UK. Human BCC tissue was obtained
from the patient who had BCC removed at the Royal London Hospital Dermatology out
patient department. Ethical committee approval was obtained (ethics number: TIO 1/034)
as well as informed consent from each patient for the use of the redundant Normal skin
and BCC tissue samples for scientific research.
Immediately after Normal skin or BCC specimens were excised they were snap frozen
in liquid nitrogen and transported from the theatre to the laboratory in liquid nitrogen.
The tissue samples were stored at -80°C until processed for RNA extraction or far In-
situ Hybridisation (see sections 2.5.0 and 2.10.0).
2.5.0 RNA extraction.
2.5.1 Total RNA extraction from cultured cells.
All materials including eppendorf tubes, glass bottles and dH20 used for RNA work
were treated with 0.1 % (v/v) Diethyl Pyrocarbonate (DEPC) overnight at room
temperature, (to inactivate RNase by covalent modification) then autoclaved for 30 min
at 120°C, 15 psi to remove traces of DEPC. All the equipment was dried before L1SC.
Sterile RNase and DNase free filter pipette tips (10 JJ.L 30 JJ.L and 200 JJ.l and I ml) were
used to avoid cross contamination. Gloves were changed frequently to minimise the risk
of RNase contamination from the skin.
Culture medium from a confluent 75cl1l 2 (Falcon) flask or 6 well plates \\ as removed
and washed twice with sterile PBSA (Phospate buffer saline with out Cat\lgl. Cells
\\ ere lysed by adding 0.1 ml RNAzol B (Biogenesis Ltd Cat No CS-I (5) per CI1l 2 cell
l) X
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culture surface area. RNA was solubilised by passing the lysate through a pipette a fe«
times. The homogenate was transferred to a sterile 14 ml (Greiner labortechnik Cat :\0
187 261) centrifugation tube. 0.2 ml chloroform per 2 ml of homogenate was added, the
centrifugation tube was covered with its top and shaken (not vortex) vigorously for 15
sec and incubated on ice for 5 min, centrifuged at 12,000xg, 4°e for 15 min. After
centrifugation the homogenate formed two phases, the lower phase (Blue, phenol-
chloroform phase) and the colourless upper aqueous phase. The DNA and the proteins
were in the interphase and lower organic phase. The RNA was in the upper aqueous
phase and the volume of aqueous phase was approximately 50 % of the initial volume
of RNAzol B plus the initial volume of cells.
The aqueous phase was transferred to a fresh centrifuge tube and equal volume of
isopropanol was added, incubated at 4°e for 15 min and centrifuged at 12,000xg, -toe
for 15 min to precipitate the RNA. Precipitated RNA formed a white yellow pellet at the
bottom of the tube. The supernatant was removed without disturbing the RNA pellet.
The RNA pellet was then washed with 1.2 ml 75% (v/v) ethanol by vortexing and
centrifuging at 7,500xg, 4°e for 8 min. Ethanol was removed and the pellet was allowed
to air dry at room temperature for 10-15 min. Extreme care was taken not to allow the
RNA pellet to dry completely, as this would have made it difficult to resuspend the
RNA pellet.
The RNA pellet was dissolved in 100-300 III DEPC treated dH20 by gently vortexing or
passing the RNA solution a few times through a 1ml pipette tip and transferred to a 1.5
mi eppendorf tube (for 6 well plates 25-50 III volume per well was used to dissolve the
RNA pellet).
2.5.2 Total RNA extraction from frozen tissue.
Tissue sections (25 11m) were cut using cryostat at -200 e, sections were collected in
RNase free weighing boat. Immediately after cutting the sections, 2 ml RNAzol-B per
100 mg tissue was added. The tissue sample was homogenised in a glass-Teflon
homogeniser, and transferred to a I-t ml (Greiner labortechnik) centrifugation tube. The
remaining procedure was the same as that followed for RNA extraction from cultured
cells (see section 2.5.1). If there were more than 3 samples the homogenate \\ as stored
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at -70°C until all the samples were homogenised and than they all were simultaneously
processed.
2.5.3 Messenger RNA isolation from total RNA.
The volume containing 75 ug of total RNA was adjusted to 100 ~I with DEPC treated
dH20 . This step was omitted if only small adjustment was required. Total RNA \\ as
denatured by incubating at 65°C for 2 min to disrupt secary RNA structures. 200 ~t1 (I
mg) of resuspended Dynabeads (Cat No 610.01, DDYNAL) Oligo (dThs were dispensed
into a 1.5 ml eppendorftube and placed in the magnetic (Dynal MPC-E-I) rack. After 30
sec the supernatant was removed while keeping the eppendorf tube in the magnetic rack.
Dynabeads were washed by removing the eppendorf tube from the magnet and
resuspending the Dynabeads in 100 ~I Binding buffer (20 mM Tris-HCI pH 7.5, 1M
LiCI, 2 mM EDTA). The eppendorf tube was placed back in the magnet rack and the
binding buffer removed after 30 sec.
The eppendorf tube was removed from the magnet rack and the Dynabeads resuspended
in 100 ~I Binding buffer, (Optimal hybridisation conditions recommended by the
manufacturers were, Binding buffer at 1: I ratio relative to the sample volume) to this
total RNA denatured above was added and mixed thoroughly to allow the messenger
RNA (mRNA) to anneal to the Dynabeads, by rotating on a roller or mixer at room
temperature for 3-5 min. The eppendorf tube was placed in the magnet rack for 30 sec
and the supernatant removed.
The mRNA bound Dynabeads were washed twice, by removing the eppendorf tube
from the magnet rack and resuspending in 150 ~I washing buffer provided in the kit the
eppendorf tube was placed back in the magnet rack and supernatant removed. \\'h~n
working with small volumes care was taken to remove all the supernatant between each
wash.
Using 10-20 ~t1 elution buffer (1 OmM Tris HCI pH 7.5) mRN:\ was eluted by
resuspending the Dynabeads in the elution buffer, incubating at 65°C for :2 min. t\ Iter
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incubation the eppendorf tube was immediately placed in the magnet rack for 30 SeC.
the supernatant containing the eluted mRNA was transferred to a new Rxase free
eppendorftube. Isolated mRNA samples concentration and integrity was determined (as
described in section 2.5.4 and 2.5.5). Purified mRNA samples were stored at -70°C if
not used immediately. Dynabeads were not allowed to dry out during the procedure as
this would have reduced their mRNA binding efficiency.
2.5.4 Determining the concentration of purified RNA.
The concentration of RNA was determined by diluting 1)11 of RNA sample with 9)11 of
RNase free dH20 . 2)11 diluted RNA sample was placed into a 2 mM path cuvate
(Genespec) and its absorbance (Abs) value at 260nm and 280nm was measured using a
spectrophotometer (Genespec). A RNA preparation free of DNA and protein was
expected to have a 260nm Abs / 280nm Abs ratio of 1.9. Following formula was used to
determine the concentration of RNA (Abs value at 260 nm x 40 ug/rnl x Dilution factor
= ug/rnl RNA). Remaining 8)11 diluted RNA sample was used in section 2.5.5.
2.5.5 Checking the integrity of purified RNA.
The integrity and the size distribution of purified RNA was checked by running 8 ~I of
diluted RNA sample from section 2.5.4 in 2 ul RNA loading buffer [50% (v/v)
deionised formam ide, 6% (v/v) formaldehyde, 1x MOPS-EDTA buffer, 6.6% (v/v)
glycerol, 0.02% (w/v) bromphenol blue, 0.02% (w/v) xylene cyanol, 39.58 ug/ml
ethidium bromide] on a 1% (w/v) RNase free ethidium bromide agarose gel in 0.5.\
(Tris-borate/ethylene diamine tetra-acetic acid [EDTA]) TBE buffer (see section 2.5.6).
The ribosomal 28S rRNA and I8S rRNA appeared as sharp bands and the 28S rRNA
was present at approximately twice the intensity of the I8S rRNA band. Equal intensity
of the two ribosomal (28S rRNA and I8S rRNA) bands indicated some degradation had
occurred, smear on the bottom of the gel with no ribosomal bands indicated complete
degradation of total RNA. RNA samples were stored at - 70°C and repeat thawing and
freezing was avoided to prevent RNA degradation.
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2.5.6 Agarose gel electrophoresis.
1% (w/v) agarose gel was made as follows. 0.35g agarose gel (Sigma) was placed in
35ml 0.5 x TBE (Tris-borate/ethylene diamine tetra-acetic acid) buffer in a 100mi
conical flask. The mixture was heated in a microwave for a minimum time required to
allow the agarose to dissolve. Heating was interrupted at regular intervals and the flask
swirled to mix the contents, to stop the solution over boiling. The gel was allowed to
cool till hand warm before adding 1ul 10mg/ml ethidium bromide, to avoid generating
ethidium bromide vapour. Ethidium bromide is carcinogenic so contact with skin was
avoided by wearing gloves. Content of the flask were mixed and the gel was poured
into a mini gel cast with a comb in it. The agarose gel was allowed to set for 20-30 min
before removing the comb. The set agarose gel cast was placed in the electrophoresis
chamber and enough 0.5 X TBE buffer was added just to cover the surface of the gel.
DNA or RNA samples were mixed with the appropriate loading buffer and loaded into
the wells along side a DNA (Cat No 10488-085 Invitrogen) or RNA Marker (Cat No
R7020 Sigma). The apparatus was connected to a power supply and the gel was run at
1-5 volts/ern to resolve different size DNA or RNA fragments. After the electrophoresis
was complete the gel was removed and placed on a UV lamp box and the image was
captured using a digital camera with Alpha computer programme.
2.6.0 Analysis of mRNA by northern blot hybridisation.
Northern analysis is a standard method used for detection and quantification of mRNA
by comparing it to a standard such as p-Actin, between samples on a single membrane.
It is the preferred method for determining transcript size and for detecting alternativel.
spliced transcripts. Basic principles of the method are; the RNA samples are first
separated by size via electrophoresis in an agarose gel under denaturing conditions. The
RNA is then transferred to a membrane cross-linked by UV and hybridized with a
specific radiolabelled in vitro transcribed DNA or RNA probe. To detect more than ~)IlC
message, initial probe was striped before hybridizing with a sec probe.
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2.6.1 Electrophoresis of mRNA on formaldehyde agarose gel.
Formaldehyde denaturing agarose gel was prepared as follows, 1.8 g of agarose gel
(Sigma) was placed in 109.5 ml DEPC dH20 in a 250 ml conical flask, the mixture was
heated in a microwave for a minimum time required to allow the agarose to dissolve.
Heating was interrupted at regular intervals and the flask swirled to mix the contents, to
stop the solution over boiling. Remaining steps were carried out in a fume hood to avoid
inhaling formaldehyde fumes which are toxic. The gel was allowed to cool to 55"C
before adding 15 ml lOx MOPS (0.4 M Morpholinopropanesulfonic acid; 0.1 M Na-
acetate-S x H20; 10 mM EDTA pH 7.2) and 25.5 ml 35% (w/v) Formaldehyde. Content
of the flask were mixed and the gel was poured in to a gel cast with a comb in it. The
formaldehyde agarose gel was allowed to set for 30-60 min before removing the comb.
The set agarose gel cast was placed in the electrophoresis chamber and enough 1 x
MOPS (40 mM morpholinopropanesulfonic acid; 10 mM Na-acetate-3 x H20; 1 III 1\ 1
EDTA pH 7.2) buffer was added just to cover the surface of the gel.
Purified 2 ug mRNA (in a 12 ~l volume) samples from section 2.5.3 of normal skin
(NS), basal cell carcinomas (BCC), HaCat, A375 and GLII infected primary
keratinocytes, and positive controls expressing GLI1, GL11 transformed polyclonel
baby rat kidney cell line and GLll expressing foetal mouse fibroblasts lOt 1/2 cell line
(obtained from Dr Muy-Teck), 5 ~l of RNA ladder (0.24-9.5 Kb Life Technologies Cat
No 15620-016) made up to 12 ~l with 0.1 M Tris-EDTA pH 8 buffer. Were mixed with
17.5 ul electrophoresis cocktail [1 ~l 20x MOPS, 10~1 formamide, 3.5 ul 37% (w/v)]
formaldehyde, 1 ul [1 mg/ml] ethidium bromide (EtBr), 2 ul blue juice [50% (v/v)
glycerol, 1 x MOPS, 0.20/0 (w/v) bromophenol blue]. The samples and the RNA ladder
were denatured at 65°C for 10 min and immediately placed on ice to prevent secary
RNA structure formation, before loading in to the wells of formaldehyde denaturing
agarose gel (see above). The electrophoresis apparatus was set up and initially the
samples were ran at 100 volt, once the samples had migrated out of the wells, the
voltage was reduced to 15-20V and electrophoresis run overnight (approximately 16
hours).
Following electrophoresis the gel was examined under UV to check the integritx of the
mRNA and the image captured with a ruler beside the marker lane, to determine the
mRNA transcript size in relation to the RNA ladder later. The wcll«. marker lane and a
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top corner of the gel were cut and discarded (the corner cut was recorded in the lab
book). The gel was washed in, 50 mM NaOH/I00 mM NaCI for 20 min, 0.1 \1 Tris-
HCI pH 7 for 20 min, 2x SSC (Standard Saline Citrate) for 20 min, on a shaker at room
temperature.
2.6.2 RNA transfer to Hybond-XL membrane.
Messenger RNA was transferred to the hybridisation membrane by setting up an
apparatus shown in Figure 2.5. Whatman 3 MM filter paper (x 3).and 1 piece of
hybridisation membrane (Hybond-XL membrane, Amersham Pharmacia Biotech Cat
No RPN 203S) were cut 2 mm larger all round than the size of the actual gel.
Hybridisation membrane was rinsed in DEPC dH20 . The membrane and two pieces of
Whatman 3 MM filter paper were soaked in 2x SSC. The gel tray cast was rinsed with
DEPC dH20 , inverted and placed in an RNase free glass tray.
A Whatman 3 MM filter paper was cut the same size as the gel cast width but 4-6
inches more then the gel cast length, so that it over hangs from each side of the gel cast.
This was place on the inverted gel cast, 20x SSC transfer buffer was poured into the
glass tray so that the edges of the filter paper stayed submerged in 20 x SSC solution.
Any air bubbles between the gel cast tray and the filter paper were rolled out using a 25
ml sterile pipette. Messanger RNA agarose gel from section 2.6.1 was inverted and
placed on the filter paper any air bubbles between the gel and filter paper were removed
as above. Exposed filter paper edges around the gel were covered with Para film, to
prevent short-circuiting of the transfer solution.
The hybridisation membrane and then two Whatman 3 MM filter paper pieces soaked in
2x SSC were placed on top of the gel, and any air bubbles formed were removed. A dry
Whatman 3 MM filter paper was placed on top and a stack of approximately 5 inches of
blotting pads (or paper towels) cut to gel size were placed on top. A flat surface object
(e.g. a plastic container lid) and a weight approximately 500 g were placed on top of the
blotting pads (see Figure 2.5). The apparatus was covered with cling film to prevent
evaporation of 20x SSC and to keep out dust. mRNA was allowed to transfer tl) the
hybridisation membrane over night at room temperature.
IO-l
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The next day the apparatus was carefully disassembled leaving the hybridisation
membrane in contact with the gel. The back of the membrane was marked with a pencil
to indicate which side the mRNA had transferred. The membrane \ as carefull
removed and washed in 6x sse for 5 min at room temperature. The hybridisation
membrane was placed on a clean filter paper, and allowed to air dry for approximately 5
min at room temperature.
The gel was examined under UV to check if all the mRNA had transferred on to the
hybridisation membrane. The mRNA was UV cross-linked to the membrane with RNA
side up, using an UV-Stratalinker (Sratagene) set at auto cross-link. The UV cross-
linked mRNA membrane was placed between two sheets of Whatman 3 MM filter
paper and wrapped in aluminium foil, and stored at room temperature until probed.
Pla stic lid to evenl y
distr ibute the weight
Hybond-XL mem brane
RNase free gla ss
tray
Inverted gel tray cas t
I Approximately 500g weight
Para film to prevent
short circuiting
Paper towel
Transfer buffer 20 . C
Figure 2.5: Different components of northem blot apparatus and how it was assembled.
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2.6.3 Probe generation for northern blot analysis.
PTCH (500 bp insert) and GLII (250 bp insert) probes cloned in HindIII, EcoRI sites of
PGEM plasmid were obtained from Dr Judith Green. GLl2 (1.6kb insert) cloned into
EcoRI site of PCRII Tapa plasmid was obtained from Dr Fritz Burg. PTCH GLI 1 and
GLI2 probes were generated by cutting them from the vectors in which they were
cloned. Beta-Actin probe was generated by PCR amplification (see section 2.7,-t).
Cloned inserts and the PCR products were run on 1-2% (w/v) agarose gel (see section
2.5.6), the insert and the PCR products were cut out and extracted from the gel using
QIAquick Gel Extraction Kit (QIAgen Cat No 28704) as per manufactures instructions
(see section 2.7.5) . The probes were quantified by running on 1-2% (w/v) EtBr agarose
gel along side a known concentration standard marker (see section 2.5.6).
2.6.4 Probe labelling.
The probes were labelled with a)2p dCTP (Amersham Pharmacia Biotech Cat No
AA0005 250 1J.Ci) using Megaprime DNA labelling systems (Amersham Pharmacia
Biotech Cat No RPN 1604/5/617) as per manufacturers instruction. Briefly, 25 ng
QIAgen purified probe, 5 1J.I Nonamer Primers made up to 151J.1 with RNase free dH20
were denatured at 100°C for 5 min and then pulse centrifuged. To this 10 I-li labelling
Buffer, 2 1J.I (1 U/1J.I) Klenow fragment, 18 I-li RNase free dH20 and 5 I-li (10 I-lCi/I-lI) a-
32p dCTP were added. The reaction was mixed by pippetting up and down, pulse
centrifuged and incubated at 37°C for 10 min. All radioactive work is carried out in
designated radioactive area.
2.6.5 Probe purification.
Labelled probe was purified using a Bio-Spin 30 chromatography column (BIO-R.\D
Cat No 732-6006). The settled gel was resuspended by inverting the column se\ cral
times; this also removed any air bubbles. The column tip \\ as snapped off and the
I I d i , ! ml micro centrifuge tube the column cap \\as removed and theco umn p ace In ,1 ... '
buffer allowed to drain and discarded. Both the column and the 2 ml micro centrifuge
1()()
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tube were taped together using autoclave tape and placed in a 50 ml centrifuge tube, and
centrifuged at 1000x g for 2 min. The buffer was discarded and the column placed in a
1.5 ml RNase-free eppendorf tube, both were taped together and placed in a 50 ml
centrifuge tube.
The labelled probe from section 2.6.4 above was carefullv transferred directlv to the
. .
centre of the column, and centrifuged for 4 min at 1000xg. Purified probe was collected
in an eppendorf tube in SSC buffer. The tape was removed and the column taken out of
the tube and discarded in a 32p waste container. Percent (%) labelling was estimated b;.
measuring the radioactivity (using a 32p series 900 mini monitor) of the column and the
purified probe. The % labelling of the purified probe was calculated as follows. Activity
of the purified probe / Total activity (column and the purified probe) x 100 = % labelled
probe. The percent labelling was around 20-55 %.
2.6.6 Mem brane pre-hybridisation.
The nylon membrane was rolled and placed into a hybridisation cylinder containing a
small amount of 2x SSC, and then unrolled in the cylinder. A 10 ml aliquot (stored at -
20eC) of pre-hybridisation solution (50 ml Forrnamide, 25 ml 20x SSC, 10 ml SOx
Denhardt's, 10 ml 0.5M pH 6.8 Sodium phosphate buffer, 2 ml 10% (w/v) Sodium
dodecyl sulphate (SDS), 3 ml RNase free dH20 ) were placed into a water bath at 65°C.
Once the pre-hybridisation solution had reached the water bath temperature, one gram
of dextran sulphate (Amersham Pharmacia Biotech Cat No 17-0340-01) was added.
Pre-hybridisation containing the dextran sulphate was heated at 65°C for approximately
4-5 hours to allow the dextran sulphate to dissolve completely.
The hybridisation solution was allowed to cool down to room temperature. 3 mg tRI'\A
(300 ~d 10 mg/ml tRNA in RNase Free dH20 from Bakers yeast, Boehringer
Mannheim, Cat No 109/495) was heated at 100GC for 10 min and immediately placed
on ice to cool before adding it to cold hybridisation solution. Excess sse was poured
off from the hybridisation cylinder and replaced with the pre-hybridisation solution and
incubated rotating at 42°C in a hybridisation oven overnight.
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2.6.7 Membrane hybridisation.
Hybridisation solution was prepared the same way as the pre-h) bridisation solution with
I mg tRNA (lOa I-ll [10 mg/ml] tRNA) instead of3 mg tRNA. To which labelled probe,
denatured at 1000e for 5 min and immediately placed on ice, was added.
The pre-hybridisation solution was removed from the cylinder and replaced with
hybridisation solution and incubated rotating at 42°e in a hybridisation oven overnight.
The following day the hybridisation solution was discarded and the blot was carefully
removed from the cylinder and washed gently in 250 ml wash buffer (2x sse, 0.1 %
(w/v) SDS pH 7.2) at room temperature for 30 sec. The wash buffer solution was
discarded and replaced with 250 ml fresh wash buffer and washed shaking for 20 min at
room temperature, this step was repeated with 250 ml fresh wash buffer. A final wash
was carried out in 250 ml wash buffer preheated to 600e, shaking at 600e for 20 min.
The blot was sealed in a plastic bag or wrapped in saran wrap and exposed to a
Phosphor Screen (Molecular Dynamics) for 16-48 hours and the screen scanned on
STROM 840 scanner.
Following autoradiography, the blot was placed in a plastic container with 250 ml strip
solution [750/0 (v/v) formam ide, 0.1 % (w/v) SDS in DEPe dH20 ] and agitated at 700e
for 10 min. The strip solution was discarded and the blot was washed 3 times with 2x
sse. The blot was sealed in plastic bag with a small amount of 2x sse, to keep it
moist, and stored at -200e until reprobed with another probe. The stripted blot was
exposed to the phosphor screen to check for any radioactivity; if there was all)
radioactivity left, the blot was left to allow the radioactivity to decay. The blot was not
re-probed, until there was no radioactivity detected. The northern blot was probed with
GLJI, PTCH, 13-Actin and GLJ2 probe in a descending order. In order to calculate the
size of the transcripts detected, the distance that each RNA marker had migrated from
the gel was measured. A log (RNA size) against the distance of marker migration in em
was plotted using a Microsoft Excel program. The 'best fit' plot was used to determine
the size of the transcript detected.
108
CI-IAIIIT:R 2: Materials and Methods
2.7.0 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).
2.7.1 Primer designing.
Forward and reverse primers (shown in Table 2.2) were designed using amplify
sequencing programme and based on the publish sequence accessed from the database
of the National Centre of Biotechnological Information (NCBI) \\ eb site
http://www.ncbi.nih.gov/.
Following criteria were used in selecting the primers. The primer length was 20-26 base
pairs (bp) and they flanked the region of interest. The G and C content was 40-60%. and
avoided using sequence which would have given rise to internal secary structures. The
3' ends of the primers were not complementary to avoid the production of primer
dimmers in the PCR reaction, and avoided having three G or C nucleotides in a row
near the 3' end of the primer. Ideally both primers should have a same annealing
temperature or +/- 5°C. The minimum melting temperature (Tm) was 50llC and the
maximum Tm 65°C. The PCR reaction annealing temperature set is dependent upon the
primer with the lowest Tm-
2.7.2 Removing contaminating DNA from total RNA preps.
To eliminate any DNA contamination present in RNA samples, total RNA samples
were treated with a Deoxyribonuclease I, Amplification Grade (DNase L Amp Grade,
Cat. No 18068-015 Invitrogen), before reverse transcribing the RNA to cDNA. A mater
mix was made up of DNaseI (1 Uhtl) in l x DNaseI reaction buffer enough for all the
total RNA samples. 1.6 III of DNaseI (1 Uzul) in lx DNaseI reaction buffer was added
to each 2.5 ug total RNA sample in 6.4 III volume (Table 2.3 and Table 2A) and mixed
by vortexing and then pulse centrifuged. All the samples were incubated at room
temperature for 15 min to allow digestion of any DNA present. The digest reaction was
stopped by adding 0.8 III of 25 mM EDTA solution the sample was mixed and pulse
centrifuged and incubating at 65°C for 10 min. to inactivate DNase!. All samples were
then immediately processed as described in section 2.7.3 below.
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2.7.3 First strand cDNA synthesis with Reverse Transcriptase.
First strand cDNA synthesis was carried out using a Promega (Cat No A3500) kit, as
per manufacturers' instruction. DNaseI treated total RNA samples from section 2.7.2
were denatured at 70°C for 10 min in a PCR thermo cycler and then pulse centrifuged
for 10 sec and immediately placed on ice.
A master mix was made to give a final concentration of the following components, ~
mM MgCb. 1x Reverse Transcription Buffer (l0 mM Tris-HCl pH 9.0 at 25"C, 50 mlvl
KC1, 0.1 % v/v Triton X -100), 1 mM each dNTP, 0.8 U/~I Recombinant RNasin
Ribonuclease inhibitor, 0.9 U/~l Avian Myeloblastosis Virus (AMV) Reverse
Transcriptase, 12.5 ng/ul Oligo (dT)ls, 12.5 ng/ul random primers, in a 25 ~I total
reaction volume. Negative control reactions were also set up using dH20 instead of total
RNA and total RNA from one of the sample (Table 2.3 and Table 204) without the
Reverse Transcriptase (RT).
16.2 ~I master mix was added per denatured total RNA sample. The reactions were
mixed by vortexing and then pulse centrifuged before incubating at room temperature
for 10 min. This allowed the hybridisation of Oligo (dT)IS and random primers to the
mRNA. The transcripts were reverse transcribe to cDNA by incubating at 42°C for I
hour. AMY reverse transcriptase was inactivated and prevented from binding to cDNA
by incubating the reaction mix at 99°C for 5 min and then placing on ice for 5 min. The
first strand cDNA Reactions were stored at -20°C if not used immediately in a PCR.
2.7.4 peR reaction.
A PCR reaction was set up 111 a 96 well plate with the final concentration of the
following components, 1 /-tl first strand cDNA reaction, 0.25 mM each dNTP. 1.25"
Reaction Buffer [25 mM (NH4hS04, 93.75 mM Tris-HCl pH 8.8 at 25"C. 1.25" I 0-2
Tween 20], 1.75 mM MgCb, 0.125 urn each (forward and reverse) primer. I Unit
thermal stable DNA polymerase (Advanced Biotechnology Red Hot DNA polymerase
Catalogue No AB-0406/B). In a total reaction volume of 20 ul made up with dH20 .
1\0
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Enough master mix (M/mix) was made up of all the components except the first strand
cDNA for all the samples, 19 ul of M/mix was added per well and to this 1 ul first
strand cDNA reaction was added to each sample. The reaction was mixed bv swirlinu
- :::
the pipette tip in the reaction mix, and overlaid with 20 fll mineral oil to prevent
evaporation during the PCR amplification. The samples were thermo cvcled. at 94"C for
1 min, (94°C for 1 min, see Table 2.5 for annealing temperature used for each set of
primers for 30 sec, 72°C for 1 min) x 40 cycles, and final extension at 72°C for 10 min.
Optimum annealing temperature was determined by carrying out PCR using gradient
temperature ranging from 50-60°C for each set of primers. Optimum rVlgCb
concentration was also determined by carrying out PCR at L 1.75,2.5 and 4 mi\lgClz A
PCR reaction was also set up for each primer sets, with a normal skin genomic DNA
samples (code M5, 100 ng/ reaction) and normal skin (code N37. 100 ng/ reaction) to
check if the primers cross intron exon boundaries.
Amplified PCR fragments were identified by mixing 5 ul PCR reaction with 1 ~L1 6x
DNA loading buffer [10 mM Tris-HCl pH 7.5, 50 mM EDTA, 10% (w/v) ficoll 400,
0.25% (w/v) bromphenol blue (BPB), 0.25% xylene cyanol FF] and resolved on 1-2%
(w/v) agarose gel, 0.5 g/ml ethidium bromide (EtBr) with 0.5 x TBE [Tris-
borate/Ethylene diamine tetra-acetic acid (EDTA)] running buffer. Subjected to
electrophoresis at 7-8 V /cm and visualised under ultraviolet (UV) transilluminator (see
section 2.5.6). The gel image was captureda digital canera, part of Alpha Imager
programme.
2.7.5 Purification of peR product form agarose gel.
The bands in the agarose gel were carefully excised under UV and PCR products were
purified using QIAquick Gel Extraction Kit (Cat No 28704, QIAGEN Ltd) as described
in manufacturers instructions manual. Briefly, the agarose gel slice was \\ eighed and
dissolved in 3 volumes of QG buffer (supplied in the kit) to 1 volume of gel (100 mg
gel is equal to 100 ul). Incubated at 50°C for 10 min and mixed with 1 volume of
isopropanol before loading onto QIAquick spin column and centrifuged for 1 min at
13000 rpm. Any remaining traces of the agarose gel were removed by washing \\ ith O. ~
ml of buffer QG. The PCR product bound to the column was washed with 0.7~ ml
I1I
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buffer PE and then eluted with 20 J.lI elution buffer (EB) [10 mM Tris-Cl pH 8.5] or
dH20 , and stored at -20°C.
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Table 2.2: PCR primer sequence designed for RT-PCR from the NCBI data base
(h~tp://www.ncbi.nlm.nih.gov[) and the size ofPCR product expected from these
pnmers.
GENE ACCESSION Forward (F) and Reverse (R) Primer nucleotide Amplicon lengthNo sequence' 5-------3' and the user reference bp
ACTA2 BC017554 ACCCTGAAGTACCCGATAGA F 425
ACGCTCAGCAGTAGTAACGA R
a-TUB AF141347 GCGTGAGTGCATCTCCATCCA F 249
GTAGGTGCCAGTGCGAACTTC R
fJ-ACT BC00425I GTTTGAGACCTTCAACACCCC F 320
GTGGCCATCTCTTGCTCGAAGTC R
COUP-TFfl M62760 CCTAGTCCTCCTGATTTCGATG F 288
AGGGAGAGCTGAAGTCGATTGT R
DES U59167 CAGCTACTCTAGCTCGCATTG F ",
GAAATGTTCTTAGCCGCGAT R
E2A M31523 CAGCTCAGGTGAGGACTACG F 591
GTCGTAGCTGGGCGATAAGG R
EBFl AF208502.1 GTCGTGGTGTCTACGACAGT F 264
CCAGCATGGTACCGAATATG R
EBF2 AY405423.1 ATCAAGGGTACATCCGCAAC F 384
GGTACAACAAGTCCGGTCAT R
EBF3 NM 001005463 GCGCGGGGGGACGACCATGAA F 450
TGGGTCAGCAGCACACGGCACATCT R
G6PDA M21248 GTTCCGTGAGGACCAGATCTAC F 152
GGCTCCTTGAAGGTGAGGATAA R
GLll NM 005269 GAAGACCTCTCCAGCTTGGA F-MOH 246
GGCTGACAGTATAGGCAGAG R-MOH
GLl2 ABOO7295 CACAAGCGCAGCAAGGTCAAGACCG F-MOH-a 179
TCAGCCTCCTGCTTACAGTCATCCC R-MOH-bb
GLl2 ABOO7295 AGGTGTATCCCACGGAAAGCACTGG F-MOH-c 1,487
GCTCTCCTCGGCGAGGCTGGTGAGC R-MOH-dd
GLl2 alfJ ABOO7295 GGGTCAACCAGGTGTCCAGCACTGT F 194
GATGGAGGGCAGGGTCAAGGAGTTT R
GLl2 X/o NM 030381 TCCCACGGAAAGCACTGGCTTCTCT F 205
CAGCCATGTTGCTGATGCCTCATTC R
GLl3 M57609 TCAGTGCCATCGATGAAACC F-MOH 328
GCTGTCCCTTCTGTTGAGCA R-MOH
lVL NM 005547 GCAACTGGATCAAGAGCTAGT F 1176
TCCAGATGTTTTAGTTGTCCG R
KRT10 NM 000421 GATACAGCTCAAGCAAGCACTACT F 590
GTAGTATTTGCTGTAGTCACGAGGC R
KRTJ.I BC042437 GGGGGAGCCTATGGGTTGGGG F 1326
AGTGCTTGGGCAGGAGAGGGG R
KRT15 X07696 AACTCACGGGCTCCAGCTAC F 1559
GAATAGAGCGCATGCAAAGC R I
CGTGACTACAGCCAGTACTA F 454 ,KRT17 BCOOO159 !
GTCTTGCTGAAGAACCAATC R
KRT19 Y00503 GCCCTCCCGCGACTACAGCCACTACTAC F 183
ATGTCGGCCTCCACGCTCATGCGCAGA R
Table 2.2 continued on next page
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Table 2.2: continued PCR primer sequence designed for RT-PCR from the NCBI data
ba.se (http://www.ncbi.nlm.nih.govQ and the size of PCR product expected from these
pnmers.
GENE ACCESSION Forward (F) and Reverse (R) Primer nucleotide Amplicon length
No sequence' 5-------3' and the user reference bp
KRT5 M21389.1 GGTGGTGGCTTTGGGCTCGGT F 1428
GCTCTTCCGGGAGGAGGAGGT R
KRT8 BC075839 GATGCCAACGCCAAGTTGTCC F 432
GACGTCAGAGGACTCAGACAC R
KfF4A AFI79308 CTTCAATACAGCAGTAGCGCCA F 282
CTCACGAGATGGGCATAGAAGA R
LOR NM_000427 TAGAGCTCTCATGATGTACCC F 120
CAGAAACCAAAGAGGCTAAAC R
MCSP X96753 ACTGTGGTGCTGACTGTCGT F 603
CTCGGTTCGAAGTATGCGTA R
NES NM_0066 I7 GGAGAATCAAGAATGTCCGA F 1167
TTGGTCCTTCTCCACCGTAT R
NRG2-A CAGCCGAGACATTCGCATCA F 343
CTGGCATGTACAATCGCAAA R
NRG2-B NM_013981 CAGCCGAGACATTCGCATCA F 330
GTTGACCATTGCGAACTGCT R
NS AY825265 ACCTGCCATAAGCGGTATAA F 911
GGAATTAAGTGGAGATACGAT R
PTCH-I U43148 CTCCCAAGCAAATGTACGAGCA F 150
TGAGTGGAGTTCTGTGCGACAC R
SIP I U82108 CAGATGAACACTTCAAGCGG F 284
AGTTGCTGAAGATTTCACGC R
SMO U84401 ACCAGGACATGCACAGCTACAT F- 297
AGGGCGTAGTACACGATGACAA R
Snail] NM 005985 CCCAAGATGCACATCCGAAG F 879
AGACATTGTTAAATTGCCCG R
Snail2 NM 003068 TCTCTCCTCTTTCCGGATAC F 336
GGTAATGTGTGGGTCCGAAT R
SUP-FU-2 AFl59447 GCACTGGCACTACATCAGCTT F 341
TGGAGGAAGGTAACTACCCCAA R
TFlJD X54993 CCACAGCTCTTCCACTCACAGA F 261
TTATCCTCATGATTACCGCAGC R
VAV2 NM 003371 GCGATGTACATCAATGAAGTTAAACG F
GCCTCCTCTTCTACGTACGTT Rl 276
GGGGTCGTCGGTCATCTTGTGGAA R2 1,-119
VAV3 NM 006113 CCTGTTGTGAGACGTTTGGAATGAG F 626
GATGGCTGACTCCACTCCACTGC R
1'".11'31 AF035442 GTGGTGTTTTACCACTCTGC F -152
CTGCAATGTGAAAAAAGCCATCTC R
I '1M X56134 AAGAGAACTTTGCCGTTGAA F 3-16
GTGATGCTGAGAAGTTTCGT R
Table 2.2 PCR primer sequence designed for RT-PCR from NCBI data base, and the
PCR product expected from these primers for the following genes; actin, alpha 2,
smooth muscle, aorta (ACTA2), alpha-tubulin (a-TUB), beta-actin (fJ-AC7), chick
ovalbumin upstream promoter transcription factor II (COUP-TFIl), desmin (DES),
Transcription factor E2-alpha (E2A), Early B-cell transcription factor (EBF1, :: and 3),
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glucose-6-phosphate-dehydrogenase variant A (G6PDA), glioma associated oncogene
GLJl, GLI2, GLI3, involucrin (lVL) , keratins KRT10, KRT1-1, KRT15. KRTi7. KRTi9.
KRT5, KRT8, Chromosome-associated kinesin (KIF-IA), loricrin (LOR), melanoma-
associated chondroitin sulfate proteoglycan (MCSP), nestin (NES), neuregulin :2 A
(NRG2-A), neuregulin 2 B (NRG2-B), nucleostemin (NS), patched-l (PTCHi), SRY-
interacting protein 1 (SIP1), smoothened (SMO), snail (Snail l , 2), suppressor of fused
(SUP-FU), transcription initiation factor (TFllD) , VAV2, VAV3, VAV3.1 are Guanine
nucleotide exchange factor for the Rho family of Ras-related GTPases. vimentin (ViJ!).
GLl2 user reference Moh-a, Moh-bb, Moh-c and Moh-dd primers were from (Tanimura
et al., 1998) and GLl2 a/fJ and GLl2 x/oprimers were from (Regl et al., 2002).
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Tabl~ 2.3: List of total R~A samples extracted from different tissue and cultured cell
used In RT-PCR and real-time-RTvl'Ck gene expression analysis.
Key Total RNA Samples Con Sample Volume DEPC dH:O
1
[ug/ul] Taken ul ~I
Basal Cell Carcinoma 0.6 4.17 'I 'I"
2 Basal Cell Carcinoma
_._J
3.41 0.73 5.67
3 Basal Cell Carcinoma 5.58 0.45 5.95
4 Basal Cell Carcinoma 1.85 1.35 5.05
5 Basal Cell Carcinoma
,
0.1 6.4
-
6 Basal Cell Carcinoma 2.78 0.90 5.50
7 Basal Cell Carcinoma 0.22 6.40 -
8 Basal Cell Carcinoma 0.41 6.10 0.30
9 Normal Skin 0.72 3.47 I 9"'1_. J
10 Normal Skin 3.75 0.67 5.73
11 Normal Skin 0.77 3.25 3.15 !
12 Normal Skin 0.74 3.38 3.02
13 Normal Skin 2.98 0.84 5.56
14 Normal Skin 0.32 6.40 -
15 HaCat 1.73 1.45
-<
-L95
16 HaCat 2.66 0.94 5.'+6 II
17 HaCat 5.2 0.48 5.92
18 Primary Keratinocytes 0.9 2.78 3.62
19 Primary Keratinocytes 2.6 0.96 5.-t-t
20 Primary Keratinocytes 6.66 0.38 6.0'1 I
21 A375 2.2 1.14 5.26
22 A375 2.4 1.04 5.36
23 A375 1.38 1.81 .+.59
24 A375 1.25 2.00 4.40
25 GUI-C3 primary Keratinocytes 2.78 0.90 5.50
26 GUI-C3 Primary Keratinocytes 1.08 2.31 .+.09
27 GUI-C3 Primary Keratinocytes 2.57 0.97 5.'+3
28 GLII-C3 lOTI/2 cell line 1.08 2.31 .+.09
29 dH20 - 0.00 6.40
30 (Bee key 1) without RT 0.6 4.17 2.23
BCC (Basal Cell Carcinoma), HaCat (a spontaneously immortalised keratinocyte cell
line), A375 (a melanoma cell line), GLII-C3 primary keratinocytcs (a transduced
primary keratinocytes with SIN-EGFP-GLl1 fusion construct retrovirus to ~\.press
exogenous GLll), GLII-C3 1OTII2 (a GLI1 expressing fetal mouse fibroblasts cell line
obtained from Dr Muy-Teck, these were used as positive control for GLI1 expression).
Table shows the concentration of each total RNA sample, volume taken from each
sample to give 2.5 ug total RNA and volume of DEPC-dH20 added to make up to 6,4
~L1. Samples 29 (dH20 ) and 30 (BCC key 1) were negative control reaction set up for
RT-PCR, no reverse transcriptase (RT) was added to sample 30.
116
CHAPTER 2: Materials and Methods
Table 2.4: Total RNA samples from transduced primary keratinocytes for real-time-
RT-PCR gene expression analysis.
Total RNA Sample Con [ug/rnl] Sample volume taken ul I DEPC-dH20 added pi !
I
GLII-GS 0.57 4.39 2.0 I
GLII +EGF 0.56 4.46 1.94
GLI +FGF 0.5 5.0 1.-.+
EGFP-GS 0.68 3.68 2.72
EGFP+EGF 0.59 4.24 2.16
EGFP+FGF 0.61 4.10
--
2.3
GLII-GS-RT 0.57 4.39 2.01
Human primary keratinocytes were transduced with retroviral particles containing Sl:-\-
EGFP-GLll (GLI 1) and SIN-EGFP (EGFP), a control retroviral construct. The
transduced cells were cultured in a defined keratinocyte culture medium containing no
growth supplements (-GS), media containing epidermal growth factor (EGF) only, and
media containing fibroblast growth factor (FGF) only. Total RNA was extracted from
these cell lines GLII-GS, GLI1+EGF, GLI I+FGF, EGFP-GS. EGFP+EGF and
EGFP+FGF. Table above shows the concentration of each total RNA sample and the
volume taken for each sample to give 2.5 ug total RNA and volume of DEPC-dH20
added to make up to 6.4 ul. GLII-GS-RT was a control reaction set up for RT-PCR to
this sample no reverse transcriptase (RT) was added.
ll~
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Table 2.5: List of primers with optimum annealing temperature used in the RT-PCR
and expected amplicon size for each set of primers.
Primers Optimum Annealing Temp Amplicon length bp
a-TUB ss'c 249
ACTA2 55ue 425 :
fJ-ACT so-c 320 ,
COUP-TFll ss-e 288 I
DES 55ue 222
E2A 55ue 591
EBFl 55ue 264
EBF2 ss'c 384 I
EBF3 ss''c 450 I
G6PDA 55ue 152 J
GLll 60ue 246 I
GLl2 a.bb 55ue 179 I
GLl2 alfi ss-e 194 I
i
GLl2 c.dd 55ue 1,487 I
ss'c 205 !GLl2 X/o
GLl3 55ue 328
lVL 55ue I178
KRT10 so-c 590
KRT14 60ue 1326
KRT15 55ue 1559
KRT17 ss'c 454
KRT19 ss'c 183
KRT5 64ue 1428
KRT8 ss-e 432
KlF4A ssc 282
LOR ss-e 120
MCSP 55ue 603
Table 2.5 continued on next page
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Table 2.5 continued List o.f prin:ers with optimum annealing temperature used in the
RT-Pt.R and expected amplicon SIze for each set of primers.
NRG2-A 550e 343 i
NRG2-B 500e
,
330
NES 550e 911
NT 55°e 1173
PTCH-l 55°e 150
SIP-l 55ue 284 II
SMO 55ue 297 i !
Snaill ss'r: 879
Snail2 550e 336
SUP-FU 550e 341
TFIID ss'c 261
VAV2 55ue 276
VAV3 5Soe 626
VAV3.1 550e 452
VIM 55°e 346
Shows optimum annealing temperature used in the RT-PCR and expected arnplicon size
for each set of primers for the following genes; actin, alpha 2, smooth muscle, aorta
(ACTA2), alpha-tubulin (a-TUB), beta-actin (j3-ACT), chick ovalbumin upstream
promoter transcription factor II (COUP-TFIl), desmin (DES), transcription factor E2-
alpha (E2A), early B-cell transcription factor (EBF1, 2 and 3) glucose-6-phosphate-
dehydrogenase variant A (G6PDA) glioma associated oncogene GLll, GL12, GL13.
involucrin (lVL), keratins KRTIO, KRTl..f, KRT15. KRTI '7, KRT19, KRT5, KRT8.
chromosome-associated kinesin (KlF4A), loricrin (LOR), melanoma-associated
chondroitin sulfate proteoglycan (MCSP), nestin (NES), neuregulin-2-A (.VRG2-.1).
neuregulin-2-B (NRG2-B), nucleostemin (NS), patched-l (PTCH1), SRY-interacting
protein 1 (SIP1), smoothened (SMO), snail (Snail 1, 2), suppressor of fused (SL'P-FL\
transcription initiation factor (TFIID), VAV2, VA r], VA V3.1 are Guanine nucleotide
exchange factor for the Rho family of Ras-related GTPases and vimentin (U.\D.
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2.8.0 Real-time RT-rcn reaction.
Real-time-RT-PCR was carried out using OyNAmoTM SYBR~Jl Green qPCR kit (Cat
No F- 400L Finnzymcs) as per manufacturers' instruction. Bricfl. a triplicate PCR
reaction were set up in a white 96 well plate (Cat No MLL-9651 MJ Research, I?\C) for
each sample on ice with the final concentration of the following components, :2 ~d first
strand cDNA (diluted 1:4 from section 2.7.3), IX OyNAmoTM SYBRJ<, Green vluster
Mix (containing modified Tbr DNA polymerase, SYBR Green 1. optimized PCR butler.
S mM MgCb, dNTP mix including dUT, 0.3 urn each forward and reverse primer
(Table 2.6) in a total reaction volume of 20 !-tl made up with dH20 . The plates were
covered with clear caps (Cat No TCS-0803 MJ Research).
A master mix (M/mix) was made up of all the components except the first strand cON.\
for all the samples, 18!-t1 of M/mix was added per well and to this 2~d first strand
[diluted 1:4] cDNA reaction was added for each sample. The reaction was mixed by
swirling the pipette tip in the reaction mix. The samples were thermo cycled on an
opticon-2 (MWG) as follows;
1. 95°C for 10 min
2. 94°C for 10 sec
3. XOC for 20 sec (temp specific for primer used: see table 2.6)
4. 72°C for 20 sec
5. XOC for 1 sec (temp specific for primer used: see table 2.6)
6. Plate read (Fluorescence data collection)
7. Repeat from step 2, 39 more times
8. Melting curve from 65-95°c, read plate every 1°c, hold for 1 sec
9. Hold: 4°C
10. End
The Real Time RT-PCR data was obtained as the cycle threshold (Ct) values from the
exponential phase, from a graph plot of Absorbance value plotted against Ct value
generated by the optican-2 computer programme, The melting curve graph of the PCR
product indicated that the data generated was from a single product and not from
multiple products. This was confirmed by mixing 5 ~d Real Time RT-PCR reaction with
I ~d 6x DNA loading buffer [10 mM Tris-HCI pH 7.5. 50 III \ I EOT:\. 10° U(\\ v) Ficoll
.+00, 0.250/0 (w/v) bromphenol blue (BPB), 0.25°0 xylene (: anol FF] and resolx cd on 1-
, I) I 0)- g/ml ethidium bromide (EtBr) \\ ith 0.5 x TBE [Iris-2~/o (w v agarose ge. .
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borate/ethylene diamine tetra-acetic acid (EDTA)] running buffer. Subjected to
electrophoresis at 7-8 V/cm and visualised under ultraviolet (UV) transilluminator (see
section 2.5.6). Each set of primers optimum annealing temperature was determined by
carrying out a gradient Real Time RT-PCR ranging from 50-65I)C. The temperature
used for fluorescence data collection was determined from the melting curve of the PCR
products for each set of primers. Setting the fluorescence data collection temperature
higher than extension temperature prevented interference from primer-dimmer
formation. Not all the primers worked with the DyNAmoTM SYBR1{ Green qPCR kit
that had previously worked with the Red Hot Taq PCR kit in section 2.7A. The list of
primers that did work is given in Table 2.6. Each reaction was carried out in triplicates
with duplicate samples for each primer set. Fold induction or repression values (x) were
calculated using the following formula X =2-~~CT. where Ct represents the mean
threshold cycle of all replicate analyses of a given gene and ~Ct represents the
difference between the Ct values of the gene in question (target) and the Ct value of the
reference gene (~-ACT). ~~Ct is the difference between the ~Ct values of the samples
for each target (e.g. ~Ct for GLII in tumour) and the mean ~Ct of the calibrator (e.g.
~Ct for GLI 1 in normal skin) reference to ~-ACT in tumour and normal skin.
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Table .2.6: Primers used with DyNAmoTM SYBR11 Green ql'Ck kit and the optimum
anne~lmg temperature and fluorescence data collection temperatures used for each set
of primers.
Primers Anneal ing Temp Plate read (fluorescence data collection) Temp
Alpha-tub 570e so'c
B-AeT 600e so-c
GIIl 60ue so-c
GIl2 57°e so'c
GIl3 57uC sc'c
KRTl9 55°e 78°e
KRTl4 600e 78ue
KRTl7 55°e 78ue
KlF4 57ue 75ue
PTCH 57°e 75ue
SMO 57°e so'c
Snail-2 55°e 78ue
SUP-FU 57°e 800e
VIM 55lJe 78°e
Shows optimum annealing temperature used in the Real-Time-RT-Pt.R and the
Fluorescence data collection temperatures used for each set of primers for the following
genes; a-TUB (alpha-tubulin), ~-AeT (beta-actin), glioma associated oncogene GLll,
GII2, GIl3, keratins KRTIO, KRTI-l, KRTI5, KRTI9, KRTI-l, KRTI', chromosome-
associated kinesin (KIF4), patched-l (PTCHI), smoothened (SMO), Snail-2, suppressor
of fused (SUP-FU), VAV2, VAV3, VAV3.1 are guanine nucleotide exchange factor for
the Rho family of Ras-related GTPases and vimentin (VIM).
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2.9.0 Cloning
2.9.1 Cloning Smoothend and Suppressor-Fused PCR products.
A ligation reaction USIng 4/-11 QIAgen purified PCR product (Smoothened and
Suppressor-Fused), 1 /-11 Salt Solution [1.2 M NaCl; 0.06 M MgCb]. 1 /11 [lOng ~d]
vector (Invitrogen Cat No 44-0301) was set up and incubated at room temperature for
30 min (see Figure 2.6 for the pCRIl Tapa vector map).
50 /-11 XLI-Blue competent cells (obtained from Dr Graham Neil) were thawed on ice
and transformed by adding 2 /-11 ligation reaction. A control reaction was also set up
using 2 /-11 dH20 , 50 /-11 XLI-blue competent cells. Cells were then incubated on ice for
30 min, then at 42°C for 90 sec, before being placed on ice for 2 min.
Transformed cells were then added to 3 ml liquid broth (LB) medium preheated to
42°C, and incubated at 37°C for 45 min whilst shaking at 200 rpm. 100-200 ul of this
transformation mix was plated onto (l00 ug / ml) Ampicillin plate and incubated at
37°C overnight. The following day several colonies were picked from each plate and
cultured in 5 ml (100 ug / ml) Ampicillin LB medium. incubated at 37°C shaking
200rpm overnight.
2.9.2 Preparing plasmid miniprep.
1.5 ml of over night bacterial cell suspension was used to prepare miniprep using a
QIAgen mini prep kit (Cat No 27104) as per manufacturers' instruction. Briefly. the
bacteria cell pellet was resuspended in 250/11 buffer PI (containing RNase A). To this.
250/-11 of buffer P2 was added and the tube gently inverted 4-6 times. 350~t1 buffer \]
was added and the tube inverted 4-6 times. Following centrifugation for 10 min at
13000 rpm the supernatant was transferred to a QIAgen spin column in a :2 ml collection
tube and centrifuged for 1 min at 13000 rpm.
The flow-through was discarded and the column was washed \\ ith 0.5 rnl buffer P8. and
then with 0.75 ml buffer PE. After discarding the flow through the column \\as
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additionally centrifuged for 1 min at 13000 rpm to remove residual \\ ash buffer. 0:\.-\
was eluted with 50 IJ.I buffer EB (lOmM Tris-CI pH 8.5) in to a clean 1.5 ml eppendorf
tube.
I IJ.I of the miniprep was run on a 1 % (w/v) agarose gel alongside a IKb plus 0;,\.-\
ladder (GIBCOBRL Life Technology Cat No 10787-018) to check the plasmid size.
The concentration of mini preps was determined by measuring its absorbance at 260nm
using a spectrophotometer. The following formula (concentration [ug/rnl] = Abs 260nm
x 50 ug/ml x dilution factor) was used to calculate the plasmid concentration.
To check whether the Smoothened and the Suppressor Fused fragment had cloned into
the vector, SMO and SUP-FU pCRII Tapa vector was digested with EcoRI restriction
enzyme from New England Biolabs (Morris et al.). 300 ng vector (miniprep), was
dissolved in NEBuffer EcoRI [50 mM NaCI, 100 mM Tris-HCI, 10 mM MgCI:. 0.025%
(v/v) Triton X-I 00 (pH 7.5 at 25°C)], containing 30U EcoRL in a total reaction volume
of 25 IJ.I. The digest mix was incubated at 37°C overnight. The following day the digest
was run on 10/0 (w/v) agarose gel to identify the insert.
In addition to SMO and SUP-FU, a 511 bp PTCH fragment and 250 bp GLll fragment
were obtained from Dr Judith Green. A 1.2 kb keratin 14 (KRTl-l) eDNA fragment was
obtained from Professor Anthony Quinn. PTCH, GLll and KRTI c/ cDNA were cloned
in to Hindi II, EcoRI site of the PGEM vector.
A human GLl2 (hGLl2) 1.6 Kb fragment was obtained from Dr Fritz Aberger
University Salzburg Austria. The hGLl2 fragment was cloned in to the EcoRI sites of
the pCRII Tapa vector. 1 IJ.g of hGLl2-1.6 kb-pCRII Tapa vector spotted on a f Iter
paper was sent to us. The Plasmid was eluted off the filter paper by cutting out the area
of the filter paper on which the Plasmid was spotted, and soaked in 50 ~d sterile dH20 .
90 ul XL I-blue competent cells were transformed with approximatelv 100 ng hGLl~
pCRII TOPO as previously described.
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/aCZuATG
M13 Reverse Primer
205 [·CAG GM ACA G::'-:C=-=T::--"M:Q-L-_ -A-'
GTC CTT TGT CGA TAC T
-- -- -'
_ .§p6 Promoter ,.
ATG ATT ACG CCA AGC TAT TTA~AC ACT ATA GAA
TAC TM TGC GGT TCG A~ MT ~CA CTG TGA TAT C'I'T
Nsf I Hird III Kpn I Sac I Ban11 I Spe I
I I I
TAC TCA AGC TAT GCA TCA AGC TTG GTA CCG AGC TCG GAT CCA CTA GTA ACG GeC
ATG AGT TCG ATA CGT AGT TCG M C CAT GGC TCG AGC CTA GGT GAT CAT TGC CGG
BstX I EcoR I EcoR I Ecofl.V
I
GCC AGT GTG CTG GM TTC GCC C_CGG TCA CAC GAC CTT M G CGG G ••• II G GGC GM TTC TeC AGA TAT
TTC CCG CTT MG ACG TCT ATA
BsfX I Not I xno I Nsf I Xba I Ape I
I I I I I I
CCA TCA CAC TGG CGG CCG CTC GAG CAT GCA TCT AGA GGG CCC MT TCG CCC TAT
GGT AGT GTG ACC GCC GGC GAG CTC GTA CGT AGA TCT CCC GGG TTA AGC GGG ATA
I! P!..omoter M13 (-20) Forward Primer M13(-40) Forward Primer
AGT GAG TCG TAT TAk:: MT TCA f TG GCC GTC GTT TTA dAA CGT CGT CAC TGC CM MC 468
~CTC AGC ATA A TTA AGT jGAC CGG CAG CM MT QTT CCA GCA CTG ACC CTT TTG
Figure 2.6: Features of pCRII-Tapa vector map in which SMO, SUP-FU, and GLl2
were cloned, and sequence surrounding the Tapa cloning site. Restriction sites are
labelled to indicate the actual cleavage site. The arrows indicate the start of transcription
for SP6 and T7 polymerases.
. loharnm 'J . Ikrarn
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2.9.3 Sequencing the cloned inserts.
To confirm that correct inserts, and to determine the direction in which they were
cloned. SMO, SPU-FU and hGL12-1.6 kb-pCRII Tapa, PTCH, GLJI and KRTl-l-1.2
kb-PGEM were sequenced using ABI PRISM Big Dye Cycle Sequencing Ready
Reaction kit (Cat No 4303152 Applied Biosystems) as per manufacturers' protocol.
Briefly, 4 ~I Terminator Ready Reaction Mix (TRRM), 200 ng pCRl1 Tapa \ ector
(mini-prep) containing the insert, 10 ng Primer SP6 or T7. in a 10 JJ.I total reaction
volume made up with dH20 . A control reaction was also set up using .f JJ.I TRRI\I. 200
ng PGEM-3Zr, 1.6 pmol M13 primers. The reaction was covered with 10 ~t1 mineral oil
and thermal cycled using a Techne PCR machine, as follows; 94"( for 60 sec, 40 cycles
at (94°C for 30 sec, 55°C for 40 sec, 72°C for 1 min), final extension at 72')C for 10 min.
The mineral oil was removed from the reaction mix by placing it on a clean sheet of
parafilm. The parafilm sheet was held at an angle so that the reaction mix trickles
slowly down it, this separated the oil from the reaction mix.
The separated reaction mix was placed in a 1,5 ml clean eppendorf tube. The extension
products were purified using an ethanol precipitation protocol. By adding 2 ul of 3 M
sodium acetate pH 5.2, 50JJ.I 95% (v/v) ethanol to the eppendorf tube containing the
separated reaction mix. The eppendorf tube was vortexed and placed on ice for 10 min
and centrifuged at 13000 rpm for 30 min. The pellet obtained was rinsed with 250 ul
70% (v/v) ethanol, care was taken each time when removing the supernatant to avoid
disturb the pellet. The pellet was driedin a speed vac centrifuge and sent to the CRLIK
sequencing facilities to be sequenced on ABI DNA sequencer.
Once the correct insert cloned was confirmed, glycerol stocks were made of
transformed cells for each clone by adding 350 JJ.I of sterile glycerol to 3.5 1111 of LB
culture and these stocks were stored at -70°C.
2.9'" Cloning a 296 bp GLl2 fragment from hGL/2-1.6 kb-pCRII-TOPO.
A smaller 296 bp GL12 fragment from 5' region of 1.6 kb hGLe insert in 11CRII-lOPO
. . h b idi t' I Figure "7) '\ double dicc-t reactionvector \\as c loned for ill-Situ y rI isa Ion (see _. .. ::-
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was set up with 0.35 IJ.g hGL12-1.6 kb-pCRII-TOPO, 7.5U Nhe! and 30 U EcoRY in lx
NEB buffer 2 plus BSA (50 mM NaCI, 10m M Tris-HCI, 10 mM \IgCI:;. I III \ I
dithiothreitol pH 7.9 at 25°C) in a 20 IJ.I total reaction volume andd incubated at 37'C
for 5 1/2 hours.
The blunt ends generated by NheI were filled by adding 5 U of Klenow (D:\'A
polymeraseI NEB) and 1 IJ.I of (0.5 mM) dNTPs to the digest reaction and mixed and
incubated at 30°C for 15 min. The reaction mix was run on 1%w/v agarose gel with the
DNA loading buffer. The vector band containing the 296 bp 5' region of GIn (hGLl~­
296 bp-pCRII TOPO) was cut out of the gel and purified using Qiagen DNA gel
extraction kit as per manufacturers' instructions. The purified DNA was eluted of the
column with 30 IJ.I (preheated to 65°C) elution buffer (EB).
Approximately 0.01 IJ.g of linerised hGL12-296 bp-pCRII TOPO vector was ligated
using 400 U of T4 Ligase, 1x Ligase reaction buffer in a 10 IJ.I total reaction volume and
incubated at room temperature overnight. 5 ~I of ligation reaction was used to transform
Xl.l-blue competent cells and a plasmid mini prep was prepared from the transformed
culture suspension as described in section 2.9.1 and 2.9.2.
0.4 IJ.g of hGL12-296 bp-pCRII TOPO was double digested with 20 U EcoRI (Morris et
al.) and IOU NotI (Morris et al.), Ix EcoRI buffer (50 mM NaCI, 100 mM Tris-HCI. 10
mM MgCb, 0.0250/0 Triton X-100), (pH 7.9 at 25°C) in a 20 ~I total reaction volume
and incubated at 37°C for 2 hours. 5 IJ.I reaction mix was loaded on to a 1%w/v agarose
gel to check for correct size insert. The GL12 insert was also sequenced using T7 and
SP6 primers confirming GL12 insert (as described in section 2.9.3). This construct \\ as
used to generate a 269 bp GL12 ribo probes for in-situ hybridisation analysis.
2.9.5 Cloning a 1.2 kb keratin KRT14 insert from PGEM in to peRIl-TOPO
vector.
A 1.2 kb keratin KI4 insert was cut out of the KRTI-l-1.2 kb-PGL:'\I vector and cloned
in to pCRII-TOPO vector in HindIll and EcoRI site (see Figure 2.8 and Figure 2.91 \
following double digest reaction was set up with 0.5 ug hGLn-1.6 kb-pCRII-TOPO. 1\
EcoRI buller 3 (50 111M NaC\, 100 ml\l Tris-HCI. 10 1ll\II\IgCI:;. 0.0250 0 Triton \-100
1' 1-,
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pH 7.9 at 25°C), 30 U EcoRI and 30 U HindIII in a 20 J.l1 total reaction volume: and
incubated at 37°C for 4 hours. After incubation double digested hGLJ2-1.6 kb-pCRII-
TOPO was dephosporlated by adding 1J.l1 of phosphotase enzyme (ClAP diluted I: 10
Cat No M 1821 Promega) to digest reaction mix and incubated at 3T'C for 1 hour.
A second double digest reaction was set up with I ug KRTI-l-l.2 kb-PGEI\l 1:\ EcoRI
buffer 3 (50 mM NaCI, 100 mM Tris-HCI, 10 mM MgCb, 0.025% Triton X-I 00 pH 7.9
at 25°C), 30 U EcoRI and 30 U HindIII in a 20 J.l1 total reaction volume and incubated at
37°C for 4 hours.
KRT14-1.2 kb-PGEM double digesed reaction and dephosphorlated hGL12-1.6 kb-
pCRII-TOPO reactions were run on 1% agarose gel, to separate the vector backbones
from the inserts. The pCRII -TOPO back bone and the KRTI-l insert (1.2 Kb) bands
were excised out and purified using Qiagen gel extraction kit as per manufacturers'
instructions. Purified pCRII-TOPO backbone and the 1.2 kb KRTI-l insert were run on
1% (w/v) agarose gel to check their quality and quantity.
A ligation reaction was set up with 1:3 ratio ofpCRII-TOPO backbone to 1.2 kb KRTI-l
insert, as follows: 2 J.l1 pCRII-TOPO back bone, 6 J.l1 1.2 kb KRTI-l insert, I J.l1 '1'-+
Ligase and 1 J.l1 lOx Ligase buffer, a control reaction was also set up without T4 Ligase
and incubated at room temperature overnight.
A 5 J.l1 of ligation reaction was used to transform XLI Blue competent cells to obtain a
plasmid mini prep as described in section 2.9.1 and section 2.9.2. A 0.5 ug KRTJ -1-1.2
kb-pCRII Tapa mini prep was double digested using EcoRI and HindIIl as described
above and run on 1 % (w/v) agarose gel to check for the 1.2 kb KRTI-l insert and
pCRII-TOPO backbone. Keratin K14 insert was confirmed by sequencing using T7 and
SP6 primers. Glycerol stocks were made from the remaining mini prep cell suspension
as described in section 2.9.3.
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2.10.0 In-situ hybridisation
2.10.1 Linearising hGLI2-1.5 kb-pCRII TOPO and hGLI2-296 bp-pCRII TOPO
plasmids for in-situ probes.
1.5 kb hGL12 sense and anti-sense ribo probes were generated by linearising hGL12-1.5
kb-pCRII TOPO with EcoRV and BamHI restriction enzymes (Morris et al.). A 296 bp
hGL12 sense and anti-sense ribo probes were generated by linearising hGLI1-296 bp-
pCRII TOPO with EcoRI and NotI restriction enzymes (Morris et al.).
The EcoRV Reaction was set up using 10 ug hGL12-1.5 kb-pCRII Tapa, lx NEB
buffer 3 (100 mM NaCI, 50 mM Tris-HCI, 10 mM MgCI:, 1 mM dithiothreitol, (pH 7.9
at 25°C), 100 ug/rnl BSA, 60 U EcoRV, in a 30 III total reaction volume and incubated
at 37°C overnight.
The BamHI Reaction was set up using l Oug hGL12-1.5 kb-pCRII Tapa, 1x NEB
BamHI buffer 150mM NaCI, 10mM Tris-HCI, 10mM MgCh, 1mM dithiothreitol, (pH
7.9 at 25°C), IOO/-lg/ml BSA, 60U BamHI, in a 30111 total reaction volume and
incubated at 37°C overnight.
The EcoRI Reaction was set up using 10 ug hGL12-296 bp-pCRI I Tapa, 1x EcoRI
buffer [50 mM NaCI, 100 mM Tris-HCI, 10m M MgCb, 0.025% (v/v) Triton X-IOO,
pH 7.9 at 25°C], 100 ug/ml BSA, 30 U EcoRI, in a 20 III total reaction volume and
incubated at 37°C for 4.5 hours.
The NotI Reaction was set up using 10 ug hGL12-296 bp-pCRII Tapa, Ix NEB buffer
3 (100 mM NaCI, 50 mM Tris-HCI, 10 mM MgCh, I mM dithiothreitol, (pH 7.9 at
250C), I00 ug/ml BSA, 15 U NotI, in a 20 III total reaction volume and incubated at
37°C for 4.5 hours.
129
CHAPTER 2: Materials and \kthods
2.10.2 Linearising KRT14-1.2 kb-PGEM and KRT14 -1.2 kb-pCRII TOPO
plasmids for in-situ probes.
KRT14-I.2 kb-PGEM and KRT14-I.2 kb-pCRIl Tapa plasmids were linearised with
EcoRI and HindIII restriction enzymes (Morris et al.).
The EcoRI Reaction was set up using 10 ug KRT1-l-I.2 kb-PGEM or KRTl-l-1.2 kb-
pCRIl Tapa, Ix EcoRI buffer 3 [50 mM NaCI, 100 mM Tris-HCL 10 mM \lgCI~.
0.0250/0 (v/v) Triton X-IOO, pH 7.9 at 25°C], 30 U EcoRI, in a 25 ul total reaction
volume and incubated at 37°C overnight.
The HindIII Reaction was set up using 10 ug KRTI-l-PGEM or KRTl-l-1.2 kb-pCRlI
Tapa, 1x NEB buffer 2 (50 mM NaCI, 10 mM Tris-HCL 10 mM MgCI]. 1 mM
dithiothreitol, (pH 7.9 at 25°C), 30 U HindIIl, in a 25 /ll total reaction volume and
incubated at 37°C overnight.
A 1 J.lI of reaction digest was run on 1 % (w/v) agarose gel along side undigested
plasmid to check whether the digested plasmid had linearised.
2.10.3 Linearising FOXE1-(UTR-332bp)-pBluescript-II-KS plasmid for in-situ
probes.
FOXEl sense and anti sense probes were generated from FOXEl-(UTR-332bp
corresponding to nucleotides 2148 -2480, [GenBank GINo 2078532])-pBluescript-ll-
KS (obtained form Dr Fritz Aberger) linearised with BamH1 and EcoRI.
The BamHI reaction was set up using IOug of FOXEl-(UTR-332bp)-pBluescript-11
KS, l x NEB BamHI buffer 150 mM NaCI, 10 mM Tris-HCI, 10 111\1 f\lgCI]. I 111\1
dithiothreitoI. (pH 7.9 at 25°C), 100 ug/rnl BSA, 60 U BamHL in a 30 ul total reaction
volume and incubated at 37°C overnight.
The EcoRI Reaction was set up using 10 ug of FOXEl-(UTR 332bp) pBlucs(ript II
KS, 1x EcoRI buffer 3 [50 mM NaCI, 100 mM Tris-HCI. 10 m'vl \ IgCI~. 0.02~o 0 (\ \)
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Triton X-I00, pH 7.9 at 25°C], 30U EcoRI, In a 30 ~I total reaction volume and
incubated at 37°C overnight.
1 ~l of each reaction digest was run on 1 °/0 (w/v) agarose gel along side undigested
plasmid to check whether the digested Plasmid had linearised.
2.10.4 Purifying linearised plasmids by ethanol precipitation.
A single digest reaction volume (from section 2.9.1) was made up to 200 ~I with sterile
dH20 . To this equal volume of phenol chloroform isoamyl alcohol 25:2-k 1 was added.
vortexed and centrifuged at 13000 rpm. The aqueous layer was transferred to a new 1.5
ml tube. 1/10th of the volume of 3 M sodium acetate pH 5.2 and 2.5x the volume of
100°10 (v/v) ethanol was added and placed at -20°C for 1 hour and centrifuged at 13000
rpm at 4°C for 15 min. The pellet was washed with 250 ul 70°/0 (v/v) ethanol and air
dried and dissolved in 10 ~I RNase free [10 mM Tris-CI pH 8.5]. Purified linearised
plasmids were diluted 1: 100 and run on a 1°/0 (w/v) agarose gel, alongside a known
concentration marker, to check the purity concentration.
2.10.5 Transcribing GLI2, Keratin KRT14 and FOXEl probes for in-situ
hybridisation.
A 1.5 kb GL12 sense probe was generated usmg 1 ~I (-200ng) EcoRV linearised
hGL12-1.5 kb-pCRII Tapa, 40 U SP6 Polymerase (Roche Cat No 810 27-+), 2 ul
digoxigenin-UTP (Dig) labelling mix (Roche Cat No 1 277073). l x transcription buffer
(0.04M Tris-HCl pH 8 at 20°C. 6 mM MgCI2, 100 mM dithiothreitol, 20 m\ I
spermidine) supplied with RNA polymerase, 40 U RNase Inhibitor (Roche Cat No 799
017), in a 20 ul total reaction volume made up with (DEPC treated) dH20 .
1.5 kb GL12 anti-sense probe was generated using 1 ~I (-200 ng) BalllHI linearised
hGL12-1.5 kb-pCRII Tapa with T7 Polymerase (Roche Cat No 881 767). Rest of the
reaction components were same as for the 1.5 kb GLn sense probe (sec ab\)\ c). Both
sense and anti-sense 1.5 kb GL12 reaction mix were incubated at 3T'C for 2 hours.
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A 296 bp GLI2 anti-sense and sense ribo probes were generated from 1 1-11 (-200 ng)
EcoRI and NotI linearised hGLI2-296 bp-pCRII Tapa. The reactions and the
components used were same as those for the 1.6 kb GIJ2 probes described abox e.
Figure 2.7 shows the vector maps and the GII2 (1.5 kb and 296 bp) probes generated.
Method and materials used for transcribing keratin 14 and FOXEl anti-sense and sense
probes were same as those described above for GIl2. Except 1.2 kb keratin14 anti-sense
probe was generated with SP6 polymerase from HindIII linearised KRI-l-1.2 kb-PGI:::\1
and with T7 polymerase from HindIII linearised KRTl-l-1.2 kb-pCRII Tapa. A 1.2 kb
keratin 14 sense probe was generated with T7 Polymerase from EcoRI linearised
KRTl4-1.2 kb-PGEM and with SP6 Polymerase from EcoRI linearised KRTI-l-l.2 kb-
pCRII Tapa (see Figure 2.8).
A FOXEl 332bp anti-sense probe was generated with T7 polymerase from EcoRI
linearised FOXEl-(UTR-332bp)-pBluescript-I1 KS and FOXEl 332bp sense probe was
generated with T3 polymerase from BamHl linearised FOXE1-(UTR-332bp)-
pBluescript-I1 KS (see Figure 2.9).
1 1-11of transcription reaction was run on 1% (w/v) RNase free agarose gel with RNA
loading buffer, to check transcribed probes. The transcribed probe bands were expected
to be of a higher intensity (approx. 10 xs) than linearised plasmid bands.
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Figure 2.7: A diagrammatic representation of the GLl2 (1.5 kb and 296 bp) anti-sense
and sense probes generated from hGLI2-1.5 kb-pCRII-TOPO and hGLI2-296 bp-pCRII-
TOPO vector. Showing the restriction sites of the nuc1eases used to linearise the
plasmids and the SP6 and T7 RNA Polymerase sites.
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Figure 2.8: A diagrammatic representation of the KRT14 1.2 kb anti-sense and sense
probes generated from KRT14-1.2 kb-PGEM and KRT14-1.2 kb-pCRII-TOPO.
Showing the restriction sites of EcoRI and HindUI nucleases used to linearise the
plasmids and the SP6 and T7 RNA Polymerase sites.
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Figure 2.9: A diagrammatic representation of the FOXEl 332-bp anti-sense and sense
probes generated from FOXE1-(UTR-332 bp)-PGEM plasmid and the restriction sites
of EcoRI and Bam-HI nuc1eases used to linearise the plasmids and the SP6 and T7 RNA
Polymerase sites.
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2.10.6 Purifying transcribed probe by ethanol, precipitation.
2.5 J.lI 4M LiCI and 75 J.lI 100 °10 (v/v) ethanol was added to the transcription reaction
and incubated at -20°C for 1 hour. Reaction mix was then centrifuged at 13000 rpm -r'C
for 15 min. The pellet was washed with 70°10 (v/v) ethanol and dissolved in 40 J.l1 DEPC
treated dH20. 1 J.lI purified probe was checked by running on a 1°10 (w/v) RNase free
agarose gel using RNA loading buffer.
2.10.7 Fragmenting 1.5 kb GLl2 and 1.2 kb KRT14 transcribed probes.
GLl2 and keratin 14 probes were fragmented by adding equal volume of 80 mlvl
NaHC03, 120 mM Na2C03 (39 ul) and incubated at 60°C (GLI] for 12.5 min and
keratin 14 for 10 min 36 sec) in a PCR machine. The length of time the probes were
fragmented for was calculated using the following formula. Min = (L-0.5) I (0.055L)
were L is the starting length (Kb) of the transcript.
2.10.8 Purifying the fragmented probe by ethanol precipitation.
150 ul RNase free dH20, 1/10 of the volume (3 M sodium acetate pH 5.2) and 2.5 x the
volume cold 100°10 (v/v) ethanol was added to the fragmented probe and vortexed.
Reaction mix was incubated at -70°C for 1 hour and centrifuged at 13000 rpm for 20
min at 4°C. The pellet was washed with 250 J.ll 70°10 (v/v) ethanol and allowed to air dry
at room temperature before being dissolved in 20 J.l1 DEPC treated dH20 . I pi
fragmented probe was run on a 1°10 (w/v) RNase free (EthBr) agarose gel with an RNA
loading buffer. Fragmented probe was seen as a smear on the gel. Purified fragmented
probes were stored at -20°C.
2.10.9 Quantifying DIG-labelled KRT14, GIl2 and FOXEl probe by dot blotting.
;\ control DIG labelled RNA was diluted to give 1 ng, 100 pg, 10 pg, I pg. 0.1 pg and
0.01 pg per :2 ul. A serial dilution A- F of KRTI-I. GLI] and FO.\I:'l DIG labelled ribo
probes were also made. :2 ul of each dilution of control and KRTI-I. Gl.I? and F(}XEJ
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DIG labelled probes were spotted on a Hybond-Xl, (RPN 203S Amersham) and
allowed to air dry and washed with DIG buffer 1 for 1 min at room temperature.
Incubated in 10 ml blocking solution (l0 ml DIG buffer L 0.5 g Marvel and 30 ul
Triton xl 00), shaking for 30 min at room temperature followed l» incubatins in Fab
. :::-
antibody (Roche Cat No 1 093 274) solution (10 ml DIG buffer 1, 0.5g Marvel, 30 ~t1
Triton xl 00 and 2 III Fab antibody) shaking for 30 min at room temperature. Then
washed with DIG buffer 1 for 15 min (2 x) and in DIG buffer 2 for :2 min at room
temperature. Dot blot membrane was covered with the BCIPINBT substrate solution
and incubated for 20 min at room temperature. A substrate reaction was stopped by
washing with dH20 and allowed to air dry. The concentration of KRTI-l. Gin and
FOXEl DIG-labelled probes was determined by comparing the intensity of the KRTI-l,
GLl2 and FOXEl spots with that of the known control DIG-labelled RNA spots.
2.10.10 Cutting paraffin wax embedded and frozen normal skin and BCC tissue
sections.
All equipment used was RNase free and all solutions were made up in 0.1 % (v/v) DEPC
dH20 . For wax embedded tissue samples Microtone water bath was cleaned with, 70%
(v/v) methanol, 1% (v/v) concentrated HCl in 0.1 % (v/v) DEPC dH20 , dried and rinsed
with 0.1% (v/v) DEPC dH20 . 1 litre of 0.1 % (v/v) DEPC dH20 was placed in the water
bath and the temperature set at 42°C.
The tissue blocks were incubated at 4°C for 1 hour before cutting 5 urn tissue sections
using a Microtone. Cut sections were place in 0.1 % (v/v) DEPC dH20 water bath
preheated at 42°C as described above, this allowed the sections to spread out and
preventing them from creasing. The sections were transferred on to a Super frost plus
microscope slides (BDH Cat No 406/0179/00). When lots of sections were cut from the
same block it started to warm up so to keep it cool it was placed on ice for few nun
before cutting more sections. The sections were dried at 42°C overnight.
Snap frozen tissue samples were embedded in a CRYO-f\I-BED embedding medium
and 8 micron tissue sections were cut on a cryostat (SLEE mainz) set at -20'1C. Each
section was collected on to a room temperature Super Frost-Plus microscope slides and
I ~ ~
.' I
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placed immediately into micro-slide box on dry ice. The slides \\ ere stored at -70°C if
not used immediately.
2.10.11. Pre-treatment of tissue sections.
The following day wax sections were de-waxed in Xylene (x2) for 5 min. The frozen
section slides were removed from the slide box on dry ice or from the -70°C freezer
and placed on a clean Kimwipe (or similar lint-free towel) and allowed to thaw for no
more then 30 sec. The slides were then transferred into a 4% (w/v) freshly made
Paraformaldehyde (Sigma) at room temperature for 15-30 min, to fix the frozen
sections. After incubating the wax sections in xylene and frozen section in
paraformaldehyde, the slides were washed separately in 0.1 % (v/v) DEPC PBS for 10
min, 1000/0 (v/v) ethanol for 10 min, 70% (v/v) ethanol for 10 min and in 0.1 % (v/v)
DEPC dH20 for 10 min. Rest of procedure described below was same for wax and
frozen sections.
To increasing the accessibility of the target mRNA two methods were used. (1) 0.01 M
citrate buffer pH 6, was microwaved for 12 min in a microwave steam cooker, the slides
were then immediately placed in the heated citrate buffer and microwaved for a further
8 min. (2) The slides were incubated with 100 ul 2.5 J.lglJ.ll Proteinase K at 37°C in a
slide Hybid incubator for 15-30 min time range, Proteinase K was inactivated b\
immersing in 0.20/0 (w/v) Glycine for 10 min.
The remaining procedure was same for both methods. After increasing the accessibility
of the target RNA, the sections were immersed in 0.1 % (v/v) DEPC PBS for 10 min
and acetylated in 0.1 M triethanolamine (TEA) pH 8. 0.25% (v/v) acetic anhydride for
10 min. This step prevented non-specific binding of the probe to positively charged
amino groups by acetylating them. After acetylation the slides were washed in 0.1 0,0
(v/v) DEPC PBS for 5 min.
2.10.12. Pre-hybridisation.
Slides were taken out of the 0.1 % (v/v) DEPC PBS and wiped around the tissue section
with sterile paper wipe. Sections were not allowed to drv at any time. If there were
US
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many slides one slide at time was wiped and the required reagent added to it. The tissue
sections were covered with pre-hybridisation solution [4x SSC. 1x Denhardts, 50%
(v/v) formam ide, SOO ug/rnl tRNA, SOOJ..1g/ml salmon testes DNA (ST-D0::-\) denatured
at 100°C for 10 min and placed on ice before adding to the mix] and incubated at 42"C
for 3-4 hours in a slide Hybaid incubator.
2.10.13. Hybridisation.
Excess pre-hybridisation solution was wiped off using a clean tissue wipe and 30 ~L1 of
hybridisation solution (same as the prehybridisation solution) containing 50-100 ng
labelled probe and 20% (w/v) Dextran sulphate was added. The probe wns denatured at
6SoC for S min and placed on ice before adding to the hybridisation mix. The sections
were covered with Para film and incubate at 42°C overnight.
The next day the sections were washed in 2x SSC for S min (x 2), 2x sse 50%
Formamide, 1x SSC SO% (v/v) Formamide, O.Sx SSC 50% (v/v) Formamide at
temperature ranging from 42-SSoC for 20 min in each solution and 0.1 x sse SO% (v/v)
Formamide at temperature ranging from 42-60oC for 20 min in a Hybid sleeve wash.
The final wash was in 2x SSC for S min at room temperature.
2.10.14. Immunological detection of Digoxigenin-labelled probes.
The sections were rinsed in DIG buffer 1 (100 mM Tris-HCI, ISO mM NaCI pH 7.5) for
S min at room temperature, and blocked by incubating for 30 min with 100 IJ.I of 10%
(v/v) normal sheep serum (NSS) in DIG buffer 1. This was replaced with 100 IJ.I of 1%
(v/v) NSS in DIG buffer I, containing sheep Anti-Digoxigenin-alkaline phosphatase
(AP) conjugated (Fab fragments, Roche Cat No 1 093 274) diluted 1:400 and incubated
for 2 hours at room temperature.
The unbound conjugate was removed by two 10 min washes in DIG buffer 1, follo« cd
by one wash for S min in DIG buffer 2 (100 mM Tris-HCI pH 9.5, 100 m\ I .'\aCL 50
,;
111M MgCb) at room temperature. The Hybrids were visualised by incubating the
section with S-Bromo-4-Chloro-3-lndoyl Phosphate / Nitro Blue Tctra/oliurn
(BCIP/NBT) liquid substrate system (Sigma Cat No 8-191 I) chromogen solution ( .., 50
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ug/]..d NBT and 175 /-lg//-ll BCIP in DIG buffer 2) in dark at -rJc overnight. The
chromogen solution being light sensitive was prepared immediately prior to use and
filtered through 0.22 urn disposable filter, wrapped in aluminium foil and placed on icc.
The colour reaction was stopped by immersing the slide in buffer 3 (10 m\1 Tris-HCI
pH 8, 1 mM EDTA) for 30 min at room temperature. The developed slides \\ ere
mounted using Aqua mount and examined under a light microscope.
2.11.0 Affymetrix analysis
2.11.1 First stand eDNA synthesis.
Superscript ds-cDNA Synthesis Kit (Cat No 11917-010, Invitrogen) was used to
synthesis first strand cDNA synthesis. Reactions were set up on ice as shown in Table
2.7.
Table 2.7: Components of the first strand cDNA synthesis reactions set up for
Affymetrix analysis.
Sample Total RNA Volume T7-(T)24 Total
[~g/~I] Taken ~I primer (100 pmol/ul) RNA ug
volume added ~I
GLII-GS 0.72 10 1 7.2
GLll+EGF 0.77 10 1 7.7
EGFP-GS 0.69 10 1 6.9
EGFP+EGF 0.76 10 1 7.6
Primary keratinocytes were transduced with GLl1 and EGFP retroviral particles and
cultured with EGF (GLI 1+EGF, EGFP+EGF), and without growth supplement (EGFP-
GS, GLI I -GS controls). The table shows total RNA concentration and the volumes
,
taken for each sample in first strand cDNA synthesis reaction for Affymetrix analysis.
The reactions were mixed by pipetting up and down and pulse centrifuged before
incubating at 70°C for 10 min, on a Hybid Pt.R block and then immediately placed on
icc. A master mix 16 ul [5x] First Strand Buffer (thaw at 37"('. put on icc). 8 pi DT I
[0. I M] and 4 ul dNTPs [10 mM each] was made up on icc. this \\ as mi:-.cd b) pipctting
up and down and pulse centrifuged. 7 ~I of this master mix was added to each reaction
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tube and incubate at 42°C for 2 min. 1ul of Superscript II reverse transcriptase [20U
U/~l] was added to each reaction tube and mixed by taping the tube and pulse
centrifuged before incubating at 42°C for 1 hour in a Hybaid thermal eyeler with heated
lid. The tubes were then immediately place on ice.
2.11.2 Second strand eDNA synthesis.
Second stand cDNA synthesis was carried out using Superscript ds-cDNA Synthesis Kit
(Cat No 11917-010, Invitrogen). A master mix 364 ~l DEPC treated dH20. 120 pi 5x
Second Strand Buffer, 12 ~I dNTPs (10 mM each), 4~1 E. Coli DNA Ligase (10 U/~t1),
16~1 E. Coli DNA Pol I (1 0 U/~l), 4 ~I E-Coli RNase H (2 U/pl) was assemble on ice.
this was mix by vortexing and pulse centrifuged. 130 ~I of the master mix was added to
each of the first strand reaction tubes and mixed by pipetting up and down and pulse
centrifuged. The reaction was incubated at 16°C for 2 hours in a Hybid thermal eyeIe
block with heat lid on. 2 ul (5 U/~l) T4 DNA Polymerase was added to each tube and
mixed by pipetting up and down and incubated for further 5 min at 16°C. The reaction
was stopped by adding 10 ~I of EDTA (0.5M) pH 8.0 to each tube. The tubes were then
placed on ice.
2.11.3 Clean-up of double stranded eDNA.
Double stranded cDNA was cleaned up using Phase Lock Gel, 2 ml light (Cat No
0032005 10, EPPENDORF). Phase-Lock tubes were centrifuged in a microfuge at
13,000 rpm for 30 sec. To the cDNA reaction equal volume approximately 162 ~L1 of
room temperature buffer saturated phenol (add 65 ~I of Alkaline Buffer [10 mM Tris-
HCI pH 8.0, 1 mM EDTA] to 1 ml of phenol-chloroform-isoamyl alcohol 25:2.+: L
[AMBION 9732], vortex for 2 min and then spin) was added and vortexed briefly to
nux.
The mixture was place into a Phase-Lock tube (taking care not to vortex) and
centrifuged at 13,000 rpm in a micro-centrifuge for 2 min and then upper aqueous phase
was transferred in to a new 1.5 ml eppendorf tube and to this (0.5 x volume) 75 ~t1
(NH40Ac [7.5 M]. .+ ul Glycogen l5 mg/ml]) and 375 ~d 100% ethanol was added. The
solution \\as mixed by tapping the tubes and centrifuged at 13,000 rpm in a micro-
I .+ I
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centrifuge for 20 min (care was taken not spin for longer). Supernatant was decanted
taking care not to displace the pellet and washed twice with 500 III 80% cold ethanol.
then centrifuged at 13,000rpm for 5 min for each wash. All the ethanol was removed
and the tubes were spun briefly to collect any residual ethanol on the sides of the tube,
this was also removed. The pellet was allowed to air dry for 5-10 min before dissolving
it in 12 III of DEPC treated dH20. If not proceeding to the next step (In vitro
transcription). The tubes were placed on dry ice to freeze the solution and then store at _
80°C.
2.11.4 Synthesis and labelling of cRNA.
Synthesis of cRNA and labelling it was carried out by using BioArray High Yield RNA
Transcript Labelling Kit (Cat No 900182, ENZO, Affymetrix). All reagents and double
stranded cDNA were allowed to thaw at room temperature and were kept at room
temperature until incubation at 37°C to reduce precipitation of OTT (dithiothreitol). The
incubation was carried out in an incubator, to reduce condensation on the inside of the
lid. A master mix was made up as shown in Table 2.8.
Table 2.8: Components of the reaction set up for the synthesis and labeling of cRNA
using a BioArray High Yield RNA Transcript Labeling Kit (Cat No 900182, ENZO,
Affymetrix)
Order of components added Reagents from the Labell ing Kit Volume Master
added III Mix JlI
1 lOx HY Reaction Buffer 4 16
2 Biotin-labelled ribonucleotides 4 16
3 OTT 4 16
RNase Inhibitor mix 4 164
T7 RNA Polymerase 2 85
DEPC treated dH20 10 406
double stranded cONA (2.8.3) 12 -7
40 112Final Volume
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Table 2.8 shows the components and the order in which they were added to the tube to
set up reaction for the synthesis and labelling of cRNA. It also shows the total volume
of the reaction and the volume taken for the master mix for 4 samples.
The master mix was mixed by pipetting and pulse centrifuged, 28 III of master mix was
added to each sample of (12 Ill) double stranded eDNA (from Section 2.11.3). The
reaction was mixed by pipetting up and down and pulse centrifuged and incubated at
37°C for 5 hours (gently mixing every hour by tapping tube and pulse centrifuainu).
~ ~
2.11.5 Purification of labelled cRNA and quantification.
Labelled cRNA was purified using RNeasy Mini Kit (Cat No 74104, QUlAGEN)
All reagents were prepared by following the manufacturers' instructions. Note p-
mercaptoethanol was not added to 1 ml of RLT Buffer and care was taken not to
touch the tip of the spin column at any time.
To the in vitro transcription reaction tubes (from section 2.11.4) 60 III DEPC treated
dH20 and 350 III RLT buffer was added and mixed thoroughly by pipetting up and
down. Then 250 III 1000/0 ethanol was added and mixed by pipetting up and down and
pulse centrifuged. 700 III volume of each sample was placed in to a separate RNeasy
spin column sitting in a 2 ml collection tube and centrifuged at 8000 xg for 15 sec.
RNeasy spin column was placed into a new 2 ml collection tube and 500 ul RPE buffer
was placed in centre of the column, and then centrifuged at 8000 xg for 15 sec.
The column was transferred into a new 2 ml collection tube and 500 ~d RPE buffer \\ as
added and centrifuged at 13,000 rpm for 2 min. Spin column was transferred to a fresh 2
ml tube and centrifuged for 1 min to dry the RNeasy membrane from ethanol, to prevent
any carryover of the RPE buffer. The Column was transferred into a nc» 1.5 ml
collection tube, and cRNA was eluted by placing 50 III DEPC dH20 on the middle or
the membrane of the column and incubated at room temperature for 2 min before
spinning at 8000 xg for 1 min. Each elute sample was then diluted 1: 10 with sterile
dH
20
(not DEPC treated) and absorbance measured using :2 micro (ell on a (icne Spcd-
(Naka Instruments) spectrophotometer. Following formula \\ as used to calculate the
concentration ofcRNA (Abs value at 260 run x -w ~lg 1111 x Dilution Lldor = pgll1l total
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RNA). The yield of cRNA obtained was between 10.5-14.5 ug, the cRNA samples \\ ere
placed on dry ice and stored at -80°C.
To the remaining diluted cRNA samples 10 III denaturing RNA loading buffer was
added and denatured at 70°C for 10 min and run on a 1 % (w/v) agarose gel along with
a 1kb plus DNA marker (as described in section 2.5.6). A DNA marker gives a rough
idea of the size of the cRNA product should be. These looked like a smear from about
100 bp to 2 kbp with a brighter region from 500 bp to 1 kb.
2.11.6 cRNA fragmentation.
To 40 III of each cRNA samples (from section 2.11.5) 10 IJ.I of Sx fragmentation buffer
was added and incubate at 94°C for 35 min in a PCR block, then immcdiatelv after the
incubation the samples were placed on ice. 1 IJ.I of each fragmented cRNA sample was
placed in a 0.7 ml eppendorf tube containing 9 IJ.I DEPC treated dH20 , to this 10 ul
denaturing RNA loading buffer (50% v/v deionised formamide, 6% v/v formaldehyde,
1x MOPS-EDTA buffer, 6.60/0 v/v Glycerol, 0.02% w/v bromphenol blue, 0.02% w/v
xylene cyanol, 39.58 ug/ml ethidium bromide) was added and the samples were
denatured at 70°C for 10 min and placed on ice immediately before running them on a 1
% (w/v) agarose gel. A 1kb plus (Cat No 10488-085 Invitrogen) marker was run
alongside the samples to estimate the size of fragmented cRNA. The fragmentation
produced a distribution of cRNA fragment from approximately 35-200 bases. Undiluted
fragmented cRNA was stored at -80°C until ready to perform the hybridisation.
2.11.7 Hybridisation cocktail for human (HG-U133 A) gene chip.
A following master mix (Table2.9) was made up for x4.2 samples of fragmented
cRNA. Note, before adding to the cocktail mix 1 vial of the 20x Eukar, otic
Hybridisation Controls and 1 vial of the Oligo 82 were allowed to completely thaw at
room temperature before heating at 65°C for 5 min and vortexed and pulse centrifuged,
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Table 2.9: Hybridisation master mix for the arrays HG-Ul33A gene chip
Reagents Volume Taken III
Control Oligonucleotide B2 21
(Cat No 900299, ENZO, Affymetrix)
20x Eukaryotic Hybridisation Controls 63
----
(Cat No 900299, ENZO, Affymetrix)
Herring sperm DNA (10 mg/ml) 12.6 --
(D7290 sigma)
!
Acetylated BSA (50 mg/ml) 12.6 !
(Sigma)
DEC dH20 315
Table 2.9 showing different reagents and the volume taken to make a master mix for
x4.2 samples, for the HG-Ul33A gene chip arrays. 101 III of above master mix was
added to 49 III of each fragmented cRNA, samples (from section 2.11.6). The samples
were transported on dry ice to the department of Molecular Oncology at Carterhouse
squre London, Cancer Research UK.
Following procedure was performed by the Affymetrix operator. Samples were
hybridised on a test chip to verify the quality of cRNA before hybridising them on
Affymetrix HG-U133A gene chip (Cat No 900366 Affymetrix). To each sample 150 III
2x Hybridisation buffer was added and heated at 99°C for 5 min in a heat block and
transferred to 45°C heat block for 5 min before spinning at maximum speed (in a micro
bench centrifuge) for 5 min to remove any insoluble material. Meanwhile probe array
was equilibrated at room temperature and filled with the appropriate volume of Ix
Hybridisation buffer (200 ~Ll for the U133 A and B arrays). Probe array was place in an
oven at 45°C for 10 min with rotation at 60 rpm. The buffer solution was removed from
the probe array cartridge and filled with the appropriate volume of fragmented cRNA
hybridisation cocktail mix (from section 2.11.7) and incubated in an oven at -+5"(' with
rotation at 60rpm for 16 hours. The washing, staining and scanning of chips were also
performed by the Affymetrix Operator. The data was obtained on a CD disk from the
operator and analysed using a Gene spring program from Sillicon Genetics.
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2.12.0 Laser-capture micro-dissection of normal skin for gene
expression analysis.
2.12.1 Tissue freezing and embedding.
Cryomold was made using silver foil and placed on dry ice and filled halfwa) with
embedding medium OCT (Cat No LAMB/OCT Raymond-A-Lamb). Normal skin tissue
was place in cold cryomold in an orientation that allowed cross section cut. Further
OCT was added to cover the entire tissue. Once the OCT had solidified and turned
white the embedded tissue was stored at -70°C freezer if sections \\ ere not cut
immediately.
Slide preparation: Cryostat was allowed to pre-cool to -25°C. Knife holder and anti-roll
plate was wiped with 1000/0 ethanol to avoid sample cross-contamination. Micro slide
box was place on dry ice near the cryostat and the crymold containing the Normal skin
specimen from the -70°C freezer was placed in the cryostat. The sample was allowed to
stand in the cryostat for 10 min so that the tissue reached an appropriate cutting
temperature (-23°C). 8 urn sections were cut using a new sterile blade for each sample.
Each section was collected on a room-temperature glass slide (Arcturus) and place
immediately into micro-slide box on dry ice. The sections were not allowed to air dry
and the slides with folded or wrinkled sections were discarded. Immediately after
cutting sections they were stained and dehydrated.
2.12.2 Staining and dehydration.
Using the HistoGene LCM Frozen Section Staining kit (Cat No KIT0401 Arcturus), 25
ml of the appropriate solutions; a) 75% (v/v) ethanol, b) distilled water, c) second
distilled water solution, d) 75% (v/v) ethanol, e) 950/0 (v/v) ethanol, f) 100% ethanol and
g) xylene were placed in labelled plastic slide jars provided with the kit. The 100%
ethanol provided in the Histo Gene Frozen Section Staining Kit was not used for an)
other step except for the staining.
Four tissue section slides were removed from the slide box on dry ice or form the -70
l'C
freezer, and placed on a clean Kim wipe (or similar lint-free towel) and allowed to thav
for no more than 30 sec. Metal sterile forceps were used to transfer slide from jar to jar.
l~h
(ll;\ I)' J LJ{ 2: i'v1 aterials and Methods
Slides were first placed in plastic jar "a" containing 75% (v/v) ethanol for 30 sec and
then transferred to plastic jar "b" containing distilled water for 30 sec. The slides were
then placed on a Kim wipe or on a horizontal staining rack. Using an Rlvase-free pipette
tip approximately 100 IJ-l of the HistoGene staining solution was placed on the tissue
section and stained for 20 sec. Then the slides were rinsed for 30 sec in each solution
starting with jar "c" containing distilled water, jar "d" containing 75~ 0 (v/v) ethanol, jar
"e" containing 950/0 (v/v) ethanol, jar 'If' containing 1000/0 ethanol and then in jar "g"
containing xylene for five min. Slides were then placed on a Kim wipe to dr) in the
fume hood for five min before transferring them to a slide box containing fresh
desiccant.
One slide was removed and dermal papilla, root sheath and epidermis area of the normal
skin were laser capture micro-dissected using the PixCell II (Arcturus) system as per
manufacturers instruction using standard Cap Sure LCM Caps (Cat No LCM020 1
Arcturus). Several dermal papillae, root sheaths and epidermis areas were captured from
same slide and from new slide on one Cap. Remaining slides were kept in the
desiccators until ready for LCM. All used staining and dehydration solutions were
discarded according to COSHH regulations.
2.12.3 RNA extraction using picopure RNA extraction kit (Cat No RIT0202
Arcturus USA).
50 ~L1 extraction buffer (XB) was placed into a 0.5 ml RNase free micro-centrifuge tube
and the Cap Sure Cap with the captured cells was placed in the tube and inverted. The
tube was taped to ensure all extraction buffer was covering the Cap before incubated for
30 min at 42°C on a heat block. With the cap on the tube it was centrifuged at 800x g
for two min to collect the cell extract into the tube. If RNA isolation was not carried out
immediately the cell extract was stored at -80°C.
RNA purification column was pre-conditioned by adding 250 ul condition buffer on to
the filter membrane and incubated for 5 min at room temperature before centrifuging in
the collection tube at 16,000 x g for one min. To the cell extract 50 ~l of 70% (\ 1\)
ethanol (EtOH) was added and mixed well by pipetting up and down (do not to
ccntri fugc). The cell extract and EtOH III ixture \\ as placed into the pre-conditioned
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purification column and centrifuged for 2 min at 100 x g and then immediately at
16,000 x g for 30 sec. The flow through was removed and 100 III Pico Pure R~A. Kit
Wash Buffer 1 (W 1) was placed into the purification column and centrifuge for one min
at 8,000xg and the flow-through was discarded. To remove traces of wash buffer the
column was re-centrifuged for one min at 16,000xg and flow-through was discarded.
The column was then transferred to a new micro-centrifuge collection tube. Any D'\A
contamination was removed by treating the column with DNase1 as described in
section 2.12.4.
2.12.4 DNaseI treatment of pico pure RNA column.
To the Pico Pure RNA column from section 2.12.3, 40 III of DNaseI solution (5 ~L1
DNaseI stock solution and 35 III buffer RDD provided with RNase-free DNasel kit, Cat
No 79254, Qiagen) was placed directly into the purification column membrane and the
column cap replaced before mixing it by gently inverting the column and incubated at
room temperature for 15 min. 40 III wash buffer (WI) was added to the purification
column and centrifuge at 8000 xg for 15 sec. Column was then washed twice by add
100111 wash buffer 2 (W2) into the purification column and centrifuged at 8,000xg for
first wash and 16,000xg for the sec wash for 1 min and the flow-through was discarded.
If any residual wash buffer remained in the column the column was re-centrifuge at
16,000 xg for 1 min and the flow-through discarded. The column was transferred to a
new 0.5 ml micro-centrifuge tube before adding 11 III of elution buffer (EB) by gently
touching the tip of the pipette to the centre of the membrane surface while dispensing
the elution buffer to ensure maximum absorption of EB into the membrane. The column
was incubated for 1 min at room temperature before centrifuging for 1 min at 1,000 xg
to distribute EB in the column, then for 1 min at 16,000 xg to elute total RNA.
The isolated total RNA was used in RT-PCR, ifnot used immediately it was stored at-
800C. Quantifying of isolated total RNA was not carried out due to the fact that total
RNA expected was estimated to be less then 1 ug. Measurements taken for samples
containing less than 1 ug of total RNA may have been affected by components in the
elution buffer, which may have resulted in an overestimation of the total R'\:\.
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2.13.0 Generating a GLI2 monoclonal antibody.
The amino acid sequence of beta GLI2 was obtained from the NCBI protein data base
(GI No 13528233, NP 084656.1). Following beta-GLI2 peptides
GLI2 C Terminal N-CATAGFGLVQPRPPLEPS-C (Corresponding to amino acid 1017
to 1033, total length 18 residues),
GLI2 N Terminal N-ESAVSSTVNPVAIHKRSC-C (Corresponding to amino acid 31 to
47, total length 18 residues) were ordered from Cancer Research UK peptide synthesis
laboratory.
2.13.1 Conjugation of C-and-N-terminaI peptides of GLI2 to mcKLH.
The C-and N-terminal peptides of beta GLI2 isoform were conjugated to a carrier
Imject Maleimide Activated Keyhole limpet hemocyanin (mcKLH, Cat No 77605
Pierce), to make them fully immunogenic, as per manufacturers instructions. An out line
of a protocol is as follows. One vial of 10 mg Maleimide Activated mcKLH was
reconstituted with 1 ml dH20 to give a 10 mg/ml solution, mcKLH formed a suspension
that appeared whitish blue. The suspension was not vortexed or heated to prevent
mcKLH precipitating. 2 mg of each peptide was dissolved in 200 ul PBSA and
immediately added to 200 ul (10 mg/ml) activated mcKLH and mixed by finger taping
before incubating at room temperature for 2 hours.
2.13.2 Conjugated peptide purification.
Conjugated beta GLI2 C-and N-terminal peptides from section 2.13.1 were purified b)
using PO-I0 desalting columns (Cat No 17-0851-01 Amersham) to remove LDTA.
EOTA is an anti-coagulant and it was not injected into laboratory animals. Desalting did
not separate non-conjugated mcKLH from conjugated mcKLH. However. a large excess
of each peptide was used which made it unlikely that any non-conjugated carrier rna)
have existed in significant quantities. If a precipitate formed during conjugation the
solution was centrifuged and the supernatant was purified and the precipitate was sav ed.
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The top cap of desalting column was removed and excess liquid was poured off before
cutting column tip and replacing the tip cap to prevent the column fron running dr. . The
column was washed with 3-5 times column volume (i.e., 15-25 ml) of PBSA.
The volume of conjugate solution was made up to 1ml with PBSA. The conjugate
supernatant was applied directly to the centre of the column disc and allowed to run into
the column before eluting it with PBSA. In a separate 1.5 ml tubes 1 ml \ olurne
fractions were collected up to 12-15 aliquots. Each aliquots absorbance was measure at
280 nm using a 10 III volume path cuvette on Gene-Spec spectrophotometer, to locate
fractions containing the conjugate. The peptide-carrier conjugate was in the first
absorbance peak detected. All fractions with acceptable levels of conjugate \\ ere pooled
and combined with any precipitated conjugate and sent to Cancer Research UK
Monoclonal Antibody production services department on dry ice for injecting into the
mice.
The following procedures were carried out at the Monoclonal Antibody services
(CRUK). The mice were given 300 ug of the peptide-carrier conjugate injection initially
and later a sec (booster) injection was given after six weeks. Elisa assay was preformed
with the test bleeds using peptide only, to see if there was an immune response. The test
bleeds that were positive with 1/10,000 dilution were tested using a western blot
analysis with NHIS-GLI2 and GFP (control) transformed primary keratinocyte cell
lysates. A 140 kD GLI2 band was expected on a western blot.
2.14.0 SDS Polyacrylamide Gel Electrophoresis and Western blot
analysis.
The SDS Polyacrylamide Gel Electrophoresis (PAGE) and western blot analysis
protocol used has previously been described in detail (Sambrook L 1989). cells \\ ere
lysed by adding 200 III of boiling buffer (50 mM Tris-HCl, pH 8.0, 2% SDS, 1 m!\ 1
sodium orthovanadate) directly to the culture dish's and cells were scraped using a fresh
cell scraper for each sample. Cell lysates were then transferred to a 1.~ ml tube and
boiled for a further 2 min before aspirating them through a fine needle and placed on
ice. To prevent protease digestion 1x protease inhibitors (Cat ~u ~6931 ~~OO I Roche)
were added to each sample. Protein quantification was measured with DC Protein :\'.sa)
I~(l
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reagent (Cat No 500-0112, Bio-Rad) as per manufacturers instructions at 655 nm using
a spectrophotometer.
Protein cell extracts were run on freshly made denaturing 375 mM Tris pH 8.8 based 8-
150/0 (v/v) polyacrylamide sodium dodecyl sulphate (SDS) mini-gels (with a 125 111\ 1
Tris pH 6.8 stacking gel) made fresh, with Ix running buffer (25 m1\1 Tris, 0.19 ;-"1
glycine, 3.5 mM SDS). 2x SDS loading dye (125 mM Tris aminomethane pH 6.8. 5%
0-mercaptoethanol, 20 % (v/v) glycerol, 4% (w/v) SDS and 0.02% (w/v) bromophenol
blue) was added to an equal volume of 5-1 0 ug protein samples and loaded onto the gel.
To determine protein size, recombinant Rainbow protein molecular weight marker (Cat
No RPN800 Amersham Pharmacia Biotech, UK) was loaded along side the samples.
Gels were run at a current of 20 mA for approximately 90 min. Protein was electro-
transferred from the gel to a methanol-activated Hybond P-PVOF membrane
(Amersham Pharmacia Biotech, UK) in 1x transfer buffer (25 mM Tris, 0.19 1\1 glycine,
20% (v/v) methanol), with a current of 20mA overnight or at 100 mA for 3 hours. The
membrane was washed 3 times in 0.1 % (v/v) Tween-20 in PBS for 5 min, before
incubation in blocking solution (5% (w/v) Marvel milk powder in 0.1 % (v/v) Tween-Zf
in PBSA) at room temperature shaking for 45 min.
Primary antibodies; GLI I 1: 1000 (goat polyclonal, Cat No C-18 Sant Cruz), panERK
1: 1000 (mouse, Cat No 610123, BD Bioscience Pharmingen), EGFR 1: 1000 (goat Cat
No SC-03-G, Santa Cruz), Vimentin 1: 1000 (mouse clone RV202 Cat No 550513. BO
Bioscience Pharmingen) and E-Cadherin (Cat No 61081 B 0 Bioscience Pharmingen).
were diluted in blocking solution, K14 1: 10 (mouse monoclonal, LLOO 1 supernatant,
CRUK) was diluted in PBS-Tween-20 0.1 % (v/v) with no milk powder and incubated
with the membrane shaking at room temperature for 60 min. The membrane \\ as then
washed three times in 0.1 % (v/v) Tween-20 in PBSA shaking for 6 min.
Secary antibodies used were rabbit anti-goat (for goat primary antibodies) or goat anti
mouse (for mouse primary antibody) conjugated to horseradish peroxidase (OAKO.
Cambridge UK) diluted 1: 1000 in blocking solution. incubated shaking ~Il room
temperature for 45 min.
1~ 1
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After washing the membrane 3 times in 0.1 % (v/vlfween-Zi) in PBS shaking for 6 min.
protein bands were visualized using the ECLplus chemiluminescence detection reagent
(Cat No RPN2132 Amersham Pharmacia Biotech, UK) according to the manufacturer's
instructions. ECLpius reagent contains Lumigen PS-3 acridan substrate, which is
oxidised by horseradish peroxidase to an accridium ester, which then reacts in alkaline
conditions to form a chemiluminescent product. In a dark room with the aide of a safety
light, this was visualized by exposing X-ray film (Kodak) to the membrane wrapped in
cling film for 20 sec to 15 min depending on band intensity. X-ray film was dex doped
by immersing in developer (Kodak) for 5 min, washing briefly in tap water and
immersing in fixer (Kodak) for 2 min.
2.14.1 Stripping western blot membrane for re-probing.
Hybond P membranes can be striped and reused to probe with a different antibody. The
membrane was stripped by incubating in stripping buffer [62 mM Tris, 2% (w/v) SDS.
0.1 M ~-mercaptoethanol pH 6.7] at 65°C for 45 min, and then washed 3 times in 0.1 %
(v/v) Tween-20 in PBSA for 5 min. To check if previous labelling had been completely
removed, the membranes were treated with ECLpius and exposed on X-ray film for 15
min, then washed 3 times in 0.1 % (v/v) Tween-20 for 5 min. The membrane was then
blocked in 50/0 (w/v) milk protein in 0.1 % (v/v) Tween-20 in PBSA and probed as
described in section 2.14.0 above with a different antibody.
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CHAPTER 3
Analysis of SHH-Pathway Genes in Normal Skin, BCC and
GLIl-transduced Human Primary Keratinocytes
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3.1.0 Introduction
The hedgehog (Hh) signal transduction pathway is involved in embryonic dc\ clopment
in patterning the developing neural tube, axial skeleton, limb, lungs skin, hair and teeth
(Bellusci et al., 1997; Hardcastle et al., 1998; Marigo et al.. 1996b: Riddle et al.. 1993:
St-Jacques et al., 1998). A more detail introduction of this pathway is described in
Chapter 1 section 1.3.0. Much of what is known of the hedgehog pathway has been
derived from studies carried out in Drosophila (Basler and Struhl, 1994: Nusslcin-
Volhard and Wieschaus, 1980; Rodriguez and Basler, 1997). In addition to hedgehog,
other members of this pathway are; patched, smoothend, kinesin like protein costai-.'.
serine/threonine kinase fused, suppressor of fused and zinc finger transcription factor
cubitus interruputus (Alcedo et al., 1996; Marigo et al., 1996a; Monnier et al., 1998:
Orenic et al., 1990; Preat et al., 1990; Sisson et aI., 1997: Stone et aI., 1996: van den
Heuvel and Ingham, 1996). Many of the key components of the pathway have been
conserved from flies to humans (Goodrich et al., 1996; Hahn et al., 1996a). Cubitus
interruptus (Ci) can function as either a transcriptional activator or a proteolytically
cleaved repressor (Aza-Blanc and Kornberg, 1999).
In vertebrates, transcriptional responses to hedgehog signalling are mediated by the
three Ci homologues GLI I, GLI2, and GLI3 (Ingham and Mclvlahon, 200 I: Matise and
Joyner, 1999; Ruiz i Altaba, I 999a) that can act in combinatorial fashion to modulate
target gene expression. GLI I and GLI2 appear to act primarily as transcriptional
activators, whereas GLI3 and at times GLI2 functions as a repressor (Ingham and
McMahon, 200 I).
Sonic hedgehog (SHH) belongs to a vertebrate evolutionarily conserved family of genes
including Desert hedgehog (DHH) and Indian hedgehog (IHH), which are related to the
Drosophila hedgehog (Hh) (Echelard et al., 1993, Marigo et al, 1995,). SHH functions
by binding a receptor protein Patched (PTCH) in target cells (Stone et al. 1996, Sm. th
et al. 1999). PTCH normally inhibits downstream signalling through a transmembrane
protein Smoothened (SMO). Genetic analysis of patients with famiIial nevoid basal cell
carcinoma syndrome (NBCCS) as well as individuals with sporadic Bee led to the
identification of the PTCH tumour suppressor gene (Gorlin, 1987: Hahn ct al., 1996b:
Johnson et al., 1996): this subsequently implicated aberrant SIIH signalling in BCC
formation. Up regulation of GIIl and GIn is frequently observed in Bces (Dahmanc
et al.. 1997: Gailani et al., 1996; Regl et al., 2002: Unden et al., I()l)7). Further e\ idcncc
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for BCC development as a result of activation of Hh-signalling pathway comes from
transgenic mouse models and skin grafting techniques. Heterozygous Ptch +/- mice
develop BCC like features upon UV-irradiation, although sporadic BCC formation does
not normally occur in these mice (Aszterbaum et al., 1999). Human keratinocytes
expressing SHh form BCC-like structures when grafted onto the back of nude mice (Fan
et al., 1997) and over expression of mediators of Hh-signalling including an oncogenic
form of SMO, SHH, GLll and GLI2 in epidermal cells of transgenic mice leads to the
induction of BCC-like tumours (Fan et al., 1997; Grachtchouk et al., 2000: Nilsson et
al., 2000; Oro et aI., 1997; Xie et aI., 1998).
Transgenic mice that are deficient in GIn are viable and have no obvious
developmental defects (Park et al, 2000). In contrast, GII2-/- mice are characterized by
severe developmental malformations including the lack of the floor plate of the neural
tube and of the anterior pituitary, and by numerous lung, forgut, skeleton and skin
defects (Ding et al, 1998; Matise et al, 1998; Mill et al, 2003). This GIn phenotype
broadly overlaps with that described for SHH or lHH deficient mice (Chiang et al,
1996; Chiang et al, 1999; St-Jacques et al, 1999). Seely, removal of GIl2 but not of
GIn leads to partial rescue of the PTCH -/- phenotype, where hedgehog signalling is
hyperactivated (Bai et al, 2002). Thirdly, GIl2 but not GIn is required for hedgehog
signalling in hair follicle development (Mill et al., 2003). This suggests that GLI2 rather
than GLII is the primary transducer of the Hh-signal. The mechanism by which GLI I
and GLI2 controls HH-mediated epidermal development and skin cancer is not known.
In the developing neural tube, SHH has been shown to regulate COUP-TFII expression
during the differentiation of motoneurons (Lutz et al., 1994). SHH stimulates COUP-
TFJI expression (Krishnan et al., 1997) thus is likely to be a downstream target of SHH
signaling, and the requirement for SHH in gastric organogenesis suggests that COUP-
TFII may playa role in stomach development (Takamoto et al., 2005).
The general transcription factor TFIID complex composed of the TATA box binding
protein (TBP) and multiple TBP-associated factors (TAFIIs) is required at many gene
promoters to initiate transcription by RNA polymerase II (Dynlacht et al.. 1991:
Hernandez, 1993). GIl-induced transcriptional activation requires the carboxy I-terminal
rec ion consensus recounition element for the human TFIID TATA box-binding protein
b 0
associated factor TAFI131 (Yoon et al., 1998). The presence of this region in the GLI
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activation domain provides a mechanism by which GLI-induces transcriptional
regulation. Expression of the genes described above involved in HH-signalling have not
been determ ined in BCC and normal skin.
The aim of this chapter was to investigate the expression of PTCHI, Gl.Il . GLl2, GLl3,
SMO, SUP-FU, the kinesin superfamily (KlF4), TFJID and COUP-TFJI genes that have
been shown to be involved in HH-signalling pathway in human skin, BCC and GLll
transduced human primary keratinocytes isolated from normal skin using Northern blot
and RT-PCR and Real Time RT-PCR analyses.
3.2.0 Results
3 2.1 Northern blot analysis of SHH-signalling pathway.
Expression of PTCH, GLll and GLl2 genes of SHH-signalling pathway were analysed
using northern blot analysis on mRNA extracted from normal skin, Basal Cell
Carcinoma (BCC), GLll transduced primary keratinocytes. GLll-EIA transformed
baby rat kidney and A375 melanoma cell lines were used as positive controls expressing
GLll. The spontaneously immortalised primary keratinocytes cell line (HaCat) and
EGFP transduced primary keratinocytes cell lines were used as negative controls that is
non-GLII expressing cell lines.
3.2.2. GLIl expression in normal skin, BCC, GLIl-ElA transformed baby rat
kidney and GLIl transduced primary keratinocytes.
Northern blot analysis of GLll in human skin and BCC is shown in Figure 3.1. In the
BCC sample lane one GLll transcript was detected (a very faint band below -+ kb).
There was no GLI I expression observed in normal skin and in the negative control
HaCat cell line Figure 3.1. GLll-EIA transformed baby rat kidney cell lines showed
three GLll transcripts around 4 kb, 5.5 kb and 6 kb in size. A weak signal for 5.5 kb and
6 kb GLll transcript indicates low expression of these transcripts in GLll-EIA
transformed baby rat kidney cell lines (Figure 3.1), these results correspond with results
obtained in (Figure 3.2). Different intensity bands of beta-actin for different sample
lanes Figure 3.1 indicates difference in the amount of mRNA loaded in each lane. The
difference in mRNA loading reflects the considerable problems I experienced in
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extracting mRNA from human skin and BCC and this contrasts with excellent yield of
mRNA from the GLll-E1A transformed baby rat kidney cell lines (see Figure 3.1 and
3.2)
Northern blot analysis of GLll transduced primary keratinocytes is shown in Figure
3.2. Figure 2.3 shows the expected mRNA from GLll transduced primary keratinocytes
and GLII transformed baby rat kidney cell line. A single expected GLI 1 transcript
around 4.8 kb was detected in the GLll transduced primary-keratinocytes cell line. In
the GLll-E1A transformed baby rat kidney cell lines three GLll transcripts were
detected around 4 kb (that was expected from exogenous GLll), 5.5 kb and 6 kb bands,
the signal at 5.5 kb compared with 4 kb and 6 kb transcripts, indicating low level
expression of these transcripts in this cell line. There was no GLll transcript detected in
EGFP infected primary keratinocytes and primary keratinocytes (control cells), HaCat
and A375 cell lines. Equal intensity bands for beta-actin were observed in all sample
indicating equal loading of mRNA (Figure 3.2), this also indicates that extraction of
intact RNA from cell lines was easer than normal skin and BCC samples.
3.2.3 GLl2 expression in GLII-EIA transformed baby rat kidney cell line, GLIl-
primary-keratinocytes, HaCat and A375 cells.
A single GLl2 transcript around 6 kb was detected in GLll-E1A transformed baby rat
kidney cells, GLll transduced primary keratinocytes and in A375 melanoma cells.
There was no GLl2 mRNA detected in HaCat, EGFP transduced primary keratinocytes
and primary keratinocytes control cells. A ~-Actin transcript band around 1.8 kb of
equal intensity was seen in all the samples confirming equal loading and quality of
mRNA Figure 3.2. This suggests that GLll may be inducing endogenous GLl2
expression in GLll transformed baby rat kidney and GLll transduced human primary
keratinocytes. It was interesting to note that there is no GLll expression in A375 and
yet I observed GLl2 expression in this cells (Figure 3.2).
3.2'" PTCH expression in GLII-EIA transformed baby rat kidney, GIll primary
keratinocytes, HaCat and A375 cells.
Two Patched (PTeH) transcripts were detected in GLll-E1A transformed baby rat
kidney cells (indicated bv bands around 8 kb and -+ kb), GLll-EGFP-primar,:>-
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keratinocytes (bands around 8 kb and 4.5 kb) and in HaCat and A375 cell lines (bands
around 8 kb and 4.5 kb). There was a very weak PTCH transcript band observed around
8 kb and possible band around 4.5 kb in EGFP-primary-keratinocytes and primary
keratinocytes (control) Figure 3.2. The level of PTCH expression in GLll-EGFP-
primary-keratinocytes appears to be increased compared to control EGFP-primary-
keratinocytes and primary-keratinocytes. This is indicated by very strong PTCH
transcript bands seen in GLll-EGFP-primary-keratinocytes lane and very weak bands
seen in control EGFP-primary-keratinocytes and primary-keratinocytes lanes. A Beta-
Actin transcript band around 1.8 kb is of equal intensity in all the samples confirms
equal loading Figure 3.2. This suggests that PTCH is expressed at lower levels in
primary-keratinocytes and is induced by GLll, thus is a target of GLI1 transcription
factor.
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Figure 3.1: Northern blot analysis of GLll and (3-ACT mRNA expression in polyclonal
(pc) GFP-GLll-E1A transformed baby rat kidney cell line , BCC, normal skin (NS) and
HaCat. 2 ug of poly-A RNA per lane were hybridised with 32P-labelled human GIll 246
bp cDNA (GI No 4885278) corresponding to nucleotides 1504-1747 and (3-ACT 318 bp
cDNA (GI No 28251) corresponding to nucleotides 409-727. There are 3 bands at 6.5 kb 5
kb and 4 kb of GLll transcripts in the pc GFP GLll-E1A transformed baby rat kidney lane.
In the BCC lane there appears to be one GLll transcript a very faint band belo w 4 kb.
There are no GLll transcripts in the normal skin and HaCat cell line negati ve controls.
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Figure 3.2: Northern blot analysis of GLIl , GLI2 , PTCH and (3-ACT mRNA. In polyclonal
(pc) GFP/GLIl-ElA transformed baby rat kidney, EGFP infected normal skin (N/S)
primary keratinocytes, GLIl/EGFP infected N/S primary keratinocytes, HaCat, A375, S
primary keratinocytes. 2 ug of poly-A per lane were hybridised with 32P-Iabelled human
PTCH 511 bp cDNA (GI No 1335863) corresponding to nucleotides 3204-3715, GLIl 246
bp cDNA (GI No 4885278) corresponding to nucleotides 1504-1747, GIl2 1,463 bp cD A
(GI No 3061313) corresponding to nucleotides 2868-4337 and (3-ACT 318 bp cD A (GI
No 28251) corresponding to nucleotides 409-727. On the right are open box m
complete amino acid coding sequences (cds) and the black filled boxes below it are the
regions corresponding to the cDNA labelled probes used for PTCH. GIl2, GIIl and (3-
ACT. Note the expected transcripts are larger then the cds as observed in the northern blot,
due to pol y-A and regulatory sequences in the mRNA.
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3.2.5 Summary of northern blot analysis.
Northern blot analysis indicates PTCH was expressed in normal skin primary
keratinocytes and EGFP transduced primary keratinocytes. When primary keratinocytes
were tranduced with GLIl the level of PTCH expression increased. similar to those for
GLIl-ElA transformed baby rat kidney cells (control). There was no GIIl expression in
normal skin primary keratinocytes and EGFP transduced primary keratinocytes
(negative controls). Although when GLIl was tranduced in primary keratinocytes a
single GLIl transcript at 4.8 kb (that was expected) was expressed in these cells. In the
GLIl-ElA transformed baby rat kidney cell line different size endogenous GIll
transcripts were expressed at 4, 5.5 and 6 kb, indicating that human GIll induces
endogenous mouse GLIl (Figure 3.1, Figure 3.2). There was no GI12 expression in
normal skin, primary keratinocytes, EGFP transduced primary keratinocytes (control)
and HaCat cells. A single GIl2 transcript at 6 kb was expressed in GIll transduced
primary keratinocytes and at very low levels (indicated by a very faint band) in GIll-
ElA transformed baby rat kidney cells (Figure 3.2).
Therefore, transduction of GLIl in human primary keratinocytes induces the expression
of different size transcripts of PTCH and a single GIl2. Expression of GIll and GI12
in GLIl-ElA transformed baby rat kidney cells suggests that human GIll induces
different endogenous GLIl transcripts and a single GIl2 transcript in mouse cells.
Northern blot analysis also highlights the difficulties in extracting good quality RNA
from normal skin and BCC tissue samples compared to cell cultures, indicated by low
expression of GLIl and p-Actin in BCC compared to GIIl-E1A transformed baby rat
kidney cell line (Figure 3.1).
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3.3.0 RT-peR analysis of SHH signalling pathway.
Several attempts were made to carry out total RNA extraction from different basal cell
carcinoma (BCC) and normal skin samples, each time the total RNA extracted was of
poor quality for Northern blot analysis indicated by smeary 28S and I8S ribosomal
bands seen on ethidum bromide agarose gel. As I was running out of BCC and normal
skin samples I decided to carry out gene expression analysis using RT-PCR and not
northern blot analysis. RT-PCR was carried out on cDNA samples synthesised from
total RNA samples from BCC, normal skin, spontaneously immortalised keratinocy res
(HaCat), primary keratinocytes, A375 melanoma, GLJI-transduced primary
keratinocytes (GLJI-primary keratinocytes) and GLJI-transduced mouse fibroblast
(GLJI-I OT 1/2) cell lines. The following negative controls were also set up: dl-l-O
replacing total RNA with reverse transcriptase (dH20 RT), total RNA with no reverse
transcriptase (-veRT) and PCR control dH20 replacing cDNA (dH20 peR). A literature
search was not carried out to determine the intron/exon boundaries of all the human
mRNA sequence from which RT-PCR primers were designed. So to check and confirm
that the primers designed expanded intron exon boundaries, a PCR was carried out with
designed primers using same genomic DNA sample for each set of primers. If the
primers expanded the intron exon boundaries then the expected PCR amplicon from the
genomic DNA would be larger than that obtained from cDNA synthesised from total
RNA samples.
3.3.1 Pf.R amplification of genomic DNA to check if the RT-PCR primers span the
intron/exon boundaries.
For GLIl, GLl3. PTCH, SMO, G6PDA and u.-TUB primers the PCR amplicons
amplified from the genomic DNA were above the expected size from the cDr\:\
summarised in Table 3.1 This indicates that these primers cross the intron/exon
boundaries and if there was genomic DNA contamination in the eDNA sample there
would be two amplicons one from eDNA and one from genomic DNA. Amplicons from
('OUP-TFIl, Kl F.:/A. GLl2-a/~ and GLl2 c/dd primers gave same size bands from both
cDNA and the genomic DNA (Table 3.1). This suggested that if there was genomic
contamination in the cDNA it could give a false positive result. To control for this a RT-
peR reaction was set up in which reverse transcriptase was omitted using one uf the
total RNA sample (Table 2.3). If peR product \\as observed in this sample that \\ as due
,llh'd.\.lkr~IJll
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to the genomic contamination and not due to cDNA. With the SPU-FU and TFIJD
primers there was no PCR amplicon observed from the genomic DNA (Table 3.1). this
suggested that these primers cross the intron exon boundaries and the intron is too large
to be amplified.
Table 3.1: Summary of results for PCR amplification from normal skin genomic DNA
(samples M5, N37) using primers designed for RT-PCR.
Primers Expected amplicon from Amplicon obtained from genomic DNA
cDNA ,
GLIl 246 bp 850 bp
~ -
GLl2 c.dd 256 or 1487 bp 1487 bp
-
GLl2 a.bb 128 or 179 bp No product
-----
GLl2 a/~ 194 bp 194 bp
GLl2 y/8 205 bp No product
GLl3 328 bp Above l-kb
---
PTCH 150 bp Above l-kb
SMO 297 bp above 850-bp
--
SUP-FU 341 bp No product
---
KIF4A 282 bp Same as cDNA
G6PDA 152 bp 400 bp
-
a-TUB 249 bp above 400 bp
-- - -
TFllD 261 bp No product
COUP-TFll 288 bp Same as cDNA
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3.3.2. GLIl expression in BCC, normal skin, HaCat, primary keratinocytes, :-\3-5.
GLll-transduced primary keratinocytes and GLll-transformed lOTl/2 cells.
RT-PCR results Figure 3.3 show that GLIl was expressed in 7/8 BCC, 3/6 normal skin.
3/3 GLl1 transduced primary keratinocytes. There was no GLII expression in negative
controls HaCat, primary keratinocytes, A375 (negative controls). This data corroborates
northern blot data in section 3.2.2. Due to unavailability of GLIl-transformed baby rat
kidney cells GLIl-transformed 10T1/2 mouse fibroblast cells were used as positiv e
control for GLIl expression in the RT-PCR analysis. However, GLIl expression was
not observed in GLIl-transformed lOTI/2 cell line, this may have been due to 10\\
transfection efficiency and thus low levels were not detected or these cells may have
lost GLIl-expression due to several round of passaging. GLIl expressing lOT I/2 cells
are frequently used to assay HH-signalling responses (Kinto et aI., 1997). in this cell
line human GLl1 induces the expression of alkaline phosphatase, which is a specific
marker for cells undergoing osteoblast differentiation. (Ruiz i Altaba, 1999a).
3.3.3 GLI3, SUP-FU, SMO, TFIID, G6PDA, PTCH, a-TUB and KIF4 expression in
BCC, normal skin, HaCat, primary keratinocytes, A375, GLIl expressing cells.
GLl3, SUP-FU, SMO, TFIID, G6PDA, PTCH, Alpha-Tub and KIF..f.·l transcript were
expressed in all normal skin, BCC, HaCat, primary keratinocytes, A375 and Gl.ll-
transduced primary keratinocytes analysed (Figure 3.3.). Gli3, Tfiid, Gtipda, Ptch. and
Kif4a transcripts were not expressed in mouse GLIl-lOTl/2 cells (Figu rc 3.3). The
primers used in this study were designed from the human sequence from the NCBl
database (Table 2.2). Therefore, the genes that did not amplify were probably due to
difference in mouse and human sequence. This was confirmed when blast search \\ as
carried out of the primers designed using NCBl data base.
A blast search of primers designed for GLJ3. TFIlD, G6PDA, PTCH and KiF..f.·l (Table
2.2) using human mRNA sequences showed none of these primers matched mouse Glis,
TjIId, G6pda, Ptch and Kif-la sequences, indicating that mouse Glis. Tflld. Gtipda. Ptch
and Kif-to transcripts would not have been expected to amplify using human primers
sequence in RT-PCR analysis (Figure 3.3).
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A blast search of primers designed for SUP-FU, SMO, and a-TUB (Table 2.2). showed
that all of these primers matched mouse Sup-Fu, Smo, and 0.-- Tub sequence. Indicating
that mouse Sup-Fu, Smo, and a-Tub transcripts would have been expected to be
amplified from these human primers sequences. This was confirmed when mouse Sup-
Fu, Smo, and 0.-- Tub transcripts bands were observed in GLI- infected lOT 1/2 mouse
cells in RT-PCR analysis (Figure 3.3).
3.3.4 COUP-TFII expression in BCC, normal skin, HaCat, primary keratinocytes,
A375, GLI1-primary keratinocytes and GLI1-IOT1I2 cells.
COUP-TFJI transcript was expressed in 3/7 normal skin and all BCC, HaCat, primary
keratinocytes, A375, GLII transduced primary keratinocytes, GLll-transduced lOTI 2
mouse cell line (Figure 3.3). An interesting point to note is that a blast search of
primers designed for COUP-TFII (Table 2.2 using human COUP-TFJI mRNA
sequence), indicates that these primers did not match mouse Coup-TjII sequence. Yet
mouse Coup-Tfll band was observed in GLll-transduced lOTI/2 cell line same size as
that for human tissue and cell lines analysed. There are two possible explanations for
this. One is that there may not be a mouse mRNA Coup-TjII sequence in the NCBl
database and this is why we did not get a match. Or that these human COUP-TFJI
primers were amplifying some other transcript which gives same size RT-PCR product,
this could have been confirmed by sequencing the PCR product. However. as this was
not the aim of the investigation the COUP-TFJI RT-PCR product from the mouse cell
line was not sequenced.
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Figure 3.3: RT-PCR agarose gel showing GLll, GLI3, SUP-FU, SMO, COUP-TFII,
TFIID, PTCH, ex-TUB (Alpha-Tubulin) and KIF4 expression. In total RNA samples from
basal cell carcinoma, normal skin, spontaneously immortalised keratinocytes (HaCat) ,
A3 75 melanoma, GLII-transduced primary keratinocytes (GLI I-primary keratinocytes) and
GLll-transduced lOTl/2 mouse fibroblast (GLIl-IOTl /2) and EGFP-transduced primary
keratinocytes (Primary keratinocytes) cells. Negative controls dH20 RT, -veRT and PCR
control dH20 PCR show no expression of these genes.
Mohamm d.. .lkrarn
Table 3.2: Summary of the data from RT-PCR 1% agrose gel from Figure 3.4.
Showing number of total RNA samples from Basal Cell Carcinoma (BCC), normal
skin, spontaneously immortalised keratinocytes (HaCat), primary keratinocytes, A375
melanoma, Gill-transduced primary keratinocytes (Gill-primary keratinocytes) and
Gill-transduced IOTI/2 mouse fibroblast (Gill-IOTl/2) cell lines that were positive
for Gill, ous, SUP-FU, SMO, COUP-TFII, TFIID, PTCH, a-TUB and KlF-I
expression.
Number of samples that were positive for a transcript that was analysed from total Ri\A
extracted from tissue and cell lines samples in a RT-PCR analysis.
Transcript BCC N/S HaCat Primary A375 GLll-primary GLlI-IOTU2
analysed keratinocytes keratinocytes II
I
n=8 n=6 n=3 N=3 n=4 n=3 n=1
Gill 7 3 0 0 0 3 0
ous 8 6 3 3 4 3 0
SUP-FU 8 6 3 3 4 3 1
SMO 8 6 3 3 4 3 1
COUP-TFll 8 3 3 3 4 3 1
TFllD 8 6 3 3 4 3 0
G6PDA 8 6 3 3 4 3 0
PTCH 8 6 3 3 4 3 0
a-TUB 8 6 3 3 4 3 0
KlF4 8 6 3 3 4 3 0
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3.3.5 GL/2 expression in BCC, normal skin, primary keratinocytes, HaCat, ..-\3-5
and GLIl expressing cell lines.
Different isoforms of human GIl2 have been identified and these are called GLn-alpha.
beta, gamma, and delta, these isoforms derived by combinations of 1\\0 independent
alternative splicing in the coding sequence (Figure 3.4) (Tanimura et al., 1998).
Therefore, Initial RT-PCR analysis experiments were carried out by using primers
specific for different isoforms of GIl2 previously published (Tanimura et al.. 1998).
These primers were given a user reference Moh-a, Moh-bb and Moh-c, Moh-dd (Table
2.2) and Table 3.3 shows the PCR products expected from these set of primers. After
several attempts at optimising the PCR conditions for GIl2 (Moh-a, Moh-bb and I\loh-
c, Moh-dd) there was no clean PCR product amplified from these set of primers.
Therefore, a new set of primers a/~ and y/8 for GIl2 (Table 2.2, Table 3.3) published
by (Regl et al., 2002) were used to amplify different isoforms of GLI2 transcripts. The
a/~ set of primer indicates 7/7 BCC, 5/6 normal skin, 3/3 HaCat, 2/3 primary
keratinocytes (the bands observed in these sample were very faint bands), 4/4 A375 (the
bands observed in two of the samples were very faint and in the other two very strong)
and 3/3 GIlJ -primary keratinocytes express a and/or ~ GIl2 (Figure 3.5). The GLf2
y/8 set of primers did not generate any PCR amplicon. This suggests that a and or ~
GIl2 transcripts are predominantly expressed in BCC, normal skin, HaCat, primary
keratinocytes, A375 and GIlJ -transduced primary keratinocytes. There was no GLf2
transcript observed in Gill-I0Tl/2 cell lines. A 194 bp GIl2 a/~ band was also
observed in genomic DNA sample suggesting that if there was genomic DNA
contamination in any of the samples this would have given a false positive result and
these sets of primers do not span the intron/exon boundaries. However. the negative
control samples dH20 and -ve RT were negative, indicating that the band observed
were from a and or ~ GIl2 transcript and not from the genomic DNA.
Having identified which genes were expressed in BCC, normal skin, HaCat. A375 and
GIll-primary keratinocytes. I went on to determine level of fold induction or repression
of these genes in these samples using SYBR Green kit.
o
I
3
I
4
I
hGLI-2a I -'------ ---.Jr----AAAA
-2P-y=-'---- r---- AAAA
-2y--j -'--------Vr---- AAAA
-26-y=-'------V Dr--- AAAAa ••bb c. .dd
•• ••
yl6 alp
Figure 3.4 Different GLI2 isoforms. Boxes represent open reading frames . Solid and
shaded regions in the boxes are the zinc finger motif and amino acid sequences
alternatively translated from different frame s. It also shows the position of (a,bb),
(c,dd), af3 and y8 set of primers used in RT-PCR (Tanimura et al., 1998).
Table 3.3: Size of PCR products expected from different isoforms of human GLl2
using Moh-a,bb and Moh-c, dd, GLI2 Ci/{3 and GLl2 "I/f> primers.
GLI2 Primers Expected SIze Expected SIze Expected SIze Expected size bp,
bp , from bp, from bp, from from
a-GLI2 f3 -GLI2 y-GLI2 8-GL12
Moh-a,bb 179 128 179 128
Moh-c,dd 1,487 256 1,487 256
GLI2 a/f3 194 194 - -
GLI2 Z/8 - - 205 205
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Figure 3.5 RT-PCR of a/~ GLI2 transcript from basal cell carcinoma, normal skin,
spontaneously immortalised keratinocyte (HaCat) cell line, primary keratinocytes, A375
melanoma cells, GLIi-transduced primary keratinocytes (GLIl -primary keratinocytes) ,
GLli-transfonned mouse fibroblast cells (GLli-10T l/2 ) total RNA samples and from
normal skin genomic DNA. using a/~ primers published in Regl et al., (2002).
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3.3.6 Real-time RT-PCR analysis.
After identifying which genes were expressed in BCC and GIll-transduced cell lines.
Real-time RT-PCR analysis was carried out on the same samples as those shown in
section 3.3.0 to identify which genes were induced or repressed in BCC, HeCat. ..\375
and GIll-transduced primary keratinocytes relative to controls. Not all the primers
worked with the (DyNAmoTM SYBR@ Green) Real Time RT-PCR kit that had
previously worked with the Red Hot Tag PCR kit (see section 3.3.0). Therefore, real-
time-RT-PCR was carried out on the primers that did work. BCC gene expression
analysis was normalised relative to normal skin and HaCat, A375 and GLll-transduced
primary keratinocyte gene expression was normalised relative to EGFP-primar~
keratinocytes. The base lane expression for each gene analysed in control samples
normal skin tissue and primary keratinocytes isolated from normal skin was I.
Therefore, values above 1 indicate induction and values below I indicate repression of
gene expression. The average fold induction or repression was determined for all the
samples as indicated in methods and materials section 2.8.0.
The values of fold induction or repression of each gene and variation of expression in
each sample analysed and the average from all BCC and cell lines analysed is shown in
Table 3.4. The variation of expression of a particular gene in same tissue or cell lines
indicates that there is variability in expression from one patient to another and cell lines
analysed. The variation in same cell line (for example HaCat and A375) may be due to
the fact that the cells may have been from different passage number and the cells have
transformed and as result have a changed gene expression. The variability in the GLll-
transduced primary keratinocytes may be due to the fact that the primary cells were
from different patients or it may also be due to difference in transduction efficiency for
each sample, it is also possible that there may be loss of GIll expression in transfected
or transformed cell lines.
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3.3.7 GLIl is only induced in BCC and GIll-primary keratinocytes and not in
HaCat and A375 cells.
GIll expression in BCC was 705.50 fold and in GIll-primary keratinocytes was
93147.85 fold, in HaCat 1.08 fold and in A375 was 0.76 fold. This indicates that GLll
was induced in BCC and GLlI-primary keratinocytes and there was no change in HaCat
and A375 cell lines relative to the control samples (Figure 3.6 and Table 3.4). This
data corroborates with the northern blot data in section 3.2.2 and the RT-PCR data in
section 3.3.2 where no GIll expression was detected in A375, HaCat cell lines, and
there was GIll expression in BCC and GIll-transduced primary keratinocytes cell line.
These results were in line with the results published by (Green et al., 1998; Regl et al..
2002).
3.3.8 GLl2 expression is induced in BCC, HaCat, A375 and GIll-primary
keratinocytes.
GIl2 expression in BCC was 2.27 fold, in HaCat 677.26 fold, in A375 27..L55 fold and
in GIll primary keratinocytes it was 3452.35 fold (Figure 3.6 and Table 3.4). These
results are in line with results published by (Regl et al., 2002) and they showed that
GIl2 was induced in BCC relative to normal skin and it was also induced in GLI 1
expressing relative to non GLII expressing keartinocytes. The results for GLf2
expression in HaCat by real-time-RT-PCR and RT-PCR do not agree with the northern
blot results (Figure 3.2). In northern blot there was no GLl2 expression observed in
HaCat cells. However, we do observe GLl2 expression in RT-PCR (Figure 3.5) and
real-time-RT-CR shows induction of GIl2 in HaCat relative to primary keratinocytes
(Figure 3.6). The real-time-RT-PCR results for A375 do confirm with northern blot
data (Figure 3.2) and RT-PCR and real-time-RT-PCR data (Figure 3.5 Figure 3.6)
show induction of GIl2 in A375 relative to primary keratinocytes. RT-PCR results of
GIl2 in BCC confirm with real-time-RT-PCR results (Figure 3.5 Figure 3.6) and
indicate that GIl2 is induced in BCC relative to normal skin.
vlohummcd.> lkram
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3.3.9 GLl3 expression is induced in BCC, HaCat, A375 and GLll-primary
keratinocytes. .
GLl3 expression was induced in A375 (59.85 fold), HaCat (17.68 fold), GLI1-
transduced primary keratinocytes (5.85 fold) and in BCC (2.07 fold). There seems to be
greater induction of GLl3 in A375 followed by HaCat and GLJ1-transduced primary
keratinocytes and lastly BCC (Figure 3.6 and Table 3.4).
3.3.10 PTCH is induced in BCC, HaCat and GLll-primary keratinocytes and there
is no change in A375 cells.
PTCH expression in BCC was 32.08 fold, in HaCat 7.33 fold, in A375 0.77 fold and in
GLJ1-primary keratinocytes it was 8.66 fold. This suggested that in BCC, HaCat and in
GLJ1-primary keratinocytes PTCH expression is induced, there was no change in PTCH
expression in A375 relative to controls (Figure 3.6, Table 3.4). In the northern blot and
RT-PCR analysis (Figure 3.2 and Figure 3.3) PTCH was expressed in HaCat, A375,
GLII expressing and non GLII expressing primary keratinocytes. Northern blot
indicates PTCH to be induced in GLJ1-transduced primary-keratinocytes relative to
control EGFP-primary-keratinocytes; this was confirmed by the real-time-RT-PCR
(Figure 3.6, Table 3.4).
3.3.11 SMO is induced in BCC, HaCat, A375 and GLll-primary keratinocytes.
SMO expression in BCC was 6297.96 fold, in HaCat 527.8 fold, in A375 285.27 fold
and in GLJ1-transduced primary keratinocytes it was 329.53 fold (Figure 3.6, Table
3.4). This suggested that in BCC, HaCat, A375 and GLIl-transduced primarj
keratinocytes SMO expression was induced relative to controls (normal skin and
primary keratinocytes).
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3.3.12 KIF4 is induced in BCC, HaCat, A375 and repressed in GIll-primary
keratinocytes.
KIF4 expression in BCC was 8.65 fold, in HaCat 8.64 fold. in A375 2.72 fold and in
GLll transduced primary keratinocytes it was 0.01 fold (Figure 3.6, Table 3.4). This
suggested that in BCC, HaCat and A375 KIF4 expression is induced and in GLlI-
primary keratinocytes it was repressed relative to control samples.
3.13 a-TUB expression is induced in A375 GLIl-primary keratinocytes and
repressed in BCC.
Alpha tublin expression in BCC was 0.47 fold, in HaCat 1.02 fold, in A375 1.72 fold
and in GIll-transduced primary keratinocytes 2.13 fold (Figure 3.6, Table 3.4). This
indicates that there was no change in alpha-tublin expression in HaCat cell line and it
was induced in GLll expressing primary keratinocytes and A375 and repressed in Bee
relative to control samples (primary keratinocytes and normal skin, normalised with ~­
Actin).
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Figure 3.6 Real-time-RT-PCR analysis showing induction or repression of GIll, GII2 ,
GLI3 , PTCH, SMO, KlF4 and Ct.-TUB genes expressed in basal cell carcinoma (BCC)
relative to normal skin (control). Genes expressed in spontaneously immortalised
keratinocytes (HaCat), A375 melanoma and GIll-transduced primary-keratinocytes (GIll-
primary keratinocytes) relative to control EGFP-transduced primary keratinocytes (EGFP-
primary keratinocytes). GLll was induced in BCC, GLI1-primary-keratinocytes. There was
no change in GLll expression in HaCat and A375 cells. GII2, PTCH, SMO and GIl3 were
induced in BCC, HaCat and GLll-primary keratinocytes. PTCH was induced in BC ,
HaCat and GLl1-primary keratinocytes. There was no change in PTCH expression in A375
cells. KlF4 was induced in BCC, HaCat and A375 cells and repressed in GIll -primary
keratinocytes. There was no change in Ct.- TUB expression in BCC, HaCat, A375 and GI ll -
primary-keratonocytes. The data is from (BCC) n=8, normal skin (n=6), Ha at (n=3),
A375 (n=4) and GLl1 -primary keratinocytes (n=3) and EGFP-primary keratinoc yte (n=3).
Each sample was ana lysed in triplicates and average fold induction or repre ion and
standard deviation (SD) calculated relative to control samples (normali ed v ith {3- ctin D r
each gene. Fold induction or repression was plotted using log2 cale.
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Table 3.4: Relative fold induction or repression of GIll, GIl2. GIl3. PTCH. 5.\/0.
KlF4 and a-TUB in basal cell carcinoma (BCC) relative to normal skin, and in
spontaneously immortalised keratinocytes (HaCat), A375 melanoma and GLI 1
transduced primary keratinocytes (GIll-primary keratinocytes) relative to control
EGFP-transduced primary keratinocytes (EGFP-primary keratinocytes) and the average
fold induction or repression from all the samples.
GU1 GU2 GU3 PTCH SMO KIF4 a-TUB
Fold SO Fold SO Fold SO Fold SO Fold SO Fold SO Fold SO
Sample Induction (+/-) Induction I(+/-) Induction (+/-) Induction (+/-) Induction (+/-) Induction (+/-) Induction (+/-)
BCC 34.4 0.8 1.7 0.9 0.4 0.8 2.3 0.7 9962.8 0.9 4.0 0.9 0.7 0.7
BCC 799.4 0.8 3.8 0.9 2.4 0.9 61.6 0.7 19701.3 0.9 33.4 0.8 2.5 0.9
BCC 3946.7 0.9 2.3 0.8 0.4 0.9 44.8 0.9 16136.1 1.0 3.2 0.8 0.2 0.8
BCC 493.3 0.9 2.4 0.9 7.9 0.9 33.8 0.8 39.5 0.8 0.9 0.8 00 0.7
BCC 22.6 0.9 1.1 0.8 5.2 0.9 36.8 0.9 1007.1 0.7 8.8 0.8 0.0 0.8
BCC 38.3 0.7 4.0 0.8 0.3 0.7 66.0 0.7 3520.4 0.8 13.4 0.7 0.2 0.6
BCC 113.6 0.9 1.9 0.9 0.0 0.8 2.2 0.7 16.7 0.7 1.2 0.7 0.2 0.8
BCC 195.6 0.8 1.0 0.9 0.0 1.0 9.1 0.7 0.0 0.8 4.4 0.9 0.0 0.7
Average BCC 705.5 0.8 2.3 0.9 2.1 0.9 32.1 0.8 6298.0 0.8 8.6 0.8 0.5 0.7
Normal Skin 1.0 1.0 1.0 1.0 1.0 1.0 1.0
HaCaT 0.3 0.9 53.6 0.9 0.7 0.8 1.9 0.8 1323.9 0.8 0.4 0.9 1.4 0.8
HaCaT 1.1 0.8 978.4 0.9 48.0 0.8 13.7 0.8 259.2 0.9 16.8 0.7 0.1 0.8
HaCaT 1.8 0.9 999.8 0.8 4.3 0.7 6.4 0.9 0.3 0.8 8.7 0.7 1.6 0.7
Average HaCat 1.1 0.9 677.3 0.9 17.7 0.8 7.3 0.8 527.8 0.8 8.6 0.8 1.0 0.8
EGFP-Primary-
Keratinocytes 1.0 1.0 1.0 1.0 1.0 1.0 1.0
A375 1.1 0.9 506.5 0.8 0.7 0.8 0.4 0.8 5388 0.9 0.7 0.7 5.9 0.8
A375 0.6 1.0 64.9 0.9 96.9 0.8 1.8 0.8 602.1 0.8 5.4 0.9 0.0 0.9
A375 0.4 0.8 419.3 0.8 141.8 0.6 0.7 0.9 0.0 0.8 4.3 0.8 0.0 0.8
A375 0.9 0.9 107.5 0.7 0.0 0.8 0.2 0.7 0.2 0.6 0.5 0.7 0.9 08
Average A375 0.8 0.9 274.5 0.8 59.9 0.8 0.8 0.8 285.3 0.8 2.7 0.8 1.7 0.9
GLl1-primary
Keratinocytes 856.4 0.7 3015.6 0.7 8.6 0.8 2.4 0.7 1.9 0.7 0.0 0.9 0.0 0.7
GLl1-primary
0.7 1.8 0.7Keratinocytes 272225.8 0.6 2922.3 0.6 0.5 0.8 2.5 0.7 0.2 0.7 0.0
GLl1-primary
0.0 0.6 45 08Keratinocytes 6361.3 0.8 4419.2 0.8 8.4 0.7 21.0 0.8 986.5 0.7
Average GLl1-
primary
0.7 0.0 0.8 2.1 0.7Keratinocytes 93147.8 0.7 3452.3 0.7 5.9 0.8 8.7 0.8 329.5
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3.4.0 Laser Capture Micro-dissection (LCM) of dermal papilla, hair
follicle root sheath and epidermis from normal skin and gene
expression analysis.
In order to understand how BCC develops, I wanted to study the changes in gene
expression from normal epidermal keratinocytes to BCC formation. To do this I decided
to extract keratinocytes from the outer edges of BCC tumour islands and keratinocytes
in the centre of the tumour islands and the adjacent normal epidermal keratinocx res
from BCC tissue, using Laser Capture Micro-dissection CLCM).
To establish the technique LCM was carried out to investigate deferentially expressed
genes in dermal papilla, hair follicle root sheath and epidermis in normal skin. The aim
of this study was to capture the cells from dermal papilla, hair follicle root sheath and
epidermis in normal skin and extract total RNA from these cells and carry out RT-PCR
gene expression analysis. It was very difficult to disect different population of
keratinocytes from normal skin. The difficulty in disecting may have been due to strong
cell to cell interactions in keratinocytes and this prevented the cells from sheering off.
However, on several occasions when I did manage to disect these cells from different
normal skin tissue samples, I did not get any p-Actin amplification from the total RNA
extracted from these LCM cells by RT-PCR. Owing to low quantities of total RNA it
was not possible to measure the amount of total RNA extracted, thus, the only way to
determine if there was any RNA present was to carry out RT-PCR using p-Actin
primers. The reason I did not get p-Actin amplification from these LCM cells was that it
was taking 40-60 min to capture the cells this might have caused the RNA to degrade.
After many attempts and perseverance and using different normal skin samples, I
managed to capture the cells from dermal papilla, root sheath and epidermis areas of
normal skin from one sample that gave me total RNA from which I could amplify the P-
Actin transcript, RT-PCR analysis was carried out using Gl.Il . GLJ2, GLJ3, PTCH and
a-Tub primers.
Figure 3.7 -A shows the dermal papilla, outer root sheath and epidermis before LC~d
and after LCM and captured cells on the LCM cap. RT-PCR analysis shows GLII
expression in cells captured from dermal papilla and root sheath, there was no GUI
expression form epidermis captured cells. GiC, GLJ3, PTCH, a-Tub and P-Al,tin were
expressed in cells captured from dermal papilla, root sheath and epidermis Figure 3. '7-
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B. This data confirms the published observations that GIll is expressed in the outer
root sheath and not in the epidermis (Ghali et aI., 1999). It also confirms with the data
from RT-PCR analysis in normal skin (Figure 3.3) where GI12, GI13, PTCH and 0.-
TUB were expressed. LCM RT-PCR data also confirms in-situ hybridisation data for
GI12 expression in Figure 4.13, in which GI12 was expressed in outer root sheath,
interfollicular epidermis in normal skin. The strong bands for GIll in RT-PCR data
(Figure 3.7-B) indicates that there may be more GIll expression in dermal papilla and
outer root sheath then GI12, GI13 and PTCH which have weaker bands, 0-Actin bands
were of equal intensity in all lanes confirming equal loading. GI12, GI13 and PTCH
seam to be expressed at similar levels in dermal papilla, outer root sheath and epidermis
(Figure 3.7-B). There was not enough eDNA to carry out real-time-RT-PCR to verify
level of GIll, GI12, GI13 and PTCH expression or amplify other genes from LCM
derma papilla, outer root sheath and epidermis cells.
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Figure 3.7: (A) Dermal papilla, outer root sheath and epiderrnis before Laser capture
micro-dissection (LCM), after LCM and LCM caps with captured cells . (B) RT-PCR
showing GLll expression in dermal papilla and outer root sheath in normal skin and there
is no GLll expression in cells captured from epidermis. GII2, GII3, PTCH, e-Tubulin (a-
TUB) and IJ-Actin (IJ-ACT) are all expressed in dermal papilla, outer root sheath and the
epidermis. The negative control -RT sample (dermal papilla with no reverse transcriptase)
was negative for all the genes analysed.
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3.5 0 Discussion
3.5.1 PTCH expression is induced in BCC, HaCat and GLII expressing cell lines.
Northern blot results show that PTCH is expressed in GLll, EGFP transduced and
untransduced primary keratinocytes, HaCat and A375 cells. PTCH expression levels in
control primary keratinocytes and EGFP-primary-keratinocytes appears to be lower
compared to GLll-EIA transformed baby rat kidney cell lines, GLll-infected prirnarj
keratinocytes and HaCat and A375 cells, although ~-Actin expression was the same in
all these samples (Figure 3.2). PTCH being a down stream target of hedgehog
signalling (Goodrich and Scott, 1998), was expected to be up regulated in GLI I
expressing cells and this is what was observed, confirming previously published data
(Regl et aI., 2002).
Multiple different size transcripts were observed for PTCH (8, 4.5 and 4.8 kb) in GLI I-
E IA transformed baby rat kidney, GLII-EGFP and EGFP (control) infected primary
keratinocytes, HaCat, A375 and primary keratinocytes (Figure 3.2). (Hahn et al.,
1996a) identified five distinct PTCH transcripts expressed in all human tissues they
examined. The most abundant PTCH transcripts were around 8 kb observed in heart,
brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. In brain, liver, skeletal
muscle and pancreas additional multiple different size PTCH transcripts were observed
all of which were below 8 kb. Data from this study also shows that the most abundant
transcript of PTCH to be around 8 kb and additional transcript around 4 kb in GLll-
primary keratinocytes, HaCat, A375 and GLll-ElA rat kidney cells and both of these
transcripts are induced by GLI1. This suggests that there are alternative splice variants
of PTCH expressed in rat kidney and in humans keratinocytes they are induced by the
GLI I transcription factor.
The real-time-RT-PCR data also confirms that PTCH is induced in GLll transduced cell
Iine (Figure 3.6 and Table 3.4). PTCH was also upregulated in BCC relative to normal
skin. In HaCat cells there was no GLll expression. However, there was PTCH induction
in these cells relative to primary keratinocytes. Induction of PTCH in Hacat cells rna.
be as result ofGLI2 or GLI3 induction (Figure 3.6). Other studies have also shown that
GLI I and GLI2 both induces PTCH expression (Agren et al., 2004: Regl et al., 2002).
In the A375 cells there was GLl2 induction yet there was no PTCH induction in these
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cells relative to primary keratinocytes (Figure 3.6 and Table 3"').
3.5.2. GLll expression is up-regulated in BCC and GLIl expressing cells.
A 4.4 kb GLIl transcript was expressed in GLIl-E1A transformed baby rat kidney cell
line and a 4.9 kb GLIl transcript in GLIl-EGFP infected normal skin primal')
keratinocytes. In GLIl-E1A transformed baby rat kidney cell line possible alternntix c
splice variants 5.5 kb and 6 kb transcripts of rat Glil were also detected (Figure 3.2).
These results are in line with results published by (Hui et al., 1994), they showed Gli1
transcript to be around 4.4 kb during mouse embryogenesis. There was no GIll
transcript detected in HaCat, A375, primary keratinocytes or control EGFP-infected
primary keratinocytes (Figure 3.2). A possible very faint band below 4kb indicates low
level expression of GLIl in BCC sample and no GL11 expression was detected in
normal skin sample with the northern blot analysis (Figure 3.1). The reason why there
was low GLIl expression in BCC sample may have been due to the fact that there was
not enough mRNA present or that mRNA may have been degraded indicated by a very
faint smeary GL11 band seen in the BCC lane. Probing the same blot with beta-actin
probe confirmed that there was less mRNA in the BCC and normal skin lanes compared
to GLIl-E1A transformed baby rat kidney and HaCat cells, this was indicated by weak
signal for beta-actin probe in BCC and normal skin lane and a strong signal in GL11-
E1A transformed baby rat kidney and HaCat cells (Figure 3.1). Therefore, low mRNA
levels and possible degradation of mRNA on the northern blot, indicates that analysis of
GLIl expression in BCC sample was not conclusive. However, on the same blot in the
positive control lane GLIl-E1A baby rat kidney cells lane indicates a strong band for
mouse Gli1 transcripts at 4 kb and weaker expression of 5.5 kb and 6 kb Gli1 transcripts
(Figure 3.1).
Expression of GLIl in BCC was confirmed by RT-PCR analysis, this showed that GIIl
was expressed in 7/8 BCCs and 3/6 normal skin samples, the three normal skin samples
had very faint GLIl bands (Figure 3.3). GL11 expression has not previously been
reported in normal skin, Green et al (1998) showed that GI11 is expressed in Bee and
not in normal skin and a study by Ghali et al (1999) showed that GLI 1 is expressed in
outer root sheath of hair follicles in normal skin. The normal skin samples used in m)
study were from different face lift procedures and some of these face lift sample- had a
lot of scalp hair. others had less and some none. Total RN.\ \\ as extracted from \\ hole
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normal skin samples; therefore, RNA was extracted from mixed cell population. It is
possible that these three samples may have come from more hairy skin compared to the
rest of the normal skin samples. Thus in these three normal skin samples GLI I
expression may have been due to hair follicle or the outer root sheath cells. This was
confirmed when RT-PCR analysis was carried out on laser captured micro dissected
cells from dermal papilla, outer root sheath and epidermis from normal skin tissue. This
study showed that GLll was expressed in dermal papilla and root sheath and not in
epidermis (Figure 3.7-A, B). Real-time-RT-PCR analysis showed that GLIl was up-
regulated in BCC relative to normal skin and in GLIl transduced primary keratinocytes
relative to primary keratinocytes (Figure 3.6 and Table 3A), this data is consistent with
the data obtained for northern blot analysis (Figure 3.2 and Figure 3.3) and also in the
litreture (Regl et al., 2002).
When comparing northern blot and RT-PCR techniques the RT-PCR was more sensitive
technique compared to northern blot and it can detect low abundant (for example GLIl)
mRNA from small amount (2-5 ug) of total RNA whereas northern blot requires
minimal of 15 ug total RNA. Another advantage of using RT-PCR technique was that it
allowed one to analysis several samples and genes within short period of time, whereas
northern blot was more complex procedure and took far too long to analyse small
number of genes. However, the disadvantage ofRT-PCR is that it does not give you the
size of transcript you are detecting, with northern blot you can detect the size of a
transcript and can also detect alternative splice variants of a gene.
3.5.3 GLl2 is induced in BCC and GLIl expressing cell lines.
A single GLl2 transcript around 6 kb was observed in GLIl-ElA transformed baby rat
kidney cell line, GLll-EGFP infected primary keratinocytes and A375 melanoma cell
line. Gli2 transcript that was detected by (Hui et al., 1994) during mouse embryogenesis
was around 7 kb. This suggests that there may be different size GLl2 transcripts
expressed in humans compared to mice. There was no GLll expression detected in
primary keratinocytes, HaCat and control EGFP infected primary keratinocytes (Figure
3.2). The blot in Figure 3.2 was probed with Gl.ll . PTCH, ~-Actin and Gl.I? probes in
descending order GLl2 being the last gene to be probed the bands detected for C;Ll~
were not as clean as that for other probes. this indicates that the blot max hax c
degenerated due to striping and re-probing.
( HAIY J LR. 3: Analysis ,,1' SIJH-Path\\a\ Genes 111 Normal Skln,BCC and (,U/-tr', '-JlIC",J lLJlu,' '
Northern blot analysis showed that in GLII-EGFP infected primary keratinocy tes and
GLII transformed baby rat kidney cells there was an induction of GLI2 expression
compared to the controls EGFP infected and normal skin primary keratinocytes (Figure
3.2). This was the first time that anyone had shown that GLI I induces GLI2 expression
in GLI I expressing cell lines. It is a well established fact that PTCH is a target gene for
GLI I (Agren et al., 2004; Matise and Joyner, 1999; Regl et al., 2002; Toftgard, 2000).
A parallel study was being carried out by our collaborators (Dr Fritz Abergers lab) and
they showed that there was an induction of GL12 in GLI I expressing keratinocytes
relative to control cells and GL12 was induced in BCC relative to normal skin (Regl et
aI., 2002). Northern blot data in this study confirmed these findings; this study has also
shown that endogenous GLI2 is induced in GLI I transformed baby rat kidney cells and
in GLI I transduced human skin primary keratinocytes. This suggests that human GUI
induces GLI2 expression in different cell lines as well as in different species.
It was very difficult to extract good quality total RNA from normal skin and BCC
samples. This was due to the difficulty in homogenising the tissue quickly and
completely to prevent RNA degradation. Total RNA extracted from most BCC and
normal skin samples was either partially or completely degraded. This resulted in
obtaining more BeC tumours and normal skin samples, this was a very lengthy process
due to H M Home Office the legislation concerning acquiring patient consent for any
tissue to be used for any kind of research, introduced after the Alder I-ky organs
scandal. Because of the difficulty in obtaining good quality RNA from BCC and normal
skin sample and the time it took to carry out northern blot analysis I decided to carry out
gene expression analysis using RT-PCR for remaining samples.
When using previously published set of primers designed by (Tanimura et al., 1998) to
amplify different isoforms a, ~, y and 8 GL12 (Moh a,bb and Moh c,dd in Table 2.2), it
was not clear as to which isoforms of GL12 were expressed in cell lines and tissues
samples analysed. Even after changing the PCR conditions such as annealing
temperature and or MgCb concentration and amount of temple. However, when primers
for a/~ and y/8 for GLI] (Table 2.2 published by (Regl et al., 2002) \\ ere used to
analyse GLl2 expression. These primers indicate 7/7 BCe, 5'6 normal skin. )1) Hatat,
2/3 primary keratinocytcs. .f..f A375 and 3/3 GLII-infected primal') keratinoc, tcs
express a. and or ~ GLn isoforrns (Figure 3.5). GLI~ (ctl~ isofonns) expression appears
I x.~
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to be low in HaCat and primary keratinocytes indicated by low intensity bands,
although G6PDA PCR bands were of the same intensity (Figure 3.3). This indicates
that the level of GL12 expression may be altered in cultured primary keratinocytes
compared to normal skin. When ylb set of primers were used they did not generate any
PCR products. This indicates that only a and or f3 GL12 isoforms are expressed in these
samples. (Regl et al., 2002) had shown that GL12 a/f3 isoforms were increased by 2 fold
in GLII infected primary keratinocytes compared to controls and 10.5 fold in BeC
compared with normal skin, and only trace amount of ylb-GL12 were detected in these
samples.
Possible explanations for why no ylb GL12 were detect in the cell lines and the tissues
analysed are; 1) Repeated freezing and thawing may have degraded the eDNA, 2) the
levels were so low that they were not detectable and lastly there is a possibility that
there were no GL12 ylb transcripts expressed in the samples analysed. Repeating the
experiments several times with newly transduced GLll-primary keratinocytes and
synthesising fresh eDNA, give same results.
GL12 mRNA was detected in GLll-infected primary keratinocytes and A375 cell lines
with northern blot (Figure 3.2) and RT-PCR analysis (Figure 3.5). There was no GLn
expression observed in Northern Blot for primary keratinocytes and HaCat cells (Figure
3.2). However, with RT-PCR analysis there was GL12 expression observed for primary
keratinocytes (Figure 3.5). The reason why we obtained this conflicting data is that
levels of GL12 expression in primary keratinocytes were very low and these were not
detectable using northern blot. However, with a more sensitive RT-PCR technique low
levels expression of GL12 was detected in HaCat and 2 out of 3 primary keratinocyte
samples. In the one primary keratinocyte sample in which GLI2 expression was not
detected, may have been due to two reasons; one is that the levels were so low they
were not detectable or there was no GL12 present.
Real-time-RT-PCR data for GLI2 confirmed the results obtained with RT-PCR and
northern blot analysis, it shows that GLI2 was induced in BCC and GLI I expressing
primary keratinocytes cells (Figure 3.6 and Table 304). These results are in line with
published data (Regl et al., 2002), they showed that GLn \\as induced in Bee rclatix c
to normal skin and in GLI 1 expressing relative to non GLI1 expressing keartinocytes.
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GLI2 expression with the real-time RT-PCR results for HaCat cells confirm with results
with RT-PCR data (Figure 3.5, Figure 3.6); both show induction of GLI2 in HaCat cell
lines relative to primary keratinocytes. The Real time RT-PCR results for A375 cells
also confirm the northern blot (Figure 3.2) and the RT-PCR data (Figure 3.5): they
show induction of GIl2 in A375 cells relative to primary keratinocytes. The results for
HaCat and A375 show that GIl2 expression levels in these cells are much greater
relative to primary keratinocytes. Thus it is possible that Hh signal transduction in these
cells may be regulated by GLI2 and not by GLII in these cells.
Other groups in this lab using same GIIl probe have shown GIIl to be expressed in
A375 cells using northern blot (personal communications). For this reason thex \\ ere
used as positive controls for GLII expression. However, these workers have not
investigated GLI2 expression in these cells. The reason for this discrepancy is unclear it
is possible that in this study a different batch of A375 were used, or they were of a
different passage number and thus they may have transformed resulting in a change in
gene expressions. Another possible explanation could be that there are two types of
A375 parental and metastatic (A375P and A375M) (Montano et al., 1994). The cells
that were used in this study were labelled as A375, so it was not clear whether these
were P or M, to investigate the discrepancy between the data these cells needed to be
investigated further, and as this was not the focus of this study this was not done. A375
cells were used as a positive control for GIIl expression, on the basis of personal
communications, along side GLI I-transformed baby rat kidney cell lines.
3.5.4 Induction of GLI3 and SMO in HaCat and A375 cells is independent of GLIl
and in GLIl-primary keratinocytes and possibly in BCC it is dependent on GLIl
expression.
RT-PCR analysis indicates that GLl3 and SMO are expressed in BCC, normal skin.
HaCat, A375, GLI I expressing primary keratinocytes and control primary keratinocytes
(Figure 3.5). Real-time-RT-PCR shows that GLI3 and SMO where induced in BCC
relative to normal skin, these results are in line with published data in which GLI3
expression has been observed in BCC samples which also express GLI I. induced
expression of SMO mRNA has also been reported in BCC (Dahmane et al.. 1997: Tojo
ct al., 1999). GLl3 and SJ\f() were also induced in HaCat. A375 and GLI1 expressing
primary keratinocytes relative to control non GLll expressing prirnary keratinoc- ks
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(Figure 3.6, Table 3.4). These results suggest that altering the expression of S\10
which activates and GLI3 which represses HH-signalling (Murone et aI., 1999: von
Mering and Basler, 1999) may be a mechanism by which activit. of Hll-sianallinc
~ 0 ~
pathway may be controlled in BCC (in-vivo) and in GLII over expressing primary
keratinocytes (in-vitro).
There was no GLll expression in HaCat and A375 cells yet we observe an induction in
GL13 and SMO expression, this indicates that there may also be GLII independent
induction of GLI3 and SMO expression in HaCat and A375s. Whereas, in GLll
expressing primary keratinocytes and may be in GLII expressing BCC samples the
induction of GLI3 and SMO was dependent on GLII.
3.5.5 KIF4 is induced in BCC, HaCat and A375 cells and GLIl represses it ID
primary keratinocytes.
The kinesin superfamily (KIF) of proteins are microtubule based motor proteins
specialized in the transport of membrane organelles, protein complexes, and mRNAs
(Hirokawa, 1998; Hirokawa and Takemura, 2005). In this chapter I have shown using
RT-PCR analysis that kinesin superfamily protein 4 (KIF4) was expressed in BCC,
normal skin, HaCat, A375, GLII-primary keratinocytes and control pnmary
keratinocytes (Figure 3.5). Real-time-RT-PCR indicates that KlF-I was induced in Bec
relative to normal skin, it was also induced in HaCat and A375 cells. However, it was
repressed in GLII expressing primary keratinocytes relative to non GLII expressing
control primary keratinocytes (Figure 3.6, Table 3.4). This suggests that there may be
GLII independent induction of KlF-I in BCC in-vivo and in-vitro in certain cells. It is
also possible that transcriptional activity of GLI I may be differentially regulated in
BCC in-vivo and in-vitro (GLII expressing primary keratinocytes) leading to alteration
in expression of KlF-I. At the time this study was carried out there was no published
data available on expression of KlF-I in BCC or in GLI1 expressing keratinocytes.
KIF4 plays multiple roles in mitosis, and its loss leads to numerous mitotic defects.
including chromosome hypercondensation, aberrant spindle formation, anaphase
briducs, defective cvtok inesis, and aneuploidy (Castoldi and Vernos, 2006; Kurasawa ct
~ .
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al., 2004; Lawrence et al., 2004; Mazumdar et al., 2006: Mazumdar and \Iisteli. 2005:
Mazumdar et al., 2004). Aneuploidy is the condition of having less than or more than
the normal diploid number of chromosomes, and is the most frequently observed t) pe of
cytogenetic abnormality that has long been suggested to contribute to tumor formation
(Dey, 2004).
A study carried out by Mazumdar et al (2006) showed that loss of KIF4 in embryonic
stem cells lead to 70% of the cells being aneuploid and this increases there potential to
form tumor in nude mice and loss of KIF4 activated the mitotic spindle checkpoints and
DNA-damage response pathways. They also detected a reduced KIF4 protein levels in
35% of human cancers from several tissues including ovary, lung, breast, eNS, renal,
melanoma and leukemia and no reduction of KIF4 was found in colon cancer
(Mazumdar et al., 2006). This indicates that loss of KIF4 is physiologically relevant in
certain tumours and cell lines. These results back the notion that loss of a molecular
motor leads to tumor formation and that aneuploidy can act as a primary trigger of
tumorigenesis. It is possible that loss of KIF4 in GLII expressing primary keratinocytes
may also be leading to cells being aneuploid. However, due to time constraints this
hypothesis was not tested.
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3.5.6 COUP-TFII and TFIID are expressed in BCC, normal skin and GLIl-
primary keratinocytes.
Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is expressed
in the mesenchyme of developing organs (Pereira et aI., 1995). COUP-TFII is shown to
be a major regulator of angiogenesis and vein identity (Pereira et al., 1999: You et al.,
2005a). In addition, it plays an important role in organ development such as stomach,
limb, heart and diaphragm (Lee et aI., 2004; Pereira et aI., 1999; Takamoto et al., 2005:
You et aI., 2005b). In the developing neural tube, SHH has been shown to regulate
COUP-TFII expression during the differentiation of motoneurons (Lutz et al., 1994).
Shh stimulates COUP-TFII expression (Krishnan et aI., 1997) thus is likely to be a
downstream target of SHH signaling, and the requirement for SHH in gastric
organogenesis suggests that COUP-TFII may play a role in stomach development
(Takamoto et aI., 2005). COUP-TFs are critical for development and differentiation in
many different tissues in several organisms (Pereira et al., 2000).
Regulation of transcription III eukaryotes requires the participation of a number of
transcription factors, many of which exist as multiprotein complexes. The general
transcription factor TFIID is one such complex composed of the TATA box binding
protein (TBP) and multiple TBP-associated factors (TAFIIs) and is required at many
gene promoters to initiate transcription by RNA polymerase II (Dynlacht et al., 199 I;
Hernandez, 1993). In the context of TFIID, TAFIIs have been shown to interact with I)
specific transcriptional activators to mediate activation, 2) basal transcription factors, 3)
other TAFIIs, and 4) specific DNA sequences, such as the downstream promoter
element or gene-specific core promoter sequence, thereby contributing to promoter
selectivity (Burley and Roeder, 1996; Hahn, 1998; Hoffmann et al., 1997: Kim et al.,
2005: Lee and Young, 1998; Orphanides et aI., 1996; Roeder, 1996; Sauer and Tjian,
1997). GLI-activate expression of reporter constructs in a concentration-dependent
manner through GLI consensus binding motifs. GLI-induced transcriptional activation
requires the carboxyl-terminal region highly similar to the a-helical herpes simplex viral
protein 16 activation domain, including the consensus recognition clement for the
human TFIID TATA box-binding protein associated factor TAFII31 the conservation of
all three amino acid residues believed to interact directly to complementary residues in
TAFIbl (Yoon et al., 1998). The presence of this region in the GLI activ .nion domain
provides a mechanism by which Gl.l-induccs transcriptional regulation.
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Due to the involvement of COUP-TFII and TFIID with SHH signaling pathway
expression of these transcriptional factors was investigated to see if GLI I changes their
expression. I have shown using RT-PCR analysis that COUP-TFII and TFIID
transcriptional factors were expressed in BCC, normal skin, HaCat, primary
keratinocytes, A375 and GLIl expressing primary keratinocytes (Figure 3.2). It was not
possible to quantify level of expression of COUP-TFII and TFIID because the primers
designed for RT-PCR analysis did not work with the (DyNAmoTM SYBR'J{ Green kit)
rcal-time-RT-PCR analysis, even after changing the template concentration, annealing
temperature and cycle number.
3.5.7 SUP-FU is expressed in BCC, normal skin and in GLIl expressing and non
expressing cells.
Suppressor of Fused (Sup-Fu) is oen of the component of Hh-signaling pathway has
been identified in Drosophila, mouse and human (Delattre et al., 1999; Ding et al.,
1999; Kogerman et al., 1999; Pham et al., 1995; Stone et al., 1999). In Drosophila, Sup-
Fu has been shown to form a complex with three other molecules, Fused (Fu) (Murone
et al., 2000), Costal-2 (Cos2) and the transcription factor Cubitus interruptus (Ci)
(homolog of GLI 1) (Monnier et al., 1998) all of which are involved in the transduction
of the Hh-signal, This complex is associated with microtubules in the absence of Sup-
Fu (Stegman et al., 2000). Human SUP-FU has been shown to bind GLII and GLl3 in
the nucleus and enhances their binding to their recognition site on the DNA (Kogerman
et al., 1999; Pearse et al., 1999), it also inhibits GLI-mediated transcription by shuttling
GLI I from the nucleus to cytoplasmic (Kogerman et al., 1999). Human SUP-FU is
expressed in; heart, brain, placenta, lung, liver, skeletal muscle, kidney pancreas,
thymus, prostate, spleen, testes, colon, ovary, small intestine, and peripheral leukocytes
(Grimm et al., 2001; Kogerman et al., 1999; Stone et al., 1999), at the time of this study
there were no reports of SUP-FU expression in normal skin or Bf.C. I have shown in
this study that SUP-FU was expressed in BCC, normal skin, HaCat, primary
keratinocytes, A375 and GLll expressing primary keratinocytes (Figure 3.2). I could
not quantify the levels of SUP-FU expression because the primers designed lor RI-
PCR analysis did not work \\ ith the (DyNAmoT!\\ SYBR,K Green kit) rcal-timc-R'I-
PCR anal) sis, even after altering the template concentration, annealing temperature and
increasing the cycle numbers.
3.5.8 a-TUB is repressed in BCC and induced in GLIl primary keratinocytes.
There appears to be a small reduction in a-tubulin (a-TUB) expressing in BCC relative
to normal skin and induction in GLII expressing primary keratinocytes relative to non
GLL 1 expressing keratinocytes (Figure 3.6). This data suggests that induction of 0.-
TUB in GLI1 expressing primary keratinocytes was dependent on GLII although in
BCC we saw an increase in GLI1 expression but there was a reduction in 0.- TL/B
expression, this indicates that a different mechanism is controlling the expression of a-
TUB in BCC. At the time this study was carried out there were no reports of a-tubulin
repression in BCC or induction by GLII in cells.
3.5.9 GL/I is not expressed in epidermis of normal skin, whereas GL/2, GL/3 and
PTCH are. GL/I, GL/2, GL/3 and PTCH are expressed in dermal papilla and outer
root sheath.
The origin of BCC has been debated. One possibility is that they derive from follicular
progenitors because hair follicles transiently express the GLI and SHH genes and use
the pathway for normal development (Dahmane et aI., 1997; Karlsson et al., 1999a; St-
Jacques et aI., 1998). More specifically, they might derive from stem cells that are
present in the bulge of the follicle (Fuchs et aI., 200 I; Taylor et aI., 2000a). However, it
is also possible that they derive from non-follicular transit amplifying precursors that
are present in the basal layer of the interfollicular epidermis. Inappropriate activation of
the SHH-GLI-pathway in epidermal stem cells might be responsible for BCC initiation?
Thus a study was carried out looking at SHH-pathway gene expression in normal skin
hair follicle, hair bulge, outer root sheet and interfollicular epidermis using LCM.
Cells were captured from dermal papilla, outer root sheath and interfollicular epidermis
of the skin. However, reproducibility of capturing the cells using the LCM was poor.
RT-PCR analysis shows GIIl is expressed in cells captured from dermal papilla and
root sheath. There was no GIIl expression in captured cells from interfollicular
epidermis. GII2, GII3, PTCH, a-TUB and ~-Actin were expressed in cells captured
from dermal papilla, root sheath and interfollicular epidermis Figure 3.7-A and B).
This data is consistent with the data obtained form RT-PCR analysis llr normal skin
(Figure 3.3) where GLI], GI13, PTCH and a-TUB were expressed. LC\I RT-PCR data
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is consistent with in-situ data for GIl2 expression in section 4.4.4, in which Gl.I? was
expressed in outer root sheath and interfollicular epidermis of normal skin.
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3.6.0 Summary
In this study I have shown by northern blot analysis that GLn, GIn and PTCH are
induced in GLIl expressing cells relative to non GLII expressing cells. RT-PCR
analysis shows that GLI2-aJf3 isoforms, GLI3, SMO, PTCH, COUP-TFJI, TFJID and
KIF4A are expressed in normal skin, BCC and GLIl expressing keratinocytes. GIn is
only expressed in BCC and GLIl expressing cells. Real-time-RT-PCR analysis shows
that GLn, GLI2-aJf3 isoforms, GLI3, PTCH, SMO and KlF-I are induced and n-Tubulin
(a-TUB) is repressed in BCC relative to normal skin. GLn, GLI2. GLI3, PTCH, S.\fO
and a-TUB are induced and KlF4A is repressed in GLII expressing keratinocytes
relative non GLI1 expressing keratinocytes.
3.7.0 Future study
KIF4A plays multiple roles in mitosis, and its loss leads to numerous mitotic defects,
including chromosome hypercondensation, aberrant spindle formation, anaphase
bridges, defective cytokinesis, and aneuploidy (Castoldi and Vernos, 2006; Kurasawa et
aI., 2004; Lawrence et aI., 2004; Mazumdar et aI., 2006; Mazumdar and Misteli, 2005:
Mazumdar et aI., 2004). Aneuploidy has been suggested to contribute to tumor
formation (Dey, 2004). A loss of KIF4 in embryonic stem cells leads to 70% of the cells
being aneuploid and this increases their potential to form tumor in nude mice, and KIF--l
protein levels are reduced in 35% of human cancers from several tissues (Mazumdar et
al.,2006).
In this chapter KlF-I was shown to be induced in BCC relative to normal skin it was also
induced in HaCat and A375 cells. However, it was repressed in GLI1 expressing
primary keratinocytes relative to non GLII expressing control primary keratinocytes
(Figure 3.6). This suggests that there may be GLII independent induction of KIF--l in
BCe in-vivo and in-vitro in certain cell lines. It is also possible that transcriptional
activity of GLI 1 may be differentially regulated in BCC in-vivo and ill-vitro leading to
alteration in expression of KIF4A. It is possible that loss of KIF--lA in GLI I expressing
primary keratinocytes may also be leading to cells being aneuploid. Thus future work is
required to identify why KIF-IA transcript is upregulated in BCe and down regulated in
GLII primary keratinocytes and do KIF--lA protein levels correlate with KIF.J.,j
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transcript levels in Bee and GLII primary keratinocytes. Also does loss of KIF-1.-:1. In
GLII expressing primary keratinocytes leading to cells being aneuploid?
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CHAPTER 4
Localisation of GLI2 in Normal Human Skin and BCC and its
regulation of GLII
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4.1.0 Introduction
In the previous chapter I characterised expression of SHH signalling path» a) genes In
human skin, BCC and GLII transduced primary keratinocytes, I had shown that Gl.I:
was induced in GLII transduced primary keratinocytes relative to control (EGFP
transduced primary keratinocytes). There was an ongoing collaboration between
Professor Anthony Quinn at Centre for Cutaneous Research (CCR), Queen Mary
University of London and Dr Fritz Aberger at Institute of Genetics, University of
Salzburg Austria, to investigate the effect of HH/GLI-signalling, in human
keratinocytes using in vitro model systems. In Regl et al (2002) we had shown that
expression of GLI 1 in human keratinocytes induced the expression of isoforms GLJ2a
and GLI2f3. Both isoforms were also shown to be expressed at elevated levels in 21
BCCs compared to normal skin. In chapter 3 I had also shown that GLI2a and or GLI2fJ
are up regulated in BCC relative to normal skin and they were also induced in GUI
transduced primary keratinocytes relative to control (EGFP transduced primary
keratinocytes) in a real-time RT-PCR analysis. This suggested that there was a positive
feedback mechanism between GLII and GLI2 transcription factors. Detailed time
course experiments monitoring the transcriptional response of keratinocytes either to
GLII or to GLI2 suggested that GLll was a direct target of GLI2, while activation of
GLI2 by GLII may be indirect (Regl et aI., 2002). Furthermore, expression of either
GLI2 or GLII showed an increase in DNA-synthesis in confluent human keratinocytes
(Regl et aI., 2002). These results suggested that there may be an important role of the
positive GLI I and GLI2 feedback loop in HH-mediated epidermal cell proliferation.
4.1.1 NHIS-GLI2 binds GLI consensus sequence in the GLI promoter and induces
GLIl expression in keratinocytes.
In collaboration with Dr Fritz Abergers laboratory, we had previously identified a
positive feed back loop between GLI I and GLI2 in primary human keratinocytes (Regl
et al., 2002). To investigate this in more detail, Dr Fritz Abergers' lab measured the
increase in GLI I mRNA and protein in HaCaT expressing N-tenninally HIS-tagged
GLI2 protein (NHIS-GLI2-HaCaT) under control of the tetracycline repressor. The)
showed that following tetracycline treatment there was a gradual increase in GLII
mRNA. In addition. activation of the direct target PTC 'H wus slightly delayed compared
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to induction of GI11 mRNA. Western blot analysis showed that NHIS-GLI2 protein
was detected 1 hour after tetracycline treatment whereas GLII protein was not detected
until 6 hours after treatment. In addition, the increase in GLI2 protein was closelx
paralleled by the gradual increase in GI11 mRNA (Ikram et al., 2004). This suggested
that GI11 represents an early GLI2 target gene. They also showed that GI11 mRNA
induction was closely followed by a gradual increase in endogenous GI12 mR1'\A
(lkram et al., 2004), confirming previous observation that a positive feedback loop
exists between GLII and GLI2 (Regl et a!., 2002).
To assess whether GLI2 may be capable of directly activating GI11 transcription b)
binding to the GI11 promoter, Dr Fritz Abergers' lab first performed in silico analysis
of the 5' flanking region of the human GI11 core promoter region (Liu et al., 1998:
Villavicencio et a!., 2002) to identify putative Gl.I-binding sites. Using the ScanAce
tool (Hughes et a!., 2000; Roth et a!., 1998) they analysed a region of approximately I
kb upstream of the transcriptional start site of GI11 (Liu et al., 1998) for motifs
identical to or closely matching the GLI-consensus binding site TGGGTGGTC (Kinzler
and Vogelstein, 1990b). An identical putative binding site was also present in the cis-
regulatory sequence of the mouse Glil gene, suggesting a possible functional relevance
of this motif in the regulation of Glil expression (lkram et aI., 2004).
To determine whether NHIS-GLI2 protein can bind to the putative GLI-binding site in
the GI11 core promoter, Dr Fritz Abergers' lab performed electrophoretic mobility shift
assays using bacterially expressed NHIS-GLI2-(332) protein and radioactively labelled
double stranded oligonucleotides containing either the putative GLI-binding site (8s) or
a mutated control oligonucleotide with two base pair exchanges in the core region
(8sm). They showed that recombinant NHIS-GLI2-(332) protein specifically bound to
the 8s sequence, but not to the Bsrn sequence, suggesting that NHIS-GLI2 protein may
be activating GI11 transcription by directly binding to the 5' flanking region of the GLll
promoter at a position close to the transcriptional-start site (lkram et al., 2004).
To analyse whether the GLI-binding site in the GI11 promoter is involved in acti. ation
of GI11 transcription by GLI2, Dr Fritz Abergers lab performed luciferase reporter
assay using wild-type and mutated GL11 promoter constructs. Co-transfection of GLI::
expression plasmid with the reporter construct containing the 5' upstream region uf
human GI11 (-1400 to +93, Liu et al., 1998) resulted in a 3-fold increase in luci ferase
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activity compared to controls. By contrast, no increase in reporter activity was observed
when the GLI-binding site at position -56 was changed from CGGGTGGTC to
CGCCTGGTC by site-directed mutagenesis (lkram et al., 2004). The GLI-binding and
luciferase reporter assay data suggest that HIS-GLI2 activates transcription of GiJI by
interacting directly with the GLI-binding site at position -56 to -48 of the GiJI
promoter (lkram et al., 2004).
The expression profile of GLI1 is well characterised in BCC and normal skin (Ghali et
al., 1999). As part of collaboration with Dr Fritz Abergers' lab, aim of this study was to
determine GLI2 localisation in normal skin and BCC by in situ hybridisation and
determined expression of GLI1 mRNA and protein in NHIS-GLI2 expressing human
primary keratinocytes.
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4.2.0 Results
4.2.1 GLI1 expression in NIDS-GLI2 human primary keratinocytes.
When human primary keratinocytes were transduced with NHIS-GLI2, GLIl (positi e
control) and GFP (negative control) retrovirus and cultured for 72 hours after which
total RNA and proteins were extracted. RT-PCR and western blot data of GLII shows
that NHIS-GLI2 induced endogenous GLIl transcript and protein expression in primary
keratinocytes (Figure 4.1) . This confirmed the observation (Ikram et al., 2004; Regl et
al., 2002) that NHIS-GLI2 induced GLIl expression in HaCat cells. This indicates that
GLIl may be a target of GLI2 in primary as well as immortalised keratinocyte cells .
GLI1~
G6PDH~
GLI1~
Pan-ERK....
GLI1
NHIS-
GLI2 GFP
(b)
(a)
Figure 4.1: GLll mRNA and protein expression In NHIS-GLI2 human pnmary
keratinocytes. Primary keratinocytes were transduced with NHIS-GLI2, GLII and GFP
retrovirus and cultured for 72 hours after which total RNA and_proteins were extracted.
This figure shows exogenous NHIS-GLI2 induced endogenous GLIl protein e pression
as shown by (a) semi-quantitative RT-PCR and (b) western blot anal sis, Pan-ERK
indicates equal protein loading. Retro viral expression of GLII was used as a po iti e
control, GFP and dH20 as negati ve controls. The data represented is of t\ 0 independent
experiments.
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4.2.2 In-situ hybridisation of GL/2 expression in normal skin and BCC.
4.2.3 Development of the In-situ hybridisation technique.
Initial experiments were carried out to develop the in-situ hybridisation method using
fragmented full-length keratin K14 (KRT14) and GLl2 ribo probes generated from
KRT14-1.2kb-PGEM and hGLI2-1.6kb-pCRII-TOPO vectors on wax embedded tissue
sections. KRT14 probe was used as a positive control for in situ hybridisation; this
allowed us to determine the integrity of mRNA and the pattern of expression. It was not
possible to generate a KRT14 sense probe from KRT14-1.2 kb-PGEM vector and when
this vector was sequenced using SP6 and T7 primers to identify KRT14 insert it was not
possible to sequence the insert using T7 primers; this suggested that there may be a
problem in this site which was not allowing to sequence the construct or to generate a
sense probe, as the control sequencing reaction with the T7 primers worked with the
M13 control vector. After liaising with other groups who had used the same KRT14-1.2
kb-PGEM vector in the department, revealed that they also were unable to generate
KRTl4 sense probe. However, after consultation with Dr Anthony Quinn it was decided
to continue with the in-situ hybridisation analysis using the KRT14 anti-sense probe
only. KRT14 anti-sense (1.2 kb) and GLl2 (1.6 kb) sense and anti-sense probes were
fragmented, this allowed them to penetrate the tissue to hybridise to the target mRNA.
To increase the accessibility of target mRNA in wax embedded normal skin and Bee
sections, citrate buffer and proteinase-K methods were used.
4.2.4 Localisation of GL/2 and KRT14 in BCC and normal skin wax sections with
citrate method.
With the citrate method keratin-14 signal was observed in the basal layer in some
regions and throughout the epidermis in other regions in the same normal skin sections.
KRT14 expression was also observed in BeC tumour islands (Figure -t.2). GLl2 signal
was observed throughout the epidermis layer in normal skin adjacent to Bee and in
tumour islands with both sense and anti-sense probes (Figure -t.3 and Figure -tA)
IYl)
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4.2.5 Localisation of GLI2 and KRT14 in BCC and normal skin wax sections with
proteinase-K method.
With proteinase-K method GL12 signal was observed in the epidermis and in Bee
tumour islands with anti-sense probe. A weaker signal was observed with GLn sense
probe in same regions (Figure 4.5). KRT14 signal was in the basal layer only in normal
skin adjacent to BCC and in tumour islands (Figure 4.6). The signal for sense and anti
sense probes for GL12 and KRT14 anti sense probe was patchy in normal skin and Bt.C
sections. KRT14 being a basal cell marker was expected to give basal signal only. This
suggested that proteinase K method give a specific signal compared to the citrate
method. Thus proteinase K method was used for KRT14 and GL12 in-situ hybridisation
on wax embedded BCC and normal skin sections. Once again a signal was observed
with GL12 fragmented sense and anti-sense probes in normal skin and Bee sections.
This indicated that signal for GL12 was non-specific. As there was no sense KRT14
probe one could not be certain if KRT14 signal observed with anti-sense probe was
specific, although the KRT14 expression pattern was specific for the basal layer in the
epidermis.
4.2.6 Localisation of GLI2 and KRT14 in BCC and normal skin frozen section with
proteinase K and citrate method.
Fresh BCC and normal skin samples were collected from the Royal London Hospital
Dermatology Department (with ethical approval). Soon after the samples were excised
they were, snap frozen to preserve the mRNA. Sections cut from these samples were
hybridised with 1.2 kb KRT14 (fragmented) and 296bp GL12 sense and anti-sense
probes generated from newly cloned KRT14-1.2 kb and hGL12-296 bp (KRT14-1.2kb-
pCRII-TOPO, hGLI2-296bp-pCRII-TOPO) vectors (see sections 2.10.5, 2.10.7) using
citrate and proteinase-K methods. With citrate method a clean and specific signal was
observed compared to the proteinase-K method for KRT14 anti-sense probe and no
signal with sense probe. This indicated that for frozen sections the citrate method works
better. However, with the GL12 sense probe there was still non specific signal observ cd
with the citrate method. Following this citrate method was used. However. in-situ
hybridisation washing temperatures were changed from 42l)C to SOllC and final wash
from 55')(' to 60°C. With these higher washing conditions. the signal observed for the
KRT14 anti-sense probe was weaker and no signal was observed \\ ith KRTI -I sense
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probe. For CLf2 anti-sense probe a strong signal was observed and with CLn sense
probe ether no signal or a very weak signal (back ground) was observed. This indicated
that each probe had different optimum washing temperature. Therefore. in-situ
hybridisation was carried out on frozen Bee and normal skin sections using citrate
method. KRT14 and CLf2 hybridisation was carried out simultaneously and only the
washes were done at different temperatures, for KRT14 at 45°e and final wash at 500e
and for CLf2 at 55°e and final wash at 600e
CLf2 signal was observed in normal skin interfollicular epidermis and in the outer root
sheath (ORS) of hair follicle with an anti-sense probe. No or very weak staining was
observed in adjacent sections with a sense probe. As a control KRTl-l expression was
also detected in basal layer of normal skin epidermis and in the outer root sheath (ORS)
of hair follicle, with an anti-sense probe. No signal was observed in adjacent sections
with the sense probe (Figure 4.7, Figure 4.8). A strong CLf2 and KRTl-l signal was
also observed in Bee tumour islands and particularly in the cells of periphery with an
anti-sense probe. No signal was observed in the adjacent sections with a sense probe
(Figure 4.9). Bee and normal skin samples examined were scored under the
microscope for CLf2 and KRT14 expression. A strong CLf2 and KRT14 expression was
consistently observed in all Bee (n=8) and normal skin (n=3) samples (Table 4.1). This
correlated with RT-peR data showing CLf2 expression in Bee and normal skin.
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Normal skin
1-K14NS3614(A) Anti-Sen
(A)
Bee
-K14BCC7519(A) 1( Sen (C)
x20
Figure 4.2 In-situ hybridisation analysis of KRT14 expression in BCC and normal skin
(wax sections using citrate buffer method). KRT14 signal in normal skin is in basal layer
(A, B x20), in BCC the signal is in the tumour islands (C, D x20).
Bee
1-GII2(Frag)BCC7519(A) Sen-
(A) :~~
Bee
Figure 4.3 In-situ hybridisation analysis of GLl2 expression in BCC ( a section using
citrate buffer method). GLl2 signal with the sense (A, C x20) and anti-sense (B, D , 20)
fragmented probes, the signal is in epidermis and in BCC tumour islands. Thu . th
signal is non-specific due to sense and anti sense probes both gi ing a ignal.
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Inter-follicular epider mis
1-GII2(Frag)NS3614 Sen
(A)
Hair follicle
1-GII2tFrag)NS3614 Sen
Figure 4.4 In-situ hybridisation analysis of GLl2 express ion III normal skin (wax
sections using citrate buffer method). GLl2 sense (A, C) and anti-sense (B, D)
fragmented probes. The signal is in the epidermis and hair follicle for both probes.
However, there is a weaker signal for the sense probe compared to the anti-sense probe
In same regions,
Tumour islands epidermis
(A) (C)
: ~ . -
Prolelnalie·K GII2 (Frag) BCC7519(A) . .. .__san x20
Figure 4.5 In-situ hybridisation analysis of GLl2 expression in BCC (wax sections with
proteinase K method). GLI2 anti -sense (A, C x20) and sense (B, D x20) fragmented
prob es. The signal is in epidermis and the tumour islands. There is very weak signal for
the sense probe compared to the anti-sense probe in the same regions. 0 shov that th
morphology of the tissue has been disrupted with proteinase K method.
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Protelnase-K K14 (Frag) BCC7519 Anti-Sen
- (A)
~~~e;;""''i.~.;)I.:. Epidermis
Tumour islands
Figure 4.6 In-situ hybridisation analysis of KRT14 expression in BCC (wax sections
with proteinase K method). With the KRT14 anti-sense (A, B x20) fragmented probe,
the signal is in the basal layer only in the epidermis and in tumour islands. This
indicates that the signal is specific.
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Normal skin GLI2
Dc
Sense Anti-sense
x20
Normal skin KRT14
, : lJ. .
.. .A
Sense Anti-sense
x20Ix20
x20
....
"-G"X1'~"-'
K x2b
Figure 4.7 In-situ hybridisation of GLl2 and KRT14 expression in normal skin (frozen
sections using citrate buffer method). GLl2 expression was detected in the epidermis
and the outer root sheath (ORS) of the hair follicle with an anti-sense GLl2 probe (B, F
and J- indicated by red arrows). No staining was observed in adjacent sections with a
sense GLl2 probe (A, E and I). KRT14 expression was detected in the basal layer of the
epidermis and the ORS of the hair follicle (D, H and L-indicated by red arrows). 0
staining was observed in adjacent sections with a sense KRT14 probe (C, G and K).
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Figure 4.8 In-situ hybridisation analysis of GLl2 and KRT14 expression in BCC (frozen
section using citrate buffer method). GLl2 expression was detected in tumour islands
and particularly in the cells of periphery with an anti-sense GIl2 probe (B, F, J and
indicated by red arrows). No staining or very weak staining was observed in adjacent
sections with a sense GLl2 probe (A, E, I and M). A strong, KRT14 expression was
detected compared to GLl2 in tumour islands and particularly in the cells of periphery
with an anti-sense KRT14 probe (D, H, L and P- indicated by red arrows). 0 staining
was observed in adjacent sections with a sense KRT14 probe (C, G, K and 0).
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Table 4.1: GLJ2 and KRT14 expression in normal skin and basal cell carcinoma.
Sample ID No Tissue GLJ2 Anti-sense GLJ2 Sense KRT14 KRT1 -l
Sample probe probe Anti-sense Sense
probe probe
170901 N/S +++ - +++ -
35499144 N/S +++ - +++ -
898921 N/S +++ - +++ -
-.
~ ~
291669 Be e +++ - +++ -
M567438 Bee ++ - +++ -
4006064969 Bee +++ - +++ -
M62058 Bee +++ - +++ -
F455 13 1 Bee +++ - +++ -
20 13 13 1 Bee +++ - +++ -
609458 Bee +++ - +++ -
M265128 Bee ++ - +++ -
Frozen sect ions were hybridised with ~ 100ng GLI2 anti-sense and sense probes and
washed at 55°e, final wash at 600e and 100ng KRT14 anti sense and sense probes
washed at so-c, fi nal wash at 55°e. Strong GLJ2 staining was consistently observed in
all basal cel l carc inoma (Bee) n=8 and normal skin (N/S) n=3 samples examined. A
control KRT14 expression (used to verify the integrity of mRNA) was detected with an
anti-sense probe. No samples were scored for GLJ2 expression if they failed to show
KRT14 mRNA expression, (+++ strong signal, ++ weak signal, + very weak signal, - no
signal).
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Figure 4.9 In-situ hybridisation analysis of GLI2 expression in BCC and normal skin
frozen section (using citrate method). GLI2 expression was detected in the epidermis
[(Epi) a, 0 , q] and in the outer root sheath (ORS) of the hair follicle (c, e g) \ ith an
anti-sense (AS) probe. No staining was observed in adjacent sections ith a sense ( )
probe (b, d, f, h, p, r). GLI2 expression was detected in BCC tumour islands with an
anti-sense probe (i, k, m). No staining was observed in adjacent sections \ ith a n
probe 0, I, n).
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4.2.7 Generation of monoclonal antibody to N-and-C-terminal of GLI2.
The presence of GLI2 transcript in normal skin and BCC does not mean that the protein
will also be present. To determine if the protein was present in areas where GLn
transcript were localised, we needed to look at protein expression in these tissue
samples. At the time these experiments were carried out there were no GLI2 antibodies
available to carry out Immunohistochemistry analysis on normal skin and BCC samples.
With the help of Dr Fritz Abergers we designed GLI2 peptides from the C-and N-
terminal sequence, obtained from the NBCI data base, to generate a GLI2 antibod) , The
availability off GLl2 antibody would have allowed us to determine if GLI2 protein is
present in areas where GLI2 transcripts had been identified in normal skin and Bee in
the in-situ hybridisation analysis. Generation of GLI2 antibody would have also allowed
us to identify if GLI2 was processed in the in-vitro systems.
The antibody generation work was carried out by the Monoclonal Antibody Service
Unit at Cancer Research UK, as detailed in the material and methods described in
section 2.13.0. After injecting the conjugated Maleimide Activated Keyhole limpet
hemocyanin (mcKLH), GLI2-N and C terminal peptides, Elisa assay were carried out
by diluting (1: 10,000) the test bleeds obtained from the immunised mice using the
peptide only as the antigen. The mouse test bleeds that were positive for the Elisa assay
did not generate any GLI2 specific band at or around 140 kO on the western blots from
GLI1, NHIS-GLI2 and EGFP (control) transduced primary keratinocytes protein
Iysates. This indicated that there was no GLI2 specific response in any of the mice that
were immunised. The Elisa assay and the testing of the bleed samples on the western
blots, was carried out by the Monoclonal Antibody Services at Cancer Research UK.
Getting to this stage had taken 6-8 months and during this time the availabilit; of
commercially produced GLI2 antibody lead led us to abandon the attempt to generate a
GLI2 antibody.
CIL\P'J [~R 4-
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4.3.1 Localisation of GLI2 in BCC and normal skin.
GLII is reported to be expressed in ORS of normal skin hair follicle (Ghali et al.. 1999)
and a positive feed back mechanism has recently been identified between GLl J and
GLI2 (Regl et aI., 2002). There were no reports of GLI2 localisation in normal skin and
Bee tissue, thus GLl2 localisation was investigated to see if there was co-localisation
expression of GLI 1, GLI2 in Bee and normal skin. At the time this study was carried
out there were no GLI2 antibodies available thus in-situ hybridisation analysis was
carried out to determine GLl2 transcript localisation in Bee and normal skin.
Initially control experiments were carried out to see if the in-situ hybridisation
technique was working using a KRT14 ribo-probe, KRT14 is expressed in the basal
layer of the skin and is induced in Bee (Apaydin et al., 2005; Fuchs and Green, 1980;
Nelson and Sun, 1983; Steinert and Roop, 1988). These experiments were carried out
using paraffin wax embedded Bee and normal skin tissue samples with citrate buffer
and proteinase K method (see section 2.10.0). Using the citrate method KRT1-l
transcripts were detected in the basal cells of the epidermis in some regions and in some
it was not confined to the basal cells, but was present throughout the epidermis in
normal skin (using fragmented KRT14-1.2 kb probe). KRT14 was also detected in the
Bee tumour islands with the citrate method (Figure 4.2).
With the proteinase K method, KRT14 expression was detected in the basal layer only
and in the Bee tumour island in the same sample with fragmented KRT14 1.2kb probe
(Figure 4.6). This indicated that the proteinase K method gives a specific signal
compared to the citrate method. When full length KRT14 1.2 kb probe was not
fragmented and used to detect localisation of KRT14 the signal obtained was strong but
not confined to the basal cells but throughout the epiderm is layer. This suggested that
the full-length probe may have been binding non-specifically compared to fragmented
probe. The reason why we observed a stronger signal with the uri-fragmented (1.2 kb)
compared to fragmented KRT14 probes is that longer probes can give a stronger signals
because they have more labelled nucleotides incorporated into them. However, probes
that are too long can give weaker signals because they penetrate less efficientf into the
cross-linked tissue. The extent to which long probes are hindered from penetrating
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depends upon the nature of the tissue, the choice of fixative, and whether pre-treatments
have been carried out to remove cellular proteins (Wilkinson 1998).
A possible reason why we observed signal throughout the epidermis for the un-
fragmented KRTl4 probe is that there are many different types of keratin expressed
throughout the epidermis layer and certain keratins have highly conserved
(homologous) regions (Fuchs and Weber, 1994). Thus, it is possible that the full length
KRTl4 probe may have hybridised to other homologous keratins which are expressed
throughout the epidermis. However, fragmented KRTl4 probe was hydrolysed
randomly which generated fragments of approximately 500bps. Therefore, it is possible
that the KRTl4 homology regions to other keratins may have been hydrolysed to
smaller fragments and these were unable to remain hybridised under the in-situ
hybridisation conditions. The KRTl4 specific regions were of larger size and these
remained hybridised to the KRTl4 transcripts under the same conditions. Thus, we
observed a more specific signal with the KRTl4 fragmented probes compared to un-
fragmented probe.
One of the controls for specific hybridisation to mRNA is to use a sense strand probe
that should not specifically anneal to the target RNA. Not being able to generate a
KRTl4 sense probe as a negative control for the in-situ hybridisation from the KRTl4-
PGEM plasmid, the plasmid (KRTl4-PGEM) was sequenced using SP6 and T7 primers
to determine if it contained the correct KRTl4 insert. KRTl4 insert sequence was
confirmed with SP6 primer but there was no sequence obtained with T7 primer. This
indicated that there was a problem with the KRTl4-PGEM plasmid in the T7 primer
regions, thus KRTl-l-PGEM could not be sequenced or used to generate a KRTl4 sense
probe using T7 primers and T7 polymerase. Other workers in the lab were also unable
to generate KRTl4 sense probe with KRTl-l-PGEM plasmid. It is possible that the
sequence in KRTl4-PGEM plasmid in T7 primer region may have been mutated and
thus we were unable to generate KRTl-l sense probe.
Using a proteinase K and citrate method there was a signal observed for GLf2 in Bee
and normal skin with fragmented 1.5 kb GLl2 sense and anti-sense probes (Figure ~.3
and Figure ~A.). A stronger signal was obtained with the citrate method in Bee and
normal skin compared with proteinase K method (Figure ~.5): this indicates that lor
GLf2 probe citrate method had worked better. There was no sense KRT/4 probe thus it
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was not clear if KRT14 signal with anti-sense probe was specific or non specific
Therefore, a smaller fragment of (296bp) GIl2 probe from hGLl2-pCRII-Tapa vector
corresponding to 2869-316Sbp (GI No 3061313) and 1.2 kb KRT1-1 probe from the
KRT14-PGEM vector corresponding to 298-1498bp (GI No 15'+31309) were cloned into
pCRII-TOPO vector to generate a more specific probes (see section 2.9.4 and 2.9.5).
Wax imbedded BCC and normal skin samples were obtained from laboratory stocks. It
was not clear how these were treated to preserve the RNA. Fresh BCC and normal skin
samples were collected and snap frozen. Sections from these samples \\ ere hybridised
with fragmented 1.2 kb KRT14 and 296bp GIl2 sense and anti sense probes generated
from 1.2 kb KRT14-pCRII TOPO and 296bp GI12-pCRII TOPO plasmids using citrate
and proteinase K methods. With citrate method a clean and specific signal was observed
compared to proteinase K method with fragmented 1.2 kb KRT1-1 anti-sense probe, this
suggested that for frozen sections citrate method worked better.
However, with 296bp GI12 sense probe there was still non-specific signal obtained, by
optimising the washing conditions for both fragmented 1.2 kb KRT1-1 and 296bp GLf2
sense and anti-sense probes using the citrate method. Indicated that each probe had
different optimum washing temperature for KRT14 it was at SO°C and final wash at
SO°C and for GI12 it was at SSOC and final wash at 60°C (see section 2.10.13). Thus,
KRT1-1 and GIl2 in-situ hybridisation was carried out simultaneously on frozen Bec
and normal skin sections using citrate method and the washes were done at different
temperatures.
GLl2 signal was observed in normal skin (n=3) interfollicular epidermis and in the outer
root sheath (ORS) of the hair follicle. As a control KRT1-1 was also detected in basal
layer of normal epidermis and in the outer root sheath (ORS) of hair follicle in the same
samples (Figure 4.7 and Table 4.1). A strong GLl2 and KRT1-1 signal was also
observed in BCC (n=8) tumour island and particularly in the cells of periphery (Figure
4.8 and Table 4.1). This correlated with RT-PCR and real-time-RT-PCR analysis
confirming that GIl2 was expressed in BCC and normal skin (Figure 3.5, Figure 3.6)
and with LCM data (Figure 3.7)
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4.3.2 A role for human GLI2 in regulating epidermal proliferation and skin
tumorigenesis.
A number of Drosophila and vertebrates developmental processes such as cell type
specification, pattern formation and regulation of cell proliferation involve HH-signal
transduction pathway. Deregulation of this pathway results in consistent up-regulation
of Hh target genes which can lead to developmental defects as well as to the formation
of various tumours such as medulloblastomas, rhabdomyosarcomas and BCCs.
(Goodrich and Scott, 1998; Ruiz, 1999; Toftgard, 2000).
Drosophila and vertebrates studies have shown that GLI family of transcription factors
are the key players in Hh-signalling. Of the three GLI genes, GLI 1 has been the focus
with respect to tumorigenesis, since it is expressed in BCC and not in normal skin
(Green et aI., 1998). Overexpression of GLll in the epidermis of transgenic mice
induces a variety of skin tumours including BCCs (Nilsson et al., 2000). More recently
it was shown that GL12 expression to be elevated in response to GLll in human
keratinocytes and GL12 transcript was expressed at elevated levels in BCCs compared
to normal skin and a positive feedback mechanism exists between GLI 1 and GLI2 in the
human keratinocyte cell line HaCaT and in mouse C3HI0T1/2 fibroblasts (Regl et al.,
2002), and coworkers had shown that GLI2 specifically binds the GLI binding
consensus sequence in the GLll promoter leading to induction in GLII expression
(lkram et al., 2004).
I have shown in this study that GL12 is expressed in interfollicular epidermis and ORS
of hair follicles in normal skin as well as in BCC tumour islands. This indicates that
there is no overlap of GLll and GLI2 expression in normal interfollicular epidermis
except in BCC and ORS of hair follicle. Overexpression of mouse Gli2 and not Gli1 has
been shown to specifically cause the development of BCC-like features (Grachtchouk et
al., 2000). These results point towards a possible important role for human GLl2 in
regulating epidermal proliferation and skin tumorgenesis. BCC is believed to originate
from stem cell residing in the hair follicle (Kruger et al., 1999) and therefore. it is
possible that deregulation of SHH pathway in transiently amplifying stem (ell 111<1\
effect co-expression of GLI I and GLI2 in ORS leading to BCe formation.
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A possible scenario in the induction of BCC formation may be activation of GLI1 by
inactivating mutations in PTCH followed by the induction of GLI2. Alternatively.
activation of HH-signalling may first lead to the induction of GLI2 expression \\ hich
directly activates GLII expression. This indicates that a feedback loop may be required
in the activation and maintenance of BCC formation, which is not active in normal skin
due to the absence of GLII expression. It is also possible that there rna) be certain
unidentified factor(s) that are present in BCC that allow GLI2 to activate GLI1 which
may not be present in normal skin.
Activation of GLI2 by GLII may also be system specific. Mice ectopically expressmg
Gli1 in the neural tube do not show any alterations of the Gli2 expression pattern
(Hynes et al., 1997). In contrast, injection of human GIll into frog embryos results in
the formation of skin tumours, which express Gli2 mRNA. Interestingly. homozygous
Gli l knock-out mice are phenotypically normal, suggesting that Gli2 expression does
not strictly depend on functionally active GLII protein. More likely, GLI2 is able to
compensate for the lack of active GLI1 protein (Park et al., 2000). Activation of GLI 1 in
response to GLI2 expression is consistent with the finding that Gli2 deficient mice
express Glil mRNA at reduced levels. Also, Gli2 expression in mouse epidermis
induces the development of BCCs expressing Glil (Ding et al., 1998; Grachtchouk et
al., 2000). This data suggest a conserved function of Gli2 in the regulation of Gli1
expression, which is cell-type specific or a system dependent effect.
4.4.0 Summary
Regal et al (2002) demonstrated a positive feedback loop between GLI1 and GLl2,
which revealed that GLII may be a direct target of GLI2. Data discribed in this chapter
from Dr Fritz Abergers' lab shows that GLI2 binds the GLI-binding consensus
sequence in the GIJI promoter. using band shift and luciferase reporter assays. this
suggest that GLI2 directly activates GLll (lkram et al., 2004). In this chapter I have
shown that retrovirally expressed GLI2 induces expression of endogenous GLJ 1 in
human primary keratinocytes and GIl2 is expressed in the interfollicular epidermis and
the outer root sheath of hair follicles in normal skin as well as in Bee tumor islands.
These results suggest that GLI2 may play an important role in regulating epidermal
proliferation and skin tumorigenesis.
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4.5.0 Future study
A BCC formation may arise due to activation of GLII by inactivating mutations in
PTCH followed by the induction of GLI2. Alternatively, activation of SHH-signalling
may first lead to the induction of GLI2 expression which directly activates GLI I
expression. This indicates that a feedback loop may be required in the activation and
maintenance of BCC formation, which is not active in normal skin due to the absence of
GLII expression. Thus it is possible that there may be certain unidentified factor(s) or
mechanisms that are present in BCC that allow GLI2 to activate GLII which may not be
present in normal skin. Identification of these factor(s) or the mechanism would be the
subject of future research.
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CHAPTERS
FOXEl Expression in Normal Skin and BCC
ClIAP'TLR 5: [()XLI Expression in',
5.1.0 Introduction
To identify GLI2-regulated genes, Dr Fritz Abergers lab expressed GLI2 under the
control of a tetracycline inducible promoter in HaCat cells (Regl et al., 2002). and
carried out cDNA array analysis on these cells lines. Expression profiling of these
samples showed that forkhead transcription factor FOXEl was upregulated in GLI2
expressing HaCat cells in a dose dependent manner compared to control cells.
(Eichberger et aI., 2004). Having shown that GLl2 was induced in Bce samples
compared to normal skin (Figure 3.6), this was also confirmed by Dr Fritz Abergers
lab they had also shown that GLl2 mRNA levels were highly elevated in Bee samples
compared to normal skin (Regl et aI., 2002). This suggests that FOXEl should also be
induced in BCC, so Dr Fritz Abergers' lab analyzed Bec samples with upregulated
levels ofGLI2 and GLII (Regl et aI., 2002) for FOXEl transcripts levels. In allIS Bee
samples tested, FOXEl mRNA levels were induced ranging from 4 to 59.2 folds with
an average fold increase of 15.8 fold relative to normal skin. Dr Fritz Abergers lab also
observed that GLl2 and FOXEl were expressed at a much higher level in normal skin
than GLll. In a Pearson correlation calculated pair wise for GLll verses FOXEl, GLn
verses FOXEl and GLll verses GLl2 using statistical package (SPSS) programme, they
showed that only FOXEl verses GLl2 was significant with the correlation p < 0.0 I
(Eichberger et aI., 2004).
5.1.1 Induction of GLl2 in human keratinocytes increases FOXEI mRNA
expression.
To identify GLl2-regulated genes, Dr Fritz Abergers' lab expressed GLI2 under the
control of a tetracycline inducible promoter in HaCat keratinocytes (Regl et aI., 2002),
and carried out cDNA array analysis on these cells lines. Expression profiling of
samples treated with tetracycline for 24 hours and 72 hours was done on filter arrays
containing approximately 2200 human expressed sequence tags (ESTs). The data from
the arrays experiments showed that forkhead transcription factor FOXE1 was
upregulated in a GLI2 overexpressing cell lines in a dose dependent manner (5..+ ±0.9'+
fold increase after 24hr and a 10 ± 1.15 fold increase after 72hr of tetracycIine treatment)
compared to control cells (Eichberger et aI., 200'+).
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They also investigated FOXEl and the direct target of GLll PTCH (as control)
expression in primary human keratinocytes transduced with GLl2 (SIN-GLI2-EGFP) or
EGFP control (SIN-EGFP) expressing retrovirus, after 72 hours transduction, using
real-time-RT-PCR. Similarly to HaCaT-GLI2-HIS cells a strong induction of FOXEI
transcript 16.6 ± 0.3 fold and PTCH 19.78 ±2.45 fold was detected in retrovirall.
transduced primary keratinocytes expressing GLI2 (Eichberger et al., 2004).
5.1.2 FOXEl is an early target of GLI2 in human keratinocytes.
Dr Fritz Abergers' lab, then went on to measure the appearance of FOXEl and GLI2
protein simultaneously in a HaCaT-GLI2-HIS cells induced for 6hr, 12hr, 24hr and -lShr
with tetracycline, and compared the mRNA and protein expression levels relative to
untreated controls from the same time points. GLI2 protein was increased over
background expression level after 6hr tetracycline addition and levels further increased
with prolonged treatment. Similarly, FOXEl transcript levels were elevated 3.42 ±0.25
fold at 6hr after tetracycline treatment and further increased in a GLI2 dose-dependent
manner (7.17 ±1.39 fold at 12 hr, 20.61 ±0.57 fold at 24hr, and 36.9 ± 1.02 fold at -lShr).
When they compared the kinetics of FOXE 1 mRNA accumulation to those of the
known GLI target PTCH a similar response was observed, PTCH was induced 7.82
±0.17 fold at 6hr, 8.15 ±0.24 fold at 12hr, 23.57 ±1.1 fold at 24hr and 26.63±2.3 fold at
48hr (Eichberger et aI., 2004). From this they concluded, that due to a rapid increase in
FOXEl mRNA transcription in response to GLI2, suggests that FOXEl represents an
early GLI2 target gene, which like PTCH may be directly regulated by GLI2
(Eichberger et aI., 2004).
Due to the fact that GLI 1 and GLI2 recognize the same consensus binding sequence and
are known to have overlapping functions (Bai and Joyner, 2001), Dr Fritz Abergers lab
went on to compare the induction of FOXEl and PTCH by GLll and GLI~ in GLI1 and
GLI2 tetracycline inducible HaCaT cells relative to un-induced controls. The data from
these experiments showed that there was a strong induction of FOXEl mRNA levels in
response to GLI2 and a reduced activation of FOXEI in HaCaT cells expressing GLII.
PTCH was upregulated to comparable levels in HaCat cells expressing GLI 1 and GLl2
(l.ichberger et al., 2004). From this they concluded that this indicates that GLl2 \\as the
main activator of FOXEl.
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5.1.3 Activation of the FOXEl promoter by NHIS-GLI2-(332) by binding GLI
consensus sequence in the FOXEl promoter.
The next set of experiments Dr Fritz Abergers' lab did was to investigate whether
FOXEl may be directly regulated by GLI2. Again they analysed the promoter region of
FOXE1. As the start site for FOXEl was not known so they mapped it by 5'-RACE
analysis to a 28bp position upstream of the known mRNA (Accession No: NM_004473)
5' end sequence. They also identified five sites differing from the GLI-binding
consensus motif GACCACCCA (Kinzler and Vogelstein, 1990b) by 2 nucleotide
substitutions (Eichberger et aI., 2004). In electrophoretic mobility shift assays they
showed that all five sites interacted specifically with recombinant purified GLI2 Zn
protein (amino acid 1-332, truncated after the Zn finger DNA binding domain). They
also showed in a luciferase reporter gene assay a 2470bp FOXEl promoter fragment
(from -1934 to + 536 containing all five GLI binding sites) induced transcription
activity by 3-fold in the presence of GLI2 compared to controls. The early induction of
FOXEl transcript by GLI2 and the presence of GLI binding sites in the FOXEl
promoter, and the activation of the FOXEl promoter in a reporter assay, led them to
conclude that FOXEI was likely to be a direct target of the GLI2 in epidermal
cells.(Eichberger et aI., 2004)
In chapter 4 I determined the localisation of GLl2 transcript in normal skin and BCe
and the fact that Dr Fritz Abergers' lab had shown that FOXEl was also upregulated in
BCC and was a direct target of GLI2. The aim of the work presented in this chapter was
to investigate FOXEl localisation in normal skin and BCC samples.
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5.2.0 Results
5.2.1 Localization of FOXEl in BCC and normal skin.
Dr Fritz Abergers' lab had shown the induction of FOXEl in BCC and in GLI2 induced
keratinocytes so as a part of this collaboration I went on to investigate the localisation of
FOXEl in BCC and normal skin. At the time there were no FOXEl antibodies
available, so in-situ hybridisation analysis was carried out to determine FOXE 1
transcript localisation. In agreement with the results of real-time-RT-PCR (Eichberger
et aI., 2004) all BCCs screened (n=6) showed intense staining throughout the tumour
islands with FOXEl anti-sense probe, no specific signal was detected in the surrounding
stroma cells. Adjacent sections stained with FOXEl sense probes showed no signal,
thus indicating specific staining for FOXEl (Figure 5.1 and Table 5.1). Our results
show that the elevated FOXEl transcript level detected with real time RT-PCR in BCt,'
(Eichberger et aI., 2004) are specific for the epithelial component of the Bce samples
and do not result from expression in surrounding mesenchymal tissue. In interfollicular
epidermis FOXEl mRNA staining was specific to the basal, suprabasal layers and to the
outer root sheath but not in the underlying mesoderm (Figure 5.2). Occasionally,
staining of mesenchymal cells of the perifollicular connective tissue sheath was
observed.
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Basal Cell Carcinoma (BCC)
(A)
FOXE1 sense RNA probe
(B)
Figure 5.1: FOXEl mRNA localisation in BCC frozen sections (using citrate method).
A and C, FOXEl expression is shown in two representative tumors by in-situ
hybridisation. Only BCC tumor islands but not surrounding stroma cells are stained. B
and D, Adjacent BCC sections hybridized with sense RNA are negative controls to
show the specificity of hybridisation.
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Figure 5.2: FOXEl mRNA localisation in normal skin frozen sections (using citrate
method). A and C, specific staining for FOXEl was observed in basal keratinocytes of
normal human epidermis (red arrows). (E) section of a hair follicle showing FOXEl
transcript is strongly expressed in cells of the outer root sheaths of the hair follicle. B, D
and F, adjacent sections were hybridized with a sense RNA probe (control) to
demonstrate the specificity of the hybridisation.
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Table 5.1: In-situ hybridisation of FOXEl mRNA expression in basal cell carcinoma
and normal skin
Sample No Tissue FOXEl FOXEl KRTl-l KRTl.:f Comments ISample anti sense Anti-sense sense I
sense
2013131 BCe +++ - +++ -
40060649 BeC +++ - ++ -
69
M567438 BeC +++ - +++ - Corium strong staining for FOXEI
F455131 BCe +++ - +++ -
M62058 BCe +++ - +++ -
609458 Bee + - - - Very patchy most -vc for both
probes
291669 Bee +++ + +++ -
35499154 NS +++ - ++ - FOXEl Around hair strong
compared to epidermis
898921 NS +++ - +++ -
Face lift NS ++ - ++ - FOXEl Around hair strong
compared to epidermis
Strong FOXEl staining was consistently observed in all Basal Cell Carcinoma (BeC)
n=8 and normal skin (N/S) n=3 samples examined. A control keratin 14 (KRT1-1)
expression was also detected with an antisense probe; this was used to verify the
integrity of mRNA. No samples were scored if they failed to show KRTl-l mRNA
expression, (+++ strong signal, ++ weak signal, + very weak signal, - no signal).
Sections were incubated with ~ 100ng FOXEl, T3 (anti sense) and T7 (sense) probe and
washed at 55°C, final wash at 60°C and 100ng KRTl-l, T7 (anti sense) and SP6 (sense)
probe washed at 50°C and final wash at 55°C.
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5.3.0 Discussion
In a search for potential downstream mediators of GLI2 function in epidermal cells a
new GLI2 target gene FOXEl was identified (by Dr Fritz Abergers' lab), which was
induced in response to GLI2 by binding GLI putative binding to GLI'binding motif in
the FOXEl promoter region (Eichberger et al., 2004). In this chapter I have shown the
localisation of FOXEl transcript which over laps with GLl2 expression (shown in
chapter 4) in human hair follicles, epidermis and BCC (Figure 5.1 and Figure 5.2).
This suggests a possible role of FOXEI in epidermal development and carcinogenesis
downstream of HH/GLI signalling. It is not clear if expression of FOXE I in
interfollicular epidermis is dependent on HH-signalling, whereas expression of HH
targets such as GLll and PTCH is mainly defined to follicular regions of the skin
(Chiang et al., 1999b; Ghali et al., 1999; Wang et al., 2000b). During formation of the
ventroposterior mesoderm in Xenopus, Gli2 expression is induced by fibroblast growth
factor (FGF) rather than HH-signalling (Brewster et al., 2000). Therefore, it is possible
that co-localisation of FOXEl and GLl2 in interfollicular epidermis may be controlled
by signals other than HH.
FOXE1 belongs to a large family of transcription factors which are characterised by
their DNA-binding domain, the forkhead/winged-helix motif. FOXEI is also named as
FKHL15/TTF2. The mechanism of FOXE1 action in vitro studies indicates that FOXE I
acts as a transcriptional repressor (Perrone et al., 2000; Zannini et al., 1997). Forkhead
proteins have been shown to be involved in variety of biological processes ranging from
embryonic development to regulation of cell growth and proliferation in adult tissues
(Carlsson and Mahlapuu, 2002; Kaufmann and Knochel, 1996). Expression of several
mammalian forkhead genes has been shown to be controlled by the HH/GLI signalling
pathway: Foxa2 (HNF-3j3) is expressed in the floor plate of the notochord; its
transcriptional activity is directly regulated by GLI1 (Sasaki et al., 1997). Foxc2 (Mfh I)
and Foxd2 (FREAC- 9/Mf2) are both involved in sclerotome cell proliferation
(Furumoto et al., 1999; Wu et al., 1998). Foxfl (FREAC-l/HFH-8) is involved in lung
and foregut mesenchyme development (Mahlapuu et al., 200 I), and FOX\II
(Trident/HFH-l1 /INS 1) is induced in human BCC (Teh et al.. 2002).
FOXE I was originally isolated from keratinocytes (Chadwick et al., 1997). its role in
epidermal development and homeostasis is not understood. FOX II TTF2 function has
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primarily been investigated in the context of thyroid development (Castanet et al.. 2002:
Clifton-Bligh et al., 1998; Damante et al., 2001; De Felice et al.. 1998; Zannini et al..
1997). Mice lacking both copies of foxel suffer from neonatal hypothyroidism
characterized by a sublingual small ectopic or completely missing thyroid gland and
cleft palate (De Felice et al., 1998). Patients with Bamforth syndrome \\ ho are
. ,
heterozygous for FOXEl, display in addition to thyroid agenesis a spiky hair phenotype
(Castanet et al., 2002; Clifton-Bligh et al., 1998). A corresponding hair phenotype is not
observed in Foxel-/- mice due to the fact that they die before hair formation (De Felice
et al., 1998). However, expression of Foxe 1 is observed in embryonic whiskers of wild
type mice (Dathan et al., 2002), this and the spiky hair phenotype of Bamforth patients
points to a role of Foxel in hair follicle development where Gli2 is essential (Mill et al.,
2003b).
The origin of BCC has been under debate for a very long time. While earlier evidence
favoured basal keratinocytes of the interfollicular epidermis, more recent data points to
the specialised cells within the hair follicle, analysis of the biomarkers in BCC suggest
that the tumour is derived from the cells of the outer root sheath (ORS) (Kruger et ai,
1999; Kurzen et al, 2001). Given the fact that GLI2, FOXEI and GLI1 are present in the
ORS and are found at high levels in BCC, a possible scenario for BCC development
may be that constitutive activation of HH-signalling in the ORS distorts differentiation
and promotes proliferation eventually leading to tumour formation.
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5.4.0 Summary
In this chapter a collaborate work with Dr Fritz Abergers' lab has shown that FOXEl is
a novel GLI2 target gene that is induced in human keratinocytes and I have shown
localisation of FOXEl in interfollicular epidermis that is specific to the basal. super
basal layers and to the outer root sheath but not in the underlying mesoderm in normal
skin (Figure 5.2). In BCC FOXEl is localised throughout the tumour islands (Figure
5.1).
5.5.0 Future study
Having characterized FOXEl as a novel GLI2 target gene in human keratinocytes, and
given the critical role of GLI2 in proliferation of hair follicle cells and tumorigenesis.
Co-expression of FOXE 1 and GLI2 in normal skin and BCC suggests that FOXE1 may
be involved in mediating the proliferative effect of GLI2 in-.... -ivo . Functional
investigation of FOXE 1 in epidermal development and disease will thus be a major aim
of future studies to shed new light on the molecular mechanisms downstream of the
HH/GLI signalling pathway.
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CHAPTER 6
Effects of EGF on Pattern of Gene Expression in GLII
expressing Keratinocytes
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6.1.0 Introduction
An interesting observation was made by Dr Graham Neill in the Centre for Cutaneous
Research laboratory when he cultured primary keratinocytes over expressing GLI I in
the presence of growth supplement in a defined growth medium, he noticed that these
cells had a changed morphology, from rounded cells to spindly phenotype. and the
colonies were more spread compared with (control cells) tightly packed EGFP primary
keartinocyte colonies. Dr Neill identified that EGF (Epidermal Growth Factor) in the
defined growth medium was causing this morphological change. It was hypothesised
that the change in cell morphology may have been due to cells undergoing epithelial-
mesenchymal transformation (EMT), where cells undergo a development change from a
epithelial phenotype to a highly motile fibroblast-like or mesenchymal phenotype. EI\ IT
plays a central role during embryonic development, as well as in cancer progression
(Balkwill, 2004; Grunert et al., 2003; Kalluri and Neilson, 2003: Nawshad et al., 2004:
Thiery, 2002; Thiery, 2003). GLII is also expressed in brain tumour (Glioblastoma)
(Kinzler et al., 1987) and neuronal cells have a spindly morphology thus it is possible
that these cells may be undergoing epithelial to neuronal differentiation. The other
possibility is that these cells are not transforming but are undergoing differentiation
which may be causing a change in morphology.
To investigate these hypotheses I identified from a literature search markers for EMT
(Vimentin, Snail, Snal2 and Alpha-Sma) (Barrallo-Gimeno and Nieto, 2005; Huber et
al., 2005; Lee et al., 2006; Radisky, 2005), neuronal markers, Nucleostemin, Nestin and
kinesin superfamily protein 4 (KIF4) (Dahlstrand et al., 1992; Kafienah et al., 2006:
Lendahl et al., 1990; Nagle, 1988; Schwartz et al., 2005; Sekine et al., 1994: Tsai and
McKay, 2002; Wislet-Gendebien et al., 2004), keratinocyte differentiation markers,
involucrin, loricrin and keratin K10 (Fuchs and Green, 1980; Ghahary et al., 200I:
Hohl, 1993; Hohl et al., 1991; Leigh et al., 1993), basal keratinocytes markers keratin
K5 and keratin K14 (Fuchs and Green, 1980), simple epithelial markers keratin K8 and
keratin K18 (Eckert, 1988; Moll et al., 1990: Moll et al., 1993). keratinocyte stem cell
markers keratin K15 and keratin K19 (Lyle et al., 1998a; Michel et al., 1996b) and
keratinocytc activation marker keratin K17 (Freedberg et al., 200 I). In order t,)
understand the interaction between the EGF and the HH-signalling pathwax I also
compared the expression of HH signalling markers GLIL GLI2. S\IO and I)ICH
(Villavicencio et al., 2000).
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The actin cytoskeleton is highly flexible structure that undergoes both transient and
permanent changes in the course of normal development and in response to extra
cellular signals. Remodeling of the actin cytoskeleton is involved in cell division,
growth, adhesion, and locomotion. This rearrangement of the actin cytoskeleton is
highly influenced by the activity of Rho family GTPases (Etienne-Manneville and Hall,
2002; Hall and Nobes, 2000). Rho GTPases are molecular switches that cycle between
two conformational states: a GTP-bound (active) state and a GDP-bound (inactive) state
to control intercellular signaling. The transition between these two conformations is
tightly regulated by three classes of proteins; 1) GTPase activating proteins (GAPs)
stimulate the intrinsic GTPase activity, thereby pushing the switch towards the inactive
state. 2) Guanine nucleotide dissociation inhibitors (GDls) keep the GTPase in the GOP
bound inactive conformation. 3) Guanine nucleotide exchange factors (GEFs) which
facilitate the exchange of GDP for GTP, thus activating RhoGTPases (Etienne-
Manneville and Hall, 2002; Hall, 1998). One well-studied family of GEFs for Rho
GTPases is the VAV family of proteins. VAVI was the first member isolated in a
hematopoietic cells and is primari Iy expressed in hematopoietic lineages, while other
mammalian VAV proteins VAV2 is ubiquitously expressed and VAV3 has a broad but
different expression profile compared to that of VAV2 (Bustelo, 1996; Bustelo, 2000;
Katzav et al., 1995; Schuebel et al., 1996; Trenkle et al., 2000). Due to VAV family of
proteins involvement in cytoskeleton remodelling and our attempts to understand the
molecular mechanism that may be leading to the spindly phenotype of over expressing
GLI I primary keratinocytes cultured with EGF (observed in section 6.2.1). I decided to
verify Asymetrix data for VAV3 protein only and not the remaining genes identified in
the Affymetrix data.
The aim of this study was to investigate differentially expressed genes in GLI I-primary
keratinocytes cultured without growth supplement (GLII-GS) and with EGF
(GLll +EGF) and in EGFP-primary keratinocytes cultured with EGF (EGFP+EGF)
relative to control EGFP-primary keratinocytes cultured without growth supplements
(EGFP-GS), using real-time RT-PCR and Affymetrix analyses.
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6.2.0 Materials and Methods.
For more detailed methods and materials see chapter 2, here is a brieflly summary of
methods and materials. Primary keratinocytes and immortalised N-TERT keratinocytes
were seeded at 1x l 05 cells per well in 6-well plates with growth supplements (GS) in
defined keratinocyte culture medium (Cat No 10744-019 Invitrogen) and incubated at
37°C in 100/0 CO2 900/0 air (v/v) for 16-18 h. Primary keratinocytes cells were then
transduced with retroviral particles encoding SIN-EGFP-GLII (GLI1), SIN-EGFP
(EGFP), SIN-EGFP-GLIl-muted Nuclear Localisation Signal (GLIl-mNLS) and SIN-
EGFP-GLI l-muted Nuclear Export Signal (GLIl-mNES) in triplicates per plate. The
immortalised N-TERT keratinocytes were also transduced with GLI1, EGFP and GLI 1-
mNLS in triplicates. Post-transduction, cells were incubated for 24 h with GS and then
for another 24 h without GS. After 48 h, the media was replaced with 10 ng/ml EGF
(Cat No E 9644 Sigma) and without growth supplement (-GS) media and incubated at
37°C in 100/0 CO2 900/0 air (v/v) for 24 h. EGFP and change in cell morphology was
visualised using a light microscope. From one set of 6 well plates for EGF and -GS total
RNA was extracted for gene expression analysis, from a sec set of 6 well plates for EGF
and -GS cell lysate was harvested for western blot analysis.
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6.3.0 Results
6.3.1 Cell morphology of GLIl-primary keratinocytes changes in presence of EGF.
GLI l-primary keratinocytes cultured in the presence of growth supplement in defined
growth medium have a changed morphology from rounded cell to spindly phenotype
and the colonies were more spread compared to control cells (EGFP-primary
keratinocytes cultured with growth supplement and GLIl-primary keratinocyte cultured
without growth supplement) Figure 6.1 A. Growth supplement contains certain growth
factors to maintain cell growth, so we investigated the effects of Epidermal Growth
Factor (EGF) on GLIl and EGFP transduced primary keratinocytes. When GLII
primary keratinocytes were cultured with EGF we observed the same phenotype change
as with growth supplement in GLI l-primary keratinocytes and in EGFP-primar)
keratinocytes (control cells) Figure 6.1 and Figure 6.2. Fluorescence microscopy also
showed that when GLI l-primary keratinocytes where exposed to EGF, GLII was
predominantly located in the cytoplasm as opposed to the nucleus (Figure 6.1). It was
also observed that when EGF growth factor was depleted the cell morphology of these
cells reverted to that of control cells. These results indicated that in the presence of EGF
changes the morphology of primary keratinocytes and the localisation of GLII from
nucleus to the cytoplasm may be the mechanism EGF is using to control transcriptional
activity of GLI I in primary keratinocytes.
GLlI-mNLS-primary keratinocytes cultured with EGF showed localisation of GLlI-
mNLS was predominantly in the cytoplasm and the morphology of these cells was
rounded (Figure 6.3) and the same as that of EGFP-primary keratinocytes cultured with
EGF (Figure 6.2). Primary keratinocytes transduced with GLlI-mNES showed the
expression of GLI I-mNES was mainly in the nucleus and the phenotype of these cells
was spindly (Figure 6.3) and the same as that for GLIl-primary keratinocytes cultured
with EGF (Figure6.2). GLI I transcription factor was expected to be active in the
nucleus and these results indicate that nuclear localisation of GLII plays an important
part in changing the phenotype of GLI I-primary keratinocytes in presence of EG F.
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A
EGFP/GLIl-GS EGFP/GLIl+GS
B
EGFP/GLIllocalisation in primary keratinocytes -GS
Figure 6.1: Change in EGFP-GLI I-primary keratinocyte cell morphology when cultured
with growth supplement. (A right) shows the change in EGFP-GLIl -primary keratinocyte
cell morphology to spindly cells with spread colonies when cultured with growth
supplement (EGFP/GLIl +GS). The control cells (A left) EGFP-primary keratinocytes
cultured with growth supplement and (A middle) EGFP/GLIl -primary keratinocytes
cultured without growth supplements (EGFP/GLIl -GS) have rounded cell morphology
with packed colonies. This indicates that GLIl causes a change in cell morphology of
primary keratinocyte in presence of growth supplement. B left showing the localisation of
EGFP/GLII in primary keratinocytes cultured without growth supplement is nuclear and
cytoplasmic and (B) middle showing cytoplasmic localisation of EGFP/GLI 1 i punctuate
and B right shows nuclear expression of EGFP/GLI.
loham mcd lkrarn
CHAPTER 6 Effects of EG F on Pattern of Gene Exp ression in GLll over expre sing K rat 10C. tes
EGFP/GLII+EGF
Figure 6.2: Expression of EGFP/GLIl in primary keratinocytes cultured with EGF and the
change in cell morphology of these cells . Top left shows the expression of EGFP in EGFP-
primary keratinocytes cultured with epidermal growth factor (EGF) right shows the
morphology of these cells is rounded and colonies are compact. Bottom left shov
expression appeared to be diffused through out the cell of EGFP/GLII in EGFP/GLI1-
primary keratinocytes cultured with EGF. Bottom right shows a change in EGFP/GLI1-
primary keratinocytes morphology from round to spindly and the colonies are mor pread
when cultured with EGF. This suggests that GLII with EGF i cau ing a morphologi al
change in primary keratinocytes.
Moharnm d.. lkrarn
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EGFP/GLI1 mNES+EGF
Figure 6.3: Expression of EGFP/GLII that has mutated Nuclear Localisation Signal
(EGFP/GLIlmNLS) in primary keratinocytes cultured with EGF. Top left shows the
expression EGFP/GLII that has mutated Nuclear Localisation Signal (EGFP/GLIlm LS)
is cytoplasmic in EGFP/GLIlmNLS-primary keratinocytes cultured with epidermal growth
factor (EGF), top right shows that the morphology of these cells is rounded. Bottom left
shows that the expression of EGFP/GLII that has a mutated Nuclear Export ignal
(EGFP/GLIlmNES) is in the nucleus in EGFP/GLIlmNES -primary keratinocyte cultured
with EGF, bottom right shows that the morphology of these cells is spindly. Thi indicat
that localisation of GLII to the nucleus is required in order to change the phenotyp f
primary keratinocytes that are expressing GLII in the pre ence of EGF from rounded t
spindly.
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6.3.2 Determining the expression of hedgehog, keratinocyte differentiation,
mesenchymal, and stem cell markers in GLIl-primary keratinocytes cultured with
EGF.
In order to understand the interaction between GLII and EGF and determine the cause
of morphology change observed in section 6.2.1 in GLI l-primary keratinocytes
cultured with EGF. The following gene primers were designed; Vimentin, Snail I.
Snail2 and Alpha-Sma (markers for epithelial-mesenchymal-transition [EMT]), Nestin,
Nucleostemin Kinesin superfamily protein 4 (KlF4) (markers for Nuronal cells),
Involucrin, Loricin and KRT10 (markers for kartinocyte differentiation), KRT1-l and
KRT5 (markers for basal keratinocyte), KRT8 and KRT19 (simple epithelial markers).
KRT15 and KRT19 (keratinocyte stem cell markers); KRT17 /kerarinocytc activation
marker), GIIl, GII2, SMO and PTCH (HH-signalling markers) and ~-Actin.
Expression of these genes was investigated using RT-PCR analysis with first strand
cDNA reaction synthesised from total RNA extracted from GLII-GS, GLiI +EGF,
EGFP+EGF and EGFP-GS primary keratinocytes. PCR products generated from these
set of primers were run on 1% (w/v) agarose and, the gel was analysed under UV. A
control PCR reaction was also set up with genomic DNA and the results tabulated
(Table 6.1).
The primers that did not generate any PCR product from genomic DNA and cDNA
(even after changing template concentration, annealing temperature and magnesium
concentrations of PCR reaction) were Snail (mesenchymal marker), Nucleostemin
(Neuronal marker), KRT10 Table 6.1. The reason these primers did not show any peR
products may have been due to the fact that these genes were not expressed in these
cells, it is also possible that these primers may have been of poor quality or design and
thus they did not work. PCR product expected from the genomic DNA was same size as
that from cDNA or of larger size if the primers span the intron exon boundaries and if
intron was greater then 3-5 kb we may not have generated a PCR product from these
sets of primers due to large size of the product. For Nestin there was a PCR product
from the genomic DNA but no product from the cDNA and negative control sample
(cDNA reaction set up with out reverse transcriptase [-RT]) Table 6.1. This indicates
that the primers for Nestin worked but the Nestin was not expressed in these cells.. \ s I
had designed several primers for EMT. neuronal differentiation, neuronal, keratinoc, tc
differentiation. basal keratinocyte. simple epithelial, kcratinocy te stem cell and HII-
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signalling genes, the primers that did not work were not redesigned. There were no PCR
products observed for any of the primer sets used in the negative -RT control samples
(Table 6.1).
RT-PCR data indicates that Snail2, Vimentin, Alpha-Sma, KRT15, Involucrin, Loricrin,
KRT1.:f, KRT8, KRT19, KRT17, PTCH, SMO, GLl2 and GIl] and Beta-Actin (control)
were all expressed in GLIl-GS, GLll +EGF, EGFP-GS and EGFP+EGF primary
keratinocytes. GIIl was only expressed in GLII-GS and GLI1+EGF pnmary
keratinocytes (Table 6.1). Lorcrin seems to have been expressed at lower levels in
EGFP+EGF and GLI1+EGF primary keratinocytes indicated by weak lorcrin bands
observed in these cell lanes compared with EGFP-GS and GLII-GS primary
keratinocytes lanes whereas, Beta-Actin bands were of equal intensity in all these cell
lanes (Table 6.1). This suggests that lorcrin may be repressed in presence of EGF in
GLII and EGFP (control) primary keratinocytes. KRT5 primer set generated multiple
bands as well as the expected band, this suggests that these primers may be amplifying
some other transcripts, due to this furthers analysis of KRT5 expression was not
determined in these cell lines. To determine if the genes identified by RT-PCR analysis
were up or down regulated relative to control cells a relative quantification analysis was
carried out using real-time RT-PCR.
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Table 6.1: PCR products amplified from cDNA from GLII and EGFP (control) transduced
primary keratinocyte cultured without growth supplement (-GS) and with EGF (+EGF)
using different primer sets for each gene and the biological function of each marker gene.
The intensity of the bands for each PCR product was scored as follows +++ = strong band
++ = weak band, - = no PCR product and m = multiple bands observed on a 1% agaro e
gel. The transcripts analysed were expressed in all cells except for KRT10, KRT15,
Nucleostemin, Nestin and Snail l , Loricrin expression may have been reduced by EGF as
indicated by low intensity bands observed in GLII and EGFP keratinocytes cultured with
EGF.
Primers for Biological marker the gene was used eDNA samples Genomic -ve
for GLI1- GLII EGFP EGFP D A control
GS +EGF -GS +EGF -RT
PTCH Hedgehog signalling +++ +++ +++ +++ +++ -
SMO Hedgehog signalling +++ +++ +++ +++ +++ -
GLII Hedgehog signalling +++ +++ - - +++ -
GLI2 Hedgehog signalling +++ +++ +++ +++ +++ -
GLI3 Hedgehog signalling +++ +++ +++ +++ +++ -
Keratin 14 Basal Keratinocyte (and expressed in BeC) +++ +++ +++ +++ +++ -
Keratin 5 Basal Keratinocyte (and expressed in BCC) +++ (rn) +++ (rn) +++ +++ +++ (m) -
Keratin 17 keratinocyte activation (and expressed in +++ +++ +++ +++ +++ -
BCC)
Keratin 19 Simple epithelial +++ +++ +++ +++ +++ -
Keratin 8 Simple epithelial +++ +++ +++ +++ +++ -
Involucrin Keratinocyte differentiation marker +++ +++ +++ +++ +++ -
Loricin Keratinocyte differentiation marker +++ +++ +++ -
Keratin 10 Keratinocyte differentiation marker (and - - - - - -
expressed in BCC)
Keratin 15 Stem cell marker +++ +++ +++ +++ +++ -
Nucleosternin Stem cell in central nervus sytem - - - - - -
Nestin Neuroepithelial stem cells - - - - +++ -
KIF4 Kinesin superfamily protein 4 (KIF4) +++ +++ +++ +++ +++ -
expressed in differentiated neurons
Vimentin Mesenchymal marker +++ +++ +++ +++ +++ -
SnaIl Mesenchymal marker. A transcriptional - - - - - -
repressor that down regulates E-cadherin.
Mesenchymal marker. A transcriptional +++ +++ +++ +++ +++ -Snal2 (Slug)
renressor that down reaulates E-cadherin.
Structural marker: Expressed in +++ +++ +++ +++ +++ -Alpha -Sma
mesenchymal cells.
Structural marker +++ +++ +++ ~ -B-Actin
lohammed..' .Ikr am
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6.3.3 EGF reduces PTCH, GLl2 and SMO expression and restores GIl3 expression
to control levels whereas GLII represses GLl3 expression.
Real Time RT-PCR analysis was carried out using HH gene specific primers described
in section 6.3.2 and using the SYBR green kit and first strand cDNA reaction from
GLI I-GS, GLI 1+EGF, EGFP+EGF and control EGFP-GS samples. The fold induction
or repression for each gene was calculated relative to EGFP-GS. The base line
expression value for each gene analysed in control cells (EGFP-GS) was 1. Therefore,
values above 1 indicate induction in expression and values below 1 indicate repression
(Table 6.2). The fold induction or repression data was plotted using log2 scale and a
graphical representation of this is shown in Figure 604.
GLJI expression was induced in GLII-GS and GLI1+EGF cells and there was very little
difference in expression of GLJI in these cell lines. There was no GLIl expression
observed in EGFP+EGF and control EGFP-GS cells (Figure 6.4.). This indicates that in
presence of EGF there seems to be no change in GLIl expression in GLll expressing
primary keratinocytes. GLl2 and PTCH expression was induced in GLII-GS and
repressed in GLI 1+EGF cells (Figure 6.4). There was no change in SMO expression in
GLI I-GS and in GLI1+EGF cells SMO expression was reduced relative to control cells
(EGFP-GS) (Figure 6.4). GLl3 expression was reduced in GLII-GS cells and in
GLI1+EGF cells GLl3 levels were similar to those of control cells (Figure 604). There
was a small induction in GLl2 expression. However, GLI3, PTCH, SMO expression
was reduced in EGFP+EGF primary keratinocytes relative to controls cells (Figure
6.4). SMO repression in presence of both GLll and EGF was less than that for EGF on
its own (Figure 6.4). GLl3 expression was reduced by GLll and EGF and when both
were present the levels appears to revert back to control levels (Figure 604). These
results suggest that EGF pathway interacts with HH signalling pathway and represses
expression of GLl2 and PTCH genes that are targets of GLII (Agren et al.. 2004;
Marigo et al., 1996b; Regl et a\., 2002; Toftgard, 2000). The data also suggest that EGF
may be reducing the expression of SMO, that is an activator, and inducing GL13, that is
repressor (Murone et al., 1999; von Mering and Basler. 1999) of HH pathway in order
to regulate this pathway.
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Cells transduced with GLIl and EGFP and cultured with and without EGF
Figure 6.4: Real-time RT-PCR analysis showing induction or repression of GIll, GII2,
GLI3, Patched (PTell) and Smoothend (SMO) in GLI1, EGFP transduced primary
keratinocytes cultured without growth supplement (-GS) and with epidermal growth factor.
(+EGF) relative to control cells (EGFP primary keratinocytes cultured without growth
supplement [EGFP-GSJ).
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6.3.4. GLIl induces expression of KRT17, KRT14, KRT19 and repress the
expression of KIF4, whereas EGF reduces this induction and repression.
The primers that had worked in section 6.2.2 were used in real-time RT-PCR anal. sis.
However, not all the primers worked with SYBR green kit, even after changing the
reaction conditions such as MgCb, template, annealing temperature and C) cIe numbers.
Thus real-time RT-PCR analysis was carried out using the primers that did work with
SYBR green kit with the first strand cDNA reaction from GLI I-primary keratinoc, res
cultured without growth supplement and with EGF and from control samples (EGFP-
primary keratinocytes cultured without growth supplement and with EGF).
KRT17 a keratinocyte activation marker, KRT14 a basal cell marker and keratin KRT19
a simple epithelial marker were induced in GLII-primary keratinocytes cultured without
growth supplement and with EGF expression was reduced to similar levels to that seen
in EGFP-primary keratinocytes cultured with EGF (Figure 6.5). If \\e compare
expression of KRT17, KRT14 and KRT19 in EGFP-primary keratinocytes cultured with
EGF and without growth supplement, expression of KRT17 was reduced, whereas
expression of KRT14 and KRT19 was induced by EGF (Figure 6.5).These results
suggest that GLI I may be activating keratinocytes and inducing basal and simple
epithelia markers and EGF reduces these to that of control cells (EGFP-primary
keratinocytes cultured with EGF).
Expression of kinesin superfamily protein 4 (KIF-I) was reduced in GLII-primary
keratinocytes cultured without growth supplement and when EGF was added there was
no change in expression of KIF-I. The reduction in expression of KIF-I was less in
EGFP-primary keratinocytes cultured with EGF compared to that of GLlI-primary
keratinocytes cultured without or with EGF (Figure 6.5). Thus both GLII and EGF
alone repress expression of KIF4. However, EGF repression is less than that seen for
GLI I and GLII plus EGF.
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Fugure 6.5: Real-time RT-PCR analysis showing induction or repression of keratins
KRT14 , KRT17, KRT19 and kinesin superfamily protein 4 (KlF4) in GLIl , EGFP
transduced primary keratinocytes cultured without growth supplemen (-GS) and with
epidermal growth factor (+EGF) relative to control EGFP primary keratinocytes cultured
without growth supplement [EGFP-GSJ) cells.
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6.3.5. GLII represses and EGF induces expression of Vimentin and Snail2
transcripts.
Expression of Vimentin and Snali2 mesenchymal markers was reduced in GLI 1-
primary keratinocytes cultured without growth supplement and when EGF was added to
these cells there was an induction in expression of Vimentin and Snail2. There was
more induction of Vimentin and Snail2 in EGFP-primary keratinocytes cultured with
EGF compared with that observed for GLll-primary keratinocytes cultured with EGF
(Figure 6.6). Therefore EGF on its own and in the presence of GLII may be inducing
mesenchymal transition in primary keratinocytes.
6.3.6 Determining expression of Vimentin, E-Cadherine, EGFR and keratin K14
proteins in GLIl primary keratinocytes cultured with and without EGF.
In order to determine if changes in mRNA levels of keratin K14 (basal cell marker) and
vimentin (EMT marker) observed in section 6.2.4 and 6.6.5 correlate to changes in
protein levels, a western blot analysis was carried out using antibodies for vimentin and
keratin 14. Protein expression of E-Cadherin is downregulated in classical EMT (Lee et
aI., 2006; Lu et aI., 2003; Strizzi et al., 2004) and epidermal growth factor receptor
(EGFR) which is down regulated upon EGF stimulation (Groves et al., 1992; Nazmi et
aI., 1990) was also determined in GLI1- and EGFP-primary keratinocytes culture with
EGF and without growth supplement.
Vimentin was only expressed in EGFP+EGF lane, E-Cadherin and K14 were expressed
in all cell lanes. EGFR was expressed in all cell lanes. However, its levels wcre reduced
in EGFP+EGF lane and further reduced in EGFP-GLI1+EGF lane (Figure 6.7). The
vimentin results suggest that EGF induces EMT and GLII opposes it. However, there
was no change in E-Cadherin protein levels in GLII-GS, GLI1+EGF, EGFP+EGF and
control (EGFP-GS) cells which may argue against EMT taking place. Vimentin
expression data corresponds with the real-time RT-PCR data in which Vimentin \\ as
induced in EGFP+EGF cells only. Although KRTl-l transcript levels were induced in
GLlI-GS, GLI 1+EGF and in EGFP+EGF relative to control cells (EGFP-GS). K14
protein levels were the same (Figure 6.7).
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Figure 6.6: Real-time RT-PCR analysis showing induction or repression vimentin (VIM)
and Snail2 (SNAI2) in GLIl, EGFP transduced primary keratinocytes cultured without
growth supplement (-GS) and with epidermal growth factor (+EGF) relative to control
EGFP primary keratinocytes cultured without growth supplement [EGFP-GS]) cells.
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Table 6.2: Real-time-RT-PCR analysis showing relative fold induction or repression of
GLll, GLI2, GLI3, patched (PTCH) , vimentin (VIM), Snail2, keratins KRTl9, KRTl7.
KRTl4, smoothend (SMO) and Kinesin superfamily protein 4 (KIF4) in GLIl-primary
keratinocytes cultured without growth supplement (-GS) and GLll, EGFP primary
keratinocytes cultured with EGF (+EGF) relative to control (EGFP primary keratinocytes
cultured without growth supplement).
cDNA Fold mRNA induction or repression
Sample
GLl1 GLl2 GLl3 PTCH SMO KIF4 K17 K14 K19 Vim Snal2
GLl1-GS 92425 13.39 0.17 22.435 1.109 6E-05 1.21 138.1 38.11 0.196 0.271
GLl1+EGF 109028 0.382 1.21 1.403 0.072 6E-05 0.55 13.37 2.098 1.638 1.398
EGFP+EGF 0.957 1.327 0.29 0.268 0.001 0.143 0.4 28.81 1.7 16.83 2.352
EGFP-GS 1 1 1 1 1 1 1 1 1 1 1
Standard deviation
GLl1 GLl2 GLl3 PTCH SMO KIF4 K17 K14 K19 Vim Snal2
GLl1-GS 0.242 0.634 0.71 0.675 0.672 0.786 0.88 0.763 0.981 0.504 0.22
GLl1+EGF 0.341 0.756 0.51 0.595 0.489 0.474 0.39 0.45 0.352 0.739 0.382
EGFP+EGF 0.51 0.835 0.97 0.395 0.934 0.797 0.81 0.878 0.892 0.823 0.925
EGFP-GS 1 1 1 1 1 1 1 1 1 1 1
Log2 fold mRNA induction or repression
GLl1 GLl2 GLl3 PTCH SMO KIF4 K17 K14 K19 Vim Snal2
GLl1-GS 16.496 3.744 -2.5 4.488 0.149 -14 0.27 7.11 5.252 -2.35 -1.886
GLl1+EGF 16.734 -1.39 0.27 0.489 -3.8 -14 -0.87 3.741 1.069 0.712 0.483
EGFP+EGF -0.064 0.408 -1.8 -1.897 -9.664 -2.81 -1.32 4.849 0.766 4.073 1.234
EGFP-GS 0 0 0 0 0 0 0 0 0 0 0
Log2 Standard deviation
GLl1 GLl2 GLl3 PTCH SMO KIF4 K17 K14 K19 Vim Snal2
GLl1-GS -2.047 -0.66 -0.5 -0.567 -0.573 -0.35 -0.19 -0.39 -0.33 -0.99 -2.186
GLl1+EGF -1.553 -0.4 -1 -0.75 -1.032 -1.08 -1.37 -1.15 -1.51 -0.44 -1.387
EGFP+EGF -0.971 -0.26 -0 -1.342 -0.098 -0.33 -0.31 -0.19 -0.17 -0.28 -0.112
EGFP-GS 0 0 0 0 0 0 0 0 0 0 0
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Figure 6.7: Western blot showing expression of vimentin, E-cadherin, Epidermal growth
factor receptor (EGFR), Keratin K14, GLII and EGFP in EGFP transduc ed primary
keratinocytes cultured without growth supplement (EGFP-GS), EGFP transduced primary
keratinocytes cultured with EGF (EGFP+EGF), GLII transduced primary keratinocytes
cultured without growth supplement (EGFP-GLIl-GS) and GLII transduced primary
keratinocytes cultured with EGF (EGFP-GLII +EGF). Vimentin is only expressed in
EGFP+EGF cells. EGFR protein expression is reduced in EGFP+EGF and there i greater
reduction in GLII +EGF cell line. There is no change in keratin 14 and E- adh rin
expression. GLII is only expressed in EGFP-GLIl-GS/+EGF cell lines. EGFP \ a
expressed in all cell lines . However, there appears to be a small induction in GLI1 and
EGFP with EGF this may be due to increase in reporter activity.
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6.3.7 Identification of differentially expressed genes in GLIl-primary
keratinocytes cultured with and without EGF.
In order to understand the spindly phenotype of overexpressing GLII primary
keratinocytes cultured with EGF observed in section 6.3.1, Affymetrix gene arrays were
used to determine differentially expressed genes in GLI I-primary keratinocytes cultured
without growth supplement and with EGF relative to control cells (EGFP-primar)
keratinocytes cultured without growth supplement). Affymetrix analysis was carried out
on one sample of each cell type and data obtained was analysed using a Gene Spring
computer programme (Silicongenetica).
Initially scatter plots of EGFP-primary keratinocytes cultured with EGF (EGFP+EGF),
GLII-primary keratinocytes cultured without growth supplement (GLlI-GS) verses
control EGFP-primary keratinocytes cultured without growth supplement (EGFP-GS)
were compared. The scatter plot data showed that there was no difference in gene
expression pattern between EGFP+EGF verses EGFP-GS and GLlI-GS verses EGFP-
GS. However, there was a change in scatter plot expression pattern of GLil +EGF
verses EGFP-GS cells Figure 6.8. The scatter plot of GLII +EGF cells verses EGFP-GS
indicates that genes that are expressed in EGFP-GS cells are repressed in GLiI +EGF
cells. This suggests that there is a greater change in gene expression pattern in
GLI1+EGF compared to GLII and EGF on their, own. In order to only identify
differentially expressed genes, the affymetrix data was filtered by selecting the genes
that were above 5 fold and below 5 fold lines on the scatter plot. Further parameters
were selected on the Gene Spring computer program and these are as follows; flags
present (P) marginal (M) were selected in lout of 4 samples, data transformation set
measurements selected were less than 0.01 to 0.01. Per chip were normalized to 50th
percentile and per gene were normalized to median. The expression values for each
gene obtained for each sample from the Gene Spring programme analysis were analysed
as follows; values ofGLII-GS, GLII+EGF and EGFP+EGF were divided by EGFP-GS
values. A total of 156 genes were identified that were deferentially expressed and are
listed in Appendix I. 106 genes were induced and 50 genes were repressed in GLlI-
primary keratinocytes cultured without growth supplement and \\ hen EGF \\ as added
96 genes were induced and 60 genes were repressed. In EGFP-primary keratinocy tcs
cultured with EGF 8.+ genes were induced and 72 repressed (Appendix 1).
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Figure 6.8: Expression profile of scatter plot of EGFP/GLIl-primary keratinocytes
cultured without growth supplement and with EGF. (A) EGFP-primary keratinocytes
cultured with EGF (+EGF) vs EGFP-primary keratinocytes cultured without growth
supplement (-GS), scatter plot (B) GLIl-primary keratinocytes -GS vs EGFP-primary
keratinocytes -GS, scatter plot (C) GLIl-primary keratinocytes +EGF vs EGFP-primary
keratinocytes -GS. The expression profile of scatter plot (C) is remarkably different to that
of scatter plots A and B. This indicates that there may be more genes differentially
expressed in GLIl-primary keratinocytes cultured with EGF compared to GLIl -primary
keratinocytes -GS and EGFP-primary keratinocytes +EGF controls. Only genes abo e and
below 5 fold lanes indicated on the scatter plots were selected for further analysi
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6.3.8 Comparing real-time RT-PCR and Affymetrix data for GLIl GLl2 GLl3
PTe, Vimentin, Snail2, KRTl9, KRTl7, KRTl4 and SMO in GLIl-~rima";' ,
keratinocytes cultured with EGF. .
The data obtained for real-time-RT-PCR for GLll, GLl2, GLl3, PTCH, vimentin.
snail2, (KRT19), KRT17 and SMO (section 6.3.4 and 6.3.5) was compared with the data
obtained from Affymetrix expression analysis to see if they correlate.
The expression values for GLll, GL12, GLl3, PTCH, vimentin, snail2, KRTI9. KRTI-
and SMO were obtained from the Affymetrix data. The fold induction or repression was
calculated as follows
Fold change = Delta A (sample) - Delta B (control)
Delta A represents expression value of a given gene for the sample minus expression
value of ~-Actin for that sample. Delta B represents the expression value of a given
gene for the control sample minus expression value of Beta-Actin for the control
sample.
Comparing the real-time-RT-PCR (Figure 6.4, Figure 6.5 and Figure 6.6) and
Affymetrix expression data (Figure 6.9) fold induction or repression of a given gene,
there was a discrepancy between the two graphs. For example in GLlI-GS cell line
GLl3 expression was up with Affymetrix and down with real-time-RT-PCR relative to
control (EGFP-GS) cells. In GLI 1+EGF cells GLII and GLI3 expression was down
with Affymetrix and up with real-time-RT-PCR. In EGFP+EGF cells, KRTI-l
expression with Affymetrix data was down and up with real-time-RT-PCR. For the rest
of the genes the value of fold induction or repression varies but the trends are the same
(that is up or down).
The real-time-RT-PCR data was from duplicate experiments in triplicates assays and the
Affymetrix data was from a single experiment with a single assay. Therefore, the values
for some of the genes may be false. It is also possible that the sensiti\ity of each assax
being different and thus there is discrepancy, although for most of the ~elles the
expression trend is the same for both Affymetrix and real-time-RT-PCR assay Another
explanation for this discrepancy clould have been, that the) ield of cR~:\ e\peded from
1\1 ol1<1 111111 cd. ".1kr.irn
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1Oug total RNA was expected to be 40-80 ug; if the yield of cRNA is less than -+0 ug it
is recommended not to be used in affymetrix analysis, as there is likely to be a problem
with cRNA preparation.
The yield of cRNA obtained was 10.5-14.5 ug from 7 ug total RNA which was below
the recommended levels. After consultation with the Affymetrix operator. it was
decided to run the fragmented cRNA samples on a test chip before running them on the
Affymetrix chip. The results obtained from test chips were of adequate quality and on
the recommendation of the Affymetrix operator the samples were run on the Affyrnetrix
chips. It is also possible that the discrepancy between real-time RT-PCR and the
Affymetrix assay may have been due to these factors. However, Affymetrix analysis
was used as a quick guide to identify key genes or pathways for further study and was
not intended as a define end point in itself.
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Figure 6.9: Affymetrix expression analysis of GLIl , GLI2, PTCH, vimentin (VIM), snail2
(SNAI2) , keratins KRTl9, KRTl7, KRTl4, smoothend (SMO) and GLl3 in GLIl , EGFP
transduced primarykeratinocytes cultured without growth supplement (-GS) and with EGF
(+EGF).
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6.3.9 VAV2, VAV3 and VAV3.1 are expressed in GLIl- primary keratinocvtes
cultured with and without EGF. .
Differentially expressed genes identified with Affymetrix analysis needed to be verified
using real-time-RT-PCR anaysis. Due to time constraint I only selected one gene
identified in the list generated from the Affymetrix analysis (Appendix 1) to verify
using real-time RT-PCR analysis. This was the VAV3 oncogene. The rational for
choosing VAV gene was due to its role in the Rho signalling pathway (Hornstein et al.,
2004). Rho signalling is involved in cytoskeleton remodelling (Etienne-Manneville and
Hall, 2002; Hall and Nobes, 2000). Therefore, this may explain the molecular
mechanism that may lead to the spindly phenotype of overexpressing GLII primary
keratinocytes cultured with EGF (see section 6.2.1.
In the Affymetrix data (Appendix 1) VAV3 was induced in GLII-primary keratinocytes
cultured without growth supplement and when EGF was added to these cells it was
repressed. There was further reduction of VAV3 in control cells (EGFP transduced
primary keratinocytes) cultured with EGF. This indicates that GLII induces, and EGF
reduces VA V3 expression in presence or absence of GLII.
In mammals, there are three family members of VAV proteins VAVI, VAV2, VAV3
and VAV3.I isoforms. VAVI is haematopoietic cell specific and VAV2, VAV3 and
VAV3.I are widely expressed in other tissue (Bustelo, 1996; Bustelo, 2000; Katzav et
aI., 1995; Schuebel et al., 1996; Trenkle et aI., 2000). Thus expression of VAV2, VA 1'3
and VAV3.1 was analysed using RT-PCR analysis, using published primers (Trenkle et
al., 2000) in GLII-and EGFP-primary keratinocytes cultured without growth
supplement and with EGF.
Figure 6.10 shows expression of VAV2, VAV3, VAV3.1 and ~-Actin in Gl.l l-and
EGFP-primary keratinocytes cultured without growth supplement and with EGF. There
was same intensity band was observed in all lanes for VA r'2, r'~4 V3. 1 and ~-Actin
(Control). A double band was observed for VAV3, the top band was around 660 bp
(expected size) and a smaller band around 400 bp. In all cell lanes the 600 bp band \\ as
of higher intensity then the 400 bp band. In Gl.I l-primary keratinocytcs cultured with
EGF and EGFP-primary keratinocytes cultured without growth supplement the 400 bp
band was of greater intensity compared to GLII-GS and EGFP-GS cells. The presence
151
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of a doublet band for VAV3 indicates that there may be alternative splice variant of
VAV3 in these keratinocytes, and this transcript may be expressed at different levels,
The band seen at around 400 bp could have been from a genomic contamination.
However, this is unlikely as the total RNA samples were treated with DNaseI to remove
genomic DNA and no bands were observed in control -RT lane. Also if there was
genomic contamination the band should have been same size as the expected band 600
bp, or it should have been larger then the expected band, if the primers expanded the
intron exon boundaries. Expression of VAV3 observed with RT-PCR analysis in all the
cell lines verified the Affymetrix data.
6.3.10 There is no change in VAV2 and VAV3.1 expression in GLIl-primary
keratinocytes cultured with EGF.
Due to two bands being obtained with the VAV3 primers in RT-PCR (section 6.2.9),
real-time RT-PCR was not carried out using VAV3 primers on cDNA from GLI1- and
EGFP-primary keratinocytes cultured with EGF and without growth supplement. This is
because SYBR Green dye used in the real-time-RT-PCR kit binds any double strand
DNA and this would not have been able to distinguish between the two bands and as
result would have given false results. Real-time-RT-PCR was carried out using VA V2
and VA V3.1 primers, the data from these primers indicates there was no change in VA J']
and VAV3.1 expression in GLI1- and EGFP-primary keratinocytes cultured with EGF
and without growth supplement (Figure 6.11, Table 6.3).
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Figure 6.10: RT-PCR analysis showing VAV2, VAV3, VAV3.1 and {3-Actin expression in
GLIl-primary keratinocytes cultured without growth supplement (GLIl-GS) and with EGF
(GLII +EGF), EGFP-primary keratnocytes cultured without growth supplement (EGFP-GS )
and with EGF (EGFP+EGF). For VAV3 there was a second band observed that was of
strong intensity in GLII +EGF and EGFP-GS lanes and very weak band in GLIl-GS and
EGFP+EGF lanes.
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Figure 6.11: Real-time-RT-PCR analysis indicating no change in VAV2 and VAV3.1
expression in GLIl- and EGFP-transduced primary keratinocytes culture without growth
supplement (GLIl-GS, EGFP-GS) and with EGF (GLII +EGF, EGFP+EGF) compared to
control cells (EGFP-primary keratinocytes culture without growth supplement [EGFP-
GSJ).
loh.immed, .lkt J 11
ell /\ Pl' ER 6 Effects of [(iF on Pattern of Cl'ne L.pr\.'ssioll in GLII over expressing Kcratinocv rc-.
6.3.11 GLII-N-TERT keratinocytes express VAV3.1 and not VAV3 and its
expression is lost when cultured with EGF.
VAV3,1 was repressed in immortal keratinocytes (HaCat) when they were cultured with
EGF (Trenkle et aI., 2000). Due to shortage of primary keratinocytes during the course
of this study immortalised N/TERT keratinocytes were used to determine the effect of
GLII and EGF on expression of VAV3.1 in. N/TERT keratinocytes were transduced
with GLIl-mutated-Nuclear-Localisation-Signal (mNLS) and GLII retroviruses and
cultured with EGF and without growth supplement. We observed the same spindly
phenotype in GLII-N/TERT keratinocytes cultured with EGF as those observed for
GLI I-primary keratinocytes cultured with EGF. GLII and GLll-mNlS N-TERT
keratinocytes cultured with EGF and without growth supplement were analysis for
expression of VAV2, VAV3 and VAV3.1.
There was no VAV3 expression in GLII-GS, GLII+EGF, GlI I-mNlS-GS and GLlI-
mNLS+EGF N/TERT keratinocytes. However, VAV2, VAV3.] and ~-Actin (control)
were expressed in these shown in Figure 6.12. This suggests that N/TERT
keratinocytes only express VAV3.1 transcript and not VA V3 and these contrasts with
primary keratinocytes that express VAV3 and VAV3.1 (Figure 6.10).
6.3.12 GLIl induces VA V3.1 and VAV2 expression in N/TERT keratinocytes and
EGF represses this induction.
In N/TERT keratinocytes VAV3.1 expression was induced in GLII-GS and in
GLI I+EGF cells there was no change relative to GlIl-mNLS-GS (control) cells in a
real-time-RT-PCR analysis (Figure 6.13). However, there was a complete repression of
VA V3.1 in GLII-mNLS+EGF cells (Figure 6.12 and Figure 1.3). There was only a
small induction of VAV2 expression in GLII-GS cells and when EGF was added this
induction appears to be reduced (Figure 6.13, Table 6.3). In GLlI+EGF. GLlI-
mNLS+EGF cells there was no change in VA V2 expression relative to control cells
(GLIl-mNLS-GS) (Figure 6.13. Table 6.3). Therefore, GlI I induces 1~1131 and
I~41'2 expression and this induction is repressed with EGF and EGF \\ ithout GLlI
completely represses 1>11'3.1 expression.
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Figure 6.12: RT-PCR analysis showing expression of VAV2, VAV3, VA V3.1 and J3-Actin
expression in GLIl and GLIl-mutant Nuclear Localisation Sequence (mNLS) transduced
N/TERT-keratinocytes without growth supplement (GLIl -GS, GLIlmNLS-GS control)
and with EGF (GLIl+EGF, GLIl-mNLS +EGF).
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Figure 6.13: Real-time-RT-PCR analysis showing relative fold repression of VAV2 and
VAV3.1 in GLlI- and GLlI-mutant Nuclear Localisation Sequence (mNLS) transduced
N/TERT keratinocytes without growth supplement (GLlI-GS, GLlImNLS-GS control) and
with EGF (GLlI +EGF, GLlI-mNLS +EGF).
tobammed.Svlkt nl
CHAPTER 6 Effects of EGF on Patt ern of Gen e Expression In GUI over e tpr ssmc K raunoc t
'" .
Table 6.3 Relative fold induction or repression of VAV2, VAV3 and VA V3. 1 in GLII and
EGFP transduced primary keratinocytes cultured without growth supplement (-GS) and
with EGF (+EGF). Also in GLIl-mutated Nuclear Localisation Signal (GLIl-m LS)
transduced N-TERT keratinocytes cultured without growth supplement and with EGF.
Primary keratinocytes
DId induction or repression SD
Samples VAV 3.1 VAV2 VAV3.1 VAV2
GLI1-GS 0.56 0.52 0.87 0.80
GLI1+EGF 0.17 0.47 0.87 0.86
EGFP -GS (Control) 1.00 1.00 1.00 1.00
EGFP+EGF 0.07 0.38 0.51 0.87
N-TERT keratinocytes
DId induction or repression SD
Samples VAV 3.1 VAV2 VAV3.1 VAV2
GLI1-GS 29.62 1.94 0.68 0.74
GLI1+EGF 1.20 0.72 0.72 0.77
GLI1-mNLS-GS (Control) 1.00 1.00 1.00 1.00
GLI1-mNLS+EGF 0.00 0.41 0.00 0.75
6.3.13 VA V3.1 is expressed in BCC and normal skin
Having shown, that VAV3. 1 is induced in GLIl expressing keratinocytes I went on to
investigate VAV3. 1 expression in BCC and normal skin. Figure 6.14 shows that VAV3.1
was expressed in BCC and normal skin.
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Figure 6.14: RT-PCR analysis showing expression of YAY3.l and G6PDH (control In
basal bell carcinoma (BCC) and Normal Skin (NS).
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6.4.0 Discussion
6.4.1 Localisation of GLIl in the nucleus is required to cause a change in cell
morphology with EGF.
The work carried out in this chapter shows EGF induces a change in EGFP-GLI 1-
keratinocyte (GLI I+EGF) cell morphology when compared to control EGFP-
keratinocytes cultured with EGF (EGFP+EGF). The localisation of GLII in GLI I
expressing cells exposed to EGF was predominantly located in the cytoplasm as
opposed to the nucleus where transcription factors normally function (Figures 6.1).
However, GLlI-mutated-Nuclear Localisation Signal-primary keratinocytes cultured
with EGF (GLI I-mNLS+EGF) in which localisation of GLII-mNLS was predominantly
restricted to the cytoplasm had a normal rounded morphology (Figure 6.3) and was the
same as that of EGFP+EGF control cells (Figure 6.2). GLI I-mutated Nuclear Export
Signal-primary keratinocytes cultured with EGF (GLII-mNES+EGF) in which
expression of GLll-mNES was mainly restricted to the nucleus showed a spindly
phenotype (Figure 6.3) and was the same as that for GLI1+EGF cells (Figure6.2)
These results suggest that localisation of GLI1 to the nucleus may be required to trigger
a change in cell morphology from rounded to spindly phenotype in presence of EGF
and that nuclear cytoplasmic shuttling is an important mechanism by which GLI activity
may be regulated.
6.4.2 EGF alters the transcriptional activity of GLIl.
EGF causes a change in cell morphology from rounded to spindly phenotype in GLI I
expressing keratinocytes. Therefore, does EGF alter the transcriptional activity of
GLI I? I have shown in this chapter that upon exposure to EGF, the transcriptional
activity of GLI 1 was reduced as revealed by reduced expression of known GLI1 target
genes GLI2 and PTCH (Agren et al., 2004; Marigo et al., 1996b; Regl et al., 2002;
Toftgard, 2000) (Figure 6"'). The results described in this chapter for PTCH
corroborates with the data published earlier (Kasper et al.. 2006) showing that P Il'H
expression was reduced in overexpressing GLI 1 primary and NITRT keratinocy tcs
cultured with EGF. However, there was no induction of PTCH promoter in a lucifcrasc
reporter assay by combinatorial GLI I/ECiF signalling in HaCat keratinocy tes (Kasper ct
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aI., 2006). This suggests that EGF signaling may alter the target gene profiles for GLI
proteins either by directly modifying GLI proteins or by regulating other transcription
factor/s or cofactor/s that may interact with GLI transcription factor's to control
promoter activation of selected target genes. EGF stimulation may also controll GLI1
transcriptional activity by shuttling GLII in and out of the nucleus and based on our
observation that with EGF, GLII expression appeared to be diffused through out the
cell (Figure 6.2) but did not appear to alter the overall levels of GlI 1 expression.
A small increase in GLll mRNA and protein observed with EGF in GLI 1 expressing
cells (Table 6.2 and Figure 6.7) may have been due to the fact that the promoter
activity was increased with EGF. A bicistronic construct EGFP-GLI 1 (Figure 2.1) was
used and the assumption that reporter (CMV) activity of this construct may have been
increased with EGF was confirmed when we probed these western blots with EGFP
antibody and observe that there was a similar level of induction in EGFP protein in
response to EGF in GLII expressing and non-expressing cells (Figure 6.7).
Expression of GLl3 in GLII expressing primary keratinocytes cultured without growth
supplement (GLII-GS) and control (EGFP expressing primary keratinocytes cultured
with [EGFP+EGF]) was reduced and when EGF was added to Gl.I l expressing primary
keratinocytes (GLI+EGF) GLl3 expression reverted back to levels that were seen in
control (EGFP expressing primary keratinocytes cultured without growth supplement
[EGFP-GS]) (Figure 6.4). SHH signalling has been shown to repress GLI3 expression
in limb development (Marigo et aI., 1996b). Smoothend (SMO) expression in GUI-GS
was similar to that of control EGFP-GS cells. Moreover, when EGF was added to GLlI
expressing primary keratinocytes SMO expression was reduced. SMO was also
repressed in EGF treated control EGFP-primary keratinocytes (EGFP+EGF cells)
(Figure 6.4). These results suggest that EGF may be altering the expression of Si\ 10
which activates, and GLB, which represses HH signalling (Murone et al., 1999; von
Mering and Basler, 1999). This may be a mechanism to control the transcriptional
activity of GLI1 in GLII overexpressing cells.
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6.4.3 EGFR expression is reduced in GLIl expressing keratinocytes cultured with
EGF.
In this study we have shown that there was a reduction in EGF receptor (EGFR) protein
levels in primary keratinocytes upon exposure to EGF and there was a greater reduction
in EGFR in GLI 1+EGF compared to control EGFP+EGF cells (Figure 6.7). A reduced
expression of EGFR has also been observed in BCC samples and this is proposed to
result from increased ligand-mediated receptor stimulation (Groves et al., 1992; Nanni
et aI., 1990). Activation of EGFR is associated with the development of many tumour
types (Kim et aI., 2001) and if it alters the oncogenicity of GLll this could hare
implications for the future development of therapy against BCC, by targing EGFR.
Such drugs include monoclonal antibodies (mAbs) directed against the EGFR
extracellular domain and or the use of small molecule tyrosine kinase inhibitors (TKls)
directed against the tyrosine kinase domain. The mAbs function at the extracellular
ligand-binding site of the receptor, whereas the small molecule TKls function at the
intracellular tyrosine kinase domain of the EGFR (Harari, 2004).
6.4.4 GLIl induces expression of KRT14, KRT17 and KRT19 and EGF represses'
this induction.
In this chapter I have shown that KRT14, a basal keratinocyte marker (Ishida-
Yamamoto et aI., 1991; Lane and McLean, 2004), KRT17 a stress response marker (De
Berker et aI., 2000; Lane and McLean, 2004; McGowan and Coulombe, 2000) and
KRT19 a putative stem cell marker (Michel et al., 1996b) were induced in GLI I
expressing keratinocytes. Moreover, when these cells were cultured with EGF,
expression of these markers was reduced (Figure 6.5). A more recent study (Kasper et
aI., 2006) showed that KRT19 was induced in GLI1 expressing N/TERT keratinocytes
and repressed when these cells were cultured with EGF. Expression of GLI I in the
absence of extracellular stimuli also induced elevated mRNA levels of KRT15 and
Nestin (stem cell markers) and EGF neutralised this induction comparable to control
cells. However, C071, which encodes the transferrin receptor and is negati vc in stem
cells (Tani et al., 2000b), was increased in response to GLI I/EGF. These results suggest
that GLII may be inducing a stem cell like expression signature in epidermal
keratinocytes and this signature may be prevented by E(iF signaling.
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Deletion of a GLI-responsive element in KRT17 promoter results In loss of GFP
fluorescence in most appendages in mice (Bianchi et aI., 2005), and results described in
this chapter for KRT17 suggest that Sonic Hedgehog signalling participates in KRTl-
regulation. The fact that expression of GIIl, KRTl-l, KRTl- and KRT19 is observed in
BCC (Apaydin et aI., 2005; Green et aI., 1998) and these keratins are induced in GUI
expressing primary keratinocytes (Figure 6.5) indicates that GLI 1 may be altering the
expression of these keratins in BCC.
6.4.5 GLIl may be a negative regulator of EpitheliallMesenchymal transformation
(EMT).
EGF induces vimentin and snail expression and reduces E-Cadherin expression during
EMT, which is associated with metastasis (Lee et al., 2006; Lu et al., 2003: Strizzi et al.,
2004). There was no change in E-Cadherin expression in GLI 1 expressing keratinocytes
with or without EGF relative to control cells (Figure 6.7). This indicates that classical
EMT may not be occurring in these cells. However, there was greater induction of
vimentin and snail2 mRNA expression in control cells (EGFP expressing primary
keratinocytes cultured with EGF) compared with GLll expressing pnmary
keratinocytes with EGF (Figure 6.6). Moreover, Vimentin protein was only detected in
control cells (EGFP expressing primary keratinocytes cultured with EGF) (Figure 6.7).
A small increase in vimentin mRNA levels but no expression of Vimentin protein in
GLII expressing primary keratinocytes with EGF indicates that expression of vimentin
may have been controlled by GLll at transcriptional and at translational level In
primary keratinocytes. Therefore EGF may be inducing certain EMT markers In
primary keratinocytes and GLll appears to be repressing the expression of these EMT
markers, this may explain why BCC's are locally invasive and are rarely subject to metastasis
(Marks, 1995). A small induction of vimentin mRNA expression is observed in Bec's
relative to normal skin although protein expression was not determined (Regl et al.,
2002), thus further investigation is required to determine Vimentin protein expression in
BCC.
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6.4.6 GLIl and EGF reduce KIF4 mRNA expression in primary keratinocytes.
I have shown in this study that KIF4 was downreguIated in GLII expressing primary
keratinocytes (Figure 6.5). A recently publication (Mazumdar et aI., 2006) has shown
that loss of KIF4 in murine embryonic stem cells leads to multiple mitotic defects
including chromosome misalignments, spindle defects, and aberrant cytokinesis and
more than 70% of KIF4 knockout cells were aneuploid (Mazumdar et aI., 2006). Loss of
KIF4 also increases the potential of embryonic stem cells to form tumors in nude mice
(Mazumdar et aI., 2006). The same authors also showed a reduced KIF4 protein lexels
in 350/0 of human cancers from several tissues (Ovary, lung, breast, CNS, renal.
melanoma and leukemia) indicating that loss of KIF4 is physiologically relevant.
although no reduction of KIF4 was found in colon cancer. They also showed that in
cells lacking KIF4, mitotic spindle checkpoints and DNA-damage response pathways
were activated (Mazumdar et aI., 2006). However, in contrast to my data showing GLI I
down-regulating KIF4 in primary keratinocytes I observed that in human BeC samples
mRNA for GIll and KIF4 were up-regulated (Figure 3.7). Whilst up-regulation of
GIll mRNA is to be expected my data showing up-regulation of KIF.f is in contlict
with my observation in primary keratinocytes. This data may indicate that in BCC KIF.f
is expressed independently of GLI 1. However, it will be important to determine whether
KIF4 protein levels are reduced in BCC as it is possible that whilst mRNA levels are
elevated this is not reflected by protein expression.
6.4.7 VAV 3.1 expressed in BCC is induced by GLIl and repressed by EGF.
In order to further our understanding on how GLll and EGF pathways interact 111
primary keratinocytes. I carried out microarray gene expression analysis in which I
identified 156 genes that were differentially expressed in GLI transduced prunary
keratinocytes cultured with EGF relative to control cells (Appendix l ). Due to time
constraints and number of genes identified I was unable to verify all of the differentially
expressed genes using RT-PCR analysis. Thus microarrays data needs further
verification by carrying out RT-PCR on identified target genes.
One gene that was differentially regulated in the list generated from the .vffymetrix data
\\ as 1'.-11 '3. There was a small induction in 1~-11 j expression in (it II expressing
keratinocytcs cultured without growth supplement and when EGF was added Il\ the-e
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cells VA V3 induction appeared to be repressed. A greater reduction in expression of
VAV3 was observed in control cells (EGFP expressing keratinocytes cultured with EGF)
compared to GLII expressing keratinocytes cultured with EGF (Appendixl). This
indicates that GLI I induces and EGF reduces VAV3 expression.
During this study we ran out of primary keratinocytes stocks thus N/TERT
keratinocytes were used to continue with the study. Both VA V3 and r>-1. V3, 1 \\ ere
expressed in primary keratinocytes (Figure 6.10). Whereas in N-TERT keratinocy 1es
only VAV3.1 was expressed (Figure 6.12) and there was no change in VAV3.1
expression in GLI l-prirnary keratinocytes cultured with or without EGF (Figure 6.11).
However, in GLI I-N-TERT keratinocytes there was a complete repression of VAV3.1
when cultured with EGF (Figure 6.13). This suggests that different VAV proteins may
be expressed in different keratinocytes and these may be differently regulated by same
stimulus. These results are in line with the published results (Trenkle et al., 2000) they
show that there appear to be no VAV3 expression in HaCat keratinocytes and r~4 VJ 1
was downregulated in these cells when they were exposed to EGF to levels that were
not detectable.
There was no published data available showing expression of VA V3.l in BCe at the
time this study was carried out. Thus having identified that r~4 V3.l was induced in
GLII expressing N/TERT keratinocytes I went on to determine if V4 V3.l was
expressed in BCC and normal skin. Figure 6.14 shows that VAV3,1 was expressed in
BCC and normal skin, due to time constraints quantification of VA V3.l was possible.
6.5.0 Summary
In this chapter I have shown that; GLI I with EGF appear to change cell morphology of
primary and N-TERT keratinocytes and EGF reduces the transcription activity of GLlI
by shuttling GLIlout of nucleus and this leads to change in expression of Sonic
hedgehog pathway genes PTCH, SMO, GIl2 and GIJ3. EGF also induces expression of
vimentin and snail2 transcripts markers of EMT and GLI I reduces the expression or
these markers and there is no change in E-Cadherin protein expression with GLli alone
or with EGF. GLI I may be reducing the effects of EGF signalling by reducing the
expression of EGFR. GLI 1 also appears to be inducing the stem cell signature and EGF
may be reduces this signature.
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There was a greater repression of KIF.:! with GLII compared to EGF in primary
keratinocytes and in N-TERT keratinocytes GLII induces and EGF represses rA ,.3.1
expression. Micro arrays data has shown that there were 156 genes that were
differentially regulated between GLI1 expressing keratinocytes cultured without growth
supplement and cultured with EGF.
6.6.0 Future work
The microarrays data needs to be verified by carrying out real-time RT-PCR anal) sis
using specific primers for the differentially expressed genes identified and or repeating
the arrays assay using triplicate samples. Once the arrays data is verified further
investigation would need to be carried out to determine how EGF and SHh signalling
pathway interact, by investigating protein levels of these genes. Also analyse the
promoter regions of these genes to identify if they have GLI binding sequence to
investigate if the genes are direct or indirect targets of GLI I. This data then would be
useful in examining BCC samples to see if any of the identified players are present ill-
vivo and what role they have in BCC formation, by carrying out immunohistochemistry
staining with specific antibodies and real-time-RT-PCR analysis.
Many of the experiments carried out in this chapter have been based upon analysis of
mRNA in either primary keratinocytes or BCC biopsies. Further work is required to
characterise patterns of protein expression. In particular my observation showing GLI I
regulation of GLI2, PTCH, SMa, keratin K17, keratin K19, KIF4 and VAV should be
followed up with a detailed investigation of protein expression both in primary
keratinocytes and N/TERT keratinocytes but also in BCC and investigate if this
correlates with GLI 1. Also investigate posphorylation of VAV proteins to determine if
they are active or not and carry out further investigate on KIF4 to see if alteration in its
expression causes an aneuploidy.
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7.1.0 Introduction
A GLII transgenic mouse model has been developed which specificall, overexpresses
GLI 1 in the basal layer of epidermis and outer root sheath of hair follicles under the
control of KRT5 promoter. These mice develop several types of spontaneous skin
tumours, including BCC (Nilsson et aI., 2000). In order to investigate molecular
mechanisms of GLI1 transcription factor and to identify particular partners involved in
tumour formation and hair growth development we decided to develop an in \'ivo mouse
model of GLI 1. The aim of this study was to generate a conditional GLIl transgenic
mouse under the control of a KRTl4 promoter activated by a site specific D:\:\.
recombinase Cre sytem (Kilby et aI., 1993). Dr Graham Neill carried out all the cloning
work and animal facilities at Clare Hall Cancer Research UK carried work in trying to
generating transgenic mice and I undertook the screening of these mice described in this
chapter.
7.1.1 Zp3-Cre GLIl transgenic mouse model system.
A site-specific DNA recombinase Cre system (Kilby et ai, 1993) was used to control
GFP-GLIl expression in mice under a KRTI.f promoter. Cre mediates the
recombination of two directly repeated target (loxP) sites to a single lox? site, with
simultaneous excision of the DNA section flanked by the loxP sites (the 'flexed DNA).
Such recombination allows activation of KRT14-Floxed-GFP-GLIl gene by excising a
floxed DNA segment that blocks its expression, by separating the regulatory KRT1-1
promoter and GFP-GLIl coding sequences. Gene activation or inactivation in vivo can
be achieved by mating two different animals, one carrying a target gene (KRT1-1-
Flo.'\ed-GFP-GLIl) with appropriately placed loxP sites and one carrying a ere
transgene (Figure 7.1.). The specificity of the system depends upon strict regulation of
ere expression.
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Figure 7.1: Diagrammatic representation of the mating scheme to generate KRT14-
Floxed-GFP-GLIl ere female germ line transgenic mice. By crossing Zp3-Cre mice
with a line of mice carrying the KRT1 4-Floxed-GFP-GLIl target gene, female
e re+/KRT14-Floxed-GFP-GLI1+ progeny were obtained. The Cre and KRT14-Floxed-
GFP-GLIl gene segregate independently in these females, and thus when they are
mated to wild type males, progeny of four different genotypes are obtained. If ere ha
been expressed in the oocyte, the one KRT14-GFP-GLIl gene is inherited in th
recombined form , regardless of whether the ere transgene is also inherited. Thu r
activit y in the female germ line can be assayed by determining the frequenc at whi h
e re+/ KRT14-GFP-GLI1+ females transmit the target gene in recombin d form.
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7.2.0 Materials and Methods.
DR G Neill carried out the cloning of KRTI-l-Floxed-GFP-GLll construct and the
mouse work was carried out at the transgenic mouse facilities at Clare Hall CRUK.
Briefly, linearised KRTI4-Floxed-GFP-GLll DNA was injected into the male
pronucleus of fertilised FIx F1 hybrid mouse embryos which were then implanted in to
pseudopregnant foster mothers. Litters obtained from the foster mothers \\ ere screened
using their tail DNA, to identify transgenic founders KRTI4-Floxed-GFP-GLIl positive
mice. These were bred to establish a "founder line" and to produce offspring with Zp3-
cre mice. The KRTI4-Floxed-GFP-GLIl founders were mated with Zp3-cre mouse:
litters from these mice were screened to identify a "second founder" line (KRTI-l-
Floxed-GFP-GLll / Zp3-cre positive mice). The "second founder" line females were
bred with wild-type mouse to recombine the Floxed DNA and thus activate GLll
expression. I extracted the DNA from transgenic mice and designed the primers and
screened the DNA to identify the founder line using PCR analysis.
7.2.1 Extracting DNA from transgenic mouse tail.
Approximately 5 mm of tail snip was placed in an eppendorf tube and 0.7 ml of tail
buffer (50 mM Tris pH 8.0, 100 mM EDTA, 100 mM NaCI, 1% (w/v) SDS, 359 ~lg
proteinase K) was added and incubated at 55°C overnight. Following incubation 0.7 ml
of 1: I phenol chloroform mixture was added per eppendorf tube and shaken using a
bench shaker for 15 min and centrifuged at 13000 rpm for 10 min.
The upper aqueous phase was transferred to a clean eppendorf tube and equal volume of
I: I phenol chloroform mixture was added, the solution was mixed and centrifuged at
13000 rpm for 10 min. The upper aqueous phase was transferred to a clean eppendorf
tube and equal volume of chloroform was added, incubated shaking at room
temperature for 15 min and centrifuged at 13000 rpm for 5 min. The LIpper aqueous
phase was transferred to a clean eppendorf tube and 0.7 ml isopropanol added and
mixed by shaking vigorously and centrifuged for 5 min. Supernatant was aspirated and
the DNA pellet was washed with 250 III 70% (v/v) ice cold ethanol. The pellet \\ as
allowed to air dry and resuspended in 50 ~L1 [10 mM Tris. CI pH 8.5] and the sample
stored at -20°C.
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7.2.2 Screening transgenic mouse DNA using Pf'R analysis.
Forward primers KRTl4 ('5 agtataaagcactcgcatcc 3'), Floxed ('5 cgccaccatgggaaatataact
3') and reverse primer GFP (5' gtgcagatgaacttcagggtca 3') were used to screen first and
second founder lines. Zp3-Cre forward primer '5 tgacccggcaaaacaggtag 3' and reverse
primer '5 tggtttcccgcagaacctga 3' amplifyied a PCR product of 521 bp were used to
screen for Zp3-Cre positive mice.
Three PCR reactions for each sample for each set of primers were set up in a 96 well
plate using 1 IJ,1 neat, 1 IJ,1 of 1: 10 and 1 IJ,1 of 1:50 diluted mouse DNA from section
7.2.1 with the final concentration of the following components for each PCR reaction.
0.25 mM each dNTP, 1.25x reaction buffer [25 mM (NH4hS04, 93.75 mM Tris-HCI
pH 8.8 at 25°C, 1.25xl0-2 Tween 20], 1.75mM MgCb for KI4-Floxed-GFP-GLI I PCR
and 3 mM MgCb for Zp3-Cre PCR, 0.125 IJ,m each (forward & reverse) primer for
KRTl4-Floxed-GFP-GLIl PCR and 0.25 IJ,m each (forward & reverse) primer for Zp3-
Cre PCR, 1 Unit thermal stable DNA polymerase (Advanced Biotechnology Red Hot
DNA polymerase Catalogue No AB-0406/B). In a total reaction volume of 20~d made
up with dH20 .
A master mix (M/mix) was made up of all the components except DNA for all the
samples; 19 IJ,1 of M/mix was added per well and 1 IJ,1 mouse DNA for each sample. The
samples were thermo cycled, at 94°C for 3 min, 40 cycles at (94°C for 30 sec, 52°C for
I min, 72°C for 1 min), and final extension at 72°C for 10 min for KRTl-l-Floxed-GFP-
GLll. For Zp3-cre PCR the annealing temperature was set at 60°C. Kk'Tl-l-Floxed-
GFP-GLIl and pPGK-Cre vectors obtained from Dr G Neil were used as positive
controls in PCR screening analysis. ~-Actin primers (Table 2.2) generating a PCR
product of 320 bp were used as positive control to indicate that enough DNA template
was present for amplification. These primers were blast searched using NCBI database.
the results showed that they can amplify mouse and human p-Actin and they do not
span the intron/exon boundaries. ~-Actin PCR was set up same as that for KRT1-1-
Floxed-GFP-GLIl except the annealing temperature was set at 60°C. DNA samples
from which ~-actin was not amplified, fresh ear snips from these mice were requested
and DNA extracted using protocol as for tail DNA extraction.
270
CHAPTER 7 Generating a Zp3-Cre-GLII Transgenic Mouse . Iode. S . tem
The peR products were analysed on 1 % (w/v) agarose gel. Figu re 7.2 shov s the
expected size bands for Floxed (KRT14-Floxed-GFP-GLIl) allele and recombined
(KRT14-GFP-GLIl) allele
IATG I
LoxP LoxP
I • . ---- -- --,- I I ~ I -
F .. ,
,
I
~
+- R
Floxed peR product.
Cre-mediated recombination in oocytes
Recombined PCR product.
Figure 7.2: Diagram of KRT14-Floxed-GFP-GLIl construct indicating the (F) Forward
and (R) reverse primers and LoxP position. A 638 bp Floxed PCR product was expected
from unrecombined KRT14-Floxed-GFP-GLIl allele and a 278 bp peR product was
excepted from recombined KRT14-GFP-GLIll allele.
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7.3.0 Results
7.3.1 In vitro ere mediated recombination of KRT14-Floxed-GFP-GLIl to KRTl.f-
GFP-GLII in 293 cells.
To check if the Zp3-cre system works, the 293 cell line was transfected with K1'+-
Floxed-GFP-GLll plasmid and co-transfected with KRTI-l-Floxed-GFP-GL1l and
pPGK-Cre plasmid, were obtained from Dr G Neill. Total RNA was isolated from these
cell lines and RT-PCR was carried out using protocols described in (section 2.5.0-and
section 2.7.0), with primers described in section 7.2.2.
KRT14-Floxed-GFP-GLll recombined to KRT14-GFP-GLll in 293 cell lines via pPGK
Cre mediated recombination. This is indicated by a band seen at 638 bp in KkTl-l-Ioxl':
GFP-GL1l lane and a band at 278 bp in cotransfected KRT14-loxP-GFP-GL1l and
pPGK-Cre lane in the RT-PCR (Figure 7.3). This indicates that the LosP Floxed Zp3-
Cre system work in vitro.
7.3.2 Generating a KI4-Floxed-GFP-GLIl mouse model under control of Zp3-Cre
activation.
There were nine KRT14-loxP-GFP-GLIl positive first founder lines (3 male. 6 female)
out of 50 mice screened. All were bred with Zp3-cre mouse to generate a sec founder
line KRT14-1oxP-GFP-GLIl and Zp3-Cre positive mice. Only one female mouse was
positive for KRT14-Floxed-GLIl and Zp3-Cre, this female was bred with wi ld-type
mouse to get KRT14-GFP-GLll recombined gene.
None of litter one (7 mice) and litter two (10 mice) of the sec founder line female had
the recombined K14-GFP-GLIl gene. Table 7.1 shows the genes for which the litter
one and litter two were positive.
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Figure 7.3 RT-PCR of KRT14-Floxed-GFP-GLIl and KRT14-Floxed-GFP-GLll
cotransfected pPGK-Cre 293 cell line. The band at 638 bp is the unrecombined KRT14-
Floxeli-GFP-GLIl transcript. The band at 278 bp is the recombined KRT14-GFP-GLll
transcript in cotransfected KRT14-LoxP-GFP-GLll and pPGK-Cre lane. There are no
bands in the negative control -ve RT KRT14-LoxP-GFP-GLll and dH20 lanes and for a
positive RT-PCR ~-actin control there are bands at 320 bp in KRT14-LoxP-GFP-GLll
and cotransfected KRT14-LoxP-GFP-GLll and pPGK-Cre lanes. Thees results indicate
that Cre mediate site specific recombination system works in vitro.
Table 7.1: Genes carried by transgenic litter one and two from the sec (female) founder
line. None of the litters were positive for recombined KRT14-GFP-GLll gene.
Genes identified in litters of sec founder line. Litter one Litter two
KRT14-Floxed-GFP-GLI1+/Zp3-cre- 1 3
KRT14-Floxed-GFP-GLI1+/Zp3-cre+ 2 4
KRT14-Floxed-GFP-GLIT/Zp3-cre+ 1 3
KRT14-Floxed-GFP-GLIT /Zp3- cre- 3 0
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7.4.0 Discussion
In vitro studies show that cotransfected KRT14-Floxed-GFP-GLll and pPGK-Cre
resulted in Floxed region removed and generating a KRT14-GFP-GLll gene in 293
cells (Figure 7.3). This shows that the LoxP Floxed Zp3-Cre system works in vitro. \\'e
were successful in generating KRT14-Floxed-GFP-GLll /Cre founder mice but were
unable to activate the target gene (KRT14-GFP-GLll) by Cre-mediated recombination
in the ocytes when mating the founder mice with wild-type mice. There are several
possibilities as to why this system has not worked; one of this is that the target gene
(KRT14-Floxed-GFP-GLll) may have been incorporated into the Gnomic DNA where
it can not be recombined by Cre. Alternatively it may be that the Cre mouse we used
did not have functional ere. Several other groups in the Cancer Research UK who had
used the same Cre mouse have had similar problems (personal communications). We
could have carried out control mating experiments to check function of Zp3-Cre in Zp3-
Cre mouse. To determine where the target gene had incorporated into the Genomic
DNA we could have carried out fluorescence in-situ hybridisation (FISH).
We also tried to generate recombined target GLll gene by injecting the Cre plasmid in
to the KRT14-Floxed-GFP-GLll mouse embryo. This method also did not generate any
recombined target gene. Due to Professor Quinn leaving and the escalating overall cost
of the project it was decided not to proceed further. Part of my PhD study was to screen
the mice to identify the founder line KRT14-Floxed-GFP-GLll and the recombined
KRT14-GFP-GLll mice. I was then to carry out gene expression analysis on the GLlI
expressing mice to identify GLll target genes. As we have been unable to generate
GLll transgenic mice this part of my project was abandoned.
7.5.0 Summary
We have shown cotransfected KRT14-Floxed-GFP-GLll and pPGK-Cre resulted in
Flexed region removed and generating a KRT14-GFP-GLll gene in 293 cells, this
indicates that LoxP Floxed Zp3-Cre system work in vitro. We \\ere also successful in
generating KRT14-Floxed-GFP-GLll founder mice but were unable to activate the
target gene (KRT14-GFP-GLll) when mating the founder mice with wild-r, pc mice.
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Mutations inactivating the HH-developmental pathway receptor protein PTCH is the
primary event in BCC formation (Gailani et aI., 1996; Hahn et aI., 1996b: Johnson et al.,
1996). Further evidence supporting the role of activated HH-signalling in BCC comes
from studies of genetic mouse models and skin grafting experiments: (Aszterbaum et
aI., 1999) human keratinocytes expressing SHH, a ligand for Patched receptor protein.
grafted onto the back of nude mice form BCC like structures (Fan et al., 1997). The
molecular mechanism of the Hh signalling pathway has been worked out in greatest
detail in Dorsophila development (Hammerschmidt et aI., 1997). Downstream of this
pathway is the zinc-finger containing transcription factor Cubitus interruptus (Ci),
which appears to be required for all aspects of Hh signalling in Drosophila (Methot and
Basler, 1999). Three homologues of Cubitus interruptus (Ci), GLI1, GLl2 and GLl3
have been identified in human and mouse (Hui et aI., 1994; Ruppert et al., 1990). The
first human GLI gene to be discovered was GLII (Kinzler et al., 1987). GLII is
overexpressed in BCC compared with normal human skin (Dahmane et al., 1997: Ghali
et al., 1999).
Deregulation of the SHH pathway leads to a number of human diseases, include birth
defects and BCC of the skin (Gailani et al., 1996; Gorlin, 1995; Hahn et al., 1996b;
Johnson et al., 1996; Kimonis et al., 1997). In transgenic mouse model systems
activation of GLI 1 by SHH-signalling is a key step in initiating BCC formation (Nilsson
et aI., 2000). However, there is limited understanding of the molecular mechanisms
involved in response to HH signalling and GLI activity in human BCC formation and
how this pathway interacts with other pathways.
This study has shown with northern blot analysis carried out in Chapter 3 that GLIl.
GLl2 and PTCH were induced in GLII expressing cells relative to non GLll expressing
cells. RT-PCR analysis shows GLI2-o//3 isoforms, GLI3, SMO, PTCH, COUP-TFJI,
TFJID and KIF4 were expressed in normal skin, BCC and GLlI expressing
keratinocytes, and GLJI was only expressed in BCC and GLlI expressing cell lines.
Real-time-RT-PCR analysis shows that GLJI, GLI2-o//3 isoforms, GLJ3, PTCH, SJfO,
KIF4 were induced and a-TUB was repressed in BCC relative to normal skin, and
GLJI, GLI2, GLI3, PTCH, SMO and a-TUB were induced and KIF4 was repressed in
GLII expressing keratinocytes relative to non GLll expressing keratinocy tcs. Having
determined that GIn was upregulated in BCC and GLI I expressing keratinoc tes. Regl
et al (200:2) also demonstrated that there was a positive feedback loop between G[ II
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and GLI2, thus it was hypothesized that GIIl may be a direct target of GLI2. To prove
this hypothesis a collaborative study was carried out with Dr Fritz Abergers' lab. The
data described in Chapter 4 from this collaboration indicated that GLI2 binds the GLI-
binding consensus sequence in the GIIl promoter (Ikram et aI., 2004). This suggests
that GLI2 directly activates GLI1. I have shown that retrovirally expressed GLI2
induces expression of endogenous GLll in human primary keratinocytes and GLf] is
expressed in the interfollicular epidermis and the outer root sheath of hair follicles in
normal skin as well as in BCC tumor islands. These results suggest that GLI2 may play
an important role in regulating epidermal proliferation and skin tumorigenesis.
In the search for potential downstream mediators of GLI2 function in epidermal cells a
new GLI2 target gene FOXEl was identified by Dr Fritz Abergers' lab. Its expression
was induced in response to GLI2 by binding GLI putative binding sites in the FOXEI
promoter region described in Chapter 5 (Eichberger et aI., 2004). I have shown that
localisation of FOXEl overlaps with GIl2 expression in human hair follicles. epidermis
and BCC. This suggests a possible role of FOXE1 in epidermal development and
carcinogenesis downstream of HH/GLI signalling.
The work described in Chapter 6 shows that GLII primary keratinocytes cultured in
presence of EGF leads to a change in cellular morphology from rounded cells to spindly
phenotype. In order to understand the molecular mechanism leading to a change in cell
shape, we found that EGF induced vimentin and snail2 expression whereas GLI 1
reduced the expression of these transcripts. There was no change in E-Cadherin (EMT
marker) protein expression with GLII alone or with EGF, which is shown to be
downregulated in classical EMT (Lee et al., 2006; Lu et aI., 2003; Strizzi et aI., 2004).
Thus classical EMT was not occurring in GLII expressing primary keratinocytes
cultured with EGF, although certain EMT markers (vimentin and snail2) were
differentialy regulated in these cells.
This study has also shown that EGF signalling reduces the transcription activity of GUI
and this may be by shuttling GLII out of nucleus and possibly by altering the
expression of SHH pathway genes PTCH. SMO, GIl2 and GI13. GLI1 also appeared to
counteract the effects of EGF signalling by reducing the expression of LGF receptor.
GUI also induces the keratinocytes stem cell marker keratin 19 (Michel ct al., 1996b)
exprcxsion whereas ~GF appears to reduces keratin 19 expression. .vffyrnctrix
'7"", I- ,
CIJAP'I ER 8 Conclusion
microarrays analysis shows that there were 156 genes (see APPENDIX I) that were
differentially regulated between GLI1 expressing keratinocytes cultured without growth
supplement and cultured with EGF.
One gene that was differentially regulated in the Affymetrix data list \\ as fA V3. GLiI
induced and EGF reduces VAV3 expression. VAV (VAV1,VAV2 and VAV3) farnil', of
proteins are Guanine nucleotide exchange factors (Bustelo, 1996; Bustelo, 2000; Katzav
et al., 1995; Schuebel et al., 1996; Trenkle et al., 2000) that are involved in regulating
Rho family GTPases between a GTP-bound (active) state and a GOP-bound (inactive)
state (Etienne-Manneville and Hall, 2002; Hall and Nobes, 2000). Re-modelling of the
actin cytoskeleton is involved in cell division, growth, adhesion, and locomotion. This
rearrangement of the actin cytoskeleton is influenced by the activity of Rho family
GTPases (Etienne-Manneville and Hall, 2002; Hall and Nobes, 2000).
During the course of this study stocks of primary keratinocytes became depleted and
primary keratinocytes from different patients were difficult to culture, thus N/TERT
keratinocytes were used to continue the study. Real-time-RT-PCR analysis showed that
GLII induced VA V3.1 expression more than VAV2 and EGF represses this induction.
EGF alone completely repressed VA V3.1 expression in N/TERT keratinocytes, These
results were in line with the results published by Trenkle et al (2000) which show that
there appears to be no VAV3 expression in HaCat cells and VA V3.1 was downregulated
to levels that were not detectable in these cells when they were exposed to EGF. My
results observed for VA V3. 1 in N/TERT keratinocytes (Figure 6.13) were similar to that
observed for VAV3 in the Affymetrix data with primary keratinocytes (Appendix I).
VAV2, VAV3 and VAV3.1 were expressed in primary keratinocytes and N/TERT
keratinocytes only express VA V2 and VA V3.1 (Figure 6.12). There was no change
observed in VA V2 and VAV3.1 expression in GLII expressing primary keratinocytes
cultured with and without EGF (Figure 6.11). However, in GLII expressing NTERT
keratinocytes VAV3.1 induction was greater then VAV2 and EGF reduced this induction.
Thus different VAV proteins may be expressed in different keratinocytes cell lines and
these may be differently regulated by the same stimulus.
Near to the end of this study Dr Grahan Neill looked at GLiI expressing \-ITRT
keratinocytes cultured with EGF using a time-lapse microscope. Ile observed that when
these cells moved they left a trailing cell body behind and the cells appeard spindly the
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movement was such that it seamed that the trailing body was sticking to the SurL1Cc of
the flask and preventing these cells from moving freely, these cells also tended to be
sticking to each other. Once these cells had moved to a new position they revert back to
rounded morphology and this process was repeated. Control cells (EGFP expressing :'\_
TERT keratinocytes cultured without growth supplement and with EGF and GLI I
expressing N-TERT keratinocytes cultured without growth supplement) move rapidly
with out leaving trailing cell body and they did not stick to each other (data not shown).
Thus the spindly phenotype that was observed for GLI primary keratinocytes cultured
with EGF may have been due to the fact that when these cells move they elongate and
form a spindly morphology which was captured at a fixed time point. Therefore, the
spindly phenotype observed for GLI primary keratinocytes cultured with EGF, may not
have been due to transformation but due to restriction in cell motility. This assumption
is supported by the fact that when EGF was depleted in GLII expressing keratinocytes
their spindly morphology reverts back to rounded morphology which was observed at a
fixed point in time. This observation and aleration in VAV expression observed for GLI 1
cells cultured with EGF (Chapter 6) supports the fact that GLII with EGF alters cell
motility and may not be causing transformation or differentiation.
Therefore, GLII may be altering the expression of VAV and this may lead to alter or
disrupt re-modelling of actin cytoskeleton during cell division, growth adhesion and
locomotion and this may lead to BCC formation. This study has also shown that VA 1'3,1
is expressed in BCC and normal skin (Figure 6.14), thus further work is required to
quantify the levels of VAV and EGFR expression in BCC relative to normal skin and to
determine if these correlate to GLII expression, to confirm whether the in-vitro system
was similar to the in-vivo (BCC) situation.
Kinesin superfamily -4 (KlF4) mRNA was induced in BCC relative to normal skin and
in HaCat and A375 cells relative to primary keratinocytes. However. it was repressed in
GLII expressing primary keratinocytes relative to non GLI1 expressing control primary
keratinocytes (Figure 3.6, Table 3.4) and there was greater repression of KIF-I with
GLll compared to EGF in primary keratinocytes relative to controls (Figure 6.5). This
suggests that there may be GLI 1 independent induction of KIF-I in BCe in-vivo and in-
vitro in certain cell Iines. It is also possible that transcriptional actix it) of GLI I may be
di ffcrcntially regulated in BCe ill-\'i\'(} and in-vitro leading to alteration in expression of
KIF-I and this may explain the discrepancy in KIF-I expression in-vivo and in vitro.
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KIF4 plays multiple roles in mitosis, and its loss leads to numerous mitotic defects,
including chromosome hypercondensation, aberrant spindle formation. anaphase
bridges, defective cytokinesis, and aneuploidy (Castoldi and Vernos, 2006: Kurasawa et
al., 2004; Lawrence et al., 2004; Mazumdar et al., 2006; Mazumdar and Misteli. 2005:
Mazumdar et aI., 2004). Aneuploidy is the most frequently observed type of cytogenetic
abnormality that has long been suggested to contribute to tumor formation (Dey. 2004),
Loss of KIF4 in embryonic stem cells lead to 70% of the cells being aneuploid and this
increases their potential to form tumors in nude mice (Mazumdar et al., 2006). A
reduced expression of KIF4 protein levels were also observed in 35% of human cancers
from ovary, lung, breast, CNS, renal, melanoma and leukemia tissue. No reduction of
KIF4 was found in colon cancer (Mazumdar et al., 2006), It is possible that loss of KIF4
in GLII expressing primary keratinocytes may also result in aneuploidy. Thus further
work is required to investigate the expression of KIF4 protein in BCC and GLI 1
expressing keratinocytes and determine how this may be differentially regulated in vitro
and in vivo.
A possible scenario in the induction of BCC formation may be activation of GLI I. by
inactivating mutations in PTCH followed by the induction of GLI2. Alternatively,
activation of HH-signalling may first lead to the induction of GLI2 expression which
directly activates GLII expression. This indicates that a feedback loop may be required
in the activation and maintenance of BCC formation, which is not active in normal skin
due to the absence of GLI 1 expression. It is also possible that there may be certain
unidentified factor(s) that are present in BCC that allow GLI2 to activate GLI 1 which
may not be present in normal skin.
The origin of BCC has been under debate for a very long time. While earlier evidence
favoured basal keratinocytes of the interfollicular epidermis, more recent data points to
the specialised cells within the hair follicle, analysis of the biomarkers in BeC suggest
that the tumour is derived from the cells of the outer root sheath (ORS) (Kruger et al,
1999: Kurzen et al, 2001). Given the fact that GLI2, FOXE1 and GLI1 are present in the
ORS and are found at high levels in BCC. a possible scenario for Bee development
may be that constitutive activation of HH-signalling in the ORS distorts differentiation
and promotes proliferation eventually leading to tumour formation.
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Most Bee rarely metastasise (Safai and Good, 1977) and are difficult to culture.
Therefore, induced expression of GLI1 may interact with EGF signalling in Bee and
alter gene expression which leads to cells being stickier and less motile and this
phenotype may be occurring by disrupting the cytoskeleton remodelling via altering
Rho signalling activity. This may also lead to alteration in expression of stem cell
markers and certain EMT markers. Loss of KIF"; in GLII expressing primary
keratinocytes in vitro model suggest that in normal skin it is possible that deregulation
of SHH signalling leads to increased expression of GLI1. This in turn results in loss of
KIF4 in stem cells; these cells become aneuploid and increase their potential to form
Bee tumors. By understanding the molecular mechanism of SHH signalling pathway
and identifying key players and how they interact with other pathways will enable us to
design better strategies to treat and prevent Bee formation. Figure 8.1 summarises the
HH-signalling pathway outlining possible regulatory mechanisms of GLI activity and a
model of tumergenesis based on published data and findings reported in this thesis.
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Figure 8. 1 A possible regulatory mechanism of GLI activity largely based on results
from studies ofDrosophila HH -signalling and a model of tumourigenesis resulting from
constitutive HH/GLI signalling in human cancer. (A) In the absence of HH-ligand, GLI
transcription factors are bound to a multiprotein complex via interactions with a
vertebrate functional homologue of Drosophila Cos2 . Phosphorylation of GLI by PKA,
GSK3 and CKI targets GLI to proteasome-dependent repressor formation. Proteolytic
processing requires functional Slimb protein. Target gene repression may invol e the
recruitment of a histone-deacetylase activity via interaction of GLI with SUFU-SAP 18-
SIN3. Alternatively, phosphorylation may simply inacti vate GLI proteins. In either
case, HH target genes are not expressed. (B) On binding of HH protein to its receptor
PTCH, phosphorylation of the cytoplasmic tail of SMO may recruit the Cos_/GLI
complex and disassemble the GLI-kinase complex, thereby allowing the acti ator form
of OLIl , OLI2 and OLI3 to translocated to the nucleus and acti ate targ t gen
transcription. The transcriptional activity of GLI proteins is further enhanc d b
interactions with Dyrkl and CBP. This study has sho n that EGF ignalling alt r
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transcriptional activity and it may be doing this via exporting GLI out of the nucleus.
(C) A model oftumourigenesis resulting from constitutive HHlGLI signalling in human
BCC. In normal tissue, HH/GLI pathway activity is controlled by the availability of
ligand and negative-feedback mechanisms such as increased expression of PTCH in
response to pathway activation. A precise balance of GLI activator (GLI-A) and
repressor (GLI-R) forms assures proper development and differentiation. Ligand-
independent tumour growth has been shown to arise from loss of PTCH or SUFU
repressor function (PTCHloss, SUFUloss) or activating mutations in the HH-effector
SMOH (SMOHact). Both ligand-dependent and ligand-independent tumours are
characterised by an increase in (GLI-A) activity and GLI target gene expression. (D)
Some possible oncogenic routes activated downstream of HHlGLI signalling have been
identified in this and other studies. These include proliferation, survival, metastasis and
stem cell activation which appear to be driven by (direct) transcriptional stimulation of
key regulators of these processes. This study has identified that GLI2 and GLIl are part
of a positive feedback mechanism in basal cell carcinoma (BCC) (Figure adapted from
Kasper et aI., 2006a).
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APPENDIX 1
Cell Growth and Maintenance
1 epidermal growth factor receptor pathway substrate 15
Cell surface Links si nal transduction
2 insulin-like owth factor bindin rotein 5
3 tumor necrosis factor (ligand) superfamily, member 10 -140.1
6 tumor necrosis factor (TNF su erfarnil , member 2)
2 bone morphogenetic protein receptor, type II (serine/threonine kinase)
5 type 1 tumor necrosis factor receptor sheddingaminopeptidase regulator -5.60
5 diphtheria toxin receptor (heparin-bind ing epidermal growth factor-like growth factor)
4 gamma-aminobutyric acid (GABA) A receptor, beta 1
7 insulin-like owth factor bindin rotein 3
19 death-associated rotein kinase 3
20 tumor necrosis factor receptor superfamily, member 6b, decoy 5.49
13 androgen-induced prostate proliferative shutoff associated protein
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Cell Death
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5 general transcription factor IIH, polypeptide 2, 44kDa
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o translation initiation factor IF2
4 euka otic translation initiation factor 4E
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5.21
6.28
8.01
5 chemokine (C-X-C motif) li and 14 ·2462
chemokine
4 chemokine (C-X-C motif) ligand I (melanoma growth stimulating activity. alpha) 12.75
9 solute carrier family I (neuronal/epithelial high affinity glutamate transporter . system Xag ), member I 18.06
2 solute carrier family 9 (sodium/hydrogen exchanger) , isoform 2 5.11
3 solute carrier family 21 (prostaglandin transporter), member 2 -6.06
6 solute carrier family 22 (organic anion transporter), member 7 -7.92
17 amyloid beta precursor protein (cytoplasmic tail ) binding prot ein 2 -5.43
17 solute carrier family 16 (monocarbo xylic acid transporters). member 3 7.44
16 solute carrier family 12 (sodium/chloride transporters), member 3 9.31
20 solute carrier family 12, (potassium-chloride transporter) member 5 6.30
17 solute carrier family 16 (monocarbo xylic acid transporters). member 3 -8.98
13 solute carrier famil y 7 (cationic amino acid transporter . y+ system). member 1 -5.34
17 solute carrier family 16 (monocarbo xylic acid transporters). member 5 5.61
10 phospholysine phosphohistidine inorganic pyrophosphate phosphatase -7.81
213664 at AW235061 SLCIAI
210040 at AF208159 SLC12A5
217691_x_at AA853175 SLC16A3
215274 at A1627943 SLC12A3
208039 _ at NM_003048 SLC9A2
212292 at AW452623 SLC7AI
202855_s_at ALS13917 SLC16A3
Structural Protein
221661 at AF210455 SLC22A7
213590 at AA705628 SLC16A5
215294_s_at AK026426 SMARCAI 23 SWUSNF related. matrix associaled. actin dependen l regulalOr ofcbromatin, subfamily .. member I 8.23
203862_s_at NM_00II03 ACTN2 1 actinin, at ha 2 -1435
Trans ort
Systematic Genbank Common Cbrom Title Aff
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APPENDIX II.
Standard Buffers and Solutions
Cell culture
Production of RM+ Concentrate.
Supplement
Hydrocortisone
Insulin (CN)
Epidermal growth factor (lCN)
Cholera toxin (lCN)
Transferrin
Lyothyronine
Final media concentrate
0.4 ug/ml
5 ug/rnl
10 ng/ml
10 x -JOM
5 ug/ml
2xl0- J1M
All come as 2ml vials, and Lyothyronine (small vial approx 501-l1)
Making up the vials for addition to the lOOx RM+ stock
Epidermal growth factor final media concentration =10 ng/ml
Therefore: 100 x RM+ = 1 ug/rnl
Dissolve 1mg in 10 ml dH20 = 100 ug/rnl and aliquot 2ml and store at -20°C.
Hydrocortisone
Final media concentration = 0.4 ug/ml
Therefore: 100 x RM+ = 40 ug/ml
Dissolve 100 mg in 25 ml dH20= 4mg/ml and aliquot 2 ml and store at -20
0e.
Insulin
Final media concentration = 5 ug/ml,
Therefore: 100 x RM+ = 500 ug/ml
Dissolve 500mg in 1Oml of 0.05 M HCI = 50mg/ml and aliquots 2 ml and store at 2UC
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Cholera Toxin
Toxic take care
Molecular weight = 84,000
Final media concentration = 1O-IOM
Therefore in 100 x RM+ = 10-8M
Dissolve 1mg in 10 ml of distilled water freeze as 2ml aliquots at -20°C (0.2mg)
Transferin
Final media concentration = 5 ug/rnl
Therefore in 1OOxRM+ = 500 ug/ml
Dissolve 500 mg in 10 ml distilled water = 50mg/ml freeze as 2 ml aliquots (100 mg)
Lyothyronine (Stock)
Molecular weight = 651.01
Final media concentration = 2x10-11M
Therefore in 1OOxRM+ = 2x 10-9M
• Dissolve 13mg Lyothyronine in 1M HCI: Ethanol (1 :2) (approx 5011) make up to
20ml [650l-lg/ml]. Freeze 19m1 in 1011 aliquots.
• Dilute 1ml [650 ug/ml] in 24ml distilled water = 26 ug/ml freeze 24 011 in 1 011
aliquots.
• Dilute 1ml [26 ug/rnl] in 9 ml distilled water = 2.6 ug/ml freeze 9 011 in I 011
aliquots.
• Freeze down 1 ml [2.6 ug/rnl] as 100 ul aliquots (260 ng) this is used to make
100x RM+ the others are stocks.
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Procedure
1. Collect 2 sterile 100 em cylinders.
2. To one of the cylinders add 100 ml of distilled water in hood. Then collect
falcon tube and add 50 ml of H20 from cylinder.
3. Start with 2 ml (50 mg/ml) insulin using a Pasteur pipette, pipette 2 ml of insulin
into the cylinder. Be careful! The way to do it is to press the pipette tip to the
inside edge of the cylinder and as you gently turn the cylinder round in circular
motion, you gently pipette out the insulin so that it trickles down the edge of the
cylinder has shown in Figure A2.1 below.
.. Pasteur pipette
Insulin drops
I+------Cylinder
Figure A2.1
4. Using the distilled water from the falcon tube, rinse the rest of the insulin
eppendorfto collect as much insulin as possible and pipette gently (as
mentioned before) into the cylinder. Use at least 20 ml of d H20 to do this
procedure if this procedure is done correctly, the solution in the cylinder i.e.
insulin plus dH20 will remain clear. If it is done too quickly, the solution will
turn cloudy.
5. Next do the same with 100 ul (2.6 ug/rnl) lyothyronine and wash the eppendorf
down with dH20.
6. Do the same with the rest of the ingredients: e.g. transferin, cholera toxin,
hydrocortisone and EGF.
7. Make up to 1OOml using dH20 as you are using the dH20 to rinse the ingredient
bottles.
8. When the ingredients are in the cylinder and the volume has reached 100 ml
because of the addition of dH20 during the procedures of adding the ingreJients
and at the end to arrive at the correct volume, and then pour the contents (100
ml) of the cylinder into a sterile bottle.
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9. Add 100 ml of the E41F12 medium (CRUK) to the sterile bottle to make up a
final volume of 200 ml.
10. Collect another sterile 400ml bottle (empty) and filter the contents of the first
bottle into the clean empty new bottle.
11. Collect> 50 bijoux small plastic containers with white screw caps and aliquot
4ml of the contents to each bijoux.
12. Date the bijoux and label them 'RM+' and store in -20°C freezer.
Production for RM- Concentrate.
Carry out exactly the same procedure as RM+ but without the addition of EGF.
Phosphate buffered saline (PBSA) 400ml bottle from CRUK
NaCL 8 g
KCl 0.25 g
Na2HP04 7.15 g
KH2P04 0.25 g
Made up to 1 litre with distilled water and adjusted pH to pH 7.2, autoclave for 20 min.
VERSINE/EDTA (CRUK)
NaCI 8 g
KCl 0.2 g
Na2HP04 0.5 6g
Versene (EDTA) 0.2 g
Phenol Red (10/0) 1.5 ml
Dissolve in distilled water in stainless steel bucket (heat if necessary) and make up to
final volume of 1 litre. Check pH = 7.2. Bottle in 16ml aliquots in universal and
autoclave for 15mins and store at 4°C.
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TRYPSIN (CRUK)
0.25% in Tris Saline
NaCI 8g
Na2HP04 0.1 g
D-Glucose 1 g
Trizma Base 3 g
KCl (190/0) 2 ml
Phenol Red (10/0) 1.5 ml
Dissolve in approx. 1/5th volume distilled water and titre pH with HCl to pH = 7.7 then
add
Penicillin
Streptomycin
Or
Pen/Strep solution
Trypsin
0.06 g
0.1 g
10 ml
2.5 g
Dissolve Trypsin (Difco 1:250*) in approx. 115th volume distilled water, assist
dissolving by bubbling air through the solution. Add dissolved Trypsin to the Tris
Saline solution. Make up to final volume with distilled water; titre pH to pH 7.7
Sterilise by filtration using Pall 0.2m filter with pre-filter. Bottle in 15 ml amounts in
universals and store at -20°C.
N.B. Trypsin is an allergenic substance and in its powdered state should always be
handled in the fume cupboard.
Yersene/Trypsin mixture used to detach monolayer's is made by adding 4ml trypsin
(0.25%) to each universal ofYersene/EDTA (l6ml vial).
Glutamine 0.42 M solution (from CRUK) 20 ml universal
Store at -20°C. Use diluted 11100 in medium (final concentration is 4.2 mM).
E4 culture medium (from CRUK) 400 ml bottle
DMEM/F12 E4 Culture medium (from CRUK) 400 ml bottle
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900/oFCS, 10% DMSO cell storage solution.
Dimethyl sulfoxide 5 ml
Foetal Calf Serum 45 ml
Northern blot
RNase Free water (DEPC treated dHzOl
• Add 1 ml diethyl pyrocarbinate (DEPC) to 1 liter of ultra pure water (18.2
Mfzcm; Milli Q plus, Millipore) and shake vigorously to bring the DEPC into
solution.
• Incubate at 37°C over night and autoclave (15 psi, 121°C for 30min) and store at
room temperature to remove any trace of DEPC.
Standard Saline Citrate 20x (SSC 20x)
Sodium Chloride (NaCl) 175.3 g
Sodium Citrate 88.2 g
In RNase free water titer to pH 7.0 with 10M NaOH and autoclave (15 psi, 121°C for
30min)
Wash Buffer
Sodium dodecyl sulphate (SDS) 10%
SSC 2x (1: 10 dilution of20x SSC with RF water)
Store the solution at room temperature.
10 mM Tris, ImM NazEDTA (TE Buffer)
Tris 1 M (tittered to pH 8.0 with 11.6 M HCI)
Na2EDTA (titrated to pH 8.0 with 10M NaOH)
RNase free water
20 ml
1980 ml
10 ml
4 ml
986 ml
Final Con
10 mM
ImM
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MOPS 20x
MOPS (3-[N-merpholino]propane-sulphonic acid) 0.4 M
Sodium acetate 0.1 M
Na2EDTA 0.2 M
Titre to pH 7.0 with 10M NaOH and treat with 0.1 % DEPC overnight at room
temperature before autoclaving, store at room temperature in dark.
Strip Solution
Formamide
SDS (l00/0)
RNase free water
750 ml
10 ml
240 ml
1.2 % Agarose/formaldehyde Gel
Agarose gel 3 g
RNase free water 195 ml
Boil in a microwave allow to cool to 60°C, before adding
MOPS 20x 12.5 ml
Formaldehyde 37 % 42.5 ml
Blue juice 10 x
50 % glycerol
0.1 mg/ml Bromphenol Blue
Denaturing RNA loading buffer lOx (Electrophoresis Cocktail)
MOPS 20x 0.5 !-LI
Deionized Formamide 5 !-L1
Fonnaldheide 37 %
Blue juice lax
EtBr (10 mg/ml)
RNase free water
Final volume
* add 10 !-L1 to 1- 1.5~lg of RNA
\1, 111~IIII \1)l·d. "-.1 kr.im
1.75 ~tl
1 ~tl
0.05 !-L1
1.7 !-L1
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lOX Tris-borate EDTA (TBE)
109.0 g Tris base
55.6 g boric acid
9.3 g EDTA
Made up to I litre with distilled water and used at Ix by diluting I: lOin distilled water
and pH adjusted to pH 8.3.
0.1 M Sodium Acetate Buffer pH5.2
Sodium acetate 8.204 g
Made up to I litre with dH20
PH adjusted to pH5.2.
In-Situ Hybridisation
O.lM TEA pH 8
Triethanolamine
RNase Free dH20
Acetic acid
Adjust pH with HCI
Make up to
7.4 g
300 mls
I ml
400ml with RNase Free dH20
Prehybridisation Solution
Stock solution Volume taken Final Con
4x SSC
Ix
50%
500 ug
500 ug
SCC 20x 200 III
Denhardts lOx 100 III
Formamide 100% 500 III
t-RNA 10 mg/ml 5 III
*Single strand DNA 10 mg/ml 50 III
RNase Free dH20 100 III
*Before adding to the mix the single strand DNA should be denatured by heating to
100°C for 10 min and immediately placed on ice for 2 min.
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Hybridisation Solution
Stock solution Volume taken Final Con
SCC 20x 200 III 4x SSC
Denhardts lOx 100 III Ix
Formamide 100% 500 III 500/0
Dextransulphate 200/0 100 III 10%
t-RNA 10mg/ml 5 III 500 ug
*Single strand DNA IOmg/ml 50 III 500 ug
*Probe 50 ng/section
*Before adding to the mix the single strand DNA and the probe should be denatured by
heating to 100GC for 10 min and immediately placed on ice for 2 min.
Blocking Solution
In-situ Hybridisation Buffer 1
Triton 100x
Normal sheep Serum
Anti-Digoxingenin-AP, Fab fragments
Blocking solution 500 III
Anti-Digoxingenin-AP [0.75 U/Ill] 1 III
4M Lithium chloride solution
Lithium chloride solution 8M (L7026 Sigma) 1 ml
DEPC dH20 1 ml
cRNA fragmentation buffer
80mM NaH03
I20mM Na2C03
In-situ Hybridisation Buffer 1
1M Tris-HCL Trizma base pH 8 100 ml
4M NaCI
Autoclaved dH20
[\.1 ulwmmc d.:--.I k1.1111
37.5 ml
862.5 ml
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In-situ Hybridisation Buffer 2
1M Tris-HCI pH 9.5 100 mI
4M NaCI 25 mI
1M MgCb 50 ml
Autoclaved dH20 825 mI
In-situ Hybridisation Buffer 3
1M Tris-HCL pH 8 10 ml
0.5M EDTA 2 ml
Autoclaved dH20 988 ml
lOX Citrate buffer
Citric acid (monohydrate) 3.78 g
Tri-sodium citrate 23.78 g
EDTA disodium salt 3.7 g
Made up to I litre with distilled water use at 1X by diluting 1: 10 in distilled water and
adjusted to pH 6.0 (using 1M NaOH, concentrated HCI).
25mMEDTA
EDTA disodium salt dehydrate
dH20
Gill's Haematoxylin
Disti lied water
Ethylene glycol
Haematoxylin
Sodium Iodate
Aluminium Sulphate
Then add 20 ml glacial acetic acid.
4.65 g
500 ml
730 mI
250 ml
2g
0.2 g
17.6 g
Acid alcohol
Methanol 700/0 (v/v)
0..+ M Hel in distilled water 300/0 (v/v)
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Affymetrix
5x cRNA fragmentation buffer
The fragmentation buffer s made with RNase free reagents. Tris-containing solutions
should not be treated with DEPC; however, once H20 has been DEPC-treated it can be
used for making the Tris solution.
Combine the following components to a total volume of20 ml DEPC-treated H20
Reagents Sx Final Con
4.0ml 1M Tris acetate pH 8.1 (Triza base adjusted with glacial acetic acid) 200 mM
0.64g Magnesium Acetate (MgOAc) 150 mM
0.98g Potassium Acetate (KOAc) 500 mM
Mix thoroughly and filter through a 0.2um vacuum filter unit. Aliquot and store at room
ternperature.
CHIP Hybridisation buffer
(Final 1X concentration is 100mM MES, 1M NaCI, 20mM EDTA, 0.010/0 Tween 20)
2x Hybridisation buffer for 50 ml
12X MES Stock 8.3 ml
5M NaCI 17.7 ml
0.5M EDTA 4.0 rnl
100/0 Tween 20 0.1 ml
dH20 19.9 ml
Store at 2-8°C, and shield from light. (If more convenient, 2x Hybridisation buffer can
be added by Affymetrix Operator)
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Western blotting
100/oSDS
SDS (Sodium dodecyl sulphate)
dH20
Cell lyses buffer (boiling buffer}
50mM Tris-HCl PH8.0
20/0 SDS
1mM-sodium orthovandate
2x Protein Sample loading Buffer
1OOmM Tris-HCl pH 6.8
4% SDS
200/0 Glycerol
0.2% Bromophenol Blue
200mM ~-mercaptoethanol
Tris-glycine Running Buffer
25 mM Tris
192 mM Glycine
0.1 % SDS
Transfer Buffer
25mM Tris
0.19M glycine
200/0 methanol
0.1 % Tween-20
50 g
500 ml
125mM Tris pH6.8
Tris base 7.57 g
dH20 300 ml
Titre the pH to pH 6.8 and make up to 500 ml with dH20 .
r-..l ohanuncd. -';.1 krum 299
A PPLNDl X II Standard Buffers and <oluiions
375mM Tris PH8.8
Tris base 22.7 g
dH20 300 ml
Titre the pH to pH 8.8 and make up to 500ml with dH20.
Blocking buffer
50/0 Marvel milk in (0.1 % Tween-20 in PBSA) Western blot
Stripping buffer
Tris PH 6.7
SOS
~-mercaptoethanol
x tohammcd.> lkrarn
62mM
20/0
O.lM
300
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GLI2 Is Expressed in Normal Human Epidermis and Bee d
Induces GLl1 Expression by Binding to its Promoter an
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Sonic hedgehog (Shh) binds to its receptor patched (PTCH), leading to the activation and rep esst f t
. th GLI f '1 f zi . r sron 0 argetgenes via e. ami y 0 zinc-finger transcription factors. Deregulation of the Shh pathway is associated with
basal cell carcinoma (BCC) due to. upregulation of GLI1 and GLl2. We recently demonstrated a positive feedback
100~ between GLl1 and GLI2, which revealed that GLl1 may be a direct target of GLI2. Using band shift and
tuclferase reporter assays, we now show that GLl2 binds the GLI-binding consensus sequence in the GLl1
promot~r. These data suggest that GLl2 directly activates GLl1 and that retrovirally expressed GLl2 induces
expression of endogenous GLl1 in human primary keratinocytes. Finally, using in situ hybridization, we show that
GLl2 is expressed in the interfollicular epidermis and the outer root sheath of hair follicles in normal skin as well as
in BCC tumor islands. These results suggest an important role for GLl2 in regulating epidermal proliferation and
skin tumorigenesis.
Keywords: basal cell carcinoma/Hedgehog signalling/human keratinocyte/GLl2 promoter/transcriptional regulation
J Invest DermatoI122:1503-1509, 2004
Hedgehog (Hh) signal transduction pathway plays an
essential role in a number of Drosophila and vertebrate
developmental processes, including cell type specification,
pattern formation, and regulation of cell proliferation. Much
of our understanding of this pathway comes from studies
carried out in Drosophila, in which Hh modulates gene
expression through the zinc-finger-containing transcription
factor Cubitus interruptus (C/). Ci can function as either a
transcriptional activator or a proteolytically cleaved repres-
sor (Aza-Blanc and Kornberg, 1999). In vertebrates, trans-
criptional responses to Hh signalling are mediated by the
three Ci homologues, G1i1, Gli2, and Gli3 (Matise and Joyner,
1999; Ruiz i Altaba, 1999; Ingham and McMahon, 2001), that
can act in a combinatorial fashion to modulate target gene
expression. Gli1 and Gli2 appear to act primarily as
transcriptional activators, whereas Gli3 (and at times GLl2)
functions as a repressor (Ingham and McMahon, 2001).
Genetic analysis of patients with familial nevoid basal cell
carcinoma syndrome (NBCCS) as well as individuals with
sporadic BCC led to the identification of the PTCH tumor
suppressor gene (Gorlin, 1987; Hahn et ai, 1996; Johnson et
ai, 1996); this subsequently implicated aberrant sonic
hedgehog (Shh) signalling in BCC formation. Indeed,
upregulation of GLl1 and GLl2 is frequently observed in
BCCs (Gailani et ai, 1996; Dahmane et ai, 1997; Unden et ai,
1997; Regl et ai, 2002). Further evidence for BCC develop-
ment as a result of activation of Hh-signalling pathway
comes from transgenic mouse models and skin grafting
Abbreviations: Shh, sonic hedgehog; BCC, basal cell carcinoma;
Hh, hedgehog; DRS, outer root sheath
techniques. Heterozygous Ptch +/- mice develop BCC-like
features upon UV irradiation, although sporadic BCC
formation does not normally occur in these mice (Aszter-
baum et ai, 1999). Human keratinocytes expressing Shh
form BCC-like structures when grafted onto the back of
nude mice (Fan et aI, 1997) and overexpression of
mediators of Hh-signalling including an oncogenic form of
SMO, Shh, GLl1, and GLl2 in epidermal cells of transgenic
mice leads to the induction of BCC-like tumors (Fan et aI,
1997; Oro et aI, 1997; Xie et aI, 1998; Grachtchouk et aI,
2000; Nilsson et aI, 2000).
The predominance of either GLl1 or GLl2 activation with
regard to BCC formation is unclear; however, we recently
identified a positive feedback loop between these two
proteins, which suggested that GLl1 is an early target of
GLl2, whereas GLl2 is likely to be an indirect target of GLl1
(Regl et aI, 2002). We now present data showing that GLl2
specifically binds to the GLl1 promoter, suggesting that
GLl1 is a direct target of GLl2. Furthermore, we show that
retrovirally expressed GLl2 induces endogenous GLl1
expression in human primary keratinocytes. Finally, using
in situ hybridization, we show that GLl2 is expressed in the
outer root sheath (DRS) of the hair follicle as well as in BCC
tumor islands. These findings suggest that GLl2 directly
activates GLl1 expression and may play an important role in
skin tumorigenesis.
Results
NHIS-GLl2 binds GLI consensus sequence in the GLl1
promoter and induces GLl1 expression .in human
primary keratinocytes We have previously identtfied a
Copyright { .. 2004 by The Society for Investigative Dermatology, Inc.
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Figure 1a also shows that GLl1 mRNA induction is
close ly followed by a gradual increase in endogenous GLl2
mRNA. This confirms our previous observat ion that a
pos itive feedb ack loop exists between GLl1 and GLl2 (Regl
et ai, 2002). In addition to studies in immortalized HaCat
cells, we have also shown in this study (Fig 2a, b) that
endogenous GLl1 expression is induced in retrovirally
transduced GLl2 primary keratinocytes , thus confirming
that GLl1 is a target of GLl2 in primary as well as
immortalized cell lines. This suggests that there is also a
positive feedback between GLl1 and GLl2 in human primary
keratinocytes and this may be important for tumor forma-
tion.
To assess whether GLl2 may be capable of directly
act ivating GLl1 transcription by binding to the GLl1
promoter, we first performed in silico analysis of the 5'
flanking region of the human GLl1 core promoter region (Liu
et ai , 1998; Villavicencio et aI, 2002) to identify putat ive GLI-
binding sites. Using the ScanAce tool (Roth et aI, 1998;
Hughes et ai , 2000), we analyzed a region of approximately
1 kb upstream of the transcriptional start site of GLl1 (Liu
et ai , 1998) for motifs ident ical to or closely matching
the GLI-consensus-binding site TGGGTGGTC (Kinzler and
Vogelstein, 1990) (Fig 3a). An identical putative-b inding site
is also present in the cis-regulatory sequence of the mouse
Gli1 gene, suggesting a possible functional relevance of this
motif in the regulation of Gli1 expression (Fig 3b) .
To determine whether NHIS-GLl2 protein can bind to the
putative GLI-binding site in the GLl1 core promoter, we
performed elect rophoret ic mobility shift assays using
bacterially expressed NHIS-GLl2-(332) protein and radro -
actively labelled double-stranded oligonucleotides contain -
ing either the putat ive GLI-b inding site (8s) or a mutated
control oligonucleotide with two base pair exchanges In the
core region (8sm). As shown in Fig 4, recombinant HIS-
GLl2-(332) protein specifically binds to the 8s sequence .
but not to the 8sm sequence, suggesting that HIS-GLl2
protein may be activating GLl1 transcription by direct l
Figure 2
GLl 1 mRNA and protein expression in NHIS GLI2 h .k t l ' - uman pnmary
era inocytes, Human pnmary keratinocytes were transduced with
NHIS-GLl2 , GLl1, and GFP retrovirus and cultured for 72 h after which
total RNA ~nd proteins were extracted. This figure shows exogenous
NHIS-G,L12 Ind~c~d endogenous GLl1 protein expression as shown by
~a) ,semi-quantitative ,RT-PC,R and (b) western blot analysis; Pan-ERK
indicates .~qual protein loading. Retroviral expression of GLl1 was used
as a positive control , ~FP and dH20 as negative controls. The data
represented are of two Independent experiments.
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positive feedback loop between GLl2 and GLl1 in primary
human keratinocytes. In particular, t ime-course analysis of
GLl1 mRNA expression in GLl2 expressing keratinocytes
provided preliminary evidence for GLl1 possibly being a
direct target of GLl2 (Regl et ai, 2002). To investigate this in
more detail, we have measured the increase in GLl1 mRNA
and protein in a sub-line of the human keratinocyte cell line
HaCaT (GLl2-HaCal), which expresses N-terminally HIS-
tagged GLl2 protein (NHIS-GLl2) under control of the
tetracycline repressor. Furthermore, we have related the
increase in GLl1 mRNA and protein to levels of NHIS-GLl2
protein. Figure 1a shows that followin g tetracycline treat-
ment, there was a gradual increase in GLl1 mRNA. In
addition , activation of the direct target gene PTCH was
slightly delayed compared with induction of GLl1 mRNA.
Western blot analysis (Fig 1b) showed that NHIS-GLl2
protein was detected 1 h afte r tetracycline treatment,
whereas GLl 1 protein was not detected until 6 h after
treatment. Moreover, the increase in GLl2 protein is closel y
paralleled by the gradual increase in GLl1 mRNA. This
suggests that GLl1 represents an early GLl2 target gene.
Figure 1
Time-course studies of GLll , PTCH , and endogenous GLI2 mRNA
and NHIS-GLI2 and GLl1 protein expression in NHIS-GLl2 HaCaT
cell line. Quant itative real-time RT-PCR (a) and weste rn blot analysis
(b) . NHIS-GLl2-HaCaT cells were treated with tetracycline for the times
indicated. Real-t ime RT-PCR data show the mean fold induction
calculated from three independent experiments, each carried out in
duplicate. Standard deviation was below 20% between all replicate
experiments. Large ribosomal protein PO (RPLPO) was used as a
refere~ce stan,dard for all analyses to control for the amount of sample
material (Martin et aI, 2001). Samples for western blot analysis were
normalized for total protein and quan titated by densitomety.
hGLll prom GGATCCTGGGGGTCCTGGGGGTGCAATAAGCCCGGCACCCCTTC'TCTT,..... ..-.,.~-
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Figure3
Organization of the human and mouse GLI1 core
promo~~r region., (a) ,Th~ putative GLI-binding site
at pOSItIOn -56 IS highlighted in bold underlined
capital letters, and the first non-coding exon is
shown in upper case italics. Transcriptional start
sites are indicated by bold underlined letters (Uu et al
1998; Kinzler and Vogelstein, 1990). (b) Sequenc~
alignment of human (hGLl1 prom) and mouse Gli1
(mGli1 prom) 5' flanking regions. The putative GLI-
binding site in the human core promoter is 100%
identical to the corresponding sequence in the
mouse pror:noter region. !he putative-binding sites
are shown In bold underlined letters. The first exon
sequence of GLl1 is shown in bold italics. Asterisks
represent conserved nucleotides.
(8)
(b)
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tttaqtqa9999ctcctccttcaacttcttctqcttcqactccqa c qqqctcctccttcaqttccccAgcqqqaqcaqaaaqcctqqaa;a;~~~~;;~~qa9aaC9qcca9c.9a
gaq99qcggcaccctccaqaaettc c qCAqtqacqtqqtgcgaaaq99qcttcaqtcccaqqqctcc~~~;~~~~~gCC99g9ttcta9g9
qcaccc4qaqcctcaqccqctqctcctt cqtqaaccacaccct
tcaccttcttccaqagccccc a qcttttatqctccataqActcc
ctctgtcccggccgctqcaa ~t~~~~acttgattt9cCCC•••cCqc••aaCCaCa9gat9qCa9aat9~tcaqttCCaaag9gtgagqcctgcagatactacctccactattatcgttctcggttqa:~~~~aaccaaaggcgact.cc
tattttcctcaatct t ctccccctgccccgcaAaaatccaagccgqgaf~a~;~f~~~~~~~~t~99gCCagCcgatccag~~~ii~~99qC~~~~i~qCt~:;~;:;~~~~~~~~;:i~~:~~~i~~~~~!
ccaqaaoqqcaaqaqqqaqqqaaata;:~~;~:2~~~~qa9Cq99aaqa9CqqCq9C9C9Cca9c99ctq9~::~~
~~ qcaaaaqqgaaaaaaaaaqtttgcqcttctcqCQQqIG
~qGGq~~~~qqCCCq9C999ct999Cc99C999a999ct99999cca
..... ~~ GGGGGTGGCATCGAGGCTGCGCTGCCGTGGCCCGCccccccrCCCCACCGCAeacCC~~CCAGACTCCAGCCCT~1~
GCGCATCCCGAGCCCAGCGCCCAGACAGAG
hGLll pcon AIiAM:-71GCGCTTCTC(31 !Wp:GGOCTTGCGGCCCGGCGGGCTGGGCCGGCOOG
JIlGl11 pcon AAMGTTTGCGCTTCTCC- ""'"QCCGGCTCGAGGCCCGGCGCGT- -GGCGGGCGG-
........•.•.•.••.•.......... . •.......•. . .
~~g Pp~: ~---------OCOCNOClC·G~ ..~--GACCCCCCTCCCCCOCCACN:ACCTCCCCCCCCCCCCAGCCCAGTTTCCAGCCCTQC
. .......... .. .. ........... . .
hGLrl prom ~'4'(2Q8q;TG"GMCGGGGGGCAGGCGGGGGACC
IllGl i 1 peon ACCACGCATCCCGAGCACCGCGCCCCGACGGAGGTGACA- -GGGGGGCAGGCGGGAGACC
... ....•.•...•• . .••.•..•. ..•••.••.•....
binding to the 5' flanking region of the GLl1 promoter at a
position close to the transcriptional start site.
To analyze whether the GLI-binding site in the GLl1
promoter is involved in activation of GLl1 transcription by
GLl2, we performed luciferase reporter assays using wild-
type and mutated GLl1 promoter constructs. Co-transfec-
tion of GLl2 expression plasmid with the reporter construct
containing the 5' upstream region of human GLl1 (-1400
to + 93, Liu et ai, 1998) resulted in a 3-fold increase
in luciferase activity compared with controls. By contrast,
no increase in reporter activity was observed when the
GIi-binding site at position -56 was changed from CGGG
TGGTC to CGCCTGGTC by site-directed mutagenesis
(Fig 5). The GLI-binding and luciferase reporter assay data
suggest that HIS-GLl2 activates transcription of GLl1 by
interacting directly with the GLI-binding site at positions
-56 to -48 of the GLl1 promoter.
GLl2 is expressed in BCC, normal interfollicular epider-
mis, and in the ORS of the hair follicle The expression
profile of GLl1 is well characterized in BCC and normal skin
(Ghali et ai, 1999). Having shown that GLl1 is a putative
direct target of GLl2, we investigated the expression pattern
of GLl2 in BCC and normal skin by in situ hybridization
(Fig 6). We report that GLl2 mRNA was expressed in BCC
tumor islands of all BCC samples analyzed (n=8) and in
normal skin (n = 3), GLl2 was expressed in the ORS of the
hair follicle, sebaceous glands, and in the interfollicular
epidermis. No staining was observed with a GLl2 sense
probe in adjacent serial sections. Only samples showing a
positive signal for keratin 14 (to confirm RNA integrity) were
analyzed.
Discussion
Members of the GLI family of zinc-finger transcription
factors are key mediators of Hh-signalling and in BCC
activation of the Hh pathway results in overexpression of
GLl1 and GLl2 (Green et ai, 1998; Regl et ai, 2002). In
primary human keratinocytes, retrovirally expressed GLl1
induces GLl2 expression and in HaCaT cells it has been
shown that a positive feedback loop between GLl1 and
GLl2 exists (Regl et ai, 2002). In this study, we have shown
by RT-PCR and western blot analysis that retrovirally
expressed GLl2 induces endogenous GLl1 expression in
primary keratinocytes, confirming that a positive feedback
loop between GLl1 and GLl2 exists. Time-course analysis of
GLl1 expression in GLl2-inducible cell line suggested that
GLl1 may be a direct target GLl2 (Regl et ai, 2002), Using
gel shift and luciferase assays, we have identified a
functional GIi-binding site in the GLl1 promoter that confers
activation of GLl1 transcription in response to GLl2. Toge-
ther with detailed time-course studies of GLl1 transcription
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in GLl2 expressing cells, these data suggest direct activa-
tion of GLl1 by GLl2; however, it is possible that the
behavior of the NHIS-GLl2 and the endogenous GLl2
protein may not be identical. Finally, we have shown by
in situ hybridization that GLl2 mRNA is expressed in both
the interfollicular epidermis and ORS of hair follicles as well
as in BCC tumor islands.
Materials and Methods
Cell culture The stud y was app roved by the local e rucat
mittee (ELCHA Research Ethics Committee , Re : TIO 1037
and adhered to the declaration of Helsinki gUidelines or U 0
The importance of Shh-Gli2 signalling in murine air
follicle development has been demonstrated by several
groups (St-Jacques et ai, 1998; Chiang et ai, 999; Karlsson
et ai, 1999; Brewster et ai, 2000; Bai et ai, 2002; ill et ai,
2003) and transgenic mice expressing G1I2 in the basal
layer develop BCC (Grachtchouk et ai, 2000). As expected
fo.ra target of G1I2, the express ion profile of G1I1 correlates
With that of G1I2 in both the ORS of the hair follicle and in
BCC. Ant ibod ies to GLl2 are not available and, there ore,
we have been unable to confirm that the patterns of G1I2
protein mimic those of its mRNA. We have shown that in
primary human keratinocytes G1I2 induces G1I1 , therefore,
the lack of GLl1 express ion may indicate that G1I2 is not
activated in the interfollicular epidermis and that other
factors may be required for transcriptional activity. It has
recently been demonstrated in transgenic mice that Gli2
activation in mouse skin is dependent on Shh. However, it
has been shown that during embryogenesis, Gli2 can be
activated in response to FGF independent of Shh, providing
evidence that GLl2 can funct ion independent of Shh.
Moreover, it has also been shown that deletion of the
N-terminal repressor domain of G1I2 produces a mutant
protein that can induce Gli1 and Ptch expression indepen-
dent of Shh (Sasaki et ai , 1999; Brewste r et ai, 2000; Mill
et ai, 2003). Currently, little is known about processing
of GLl2 and it will be important to determine, therefore,
whether G1I2 is processed and if so whether differences in
processing occur between normal skin compartments, such
as interfollicular epidermis. ORS of hair follicle and in BCC.
We have recentl y found that G1I2 represses expression of
genes associated with epidermal differentiation, suggesting
that GLl2 may have repressor activity in the human
epidermis (Regl et ai , in press).
In BCC, GLl1 and GLl2 are consistently expressed in
tumor islands and this may be acco unted for by the posit ive
feedback mechanism that we have identified (Green et ai ,
1998; Regl et et, 2002). Autoregu lation of Gli1 expression
has previously been observed in frog embryos, suggesting
that positive feedback loops may be a common feature to
sustain pathway act ivation in the absence of Shh stimula-
tion (Dahmane et ai , 2001). Whether Gli1 or Gli2 is the initial
factor that induces the feedback loop and possibly tumor
formation remains to be determined. In contrast to Gli1,
expression of Gli2 is not dependent on Shh and during
mouse embryogenesis Gli2 is expressed before the onset of
Shh and Gli1 transc ript ion (Bai et ai, 2002). In addition, Gli2
is required for the expression of Gli1 in murine skin (Mill
et el, 2003). This suggests that Gli2 induces Gli1 , which in
turn further increases Gli2 levels leading to hyperprol ifera-
tion (Regl et ai , 2002).
In summary, we provide further evidence for a positive
feedback loop between GLl1 and G1I2 that potentiates the
Shh signal in hair follicle morphogenesis and BCC forma-
tion . This indicates a possible important role for human GLl2
in regulating skin tumorigenesis.
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Figure4
NHIS-GLl2-(332) binds GLI consensus sequence. Electrophoretic
mobility shift assay demonstrating specific binding of NHIS-tagged
recombinant GLl2 protein corresponding to amino acids 1-332 (NHIS-
GLl2-(332)) to the GLI-binding site (Bs) in the GLl1 core promoter region
(indicated by the band shift). The Bs oligonucleotide sequence used for
theanalysis is shown below. The region with a high sequence similarity
to the GLI-consensus-binding site is underlined. The two central
nucleotides shown in capital letters (TG) were changed to AA to give
rise to mutated Bsm. The synthetic polymer poly-(dl-dC) was used in
DNA-binding protein studies to absorb non-specific-binding proteins.
Excess competitors unlabelled Bsm, Bs, and poly-(dl-dC) were used
with 32P-labelled (Bsm 32p) and (Bs 32p).
300
100
FigureS
Luciferase reporter assays showing activation of the GLI1
promoter by NHIS-GLl2. 293 cells were either transfected with wild-
type (GLl1 prom-WT) or mutated GLl1 promoter reporter construct
(GLl1 prom-Mut), together with either empty vector or NHIS-GLl2
expression vector. Data represented are of mean values of three
independent experiments as relative luciferase units (RLU). These data
show a 3-fold increase in luciferase activity in GLl2/GLl1 prom-WT
compared with controls. By contrast, no increase in reporter activity
was observed when the Gli-binding site at position -56 was mutated
from CGGGTGGTC to CGCCTGGTC (GLl2/GLl1 prom-Mut).
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Figure 6
In situ hybridization analysis of GLI2 expression
in basal cell carcinoma (BCC) and normal skin.
GLl2 expression was detected in the epidermis (a
0, q) and in the outer root sheath of the hair follicl~
(c , e, g) with an anti-sense probe. No staining was
observed in adjacent sections with a sense probe
(b, a, f, h, p, r). GLl2 expression was detected in
BCC tumo.r .islands with an anti-sense probe (i, k,
m). No staining was observed in adjacent sections
with a sense probe (j, I, n).
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human tissue .) HaCaT cells were grown at 3rC in Dulbecco 's
modified medium (DMEM) adjusted to pH 7.5 with 5 mM HEPES,
containing 10% fetal calf serum (FCS), 100 mg per L streptomycin,
and 62.5 mg per l penicillin. Double-stable HaCaT lines,
expressing N-terminally HIS-tagged human GLl2 (GenBank GI
No. 3061315) (NHIS-GLl2) under the control of the tetracycline
repressor, were generated using the T-REX system (Invitrogen,
Carlsbad, CAl. NHIS-GLl2 expression was induced by culturing
cells in DMEM-high glucose (Invitrogen) , containing 10% FCS and
1 mg per l tetracycline (Invitrogen). Primary human keratinocytes
were isolated and cultured according to the methods described in
Regl et al (2002).
Vector construction and retroviral transduction of primary
keratinocytes and cell transfections The retroviral SIN-GLl1-
EGFP construct was generated as described in Regl et al (2002).
To generate the retroviral bicistronic GLl2-EGFP expression
construct, N-terminally HIS-tagged GLl2 was cloned into pI2E-A,
a modified version of the pIRES2-EGFP plasmid (Clontech ,
Hampshire, UK) (Regl et aI, 2002) , PI2E-A-GLl2 was digested with
San and Notl to excise CMV-GLl2-IRES-EGFP. The resulting
fragment was cloned into Xhol-Notl digested retrov iral SIN-IP
plasmid (a gift from Prof. P. Khavari) to create SIN-GLl2-EGFP.
Retroviral transduction of primary keratinocytes and cell transfec-
tions were carried out as described in Regl et al (2002). Cells were
harvested at the time points indicated in the text.
RNA isolation and real-time RT·PCR analysis Isolation of total
RNA from HaCaT cells and real-time RT-PCR was carr ied out as
described previously in Regl et al (2002). Total RNA from primary
keratinocytes was isolated using RNAzol B (Biogenesis Ltd , Poole,
Dorset, UK) as per the manufacturer's instructions. Genom ic DNA
was removed by treatment with DNasel (Boeringer Mannhe im,
Roche; Basal , Switzerland) and cDNA was synthesized using AMV
Reverse Transcriptase (Promega A5000 kit, Mad ison, WI) accord-
ing to the manufactu rer's instructions. PCR was carried out using
1 III cDNA react ion, 0.25 mM each dNTP, 1 x (25 mM (NH4bS04'
93.75 mM Tris-HCI, pH 8.8, at 25°C, 1.25 x 10- 2 Tween 20)
react ion buffer, 1.75 mM MgCI2 , 0.125 11M each (forward and
reverse) primers with 1 U thermal stable Red Hot DNA polymerase
(Advanced Biotechno logy, Epsom, UK) in a total reaction volume of
20 ul., The samples were thermo cycled, at 94°C for 1 min (94 C for
1 min, 60°C for 30 s. 72°C for 1 min) x 40 cycles, and final exten-
sion at 72°C for 10 min. G6PDH was amplified with an annealing
temperature set at 55°C in 35 cycles. A negative primer-only con-
trol without eDNA was also set up. PCR-primer sequences were
as follows : GLl1 forward primer 5' gaagacctctccagcttgga 3'
corresponding to 1504-1 523 nucleotides and reverse primer 5'
ggctgacagtataggcagag 3' corresponding to 1728-1747 nucleo-
tides of GLl1 (GenBank GI No. 4885278). G6PDH forward primer 5'
gttccgtgaggaccagatctac 3' corresponding to 584-605 nucleotides,
reverse primer 5' ggctccttgaaggtgaggataa 3' corresponding to
712-733 nucleot ides of G6PDH (GenBank GI No. 182870).
Western blot analysis Western blot analysis of GLl1 and NHIS-
GLl2 protein expression was carried out as described in Regl et al
(2002). GLl1 protein was detected with polyclonal goat anti-GLI
antibody (C-18, Santa Cruz Biotechnology. Santa Cruz. CA) and
NHIS-GLl2 with peroxidase-conjugated monoclonal ant i-polytustr-
dine antibody (Sigma, clone HIS-1, Sigma, Vienna Austria; Dorset,
UK). Proteins were visualized by chemiluminescence detection
(ECl, Amersham Biosciences, Bucks, UK; Uppsala. Sweden).
Proteins levels were quantified by densitometric analysis usmq h
AIDA/2D densitometry software package (RAYTEST).
Recombinant GLl2 protein expression and purification For the
production of recombinant GLl2 protein. a fragment encoding
amino acids 1-386 of GLl2 was PCR amplified usmq the folio Ing
primers: forward: 5' gagggatccgccctcacctccatcaat 3' . re ers 5
gaggaattcctaggtcatcatgttcagg 3' . The amplicon as cloned In 0
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the EcoRl-Ba~HI sites of Escherichia coli expression vector pHIS-
Parall.el2 (Sh~ffleld et ai, 1999). To increase the solubility of GLl2
protein, the Inse~ w~s further truncated at the C-terminus with
Smal and .Xhol Yielding a protein corresponding to amino acids
1-332, which encompasses the N-terminus and the entire zinc-
finge~ DNA-bin~in~ domai.n (N.HIS-GLl2-(332)). NHIS-GLl2-(332)
protein ~~presslon In E. coli strain BL21 was induced for 60 min by
the addlt~~n of 1.mM ~PTG (Sigma). HIS-tagged GLl2-(332) protein
was p~nfled with NI-NTA Agarose (Qiagen, Hilden, Germany)
according to the manufacturer's instructions.
Electrophoretic mobility shift assay Binding reactions for band
shift assays were carried out in 1 x BS buffer (20 mM Tris, pH7.8,
25 m~. KCI, 5 mM MgCI2 , 0.5 mM DTT, and 10 11M ZnS04)
containing 0.77 Ilg poly-(d1-dC) (Sigma) and 10% glycerol. Five
mi~rogr~ms of purified NHIS-GU2-(332) protein and 8 ng of
radioactively labelled double-stranded oligonucleotide were added
to the reaction and incubated for 25 min at room temperature. In
competition experiments, 400 ng of specific or mutant unlabelled
oligonucleotide were used per reaction. For unspecific competi-
tion, 1.5 Ilg poly-dl-dC was added to the reaction. Samples were
separated on 6% acrylamide gels. Following electrophoresis, gels
were dried, exposed overnight, and scanned with a BAS-180011
phosphoimager (Fuji, Fuji, Japan).
Luciferase reporter assays and site-directed mutagenesis The
5' upstream regulatory region of the human GU1 gene from -1400
to +93 relative to the transcriptional start site (Liu et ai, 1998) was
amplified by PCR using the FailSafe PCR system for high-fidelity
PCR cloning (Epicentre, Madison, WI). To mutate the Gli-binding
site, the GU1 promoter was first subcloned into pBluescript II
SK+ (Stratagene, La Jolla, CAl and then subjected to site-directed
mutagenesis with the QuickChange Kit (Stratagene, la Jolla, CA)
according to the manufacturer's instructions. Followinq mutagen-
esis, the GLl1 promoter region was transferred back to pGl3
reporter vector. The sequence of the oligonucleotide used for
mutagenesis was 5' GCGCTTCTCGCGCCTGGTCCGGGCTTG 3'.
Successful mutagenesis was verified by DNA-sequencing on an
ASI 310 automated sequencer. For luciferase reporter assays, 293
cells were co-transfected in 12-well plates with GLl2 expression
plasmid (GLl2b in pcDNA4!TO, Invitrogen) or empty pcDNA4fTO,
and wild-type or mutated GLl1 reporter plasmid. p-galactosidase
expression vector (pcDNA4!TO-lacZ, Invitrogen) was co-trans-
fected for normalization of transfection efficiency. Cells were
harvested at 48 h post-transfection and luciferase assays were
carried out using luciferase Assay Substrate (Promega), according
to the manufacturer's instructions. luciferase activity was mea-
sured on a lucy II luminometer (Anthos, Wals, Austria). To
normalize results for lacZ activity, 10 III of cell lysate was mixed
with 240 III Z-buffer (100 mM NaP04 (pH 7), 10 mM KCI2 , 1 mM
MgS04 , 50 mM b-Mercaptoethanol), and 50 III Q-nitro-et-D-
phenyl-galactopyranoside (4 mg per ml) and incubated at 28°C
until yellow staining became visible. Reactions were stopped by
adding 250 III 1 M NaC03 . p-galactosidase activity was quantified
by measuring absorbance at 405 nm on an SlT-Spectra plate
reader (SlT, Austria).
In situ hybridization GLl2 and keratin 14 sense and anti-sense
probes were generated from GLl2 cDNA corresponding to 28,270-
28,566 nucleotides (GenBank GI No. 3061315) and keratin 14
cDNA corresponding to 298-1498 nucleotides (GenBank GI No.
15431309) cloned into pCRII-TOPO vector, using DIG-labelling kit
(Roche, Basal, Switzerland; lewes East Sussex, UK) as described
by the manufacturer's instructions. Keratin 14 probes were
fragmented and purified using sodium acetate ethanol precipita-
tion method (Wilkinson, 1998). Eight micrometer tissue sections
were pre-hybridized with (4 x SSC, 1 x Denhardt's, 50% forma-
mide (500 Ilg per ml tRNA and 500 Ilg per ml Salmon Testes DNA
denatured at 1OO'C for 10 min and placed on ice) before adding to
the mix) and incubated at 42°C for 3-4 h. Hybridization was carried
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out using fresh pre-hybridized solution containing (80-100 n
labelled probe denatured at 65 C for 5 min) at 42C overnight. Th~
~ext day, the sections were washed in 2 x SSC for 5 min ( x 2) and
In, (2 x SSC, 1 x SS~' 0.5 x SSC each containing 50% forma-
mlde).at 45-55-C and In ?1 x SSC 50% formamide at 5Q-60'C for
20 min, followed by a final wash in 2 x SSC and rinsed in DIG
buffer 1 (100 mM Tris-HCI 150 mM NaCI pH 7 5) Sect'blocked wl ' ,.. Ions were
. ocked With. 10% ~o~al sheep serum (NSS) in DIG buffer 1 and
Incubated. With antl-d,.goxigenin-alkaline phosphatase conjugated
(Roc~e) ~lluted 1:400 In 1% NSS DIG buffer 1 for 2 h, followeo by
washing In DIG buffer 1 ( x 2) and DIG buffer 2 (100 mM Tris-HCI,
p.H 9.~, 100 m.M NaCI.. 50 mM MgCIz) for 10 min. The Hybrids were
Visualized ?y Incubating the section with BCIP/NBT (Sigma) liquid
substrate In. the d~rk at 4JC overnight. The color reaction was
stopped by Immer:slng the sections in (10 mM Tris-HCI, pH 8, 1 mM
EDTA~ for 30 ~In. The developed slides were mounted and
examined by microscopy.
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FOXE1, A ~ew ~ranscriptional Target of GLl2, Is Expressed
Human Epidermis and Basal Cell Carcinoma
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Sonic hedgehog (Hh) signaling plays a key role in epidermal development a d ki '" .
n s In cancer. Mutational inactivation
of th~ tur:nor s.up~ressor gene patched (PTCH) leads to constitutive activation of the Hh signaling pathway
resulting In activation of target gene transcription by the zinc finger transcrl tl f t GLI1 '
. .. . Ip Ion ac ors and GLl2. Recent
experiments In mice POint to GLl2 as the key mediator of Hh signal'lng 'In skt W h
. ... . . In. e ave concentrated on the
Identification of candidate mediators of GLl2 function in the human epidermis. We show here that th f kh dl
. d h llx domai t . tl f e or ea~mge . - e IX ~~aln ranscnp Ion actor FOXE1 is likely to be a direct GLl2 target gene. The kinetics of FOXE1
I~ductlo~ are similar t~ t~e k~own direct target PTCH, and a 2.5 kb upstream fragment containing five GLI-binding
sites activates transcnptlo.n In ~ reporter assay. We show by in situ hybridization that FOXE1 is expressed in the
outer root sheath of the hair follicle, where murine Gli2 is also expressed. FOXE1 expression is also found in basal
keratinocytes of the human epidermis and basal cell carcinoma (BCC). These data point to a putative role of FOXE1
in mediating Hh signaling in the human epidermis downstream of GLl2.
Key words: forkhead transcription factor/GLI transcription factor/hair follicle/hedgehog signaling
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Hedgehog (Hh) signaling plays a key role in vertebrate
development, where it is involved in a multitude of biological
processes such as cell differentiation, proliferation, and
growth (reviewed in Ingham and McMahon, 2001; Nybak-
ken and Perrimon, 2002). Inappropriate activation of Hh
signaling has been implicated in developmental defects and
a predisposition to various malignancies such as basal cell
carcinoma (BCq, medulloblastoma, and rhabdomyosarco-
ma (reviewed in Toftgard, 2000; Bale, 2002; Mullor et ai,
2002). Analysis of hereditary and sporadic BCCs revealed
that ligand-independent activation of Hh signaling in
epidermal cells is the primary event in tumorigenesis.
Uncontrolled activation is caused by inactivating mutations
in the human tumor suppressor gene patched (PTCH) or, in
rare cases, by gain-of-function mutations in the Smooth-
ened gene (SMOH) (Gailani et ai, 1996; Hahn et ai, 1996;
Johnson et ai, 1996; Aszterbaum et ai, 1998; Xie et ai, 1998).
Normally, transduction of the HH signal is triggered by
binding of secreted HH protein to the 12 pass transmem-
brane receptor protein (PTCH). Binding of HH to PTCH is
thought to relieve the inhibitory effect of PTCH on the seven
pass transmembrane protein Smoothened (SMOH), leading
to transduction of the signal to the nucleus (reviewed in
(Ingham and McMahon, 2001; Nybakken and Perrimon,
2002). The zinc finger transcription factors (TF) GU1 and
Abbreviations: BCC, basal cell carcinoma; Hh, hedgehog; PTCH,
12 pass transmembrane receptor protein; PTCH, human tumor
Suppressor gene patched; Tet, tetracycline
GU2 have been identified as key mediators of HH signal
transduction and like PTCH are themselves HH target genes.
Consequently, BCCs express elevated levels of GU1, GU2,
and PTCH, and other HH target genes (Gailani et ai, 1996;
Dahmane et ai, 1997; Ghali et ai, 1999; Regl et ai, 2002).
Support for a critical role of GU1 and GU2 in BCC
development has come from transgenic mouse models
showing that overexpression of either protein in epidermal
cells can induce the formation of tumors, some of which
display BCC-like characteristics (Grachtchouk et ai, 2000;
Nilsson et ai, 2000; Sheng et ai, 2002). More recently,
studies of knockout mice have pointed to a role of Gli2
rather than Gli1 as the primary mediator in Hh signal
transduction. Firstly, mice deficient in Gli1 are viable and
have no obvious developmental defects (Park et ai, 2000). In
contrast, Gli2-1- mice are characterized by severe devel-
opmental malformations, including the lack of the floor plate
of the neural tube and of the anterior pituitary, and by
numerous lung, foregut, skeleton, and skin defects (Ding
et ai, 1998; Matise et ai, 1998; Mill et ai, 2003). This Gli2
phenotype broadly overlaps with that described for Shh- or
lhh- deficient mice (Chiang et ai, 1996, 1999; St-Jacques
et ai, 1999). Secondly, removal of Gli2 but not of Gli1 leads
to partial rescue of the me:': phenotype, where Hh sig-
naling is hyperactivated (Bai et ai, 2002). Thirdly, Gli2 but not
Gli1 is required for Hh signaling in hair follicle development
(Mill et ai, 2003). Together, these findings suggest that Gli2
rather than Gli1 is the primary transducer of the Hh signal.
To elucidate the mechanism by which GLl2 controls
HH-mediated epidermal development and skin cancer, we
Copyright { 2004 by The Society for Investigative Dermatology, Inc.
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Figure2
FOXE1 mRNA exp ress ion is an early response to GLl2 . Time-course
analysis of FOXE1 expression in HaCaT-GLl2His cells treated with
tetracycline for the times indicated is shown. (A) Western blot of
GLl2His transgene expression. (8) Real-time RT-PCR measurements of
FOXE1 mRNA levels. For comparison, patched (PTCH) is shown.
Expression levels are given as fold induction compared with uninduced
samples . Data represent the average of three independent PCR runs
carried out in duplicate. Error bars are given as standard deviation (SO).
All results were normalized for total RNA amount using large ribosomal
protein PO (RPLPO) as reference (Martin et aI, 2001).
Since cell lines derived from the spontaneously immor-
ta lized HaCat cell line may not always reflect the situation in
primary cells, the induction of FOXE1 in response to GL/2
was con firmed in primary human kerat inocytes infected
with either GLl2 expressing retrovirus (SIN-GLl2-EGFP) or
retrovirus expressing EGFP (SIN-EGFP) only as reference
(Regl et aI, 2004). Express ion of FOXE1 and the direct target
PTCH as contro l was measured by real-time RT-PCR in cells
72 h after infection. Similar to HaCaT-GLl2His cell lines, a
strong induction of FOXE1 transcription ((16.6 ± 0.3)-fold)
and PTCH ((19.78 ± 2.45)-fold) was detected in retrovirally
infected primary keratinocytes expressing GLl2 (data not
shown).
Real-t ime RT-PCR was also used to validate FOXE1
induction levels as measured by cDNA arrays in HaCaT cell
lines expressing GL/2. Additionally, the kinetics of the
transcript ional response of FOXE1 and the appea~ance o.t
the GL/2 protein were simultaneously analyzed In detail
(Fig 2A , B). RNA and protein samples were taken tr~m
HaCaT-GLl2His cells induc ed for 6 h, 12, 24, and 48 h With
tet and compared with untreated controls from the same
time po ints. GLl2 protein was c1earl~ i n~reased over
background expression level, also seen In ~nlnduced ce."s
6 h afte r tet addition, and levels furthe r Increased w~th
prolonged treatment (Fig 2A) . Similarly, FOXE1 transcript
levels were already elevated (3.42 ± 0.25)-told at 6 h o~ tet
treatment and further increased in a GLl2 concentration-
dependent manner ((7.17 ± 1.39)-fold at 12 h, (20.61 ~
0.57)-fold at 24 h up to (36.9 ± 1 .02~ -fold at 48 h). The
kinetics of FOXE1 mRNA accum ulation were com~a~ed
with those of the known GLI target PTCH and a Similar
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Results
focused on the identification of GLl2-regulated genes with a
putative role in mediat ing Hh signa ling do wnstream of GLl2
in epidermal cells. Here , we present data that the forkhead
transcription factor FOXE1 may be a direct GLl2 target
gene. Like GL/2, FOXE1 is expressed in normal epidermis
and BCC, suggesting an involvement of FOXE 1 in executing
the transcriptional program triggered by GL/2.
Overexpression of GLl2 in human keratinocytes in-
creases FOXE1 mRNA levels To identify GLl2-regulated
genes, we have expressed GLl2 in human keratinocytes
followed by cDNA array analysis of GLl2 expressing cells
and controls. We have genetically modified the human
keratinocyte cell line HaCaT (Boukamp et ai, 1988) to allow
tetracycline (tet)-inducible expression of human GL/2
(referred to as HaCaT-GLl2His) (Regl et ai, 2002). Tet-
inducible cell lines offer the advantage of precise temporal
control of GLl2 expression, which has proved invaluable for
the identification of early target genes. Expression profiling
of samples treated with tet for 24 and 72 h, respectively,
was carried out on filter arrays containing approximately
2200 human expressed sequence tag (EST) (unpublished
data). To eliminate differences between clonal HaCaT-
GLl2His lines, RNA from four independently isolated lines
was pooled and used for cDNA array analysis. As shown in
Fig 1, the forkhead transcription factor FOXE1 was highly
upregulated in a GLl2 concentration-dependent manner
compared with controls, with a (5.4 ± 0.94)-fold increase after
24 h and a (10 ± 1.15)-fold increase after 72 h of tet treatment.
Figure 1
FOXE1 is upregulated in response to GL/2 expression in HaCaTand
primary human keratinocytes. cDNA array screen ~or GLl2 target
genes in HaCaT-GLl2His cell lines. The uprequla tion of FOXE1
transcript is shown as fold induction co~pare.d ~ith uninduced
samples. Tetracyclin e was added at the times Indicated ". Average
induction and standard deviat ion (SO) were calculated from eight data
points. Spots representing FOXE1 are shown in the upper panel (black
arroWheads).
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c ble expression of human GL/2.
Table I FOXE1 transc . frip Ion IS preferentially activated by GLl2
FOXE1 mRNA ( ± SO) PTCH mRNA (
-r Tet (h)
SO)
12 24 72 12 24
HaCaT-GLl1
72
2.15 5.83 11.97
,
8.67 13.27
( ± 0.09) ( ± 0.19)
20.96
( ± 2.40) !
HaCaT-GLl2His 6.16
( ± 1.05) ( 0.28) ( - 1.12)
19.65 39.60 13.48 I 13.95
(± 0.52)
I 24.57
( ::!: 1.90) (± 5.19) I (±1.14) ( - 1.99)
Tet, tetracyline; HaCaT-GLl2His, tet-indu i
I
(= 5.81)
.-
A I Q.SItb I
with the activation of the FOXE1 promoter in a reporter
assay, indicate that FOXE1 is a likely direct target of the
GU2 transcription factor in epidermal cells.
1 Z ,.
FOXE1 is overexpressed in BCCs We have previously
shown that GU2 mRNA levels are highly elevated in BCC
samples compared with normal skin (Regl et aI, 2002). Thus,
if FOXE1 acts as a downstream target of GU2 in vivo and
has a relevant role in GU2 induced processes such as BCC
development, FOXE1 should also be present in these
tumors. We have, therefore, analyzed BCC samples with
known GU2 and GU1 levels (Regl et aI, 2002) for FOXE1
transcript levels (Table II). In all 15 BCC samples tested.
FOXE1 mRNA was detected at levels higher than in normal
skin. The normal skin sample, used as standard in all
experiments, consisted of a pool of four independently
isolated human skin biopsies to reduce site-specific and
Figure3T~e 5' upstream region of FOXE1 contains potential GLI binding
sites. (A) Location of five GLli-binding sites (1-5), which were identified
by ~MSA analyses. ~B). Sequence and position of the binding sites
relative to the transcriptional start site (+ 1) as determined by 5'RACE.
Bases that differ from the published GLI binding consensus sequence
(GA~CACCCA (Kinzler and Vogelstein, 1990)) are underlined. C)
tuctterase reporter assay showing activation of the putative FOXE1
promoter (-1934 to + 536) by GU2. HaCaT cells were transfected with
FOXE1 promoter reporter construct (FOXE1 prom), together with either
control vector or GLl2 expression vector. Data represent average value
of three independent experiments. RLU, relative luciferase units.
Hlndlll (.11341 ·1 t·~1
3.711_
'OXII!' ..._
B C ,..
,..
Sit. Po.i~i_ S."".DC. ,.
I lUI . l·UU) GATCTCCCA
,.
J -1111 ·1-11011 GATCTCCCA ! ...) -lOa) l-'Hl OO~C:"CCC"
• 9.9
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S .J •• I.H)1 GACCGCCCO ~ •
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response was observed ((7.82 ± 0.17)-fold at 6 h, (8.15 ±
0.24) at 12 h.' (~3.57 ± 1',1) at 24 hand (26.63 ± 2.3)) (Fig
28). The rapid Increase In FOXE1 mRNA transcription in
response to GLl2, which was also observed by northern blot
(data not shown), suggests that FOXE1 represents an early
GLl2 target gene, which like PTCH may be directly
regulated by GLl2.
Since GLl1 and GLl2 recognize the same consensus-
~inding s.equence and are known to have overlapping func-
nons (Bal and Joyner, 2001), we compared the induction of
FOXE1 by GLl1 and GLl2 in the respective HaCaTcelllines.
Expression levels for FOXE1 and PTCH, given as fold
induction compared with uninduced samples, are shown in
Table I.
In contrast to the strong induction of FOXE1 mRNA
levels in response to GLl2, a significantly reduced activation
of FOXE1 was detected in HaCaT cells expressing GLl1,
pointing to GU2 as the main activator. No such differences
were observed for PTCH, which was upregulated to com-
parable mRNA levels in HaCaT-GLl1 as well as in HaCaT-
GLl2His cell lines. Since, however, there exists a positive
feedback loop between GU1 and GU2 expression (Regl
et ai, 2002), it is difficult to say what part of FOXE1
activation by GLl1 may actually be due to GLl2.
The promoter region of FOXE1 contains GLI-binding
sites The early response of FOXE1 to GLl2 prompted us to
investigate whether FOXE1 might be directly regulated by
GL/2. We analyzed the putative FOXE1 promoter region
encompassing from -2000 to +688 (translational start site)
relative to the transcriptional start site (+ 1) for the presence
ofpotential GIi-binding sites. Since the transcription start for
FOXE1 was not exactly known, we mapped it by 5'-RACE
to a position 28 bp upstream of the known mRNA 5' end
(Ace. no.: NM_004473) (data not shown).
Five sites differing from the GLI-binding consensus motif
GACCACCCA (Kinzler and Vogelstein, 1990) by two
nucleotide substitutions were found (Fig 3A, B). All were
shown to interact specifically with recombinant purified
GLl2 Zn protein (amino acids 1-332, truncated after the Zn
finger DNA-binding domain) in electrophoretic mobility shift
assays (EMSA) (data not shown).
In a luciferase reporter gene assay, a 2470 bp fragment
(-1934 to +536) (Fig 3A) containing all five GLI-binding
sites was shown to activate transcription 3-fold in the
presence of GLl2 compared with control (Fig 3C). The early
response of FOXE1 transcription to GU2, and the presence
ofGLI-binding sites in the FOXE1 promoter region, together
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Table II Comparison of FOXE. 1, GLI2, and GU1 mRNA levels in ace-
-
BCCID FOXE1 ( ± SD)b GUZ; IGLl1e
25 59.21 (± 1.03) 67.28
Type Origin
-
1861.82
I
Nodular
37 32.41 (± 6.00)
Neck
16.14 , 53.02 I
6 25.66 ( ± 4.58)
Nodular Back
5.63 16.51
32 22.78 ( ± 2.28)
I Nodular Head
18.22 591.81
-
38 22.59 ( ± 0.55)
Nodular Pool of 3
18.61 128.80
27 15.54 ( ± 1.82)
, Nodular Upper ann
8.62 I 225.03 i Nodular
12 12.37 ( ± 1.49)
Head
8.02 267.43 :
23 10.72 ( ± 2.36)
Nodular Head
13.70 I 814.63 i
----
_.
.-
31 10.11 (±2.12)
Nodular Head
5.65 135.96 Nodular Back
30 8.73 ( ± 0.66) 12.32
-
206.64 Nodular Thorax
18 7.32 ( ± 0.42) 7.89 3024.54 Nodular Head
2 7.29 ( ± 0.27) 9.74 116.48 Nodular Head
35 5.58 (± 0.19) 2.81 I 17.82 Nodular Thorax
8 4.84 ( ± 0.72) 6.69 95.50 Nodular Thorax
9 4.02 ( ± 0.28) 3.35 157.53 INodular Head
arhe Pearson correlation (two-tailed) was calculated pairwise u In SPSS f II ..with a Pearson coefficient of 0.883. s g or a combinations. Only FOXE1 versus GL/2 was significant at 0.01 level
byalues forFOXE1 expression represent theratio of FOXE1 mRNA int t h . ..four real-time RT-PCR measurements. umor 0 t at In normal skin. Ratios and SO were calculated from the average of
F~~~~a~~N~~t2 and GU1 expression are taken from Regl et at (2002) and are shown here for comparison. The same tumor samples were used for
Bee, basal cell carcinoma.
individual variations. It should be noted that GLl2 and
FOXE1 are expressed at a much higher level in normal skin
than GLl1. These ratios shown do not reflect absolute
concentration. Upregulation of FOXE1 mRNA levels ranged
from 4-fold (BCC9) to 59.2-fold (BCC25) with an average
fold increase of 15.8-fold. Pearson's correlation was
calculated pairwise for GLl1 versus FOXE1, GLl2 versus
FOXE1 and GLl1 versus GLl2 using SPSS (SPSS, Chicago,
IL). Only FOXE1 versus GLl2 showed significant correlation
(p<0.01) (Table II). Since upregulation of FOXE1 expression is
GLl2 dependent in a cultured human keratinocyte line as well
asin primary human keratinocytes, it is likely that the elevated
levels of FOXE1 reflect increased GLl2 activity in BCC.
In situ localization of FOXE1 in Bee and normal
skin We next investigated FOXE1 expression in BCC by
in situ hybridization. In agreement with the results of real-
time RT-PCR, all tested BCC (n = 6) showed intense staining
throughout the tumor islands (Fig 4A, C). No specific signal
was detected in the surrounding stroma cells. The speci-
ficity of tumor staining was demonstrated by hybridizing
adjacent sections with FOXE1 sense RNA probes (Fig 48,
D). Thus, the results show that the elevated FOXE1
transcript level detected with real-time RT-PCR in BCC is
specific for the epithelial component of the BCC samples
and does not result from expression in surrounding
mesenchymal tissues.
Next, we analyzed follicular and interfollicular human
epidermis for FOXE1 mRNA expression. In interfollicular
epidermis, specific staining was detected in the basal
and suprabasal layers but not in the underlying mesoderm
(Fig 5A, C). It should be pointed out that the quantitative RT-
PCR data in Table II indicate that expression must be much
lower than in BCC. In hair follicles, the highest level of
FOXE1 mRNA was present in the outer root sheath (Fig 5C,
E). Occasionally, staining of mesenchymal cells of the
perifollicular connective tissue sheath was observed.
Discussion
HH/GLI signaling has been implicated in the regulation of
hair follicle development and skin tumorigenesis (lseki et ai,
1996; Oro et ai, 1997; St-Jacques et ai, 1998; Chiang et ai,
1999; Oro and Higgins, 2003). A growing body of data
points to a decisive role of the zinc finger transcription
factor GLl2 in mediating these processes in response to HH
signaling (Bai et ai, 2002; Sheng et ai, 2002; Mill et ai, 2003).
In a search for potential downstream mediators of GLl2
function in epidermal cells, we have identified a new GLl2
target gene, FOXE1, whose expression is strongly en-
hanced in response to GLl2. The presence of five GLI-
binding sites in the putative promoter region of FOXE1.
together with the activation of reporter gene expression by
this region in the presence of GLl2, points to direct
regulation of FOXE1 by GLl2. The largely overlapping
expression domains of FOXE1 and GL/2 in human hair
follicles, epidermis, and BCC Ikram et al,1 suggest a role of
---------------------
'Ikrarn 51, Neill GW, Regl G, at a/: GU2 is expressed In normal
human epidermis and BCC and induces Gut expression by
binding to its promoter. Accepted for publication, J Invest Dermatol
(M5 JID-2003-0435)
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downstream of HH/GLI signaling. Whether expression of
FOXE1 in interfollicular epidermis is dependent on HH
signaling is unclear since expression of well-characterized
Hh targets such as GLl1 and PTCH is mainly restricted to
follicular regions of the skin. Co-expression of FOXE1 and
GLl2 in interfollicular epidermis may therefore be controlled
by signals other than Hh, a situation that has been
described for Gli2 in ventroposterior mesoderm formation
ofXenopus, where Gli2 expression is induced by FGF rather
than Hh signaling (Brewster et aI, 2000).
FOXE1 (also named FKHL 15jTTF2) belongs to a large
family of transcription factors characterized by their DNA-
binding domain-the forkhead/winged-helix motif. In vitro
analysis of the mechanism of foxe 1 action suggested a role
forFoxe1 as a transcriptional repressor (Zannini et aI, 1997;
Perrone et aI, 2000). Forkhead proteins display a remark-
able functional diversity and are implicated in a variety of
biological processes ranging from embryonic development
to regulation of cell growth and proliferation in adult tissues
(Kaufmann and Knochel , 1996; Carlsson and Mahlapuu,
2002). Notably, expression of several mammalian forkhead
genes has been shown to be controlled by the Hh/Gli
signaling pathway: foxa2 (HNF-3~), expressed in the floor
plate of the notochord via direct transcriptional regulation
by GLl1 (Sasaki et aI, 1997), foxc2 (Mfh1) and foxd2
(FREAC-9jMf2) ryvu et aI, 1998 ; Furumoto et aI, 1999), both
involved in sclerotome cell proliferation, foxf1 (FREAC-1j
HFH-B) in lung and foregut mesenchyme (Mahlapuu et aI,
2001), and FOXM1 (TridentjHFH-11jINS1) in human BCC
(Teh et aI, 2002) .
Although FOXE1 was originally isolated from keratino-
cytes (Chadwick et aI, 1997), its role in epidermal develop-
ment and homeostasis is not understood. FOXE1mF2
function has primarily been investigated in the context of
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Figure4
FOXE 1 mRNA loc alizes to Beetumor islands.
~OXE1 expression is shown in two representa-
tive tumors by in situ hybridization. (A and C)
Only BCC tumor islands but not surrounding
stror:na cells are stained. (B and OJ Adjacent
sections were hybridized with sense RNA as
negative controls to show the specificity of
hybridization.
thyroid development (Zannini et aI, 1997; Clifton-Bligh et aI,
1998; De Felice et aI, 1998; Damante et aI, 2001 ; Castanet
et aI, 2002). Mice lacking both cop ies of foxe 1 suffer from
neonatal hypothyroidism characterized by a sublingual
small ectopic or completely missing thyroid gland and
cleft palate (De Felice et aI, 1998). Patients with Bamforth
syndrome, who are heterozygous for FOXE1, display in
addition to thyroid agenesis a spiky hair phenotype (Clifton-
Bligh et aI, 1998; Castanet et aI, 2002). A corresponding hair
phenotype was not observed in foxe t :' : mice since they
die before hair format ion (De Felice et aI, 1998). Expression
of foxe 1 was, however, observed in embryonic whiskers of
wild-type mice (Dathan et aI, 2002). Together with the spiky
hair phenotype of Bamforth patients, this points to a role of
Foxe1 in hair follicle development where Gli2 is essential
(Mill et aI, 2003) .
In summary, we have characterized FOXE1 as a novel
GLl2 target gene in human keratinocytes. Given the crit ical
role of GLl2 in the proliferation of hair follicle cells and
tumorigenesis, co-expression of FOXE 1 and GLl2 in normal
skin and BCC suggests that FOXE1 may be involved in
mediating the proliferative effect of GLl2 in vivo . Functional
analysis of FOXE1 in epidermal development and disease
will thus be a major aim of future studies to shed new light
on the molecu lar mechanisms downstream of the Hh/GLI
signaling pathway.
Materia ls and Methods
RNA iso lat ion and real-time RT-PCR analyses BCC and normal
skin were snap-frozen after surg ical removal and stored at - 70 C
until use. Ethical committee perm ission was obtained from the Eas
Lond on and City Area Health Authority and all biopsies and s In
samples were taken with full patient consent. Total R A as
isolated after homogenization with a high-speed dispersinq too l
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re~re~ents the difference between the C values of the gene I
q eS~lon (target) and the Ct value of the reference gene (RPLPO)
(Martin et aI, 2001). ~~Ct is the diffe rence between ~C values 0
the samples for each target (e.g. ~Ct for FOXE1 in tumor) and he
mean.zc, of the calibrator (e. ~. zc, for FOXE1 in normal s in).
Pnmer sequences for real-t ime RT-PCR studies were as folio S '
RPLPO forward primer (5'- 3') GGCACCATIGAAATCCTGAGT~
GATGTG, reverse primer (5'- 3') TIGCGGACACCCTCCAGGAAGC'
GLl2 forward prim er (5'- 3') TGGCCGCTICAGATGACAGATGTIG'
reverse primer (5'- 3') CGTIAGCCGAATGTCAGCCGTGAAG; PTc H
fo~ard p,n~er (5'- 3') TCCTCGTGTGCGCTGTCTICCTIC, reverse
pnmer (~ -3) CGTCAGAAAGGCCAAAGCAACGTGA; FOXE1 for-
w~rd pnmer (5'- 3') CATCTIGGATGCTGCCCTGCGTATI, reverse
pnmer (5'- 3') CCAGCACGTCCTGCTCAAAAGTICA.
Screening of cDNA arrays A non-redundant set of 2200
sequence verified EST-clones obtained from the human-UniGem
V2.0 clone set (lncyte Genom ics , Cambridge, UK) was ampl ified by
PCR and products were spotted in quadruplicate on a 22 11cm
nylon membrane (Hybond N + , Amersham Bioscience, Uppsala,
Sweden) using the MicroGridll arrayer (BioROBOTICS, Huntingdon,
UK). The membranes were hybridized with pro bes obtained from
total RNA prepared from GL/2 expressing HaCaT cells and controls
using TRI-reagent (Molecular Researc h Center, Cincinnat i, Ohio)
followed by a LiCI prec ipitat ion step . Fifteen micro grams tota l RNA
from each sample were reverse transcribed with Superscript II
(Rnase H-) reverse transcriptase (Invitrogen) in the presence of 70
llCi [33PjdCTP (spec ific act ivity 3000 Ci per mmol) (Amersham
Bioscience). labeled cDNA was pur ified with GFX DNA Purification
Kit (Amersham Bioscience). Hybridization was carried out for 36 h
in 5 x SSC, 5 x Denhard 's, 1% SDS followed by extens ive
washing with 2 x SSC, 0.1% SDS; 0.2 x SSC, 0.1 % SDS and
0.1% SSC, 0.1% SDS. Filters were expo sed for 4 d onto a
phosphoimager screen (Fuji, Japan) and scanned with BAS-180011
(Fuji, Tokyo , Japan) . The images were analyzed using the AIDA
Metrix suite (RAYTEST, Straubenhardt, Germany).
Western blot analysis Western blot analysis of GL/2 prote in
expression in HaCaT-GL/2H is cells was performed according to
standard procedures using a monoclon al mouse anti- HIS perox-
idase-conjugated ant ibody (A7058, SIGMA-Aldrich, Vienna, Aus-
tria) followed by ECl detection (Amersham Bioscience). Proteins
were blotted on Hybond-ECl (Amersham Bioscience) and ex-
posed to Hyperfilm ECl (Amersham Biosc ience).
Cell culture and generation of tet-inducible HaCaT li nes HaCaT
cells were cultured in Dulbecco's modified Eagle med ium (DMEM
pH 7.2, high glucose, Invitrogen Life Technologies, Carlsbad ,
California) supplemented with 10% fetal calf serum (FCS) (Invitro-
gen), 100 mg per liter streptomyc in and 62.5 mg per liter pen icillin
at 3rC, 5% CO2 atmosphere. The T-Rex system (Invitrogen) was
used to generate double stab le inducible HaCaT lines expre ssing
human GU1 and GU2 tagged with a 6 x HIS epitope under the
control of the bacterial tet repressor (HaCaT-GL/2His). Double
stable lines were establ ished and grown in the presence of Zeocm
(Invitrogen) and Blast icidin-S (ICN-Biomedica , Costa Mesa, Cali-
fornia) . Transgene expression was induced by add ing 1mg per liter
tet to the cell culture med ium.
To generate the retroviral bic istron ic GL/2-EGFP expression
construct, N-terminally His-tagged GU2 was clon ed into pI2E-A, a
modified vers ion of pIRES2-EGFP plasm id (Clontech , Hampshire,
UK) (RegI et aI, 2002). PI2E-A-GL/2 was digested with Sanand Not1
to exc ise CMV-GL/2- IRES-EGFP. The resulting fragment was
cloned into Xhol- and NoN-digested retrov iral SIN-IP plasmid (a
gift from Prof . P. Khavar i) to create SIN-GL/2-EGFP. Retrovirus
production and transduction of primary kerat inocytes were earned
out as previously described (Regl et ai, 2002).
Luciferase reporter assay The 5' upstream regulatory region 0
the human FOXE1 gene from - 1934 to 539 relative to he
transcript ional start site was amplified by PCR from genomic D A
D
. F. .... -
Figure 5
FOXE1 is expressed in the human epidermis and the outer root
sheath of the hair. FOXE1 mRNA expression was visualized by in situ
hybridization (A and C) Specific staining for FOXE1 was observed in
basal keratinocytes of a normal human epidermis (red arrows). E)
Sections of a hair follicle show that FOXE1 transcript is strongly
expressed in cells of the outer root sheaths of the hair. (8, D, and F)
Adjacent sections were hybridized with a sense RNA probe (control) to
demonstrate the specificity of the hybridization.
:"
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(ULTRA TURRAX T18 basic, IKA Labortechnik, Staufen, Germany)
using TRI-reagent (Molecular Research Center, Cincinnati, Ohio)
followed by further purification using the High Pure RNA Isolation
Kit (Roche, Basel, Switzerland), which includes a DNAase treat-
ment to remove genomic DNA. RNA quality and quantity were
assayed on a Bioanalyzer 2100 (Agilent Technologies, Palo Alto,
California). cDNA was synthesized with Superscript II (Rnase H-)
reverse transcriptase (Invitrogen, Carlsbad, California) accord ing to
the manufacturer's instructions. Real-time RT-PCR analysis was
carried out on a Rotorgene 2000 (Corbett Research, Sydney,
Australia) using iQ SYBR Green Supermix (BIORAD, Hercules,
California). Fold -induction values (x) were ca lculated using the
fOllOWing formula: x = 2- L\C" where Ct represents the mean
threshold cycle of all replicate analyses of a given gene and ~Ct
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using FailSafe PCR system (Epicentre, Madison, WI). The following
primers were used: Forward primer: 5'-GAATIAAGGAAGGAGA-
GAACTGCGG-3', reversed primer 5'-GAGAAGCTTCCGCGTGG-
TGCnCTCGAGGCGGGC-3'. PCR fragment was digested with
Hina111 and cloned into the Hindlll site of pGL3basic reporter vector
(Promega, Madison, Wisconsin) yielding the construct FOXE1-
prom. For luciferase reporter assays, HaCaT cells were co-
transfected in 12-well plates with FOXE1 (FOXE1 prom) reporter
plasmid and GLl2 expression plasmid (human full-lenqth GLl2b
(Acc. no. AB007296.1) (a gift from Dr David Markovitz) in pcDNA4/
TO (Invitrogen)) or empty pcDNA4/TO. ~-Galactosidase expression
vector (pcDNA4/TO-LacZ; Invitrogen) was also co-transfected for
normalization of transfection efficiency. Cells were harvested 48 h
post-transfection and luciferase assays were carried out using
Luciferase Substrate (Promega), according to the manufacturer's
instructions. luciferase activity was measured on a lucy II
luminometer (Anthos, Wals, Austria). To normalize results for lacZ
activity, 20 III of cell lysate was mixed with 240 III Z-buffer (100
mM NaP04 (pH 7), 10 mM KGI2, 1 mM MgS04 , 50 mM ~_
mercaptoethanol) and 50 III o-nitro-a.-o-phenyl-galactopyranoside
(ONPG, SIGMA-Aldrich)(4 mg per ml in 100 mM NaP04) and
incubated at 28°C until yellow color became visible. Reactions
were stopped by adding 250 III 1 M Na2C03. ~-Galactosidase
activity was quantified by measuring absorbance at 405 nm on an
SLT-Spectra plate reader (SlT (Tecan), Groedig, Austria).
In situ hybridization DIG-labeled FOXE1 sense and antisense
probes were generated from a 332 bp BamHI/Pstl fragment of the
3' UTR of FOXE1 (corresponding to nucleotides 2148-2480,
GenBank GI No. 2078532) subcloned into pBluescript II KS, using
a DIG labeling kit (Roche) as described by the manufacturer's
instructions. 811m tissue sections were pre-hybridized in pre-hyb-
solution (4 x SSC, 1 x Denhardt's, 50% formamide, 500 Ilg per
mL tRNA and 500 Ilg per ml salmon testes DNA (denatured at
100°C for 10 min and placed on ice before adding to the mix) and
incubated at 42°C for 3-4 h. Hybridization was carried out using
fresh pre-hyb-solution containing 80-100 ng labeled probe
(denatured at 65°C for 5 min) at 42°C overnight. Next day, the
sections were washed in 2 x SSC for 5 min (two times) and in 2 x
SSC, 1 x SSC, 0.5 x SSG, each containing 50% formamide, at
45°G-55°C and in 0.1 x SSC 50% formam ide at 50°C -60°C for
20 min. A final wash in 2 x SSC and rinsed in DIG buffer 1 (100
mM Tris-HCI, 150 mM NaGI pH 7.5). Sections were blocked with
10% normal sheep serum (NSS) in DIG buffer 1 and incubated with
anti-digoxigenin-alkaline phosphatase-conjugated (Roche) diluted
1:400 in 1% NSS DIG buffer 1 for 2 h, followed by washing in DIG
buffer 1 ( x 2) and DIG buffer 2 (100 mM Tris-HCI pH 9.5, 100 mM
NaCI, 50 mM MgCI2) for 10 min. The hybrids were visualized
by incubating the section with BCIP/NBT (SIGMA-Aldrich) liquid
substrate in dark at 4°C overnight. The color reaction was stopped
by immersing the sections in (10 mM Tris-HCI pH 8, 1 mM EDTA)
for 30 min. The developed slides were mounted and examined
under a light microscope.
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